ISRAEL STATE RECORDS - Nevo.co.il · israel aerospace industries ltd. 22/10/2009 201681 b64d ( 010.012 ) uav system and method " ˘ ˘ " ˘ ˘ israel aerospace industries ltd. 15/11/2009

December-א"בטבת התשע' כג 30, 20101

9/2010א"תשע/'

רשומותISRAEL STATE RECORDS

December, 2010א"בטבת התשע' כג 30

יומ� הפטנטי� והמדגמי�PATENTS AND DESIGNS JOURNAL


Page/עמודPatentsפטנטי�

4Applicationsבקשות שהוגשו filedApplications 231בקשות שקובלו acceptedPatents 464פטנטי� שניתנו grantedPatents 465פטנטי� שחודשו renewed

not 465פטנטי� שתוקפ� פקע in forcePatentsChanges 475שינויי� בפרטי� רשומי� בפנקס in particulars entered in

registerCountry 502קודי� למדינות codes

מפתחות לבקשות שהתקבלו מדגמים

493 Indices of applications acceptedDesigns

476Designsמדגמי� שנרשמו registered487Desginsמדגמי� שחודשו renewed488Designsמדגמי� שבוטלו void


ידיעות כלליות

אל' וכו, מסמכים, מכתבים :בענייני פטנטים ומדגמים יש לשלוח.ירושלים, מלחה5בנין, גנים טכנולוגיים ירושלים, רשם הפטנטים והמדגמים

'אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מסיש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה. 0-24145-2

.שולמה

GENERAL INFORMATION

Letters, documents, etc. concerning Patents and Designs should be addressed to:The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of theAuthority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the officetogether with the application for the action for which the fee has been paid.

זכות היוצרים בתקצירים אלה שמורה למדינתאין להעתיק מתקצירים אלה אלא, ישראל

.ברשות לשכת הפטנטים

Copyright by the State of Israel. NoExtracts may be published except with thepermission of the Patent Office.


PATENTS פטנטי�-ז"תשכ, לחוק הפטנטים16הודעה לפי סעיף

1967 NOTICE UNDER SECTION 16 OF THEPATENTS LAW, 5727-1967

להלן רשימת בקשות חדשות הממלאות אחרלתקנות)א(32הדרישות שנקבעו בתקנה

:1968-ח"תשכ, הפטנטים

In the following there are listed newapplications complying with the provisionsof rule 32(a) of the Patent Regulations, 5728-1968:

Particulars: פרטי הבקשות מובאים לפי סדר זה of the applications are given inthe following order:

ותאריך הגשתה וארבעה–מספר הבקשה הסמנים הראשונים של הסיווג הבינלאומי

Number and date of application and the firstfour symbols of the InternationalClassification.

ע(שם האמצאה Title)י המבקש"כפי שהוצע of invention (as proposed by applicant)Applicant המבקש

Convention–מדינת האיגוד: דין קדימה country-Priority right:Number תאריך ומספר and date ofForeign בקשת החוץ application

International מספר בקשה בינלאומית Application NumberInternational מספר פרסום בינלאומי Publication Number


)2010.01 (F04B20102917/09/2009

FLUID מכשיר המופעל על ידי נוזלים DRIVEN APPARTUS

ISRAELמ"התעשייה האוירית לישראל בע AEROSPACE INDUSTRIESLTD.

)2010.01 (B64D20168122/10/2009

UAVט"מערכת ושיטה עבור מל SYSTEM AND METHOD

ISRAELמ"התעשייה האוירית לישראל בע AEROSPACE INDUSTRIESLTD.

)2010.01 (F41A20214715/11/2009

י GUNריחרך PORTGLOBALמ"גלובל שילד בע SHIELD LTD

)2010.01 (F41A20258007/12/2009

FLOATING מתקן הדק צף לכלי ירי TRIGGER APPARATUSFOR FIREARMS

URI ענבל-א זלינגרגי COHEN


)2010.01 (C06B20377708/02/2010

INCENDIARY חומר תבערה ושיטה לייצורו AGENT AND AMETHOD FOR ITS MANUFACTURE

ל"רפא פיתוח אמצעי לחימהל רשותמ"בע

RAFAEL ADVANCED DEFENSESYSTEMS LTD.

)2010.01 (F41A20392914/02/2010

BLAST מחסום המעטת הדף ATTENUATION BARRIERבעאורטק מע ORTECHמ"רכות מיגון DEFENCE SYSTEMS LTD.

)2010.01 (F41A20393014/02/2010

פלטות מיגון ושיטה לשימוש בפלטות ליצירת חומת מגן

ARMOR TILES AND A METHOD OFUSING SUCH TILES TO FORM APROTECTIVE SHIELD

ORTECHמ"אורטק מערכות מיגון בע DEFENCE SYSTEMS LTD.

)2010.01 (F41A20398316/02/2010

LAUNCHING קליע מפלטפורמהשיגור A PROJECTILE FROM APLATFORM

RAFAELמ"רפאל מערכות לחימה מתקדמות בע ADVANCED DEFENSESYSTEMS LTD.


)2010.01 (G08B20408321/02/2010

TUNABLE חישן אינפרא אדום בר כוונון IR DETECTOR

TECHNIONמ"מוסד הטכניון למחקר ופתוח בע RESEARCH ANDDEVELOPMENT FOUNDATION LTD.

)2010.01 (G06T20408721/02/2010

שיטה ומערכת להצגה עוקבת של שני שטפי וידאו

METHOD AND SYSTEM FORSEQUENTIAL VIEWING OF TWOVIDEO STREAMS


)2010.01 (F41A20408821/02/2010

AMMUNITION מחסנית תחמושת והתקן טעינה לכך MAGAZINE ANDLOADING DEVICE THEREOF

ELBITמ"אלביט מערכות בע SYSTEMS LTD.

)2010.01 (G08B20408921/02/2010

שיטה ומערכת לגילוי ועקיבה מבוססות הדמאה בריבוי תדרים ובריבוי מבטים

METHOD AND SYSTEM FORDETECTION AND TRACKINGEMPLOYING MULTI - VIEW MULTI -SPECTRAL IMAGING

בעאלבי ELBITמ"ט מערכות SYSTEMS LTD.


)2010.01 (G06F20613902/06/2010

EFFICIENT משתנים–ייצור יעיל של חתימות מרובות MULTIVARIATESIGNATURE GENERATIONNDS LIMITED

)2010.01 (C07K20614403/12/2008

IIפפטיד המסוגל לקשור למולקולותCLSS MHCותכשירי רוקחות המכילים

אותו

PEPTIDE CAPABLE OF BINDING TOMHC CLASS II MOLECULES ANDPHARMACEUTICAL COMPOSITIONSCONTAINING ITMERCK SERONO S.A.

03/12/2007102007059924.4DEPCT/EP/2008/010230WO/2009/071276

)2010.01 (A47K20614501/12/2008

WEARABLE מגבת שניתן ללבוש TOWELCHAZON STEIN

05/12/200760/992406US27/03/200812/056467US28/08/200812/200155US

PCT/US/2008/085102WO/2009/076078

)2010.01 (C07D20614604/12/2008


דיבנזואזפין ודיבנזואוקסאזפין אגוניסטים1TRPAשל

DIBENZOAZEPINE ANDDIBENZOOXAZEPINE TRPA1AGONISTSJANSSEN PHARMACEUTICA, N.V.

05/12/200707122339.0EP29/05/200808157200.0EP

PCT/EP/2008/066813WO/2009/071631

)2010.01 (C07K20614708/12/2008

ל –מולקולות נוגדן ממקור אנושי בררניות31–IL

HUMANIZED ANTIBODYMOLECULES SPECIFIC FOR IL-31

ZYMOGENETICS INC.07/12/200761/012362US

PCT/EP/2008/067024WO/2009/071696

)2010.01 (C08J20614811/12/2008

פריטים, שיטה להכנתו, הרכב פולימריהמבוססים על ההרכב הפולימרי ושימוש

בהם

POLYMERIC COMPOSITION,METHOD FOR THE MANUFACTUREOF THE POLYMERIC COMPOSITION,ARTICLES BASED ON THISPOLYMERIC COMPOSITION ANDUSE OF THESE ARTICLESRHODIA POLIAMIDA EESPECIALIDADES LTDA

14/12/200707/08724FR30/07/200808/04334FR

PCT/IB/2008/003429WO/2009/077834

)2010.01 (C12Q20615105/12/2008

תרמיל רב תאי לאחסון קרישה ושיטה לשימוש בו

MULTIPLE COAGULATION TESTCARTRIDGE AND METHOD OFUSING SAMESHELDON GOLDSTEIN


07/12/200711/952914USPCT/US/2008/085699WO/2009/073851

)2010.01 (C12N20615326/11/2008

לווסת, אנטאגוניסטיותRNAתרכובותCA3PIKתכשירים המכילים אותן

ושימושים בהן

RNA ANTAGONIST COMPOUNDSFOR THE MODULATION OF PIK3CACOMPOSITIONS COMPRISING THESAME AND USES THEREOFSANTARIS PHARMA A/S

03/12/200760/992050USPCT/DK/2008/000418WO/2009/071082

)2010.01 (A61K20615608/12/2008

נוגדנים נגד וירוס השפעת ושיטות לשימוש בהם

ANTIBODIES AGAINST INFLUENZAVIRUS AND METHODS OF USETHEREOFDANA-FARBER CANCER INSTITUTEINC.

06/12/200761/005725US25/08/200861/091599US

PCT/US/2008/085876WO/2009/079259

)2010.01 (C12N20615704/12/2008

חלבוני אלסטאז רקומביננטים ושיטות לייצורם ושימוש בהם

RECOMBINANT ELASTASEPROTEINS AND METHODS OFMANUFACTURING AND USETHEREOFPROTEON THERAPEUTICS, INC.

04/12/200760/992319US03/12/200812/327809US

PCT/US/2008/085559WO/2009/079220


)2010.01 (C07K20615815/01/2009

טיהור של פולי פפטידים מחוסרי גליקוזילציה

PURIFICATION OF NOT-GLYCOSYLATED POLYPEPTIDES

F. HOFFMANN-LA ROCHE AG18/01/200808000884.0EP

PCT/EP/2009/000192WO/2009/090056

)2010.01 (A01N20615905/12/2008

ORAL צורות מינון רוקחיות למתן פומי PHARMACEUTICAL DOSAGEFORMSDURECT CORPORATION

06/12/200761/005681US06/12/200761/005685US03/11/200861/198201US

PCT/US/2008/013381WO/2009/088414

)2010.01 (A61K20616005/12/2008

תנאים, שיטות שימושיות לטיפול בכאבאו דלקת,ת פרקיםהקשורים לדלק

הקשורה למצב כרוני

METHODS USEFUL FOR THETREATMENT OF PAIN, ARTHRITICCONDITIONS, OR INFLAMMATIONASSOCIATED WITH A CHRONICCONDITIONDURECT CORPORATION

06/12/200761/005681US06/12/200761/005685US03/11/200861/198201US

PCT/US/2008/013404WO/2009/075782

)2010.01 (C07K20616116/12/2008

,BIVALENT סגוליים–דו,ערכיים–נוגדנים דו BISPECIFIC ANTIBODIES



PCT/EP/2008/010703WO/2009/080252

)2010.01 (C07D20616211/12/2008

–4, דיאונים–5,3–פנילפיראן–4ו–5,3–פנילתיאופיראן –2–דיאונים

תריאונים–5,3,1–פנילציקלוהקסאןי עשביםכקוטל

4-PHENYLPYRANE-3,5-DIONES, 4-PHENYLTHIOPYRANE-3,5-DIONES AND2-PHENYLCYCLOHEXANE-1,3,5-TRIONES AS HERBICIDES

SYNGENTA PARTICIPATIONS AG13/12/20072616/DEL/2007IN

PCT/EP/2008/010513WO/2009/074314

)2010.01 (D03D20616303/06/2010

שיטה והתקן לייצור רציף של מבנהאריג העמיד לניקוב ולחדירה ומבנה

אריג המתקבל כך

METHOD AND APPARATUS FORCONTINUOUS PRODUCTION OF ATEXTILE STRUCTURE RESISTANT TOPERFORATION AND PENETRATIONAND TEXTILE STRUCTURE THUSOBTAINEDF. LLI CITTERIO S.P.A.

08/06/2009MI2009A000991IT

)2010.01 (A47G20616403/06/2010

ת שולחן ממנה ניתן ליצור חללים מפA סגורים CAVITY FORMING TABLECLOTH

YAIR יאיר שושן SHUSHAN


)2010.01 (A61P20616509/12/2008

ORGANIC תרכובות אורגניות COMPOUNDSNOVARTIS AG

10/12/200707122739.1EPPCT/EP/2008/067110WO/2009/074575

)2010.01 (A61K20616608/12/2008

חד'הידרוג BIODEGRADABLE שלבי מתכלה–ל מלוכד SINGLE-PHASECOHESIVE HYDROGELLABORATOIRES VIVACY

07/12/20070759641FRPCT/EP/2008/067029WO/2009/071697

)2010.01 (A61K20616707/12/2008

בטא גליקוליפידים לטיפול בהסתיידות ניווניות הקשורה להפרעות

BETA GLYCOLIPIDS FOR THETREATMENT OF CALCIFICATIONRELATED DEGENERATIVEDISORDERS

HADASITמ"הדסית שירותי מחקר רפואי ופיתוח בע MEDICAL RESEARCHSERVICES AND DEVELOPMENT LTD

06/12/2007187959ILPCT/IL/2008/001587WO/2009/072132

)2010.01 (A44C20616809/01/2008

ORNAMENTAL שלבי–יהלום קישוט בעל פביליון דו DIAMOND HAVINGTWO-STAGE PAVILIONHOHOEMI BRAINS, INC.

PCT/JP/2008/050144WO/2009/087763


)2010.01 (G02B20616921/11/2008

מכשיר הדפסת אבן ושיטה, מכשיר פיקוח למדידת תכונות הסובסטרט

INSPECTION APPARATUS,LITHOGRAPHIC APPARATUS ANDMETHOD OF MEASURING APROPERTY OF A SUBSTRATEASML NETHERLANDS B.V.

05/12/200760/992585USPCT/EP/2008/009887WO/2009/071207

)2010.01 (C12N20617018/12/2008

MAMMALIAN וקטור ביטוי של יונקים EXPRESSION VECTORNOVARTIS AG

21/12/200707150339.5EPPCT/EP/2008/067947WO/2009/080720

)2010.01 (B65D20617107/11/2008

TABLET מתקן עזר לטבליות DISPENSERVIFOR (INTERNATIONAL) AG.

07/12/200707122586.6EPPCT/EP/2008/065097WO/2009/071415

)2010.01 (C07D20617204/12/2008

GAMMA מודולטורים לגמא סקרטאז SECRETASE MODULATORSSCHERING CORPORATION

06/12/200760/992839USPCT/US/2008/085515WO/2009/073777


)2010.01 (C07D20617305/12/2008

נגזרות אוקסיאינדול המותמרות בהלוגןושימושיהן לטיפול במחלת5בעמדה

בווסופרסיןהתלויות

5-HALOGEN-SUBSTITUTEDOXINDOLE DERIVATIVES AND USETHEREOF FOR TREATINGVASOPRESSINE-DEPENDENTDISEASESABBOTT GMBH & CO. KG

07/12/200761/012234USPCT/EP/2008/066934WO/2009/071689

)2010.01 (G02C20617417/12/2008

HYPER-OSMOTIC אוסמוטית–עדשת מגע לעין היפר EYE CONTACTLENS

MORמ"מור יישום מחקרים בע RESEARCH APPLICATIONSLTD.

17/12/200761/008320USPCT/IL/2008/001635WO/2009/078021

)2010.01 (F16L20617524/11/2008

IMPROVED חיבור צינורות משופר בעל גריפ מובנה PIPE COUPLING WITHBUILT-IN GRIP

KRAUSZמ"קראוס תעשיות פיתוח בע INDUSTRIESDEVELOPMENT LTD.

04/12/200711/987802USPCT/IL/2008/001541WO/2009/072109

)2010.01 (G06F20617626/11/2008

התקן ושיטה לביצוע פעולות תמורה על נתונים

APPARATUS AND METHOD FORPERFORMING PERMUTATIONOPERATIONS ON DATAARM LIMITED


22/01/20080801137.1GBPCT/GB/2008/003948WO/2009/092987

)2010.01 (C07K20617705/12/2008

שיטות ליצירת צמחים טרנסגניים ללא סמנים

METHODS FOR GENERATINGMARKER FREE TRANSGENICPLANTSKEYGENE N.V.

05/12/200707122354.9EPPCT/NL/2008/050775WO/2009/072883

)2010.01 (A61N20617804/12/2008

חות קרינה פועמתגילוי פוטונים בנוכDETECTING PHOTONS IN THEPRESENCE OF A PULSED RADIATIONBEAM

NAVOTEKמ"נבוטק מדיקל בע MEDICAL LTD05/12/200760/992,691US

PCT/IL/2008/001575WO/2009/072124

)2010.01 (A61K20617907/12/2008

נשאי תרופות חלקיקיים כגורמים להפחתת רגישות יתר

PARTICULATE DRUG CARRIERS ASDESENSITIZING AGENTS

יישום חברה לפיתוח המחקר שלמ"האוניברסיטה העברית בירושלים בע

YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD.

06/12/200760/992728USPCT/IL/2008/001591WO/2009/072136

)2010.01 (A61K20618003/12/2008


פפטידים אמפיפיליים ומטריצות לטיפול באוסטאופורזיס

AMPHIPHILIC PEPTIDE MATRICESFOR TREATMENT OF OSTEOPOROSIS

אוניברסיטת בן גוריון בנגב הרשות למחקר ופיתוח

BEN-GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY

04/12/200760/992109USPCT/IL/2008/001570WO/2009/072119

)2010.01 (B21J20618103/06/2010

שיטה לייצור חישול מסגסוגת גמא טיטניום מבוססת אלומיניום

METHOD FOR PRODUCING AFORGING FROM A GAMMATITANIUM ALUMINUM-BASEDALLOYBOHLER SCHMIEDETECHNIK GMBH& CO KG

05/06/2009A879/2009AT

)2010.01 (A61K20618403/12/2008

SYSTEMS מערכות ושיטות להעברת חומרים AND METHODS FORDELIVERY OF MATERIALSLANDEC CORPORATION

04/12/200761/005400US04/12/200711/999415US04/06/200861/131123US10/06/200861/131716US

PCT/US/2008/013335WO/2009/073192

)2010.01 (C07D85206106/12/2008

שיטה להגברת תאי גזע המטופואיטיניים על ידי שימוש בתרכובת הטרוציקלית

METHOD FOR EXPANDINGHEMATOPOIETIC STEM CELLSUSING HETEROCYCLIC COMPOUNDREPROCELL INCORPORATED


06/12/20072007-316276

JP

PCT/JP/2008/072207WO/2009/072635

)2010.01 (G08G20618706/11/2008

שיטה ומכשיר בדיקה לבדיקת מערכת לבקרת תנועה

METHOD AND TESTING DEVICE FORTESTING A TRAFFIC-CONTROLSYSTEMSIEMENS AKTIENGESELLSCHAFT

27/12/2007102007062741.8DEPCT/EP/2008/065072WO/2009/083316

)2010.01 (C07K20618809/12/2008

ANTIGEN חלבונים קושרי אנטיגן BINDING PROTEINSGLAXO GROUP LIMITED

11/12/20070724185.4GB04/04/20080806230.9GB10/04/200861/043839US

PCT/EP/2008/067138WO/2009/074583

)2010.01 (A61K20618912/12/2008

COMPOUND תרכובות לשימוש בטיפול בסרטן FOR USE IN THETREATMENT OF CANCERPLEDPHARMA AB,

14/12/200761/006010USPCT/SE/2008/051450WO/2009/078794

)2010.01 (G01N20619209/12/2008


MODULATORS מאפנני היווצרות מחדש של תאי עצב OF NEURONALREGENERATIONGENENTECH, INC.

11/12/200761/007276US13/05/200861/052949US

PCT/US/2008/086075WO/2009/076359

)2010.01 (B29C20619315/12/2008

PROCESS הליך לייצור מקור חימום גלילית FOR THE PRODUCTION OFA CYLINDRICAL HEAT SOURCEPHILIP MORRIS PRODUCTS S.A.

13/12/200707254857.1EPPCT/IB/2008/003691WO/2009/074870

)2010.01 (C12Q20619415/12/2008

שינויי מספר עותקים שחוזים גרורות של סרטן שד אנושי

COPY NUMBER ALTERATIONS THATPREDICT METASTATIC CAPABILITYOF HUMAN BREAST CANCERVERIDEX, LLC

14/12/200761/007650USPCT/US/2008/086815WO/2009/079450

)2010.01 (A61K20619524/11/2008

–שיטה לטיפול באנמיות שנגרמות מתת תגובה לאריתרופויאטין

METHOD OF TREATINGERYTHROPOIETINHYPORESPONSIVE ANEMIASCENTOCOR ORTHO BIOTECH INC.

07/01/200861/019367USPCT/US/2008/084497WO/2009/088572


)2010.01 (G01N20619615/12/2008

FORMATION יצירת שכבות של מוליקולות אמפיפיליות OF LAYERS OFAMPHIPHILIC MOLECULESOXFORD NANOPORETECHNOLOGIES LIMITED

19/12/20070724736.4GB14/07/200861/080492US

PCT/GB/2008/004127WO/2009/077734

)2010.01 (C07C20619705/12/2008

ג –R1,R2)–3–(3(בישיים של שינויים–)פרופיל–מתיל–2–אתיל–1–דימתילאמינו

פנול

CRYSTALLINE MODIFICATIONS OF(1R,2R)-3-(3-DIMETHYLAMINO -1-ETHYL-2-METHYL-PROPYL)-PHENOLGRUNENTHAL GMBH

07/12/200707023728.4EPPCT/EP/2008/010330WO/2009/071310

)2010.01 (H04W20619808/12/2008

שיטה ומנגנון של איתות והליך לתמיכה בקביעת דרגת כח תקשורת עם לוויין

METHOD AND APPARATUS OFSIGNALING AND PROCEDURE TOSUPPORT UPLINK POWER LEVELDETERMINATIONINTERDIGITAL PATENT HOLDINGS,INC.

07/12/200761/012281USPCT/US/2008/085864WO/2009/076286

)2010.01 (C23C20619904/12/2008

COATED חפץ מצופה ARTICLECERATIZIT AUSTRIA GESELLSCHAFTM.B.H

06/12/2007GM732/2007AT


PCT/AT/2008/000430WO/2009/070820

)2010.01 (A23L20620029/10/2008

STABLE אבקה תזונתית יציבה NUTRITIONAL POWDERABBOTT LABORATORIES

20/12/200761/015312USPCT/US/2008/081534WO/2009/085386

)2010.01 (C07D20620108/01/2009

–)3S[(–4{–2תרופות מלח קבילות של–7–אינדאזול–2H–}פניל]איל–3–פיפרדין

קרבוקסאמיד

PHARMACEUTICALLY ACCEPTABLESALTS OF 2-{4-[(3S)-PIPERIDIN-3-YL]PHENYL}-2H-INDAZOLE -7-CARBOXAMIDEMERCK SHARP & DOHME LTD

08/01/200861/010333USPCT/GB/2009/000041WO/2009/087381

)2010.01 (C07D20620211/12/2008

–4–פלואורו–2(–6–דיפלואורו–3,2[–4 פיפרידין–]פניל–)פנילסולפניל–מתיל

4-[2,3-DIFLUORO-6-(2-FLUORO-4-METHYL-PHENYLSULFANYL)-PHENYL]-PIPERIDINEH. LUNDBECK A/S

14/12/2007PA200701792DKPCT/DK/2008/050301WO/2009/076961

)2010.01 (C07D20620304/12/2008


–3צורות מוצקות של חומצה בנזואית]D][3,1[דיפלורובנזו–2,2(–1(–6(

–5–דיאוקסול–3–)ציקלופרופנקרבוקסאמידו)יל

תכשירים המכילים)יל–2–מטילפירידין אותן ושיטות לייצורן

SOLID FORMS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID,COMPOSITIONS COMPRISING THE SAMEAND PROCESSES FOR PRODUCING THESAMEVERTEX PHARMACEUTICALSINCORPORATED

07/12/200761/012162USPCT/US/2008/085456WO/2009/073757

)2010.01 (A61K20620404/12/2008

–2,2(–1(–6(–3תכשירי חומצה בנזואית[D[דיפלורובנזו –5–ולדיאוקס]3,1]

–3–)ציקלופרופנקרבוקסאמידו)יל ושימושים בהם)יל–2–מטילפירידין

FORMULATIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOICACID AND USES THEREOFVERTEX PHARMACEUTICALSINCORPORATED

07/12/200761/012168USPCT/US/2008/085457WO/2009/076141

)2010.01 (C07D20620504/12/2008

שיטות להכנת חומצות בנזואיות של פרידין–ציקלואלקילקרבוקסיאמידו

PROCESSES FOR PRODUCINGCYCLOALKYLCARBOXIAMIDO-PYRIDINE BENZOIC ACIDSVERTEX PHARMACEUTICALSINCORPORATED

07/12/200761/012181US30/10/200861/109573US

PCT/US/2008/085458WO/2009/076142


)2010.01 (H04L20620618/09/2008

METHOD שיטה וסידור במערכת תקשורת AND ARRANGEMENT IN ATELECOMMUNICATION SYSTEMTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

08/02/200861/027110USPCT/SE/2008/051047WO/2009/099369

)2010.01 (B01F20620705/12/2008

DEVICE התקן להחדיר גז לתוך נוזל TO INFUSE GAS INTOLIQUIDBLUE PLANET ENVIRONMENTALINC

07/12/200761/012077USPCT/CA/2008/002136WO/2009/070893

)2010.01 (A01N20620905/12/2008

טיפול בסרטן עם תערובות מעכביPARPטופואיזומראז ומעכבי

TREATMENT OF CANCER WITHCOMBINATIONS OFTOPOISOMERASE INHIBITORS ANDPARP INHIBITORSBIPAR SCIENCES, INC.

07/12/200761/012364USPCT/US/2008/085756WO/2009/073869

)2010.01 (H03M20621103/12/2008

התקן לסנכרון חוזר של אותות אנלוגייםשיח על ידי ממירים דיגיטלי–שקובלו בדו

של אותות דיגיטלייםDDRלאנלוגי םמסונכרי

DEVICE FOR RESYNCHRONISINGANALOG SIGNALS OBTAINED BYCONVERSION USING DDR DIGITAL-TO-ANALOG CONVERTERS OFSYNCHRONISED DIGITAL SIGNALSTHALES

07/12/20070708550FR


PCT/EP/2008/066677WO/2009/071568

)2010.01 (H04L20621305/12/2008

METHOD שיטה להצגת וידאו בדואר חשמלי TO DISPLAY A VIDEO INAN EMAILVIDIENSE TECHNOLOGY PTY LTD

07/12/20072613821CAPCT/CA/2008/002112WO/2009/070878

)2010.01 (H01Q20621426/11/2008

שיטה והתקן עבור תקשורת אלחוטיתהמשתמשים בטכניקות של ריבוי כניסות

וריבוי יציאות

METHOD AND DEVICE FORWIRELESS COMMUNICATION USINGMIMO TECHNIQUES

DESIGNARTמ"דזיינארט נטוורקס בע NETWORKS LTD04/12/200711/949791US

PCT/IL/2008/001543WO/2009/072110

)2010.01 (G06F20621508/01/2009

שיטת הסטייה הממוצעת הריבועית)MMSE(המינימאלית

MINIMUM MEAN SQUARE ERROR(MMSE) METHOD

DESIGNARTמ"דזיינארט נטוורקס בע NETWORKS LTD08/01/200861/019615US

PCT/IL/2009/000031WO/2009/087629

)2010.01 (G02B20621604/12/2008


שיטה לתכנון ולייצור מחזירי אור לשידורוקבלת אנרגיה ומחזירי אור שיוצרו

בשטיה זו

A NOVEL METHOD OF DESIGNINGAND PRODUCING REFLECTORS FORRECEIVING/TRANSMITTINGENERGY AND REFLECTORSPRODUCED BY THIS METHOD

בע CONVERTPOWERמ"קונברטפאואר LTD04/12/2007187890IL

PCT/IL/2008/001585WO/2009/072130

)2010.01 (E03D20622002/12/2008

ע י"התקן שרותים המאפשר חסכון במים שימוש באויר דחוס

PRESSURIZED TRAP WATER SAVERTOILET

P&C HENNESSY HOLDINGS, INC.11/12/200712/001338US

PCT/CA/2008/002100WO/2009/073957

)2010.01 (C07D20622109/12/2008

תולדות של תיאופן כאגוניסטים של1EDGI/1P1S

THIOPENE DERIVATIVES AS AGONISTSOF S1P1/EDG1

ACTELION PHARMACEUTICALS LTD.10/12/2007PCT/IB2007/054991IB

PCT/IB/2008/055156WO/2009/074950

)2010.01 (C08B20622215/12/2008

שיטה לייצור נגזרת עמילן הידרוקסיאלקילית עם שני מקשרים

METHOD FOR PRODUCING AHYDROXYALKYL STARCHDERIVATIVE WITH TWO LINKERSFRESENIUS KABI DEUTSCHLANDGMBH

14/12/200707024351.4EPPCT/EP/2008/010659WO/2009/077153


)2010.01 (C08B20622315/12/2008

תולדות עמילן הידרוקסיאלקיליות ותהליך להכנתן

HYDROXYALKYL STARCH\DERIVATIVES AND PROCESS FORTHEIR PREPARATIONFRESENIUS KABI DEUTSCHLANDGMBH

14/12/200707024350.6EPPCT/EP/2008/010660WO/2009/077154

)2010.01 (G01N20622515/12/2008

TIABSCOMPOSITIONSתכשירים ושיטות לגילוי AND METHODS OFDETECTING TIABSTRANSMEDI SA

14/12/200707301680.0EPPCT/IB/2008/003836WO/2009/077864

)2010.01 (A61K20622623/12/2008

תרכובות לטיפול בררני ברכיב דלקת חיסונית של המעיים של מחלת צליאק

COMPOUNDS FOR THE SELECTIVETREATMENT OF THE INTESTINALIMMUNO-INFLAMMATORYCOMPONENT OF THE CELIAC DISEASEGIULIANI INTERNATIONAL LIMITED

24/12/2007MI2007A002429ITPCT/EP/2008/068265WO/2009/080828

)2010.01 (C07K20622716/12/2008

20CDCRYSTALLIZATION–התגבשות של נוגדנים אנטי OF ANTI-CD20ANTIBODIESGENENTECH, INC.

21/12/200761/016288US


PCT/US/2008/087008WO/2009/085765

)2010.01 (A61L20622819/12/2008

תכשירים ושיטות לצירוף חללים שאינם מחוברים

COMPOSITIONS AND METHODS FORJOINING NON-CONJOINED LUMENS

TAUTONA GROUP, L.P.20/12/200761/015660US

PCT/US/2008/087840WO/2009/086206

)2010.01 (A61N20623008/12/2008

SYSTEM מערכת והתקן לטיפול דרמטולוגי AND APPARATUS FORDERMATOLOGICAL TREATMENTTHE GENERAL HOSPITALCORPORATION

07/12/200761/012238USPCT/US/2008/085910WO/2009/076306

)2010.01 (H01M20623110/12/2008

BATTERY מבנים להפרדת סוללות SEPARATOR STRUCTURESP.H. GLATFELTER COMPANY

11/12/200761/007082USPCT/US/2008/086159WO/2009/076401

)2010.01 (C12N20623319/12/2008

ORGANIC תרכובות אורגניות COMPOUNDSNOVARTIS AG

21/12/200707150326.2EPPCT/EP/2008/068046WO/2009/080759


)2010.01 (A01N20623411/12/2008

תולדות בנזילפניל ציקלוהקסאן ושיטות לשימושן

BENZYLPHENYL CYCLOHEXANEDERIVATIVES AND METHODS OFUSETHERACOS, INC.

13/12/200761/013517USPCT/US/2008/086472WO/2009/076550

)2010.01 (C07D20623519/12/2008

תולדות אוקסאדיאזול הפעילות על)P1S(פוספאט–1–ספינגוזין

OXADIAZOLE DERIVATIVES ACTIVEON SPHINGOSINE-1-PHOSPHATE(S1P)GLAXO GROUP LIMITED

21/12/20070725120.0GB01/12/20080821918.0GB

PCT/EP/2008/067965WO/2009/080725

)2010.01 (C07C20623627/02/2009

–1–אמינו–2(–4תולדות שלשל)הידרוקסיאתיל פנול כאגוניסטים

לה 2B–רצפטור האדרנרגי

DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL ASAGONISTS OF THE B2 ADRENERGICRECEPTORALMI RALL, S.A.

28/02/200808382008.4EPPCT/EP/2009/001431WO/2009/106351

)2010.01 (C07D20623710/12/2008


פירידילפירידונים כאנטאגוניסטים–ביס מלאנין–להורמון מרכז1לרצפטור

BIS-PYRIDYLPYRIDONES ASMELANIN-CONCENTRATINGHORMONE RECEPTOR 1ANTAGONISTSGLAXO GROUP LIMITED

10/12/200761/012525USPCT/US/2008/086131WO/2009/076387

)2010.01 (B22F20624419/12/2007

SINTERING תנור דיבקוק ושיטה ליצירת כלי חיתוך FURNACE AND METHODOF MAKING CUTTING TOOLSSANDVIK I NTELLECTUALPROPERTY AB

21/12/20070702911-9SEPCT/SE/2008/051525WO/2009/082349

)2010.01 (C23C20624508/12/2008

A מערכת טריס SHUTTER SYSTEMSANDVIK I NTELLECTUALPROPERTY AB

12/12/20070702772-5SEPCT/SE/2008/051416WO/2009/075635

)2010.01 (H04L20624701/12/2008

STATUS דיווח מצב עבור פרוטוקול שידור חוזר REPORTING FORRETRANSMISSION PROTOCOLTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

07/01/200861/019417USPCT/SE/2008/051380WO/2009/088343


)2010.01 (H04W20624814/07/2008

לינק עבור מסופים מוגבלי–בקרת כוח אפ כוח

UPLINK POWER CONTROL FORPOWER LIMITED TERMINALSTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

07/01/200861/019335US07/01/200861/019337US

PCT/SE/2008/050869WO/2009/088335

)2010.01 (H04L20624902/07/2008

שיטות והתקנים לתקשורת דרך ערוץ רדיוMETHODS AND DEVICES FORCOMMUNICATING OVER A RADIOCHANNELTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

14/12/200761/013788USPCT/SE/2008/050826WO/2009/078785

)2010.01 (F15B20625019/12/2008

על לכן נחיתה המשתמש–מנגנון נעילת בהנעת שינוי פאזה תרמי

LANDING GEAR UPLOCKMECHANISM EMPLOYING THERMALPHASE-CHANGE ACTUATIONMESSIER-DOWTY INC.

21/12/200761/016278USPCT/CA/2008/002255WO/2009/079785

)2010.01 (C07K20625210/12/2008

תרכובות פפטידומימטיות עם פעילותל –אנטגוניסטית לגלוקגון ואגוניסטית

1–GLP

PEPTIDOMIMETICS WITH GLUCAGONANTAGONISTIC AND GLP-1 AGONISTICACTIVITIES


CADILA HEALTHCARE LIMITED11/12/20072420/MUM/2007IN11/08/20081696/MUM/2008IN

PCT/IN/2008/000831WO/2009/125424

)2010.01 (C12N20625319/12/2008

חלבונים לטיפול בתאי מין–מוצרים ללא ועוברים ומדיה תרבית

PROTEIN-FREE GAMETE ANDEMBRYO HANDLING AND CULTUREMEDIA PRODUCTSALI B IN M. ABDULLAH, JAFFAR

21/12/200761/015764US21/12/200720076604NO

PCT/US/2008/087818WO/2009/086191

)2010.01 (C07D20625405/12/2008

CYCLOPROPYL נגזרות ציקלופרופיל אמין AMINEDERIVATIVESABBOTT LABORATORIES

14/12/200711/956816USPCT/US/2008/085622WO/2009/079225

)2010.01 (B28D20625611/12/2008

מכשיר ושיטה להפרדת מצע סיליקוני ממחסנית מצעים כאלו

METHOD OF, AND APPARATUS FORSEPARATING WAFERS FROM A WAFERSTACKGEBR. SCHMID GMBH & CO.

11/12/2007102007061410.3DEPCT/EP/2008/010527WO/2009/074317


)2010.01 (G02B20626310/12/2008

COMPACT טלסקופ סטריאוסקופי קומפקטי להדמייה STEREOSCOPIC IMAGINGTELESCOPETHALES

11/12/200707/08622FRPCT/EP/2008/067169WO/2009/074596

)2010.01 (A61K20626410/12/2008

שיטות לטיפול בסרטנים המטולוגיםכגוןPNPבאמצעות שימוש במעכבי

ב עם גורמי אלקילציה או פורודזין בשילו20CD–גורמים אנטי

METHODS OF TREATINGHEMATOLOGIC CANCER USING PNPINHIBITORS SUCH AS FORODESINEIN COMBINATION WITHALKYLATING AGENTS OR ANTI-CD20 AGENTSBIOCRYST PHARMACEUTICALS,INC.

10/12/200761/012762USPCT/US/2008/086256WO/2009/076455

)2010.01 (A01N20626508/01/2009

צרוף לקטילת אורגניזמים חיים לשימוש ביישומים חקלאיים

BIOCIDE COMBINATION FOR USE INAGRICULTURAL APPLICATIONS

INDUSTRIE DE NORA S.P.A09/01/2008MI2008A000027IT

PCT/EP/2009/050165WO/2009/087188

)2010.01 (A61K20626605/02/2009

תהליך לקבל בחזרה פלורפניקול מתכשירי רוקחות

PROCESS FOR RECOVERINGFLORFENICOL FROMPHARMACEUTICAL COMPOSITIONSINTERVET INTERNATIONAL B.V.

20/11/200861/116330USPCT/US/2009/033205


WO/2010/059259

)2010.01 (B29C20626712/12/2008

תהליך לקבל בחזרה פלוניקסין מתכשירי רוקחות

PROCESS FOR RECOVERINGFLUNIXIN FROM PHARMACEUTICALCOMPOSITIONSINTERVET INTERNATIONAL B.V.

14/12/200761/013855US20/11/200861/116330US

PCT/US/2008/086498WO/2009/079345

)2010.01 (C07D20626809/12/2008

STORAGE תמיסות של מבהירים אופטיים לאחסון STABLE SOLUTIONS OFOPTICAL BRIGHTENERSCLARIANT FINANCE (BVI) LIMITED

12/12/200707123044.5EPPCT/EP/2008/067070WO/2009/074548

)2010.01 (C07F20626925/11/2008

, סינתזה של ביגואנידינים וטריאזיניםאלומיניום–וקומפלקסים של ביגיואנידינו

כחומרי ביניים

SYNTHESIS OF BIGUANIDINES ANDTRIAZINES, AND BIGUANIDINO-ALUMINIUM COMPLEXES ASINTERMEDIATESBAYER CROPSCIENCE AG

14/12/200707024256.5EPPCT/EP/2008/009962WO/2009/077059

)2010.01 (H04N20627009/12/2008

IMAGING מערכת הדמייה SYSTEMSELEX GALILEO LTD


10/12/20070724064.1GBPCT/EP/2008/067140WO/2009/074584

)2010.01 (A61K20627327/12/2007

DISMUTASEתרכובת המכילהSUPEROXIDEו–GLUCAN 1,3–BETA

METHYL CARBOXY

COMPOSITION COMPRISINGSUPEROXIDE DISMUTASE ANDCARBOXY METHYL BETA-1,3GLUCAND.M.G. ITALIA SRL

PCT/IT/2007/000914WO/2009/084044

)2010.01 (C07D20627609/01/2009

PYRIDINE תולדות פירידין DERIVATIVESNOVARTIS AG

11/01/200808150187.6EP03/11/200808168207.2EP

PCT/EP/2009/050208WO/2009/087212

)2010.01 (C07D20627719/12/2008

אוקסאדיאזול לטיפול–4,2,1תרכובות במחלות אוטואימוניות

1,2,4-OXADIAZOLE COMPOUNDSFOR THE TREATMENT OFAUTOIMMUNE DISEASESGLAXO GROUP LIMITED

21/12/20070725102.8GBPCT/EP/2008/067972WO/2009/080730

)2010.01 (C07D20627819/12/2008


תולדות אוקסאדיאזול פעילות על)P1S(פוספאט–1–ספינגוזינ

OXADIAZOLE DERIVATIVES ACTIVEON SPHINGOSINE-1-PHOSPHATE(S1P)GLAXO GROUP LIMITED

21/12/20070725101.0GBPCT/EP/2008/067963WO/2009/080724

)2010.01 (B29C20627915/12/2008

MOULD תבנית הכוללת התקן נעילה INCLUDING A LOCKINGDEVICECOGEMOULE

14/12/200707305001.5EPPCT/EP/2008/067566WO/2009/077508

)2010.01 (C07K20628012/12/2008

תרופות לפמפיגוס המכילות נוגדנים כנגדFASליגנד

REMEDIES FOR PEMPHIGUSCONTAINING ANTI FAS LIGANDANTIBODIESPINCELL SRL

12/12/200761/013147US09/05/200861/051801US

PCT/EP/2008/010597WO/2009/074339

)2010.01 (H04L20628107/10/2008

METHOD במערכת תקשורתשיטה וסידור AND ARRANGEMENT IN ATELECOMMUNICATION SYSTEMTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

08/01/200861/019746USPCT/SE/2008/051139WO/2009/088337


)2010.01 (C07D20628418/12/2008

תולדות ביציקליות לשימוש בטיפול במצבים הקשורים בקולטן לאנדרוגן

BICYCLIC DERIVATIVES FOR USE INTHE TREATMENT OF ANDROGENRECEPTOR ASSOCIATEDCONDITIONSASTRAZENECA AB

21/12/200761/015755US11/09/200861/096090US23/10/200861/107804US

PCT/GB/2008/051206WO/2009/081197

)2010.01 (C01B20628503/12/2008

PROCESS זאוליטיםTS–1תהליך להכנת FOR THE PREPARATION OFTS-1 ZEOLITESPOLIMERI EUROPA S.P.A.

14/12/2007MI2007A002342ITPCT/EP/2008/010290WO/2009/077086

)2010.01 (C07D20628618/12/2008

PIתולדות תיאזול המשמשות כמעכבי 3 קינז

THIAZOLE DERIVATIVES USED AS PI3 KINASE INHIBITORS

NOVARTIS AG20/12/200707150228.0EP

PCT/EP/2008/067859WO/2009/080694

)2010.01 (A61K20628813/03/2009

NOVEL תכשיר ומינון חדשים DOSAGE ANDFORMULATIONALMI RALL, S.A.

13/03/200808382009.2EP


PCT/EP/2009/001831WO/2009/112273

)2010.01 (G03F20629009/12/2008

ה כלי כיסוי מטרולוגי מבוסס דיפרקצי ושיטה

DIFFRACTION BASED OVERLAYMETROLOGY TOOL AND METHOD

ASML NETHERLANDS B.V.17/12/200761/006073US

PCT/NL/2008/050785WO/2009/078708

)2010.01 (C07D20629116/12/2008

INSECTICIDAL תרכובות קוטלות חיידקים COMPOUNDSSYNGENTA PARTICIPATIONS AG

24/12/20070725219.0GB29/07/20080813849.7GB

PCT/EP/2008/010701WO/2009/080250

)2010.01 (C10L20629231/12/2008

שיטה לייצור שרשרת קצרה של חומצותקרבוקסיליות ואסטרים מביומאסה ותוצר

השיטה

METHOD FOR PRODUCTION OFSHORT CHAIN CARBOXYLIC ACIDSAND ESTERS FROM BIOMASS ANDPRODUCT OF SAMEUNIVERSITY OF NORTH DAKOTA

31/12/200761/074206USPCT/US/2008/014145WO/2009/085324

)2010.01 (A01N20629426/01/2009

שיטות ותכשיריםלאיבחון סיבוכי היריוןMETHODS AND COMPOSITIONS FORDIAGNOSING COMPLICATIONS OFPREGNACY


ג בע'רוזטה ROSETTAמ"נומיקס GENOMICS LTD.27/01/200861/023859US30/03/200861/040671US

PCT/IL/2009/000101WO/2009/093254

)2010.01 (C07D20629612/12/2008

AMINOPYRAZOLE תולדות אמינו פיראזול DERIVATIVESACTELION PHARMACEUTICALS LTD.

14/12/2007PCT/IB07/055111IB10/09/2008PCT/IB08/53648IB

PCT/IB/2008/055251WO/2009/077954

)2010.01 (C07K20629711/12/2008

40Xמולקולות קושרות לקולטן Oאנושי BINDING MOLECULES TO THEHUMAN OX40 RECEPTORPFIZER INC

14/12/200761/013947USPCT/US/2008/086417WO/2009/079335

)2010.01 (C07D20629810/12/2008

אנטגוניסטים לחישוב דרך של קיפוד ושימושים רפואיים שלהם

HEDGEHOG PATHWAYANTAGONISTS AND THERAPEUTICAPPLICATIONS THEREOFSIENA BIOTECH S.P.A.

13/12/200707024218.5EPPCT/EP/2008/010470WO/2009/074300

)2010.01 (G06Q20629929/12/2008


מערכת ושיטה למיקוד המלצות בשימוש ברשתות משחקים חברתיים

SYSTEM AND METHOD FORTARGETED RECOMMENDATIONSUSING SOCIAL GAMING NETWORKSMICROSOFT CORPORATION

31/01/200812/023944USPCT/US/2008/088432WO/2009/099496

)2010.01 (C12N20630010/12/2008

ביטוי של חומצה אמינית לא טבעית בגוףPASTORISהחי בשמרים PICHIA מתילטרופים

IN VIVO UNNATURAL AMINO ACIDEXPRESSION IN THEMETHYLOTROPHIC YEAST PICHIAPASTORISTHE SCRIPPS RESEARCH INSTITUTE

11/12/200761/007341USPCT/US/2008/013568WO/2009/075847

)2010.01 (C08K20630112/12/2008

חומרים בולעי קרינה אולטראסגולית עם מבנה ננו

NANO STRUCTURED UVABSORBERS

BASF SE21/12/200707150289.2EP

PCT/EP/2008/067366WO/2009/080548

)2010.01 (C01B20630210/12/2008

חומר לאחסון מימן העשוי ממגנזיום הידריד

HYDROGEN STORAGE MATERIALMADE FROM MAGNESIUM HYDRIDE

UNIVERSITE JOSEPH FOURIER10/12/20070759689FR

PCT/FR/2008/052264WO/2009/080986


)2010.01 (C07D20630314/01/2009

חומצה קרבוקסילית–4–תולדות פיפרידיןפניל אלקיל אמיד חדשות ושימוש בהן כמעכבי לקיחה מחדש של מוליך אות

עצבי מונואמיני

NOVEL PIPERIDINE-4-CARBOXYLICACID PHENYL-ALKYL-AMIDEDERIVATIVES AND THEIR USE ASMONOAMINE NEUROTRANSMITTERRE-UPTAKE INHIBITORSNEUROSEARCH A/S

15/01/2008PA200800056DK16/01/200861/021517US

PCT/EP/2009/050328WO/2009/090173

)2010.01 (H04L20630402/12/2008

ב –שיטה ומודול לתיקון שגיאות שידורDATASTREAM

METHOD AND MODULE FORCORRECTING TRANSMISSIONERRORS IN A DATASTREAMTHALES

11/12/20070708623FRPCT/EP/2008/066618WO/2009/074489

)2010.01 (A01N20630519/12/2008

NOVEL קוטל מזיקים מערכתי SYSTEMIC INSECTILIDEMEIJI SEIKA KAISHA, LTD.

21/12/20072007-329998

JP

PCT/JP/2008/073165WO/2009/081851

)2010.01 (C02F20630604/12/2008

WATER התקן לטיהור מים PURIFICATION DEVICECREAHOLIC S.A.

13/12/200707405353.9EPPCT/CH/2008/000515WO/2009/073994


)2010.01 (A61K20630718/12/2008

VACCINE חיסוןGLAXOSMITHKLINE BIOLOGICALSS.A.

21/12/200761/015767US09/01/200861/019951US

PCT/EP/2008/067945WO/2009/080719

)2010.01 (A61K20630818/12/2008

VACCINES חיסונים למלריה FOR MALARIAGLAXOSMITHKLINE BIOLOGICALSS.A.

21/12/200761/015762USPCT/EP/2008/067925WO/2009/080715

)2010.01 (G06F20630912/11/2008

ע י שימוש במסגרת זיהוי"אימות מסמך מסמך דינמית

DOCUMENT VERIFICATION USINGDYNAMIC DOCUMENTIDENTIFICATION FRAMEWORK3M INNOVATIVE PROPERTIESCOMPANY

12/12/200711/955136USPCT/US/2008/083163WO/2009/075987

)2010.01 (C12N20631012/12/2008

אמצעים להעברת חומצות גרעיןע י שימוש"הפעילות להשתקת גנים

בפולימרים סינתטיים

MEANS FOR DELIVERY OF NUCLEICACIDS ACTIVE FOR GENESILENCING USING SYNTHETICPOLYMERS


POLYPLUS- TRANSFECTION13/12/200761/013358US

PCT/IB/2008/055256WO/2009/074970

)2010.01 (A61K20631122/12/2008

VACCINES חיסונים למלריה FOR MALARIAGLAXOSMITHKLINE BIOLOGICALSS.A.

24/12/200761/016522US24/12/200761/016525US

PCT/EP/2008/068130WO/2009/080803

)2010.01 (F17C20631209/12/2008

HYDROGEN מיכל לאחסון מימן STORAGE TANKUNIVERSITE JOSEPH FOURIER

10/12/20070759690FRPCT/FR/2008/052252WO/2009/080975

)2010.01 (H01L20631310/12/2008

וולטאי ויחידת לוח סולרי–לוח פוטוהעשויה משימוש בלוחות פוטו וולטאים

מאותו סוג

PHOTOVOLTAIC PANEL ANDSOLAR-PANEL UNIT MADE USINGPHOTOVOLTAIC PANELS OF THESAME SORTLASEN DEVELOPMENT LLC

11/12/200712/001376USPCT/EP/2008/067251WO/2009/074615

)2010.01 (G06F20631412/11/2008


זיהוי ואמות של מסמך לא ידוע בהתאם לתהליך הדמייה אייגן

IDENTIFICATION ANDVERIFICATION OF AN UNKNOWNDOCUMENT ACCORDING TO ANEIGEN IMAGE PROCESS3M INNOVATIVE PROPERTIESCOMPANY

12/12/200711/955163USPCT/US/2008/083158WO/2009/075986

)2010.01 (G01C20631708/12/2008

A פלס SPIRIT LEVELSPARROW, PAUL ANDREW

10/12/20070724065.8GBPCT/GB/2008/004048WO/2009/074781

)2010.01 (G06Q20631811/12/2007

ניהול סיכונים לחשבונות ומערכתאישורים למניעת שימוש לא חוקי

בחשבונות

ACCOUNT RISK MANAGEMETN ANDAUTHORIZATION SYSTEM FORPREVENTING UNAUTHORIZEDUSAGE OF ACCOUNTSXS INNOVATION HOLDINGSLIMITED

PCT/IB/2007/055015WO/2009/074847

)2010.01 (G06F20632311/01/2009

של שיטה ומערכת לדירוג אוטומטי סקירות מוצרים על פי תועלת הסקירה

METHOD AND SYSTEM FORAUTOMATICALLY RANKINGPRODUCT REVIEWS ACCORDING TOREVIEW HELPFULNESS

יישום חברה לפיתוח המחקר שלמ"האוניברסיטה העברית בירושלים בע

YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD.

10/01/200861/020294US


PCT/IL/2009/000039WO/2009/087636

)2010.01 (H04B20632417/12/2007

מערכת ושיטה לחישוב זמן שידור בתחנת ממסר

SYSTEM AND METHOD FORTRANSMIT TIME COMPUTATION ATA RELAY STATIONTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

PCT/SE/2007/051017WO/2009/078768

)2010.01 (H04L20632518/02/2009

ניהול תקלות קישוריות לשירותים מסוג)TREE–E(עץ אתרנט

CONNECTIVITY FAULTMANAGEMENT FOR ETHERNETTREE (E-TREE) TYPE SERVICESTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

29/02/200861/032527USPCT/SE/2009/050172WO/2009/102278

)2010.01 (H04L20632626/06/2008

שיטה ומכשיר להערכת איכות קישור במערכת תקשורת

LINK QUALITY ESTIMATIONMETHOD AND APPARATUS IN ATELECOMMUNICATION SYSTEMTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

11/02/200861/027535USPCT/EP/2008/058217WO/2009/100775

)2010.01 (H04L20632715/01/2009


DURATION-SHORTENED בעלי אורך זמן מקוצרOFDMאותות OFDMSYMBOLSTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

16/01/200861/021499USPCT/US/2009/031089WO/2009/091881

)2010.01 (H04W20632807/10/2008

שיטות והתקנים לבקרת כח גישה אקראית ברשת תקשורת

METHODS AND DEVICES FORRANDOM ACCESS POWER CONTROLIN A COMMUNICATIONS NETWORKTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

11/01/200861/020493USPCT/SE/2008/051142WO/2009/088338

)2010.01 (A23L20632915/07/2008

מוצרים מוצקים ראויים לאכילה ושיטות להכנתם

SOLID EDIBLE PRODUCTS ANDPROCESSES FOR THE PREPARATIONOF SAMEAEGS VENTURES, LLC

11/12/200761/007199USPCT/US/2008/008683WO/2009/075699

)2010.01 (C07D20633019/12/2008

–8–פיראזין]B–3,2[תרכובות פירידו מותמרות והשימוש בהן

PYRIDO [2,3-b]PYRAZINE-8-SUBSTITUTED COMPOUNDS ANDTHEIR USETHE INSTITUTE OF CANCERRESEARCH: ROYAL CANCERHOSPITAL

19/12/200761/015019USPCT/GB/2008/004208WO/2009/077766


)2010.01 (G01J20633119/12/2008

PARTICLE אנליזה של חלקיקים בציטומטר אקוסטי ANALYSIS IN ANACOUSTIC CYTOMETERLOS ALAMOS NATIONAL SECURITY,LLC

19/12/200761/008422US11/09/200812/283461US11/09/200812/283491US

PCT/US/2008/087579WO/2009/086043

)2010.01 (C07C20633216/12/2008

ת אורגנית המסומנת תהליך להכנת תרכוב עם פלואור רדיואקטיבי

PROCESS FOR PRODUCTION OFRADIOACTIVE-FLUORINE-LABELEDORGANIC COMPOUNDNIHON MEDI-PHYSICS CO., LTD.

19/12/20072007-327444

JP

PCT/JP/2008/072827WO/2009/078396

)2010.01 (H04L20633310/12/2008

ע י ישות"בקרה של ישות שתישלט מבקרת

CONTROL OF AN ENTITY TO BECONTROLLED BY A CONTROLENTITYMORPHO

12/12/20070708662FRPCT/FR/2008/052271WO/2009/080992

)2010.01 (C07K20633411/12/2008


ו SARP-I מזוגים והשימוש בהםSARP–חלבוני FUSION PROTEINS ANDTHEIR USEMERCK SERONO S.A.

13/12/200707123115.3EP17/12/200761/008329US

PCT/EP/2008/067298WO/2009/074637

)2010.01 (H04N20633521/12/2007

מערך חיישן תמונה, מערך חיישן תמונההתקן מערך חיישן תמונה מופגז, מוגבר

ובנוסף יחידת חיישן פיקסל, באלקטרוניםח יישן תמונה האמורלשימוש במערך

AN IMAGE SENSOR ARRAY, ANINTENSIFIED IMAGE SENSORARRAY, AN ELECTRONBOMBARDED IMAGE SENSORARRAY DEVICE AS WELL AS APIXEL SENSOR ELEMENT FOR USEIN SUCH AN IMAGE SENSOR ARRAYPHOTONIS NETHERLANDS B.V.

PCT/NL/2007/000330WO/2009/082193

)2010.01 (A01N20633711/12/2008

תכשירים המכילים תמיסות בופר מימיותלטיפול בסביבה תאית ותעלות יוניות

ושיטות לשימוש בהן

COMPOSITION OF AQUEOUSBUFFER SOLUTION FOR THETREATMENT OF CELLULARENVIRONMENT AND ION CHANNELSAND METHODS FOR USING SAMESTEPHEN MONROE

11/12/200761/007228USPCT/US/2008/086477WO/2009/076553

)2010.01 (C07D20633812/12/2008

THEOBROMINE תהליך לייצור תאוברומין PRODUCTION PROCESSPERRIGO TRADING (SHANGHAI) CO.LTD

14/12/2007200710116000.8CN


14/12/2007200710116201.8CNPCT/CN/2008/001998WO/2009/089677

)2010.01 (G01N20633911/12/2008

LIQUID ערכת בדיקה נוזלי TESTERORIT MAROM ALBECK

12/12/200711/954304USPCT/IL/2008/001609WO/2009/074992

)2010.01 (A61K20634122/12/2008

תכשירים רוקחים מצופים בעלי שחרור ממושך של לבטיראצטם

COATED EXTENDED RELEASEPHARMACEUTICAL COMPOSITIONS OFLEVETIRACETAMALEMBIC LIMITED

21/12/20071849/MUM/2007INPCT/IN/2008/000851WO/2009/087675

)2010.01 (H02J20634212/12/2008

תקשורת בזמן אמת המבוססת על נוכחות לרשת ניהול של אנרגיה מחולקת

PRESENCE-BASED REAL TIMECOMMUNICATION FORDISTRIBUTED ENERGYMANAGEMENT NETWORKENERNOC, INC.

12/12/200761/013079USPCT/US/2008/086657WO/2009/076626

)2010.01 (H01L20634326/05/2009


וולטאי עם יכולת ריכוז אור–פאנל פוטונמוכה העשוי במקשה אחת ואשר מבוסס

פ וולטאים המשובצים–וטועל תאיםבפולימר ועל מרכזי אור פאראבוליים

מורכבים

A MONOLITHIC LOWCONCENTRATION PHOTOVOLTAICPANEL BASED ON PLOYMEREMBEDDED PHOTOVOLTAIC CELLSAND CROSSED COMPOUNDPARABOLIC CONCENTRATORS

בע'אימפל מיקרוצ IMPELמ"יפ MICROCHIP LTD26/05/2008191713IL25/05/2009198954IL

PCT/IL/2009/000520WO/2009/144715

)2010.01 (C07D20634412/12/2008

אינדולין–2צורות פולימורפיות שלב פירול–3–מותמר

POLYMORPHIC FORMS A 3-POLYROLE SUBSTITUTED 2-INDOLINONEMEDICHEM S.A.

12/12/200761/013117USPCT/IB/2008/003458WO/2009/748862

)2010.01 (E02B20634508/12/2008

IMPROVEMENTS גליתשיפורים לממיר אנרגיה TO WAVE ENERGYCONVERTERPROTEAN POWER PTY LTD

12/12/20072007906745AUPCT/AU/2008/001806WO/2009/073915

)2010.01 (C07D20634620/11/2008

–כנת נגזרות של טטרהתהליך לה הידרוקוינולון

PROCESS FOR PREPARINGTETRAHYDROQUINOLINEDERIVATIVESMERCK PATENT GMBH

18/12/200707024509.7EPPCT/EP/2008/009805WO/2009/077052


)2010.01 (B64C20634715/12/2008

REDUNDANCIES גיבויים וזרמי אוויר בכלי תחבורה AND FLOWS INVEHICLES

URBANמ"אורבן איירונוטיקס בע AERONAUTICS LTD.14/12/200761/006022US

PCT/IB/2008/055301WO/2009/077968

)2010.01 (C07D20635309/12/2008

אנטאגוניסטים לרצפטורא סטרואידי שהופקו–למינרלקורטיקואיד

אוקספיין]E,B[דיבנזו–6H–מ

6H-DIBENZO [B,E] OXEPINEDERIVED NONSTEROIDALMINERALOCORTICOID RECEPTORANTAGONISTSELI LILLY AND COMPANY

19/12/200761/014776USPCT/US/2008/085997WO/2009/085584

)2010.01 (A61K20635413/03/2009

NOVEL תכשיר ומינון חדשים DOSAGE ANDFORMULATIONALMI RALL, S.A.

13/03/200808382010.0EPPCT/EP/2009/001832WO/2009/112274

)2010.01 (C07D20635508/01/2009

אנלוגים של פרולין כליגנדים לרצפטורים לקאנאבינואיד לטיפול בכאב

PROLINE ANALOGS AS LIGANDSFOR CANNABINOID RECEPTORS FORTHE TREATMENT OF PAINPURDUE PHARMA L.P.

08/01/200861/010447US


PCT/IB/2009/000023WO/2009/087564

)2010.01 (A61K20635622/12/2008

מולקולות קישור משופרות מבוססות פיברונקטין ושימושן

IMPROVED FIBRONECTIN-BASEDBINDING MOLECULES AND THEIRUSENOVARTIS AG

27/12/200761/009361USPCT/IB/2008/003962WO/2009/083804

)2010.01 (C07D20635727/01/2009

NOVEL פירידינונים ופירידאזינונים חדשים PYRIDINONES ANDPYRIDAZINONESF. HOFFMANN-LA ROCHE AG

05/02/200861/026204US15/12/200861/122510US

PCT/EP/2009/050875WO/2009/098144

)2010.01 (C07D20635816/02/2009

PYRROLOPYRAZINE מעכבי פירולופיראזין קינאז KINASEINHIBITORSF. HOFFMANN-LA ROCHE AG

25/02/200861/031035US22/01/200961/205724US

PCT/EP/2009/051757WO/2009/106442

)2010.01 (C07D20635912/01/2009

SULFONAMIDES סולפונאמידים כאנטגוניסטים של אורקסין AS OREXINANTAGONISTS



PCT/EP/2009/050272WO/2009/092642

)2010.01 (C07D20636008/01/2009

QUINOLINE תולדות קווינולין ושימושן כקוטלי פטריות DERIVATIVES ANDTHEIR USE AS FUNGICIDESSYNGENTA PARTICIPATIONS AG

10/01/20080800407.9GBPCT/EP/2009/000069WO/2009/087098

)2010.01 (A61K20636105/01/2009

סקרטאז לטיפול–שימוש במעכב גמא בסרטן

USE OF A GAMMA-SECRETASEINHIBITOR FOR TREATING CANCER

F. HOFFMANN-LA ROCHE AG11/01/200861/020447US

PCT/EP/2009/050047WO/2009/087130

)2010.01 (C12N20636303/12/2008

עם תהליך להכנת ביומסת אלגל תכולת ליפיד גבוהה

PROCESS FOR THE PRODUCTION OFALGAL BIOMASS WITH A HIGH LIPIDCONTENTENI S.P.A.

14/12/2007MI2007A002343ITPCT/EP/2008/010291WO/2009/077087

)2010.01 (A61K20636418/12/2008


תכשירים רפואיים המכילים לפחות מרכיבחלבוני פעיל אחד המוגן מאנזימים

מעכלים

PHARMACEUTICAL COMPOSITIONSCONTAINING AT LEAST ONEPROTEIN ACTIVE INGREDIENTPROTECTED FROM DIGESTIVEENZYMESFARID BENNIS

19/12/20070759971FRPCT/FR/2008/052357WO/2009/083686

)2010.01 (A01H20636519/12/2008

METHODS שיטה לשיפור יבול שתילי מלפפונים FOR IMPROVING THEYIELD OF CUCUMBER PLANTSMONSANTO INVEST N.V.

20/12/200707150267.8EPPCT/NL/2008/050834WO/2009/082222

)2010.01 (A23L20636617/12/2008

שיטה ליצור מוצר מזון פונקציונלי מבוסס חלמון ומוצרים המתקבלים מכך

METHOD OF PRODUCING EGG YOLKBASED FUNCTIONAL FOODPRODUCT AND PRODUCTSOBTAINABLE THEREBYNEWTRICIOUS B.V.

17/12/200707123322.5EPPCT/NL/2008/050810WO/2009/078716

)2010.01 (A01G20636718/12/2008

התקן ושיטה להשבה של לחות באטמוספירה

DEVICE AND METHOD FORRECOVERING MOISTURE IN THEATMOSPHEREP.M.M. HOFF HOLDING B.V.

18/12/20072001099NL15/01/20082001185NL

PCT/NL/2008/050816WO/2009/078721


)2010.01 (A23G20637003/02/2009

FROZEN מוצר ממתק קפוא CONFECTIONARYPRODUCTNESTEC S.A.

29/02/200808152135.3EP29/02/200808004062.9EP

PCT/EP/2009/051173WO/2009/109437

)2010.01 (B01D20637217/12/2008

שיטות לניקוי או הסרת מולקולות או תאים

METHODS FOR PURIFYING ORDEPLETING MOLECULES OR CELLSOF INTEREST

AFFISINKמ"אפיסינק ביוטכנולוגיה בע BIOTECHNOLOGY LTD17/12/200761/006067US

PCT/IL/2008/001631WO/2009/078018

)2010.01 (H04W20637309/01/2009

הודעה וגילוי של שינוי מידע מערכת בתקשורת אלחוטית

SYSTEM INFORMATIONMODIFICATION NOTIFICATION ANDDETECTION IN WIRELESSCOMMUNICATIONSQUALCOMM INCORPORATED

11/01/200861/020705US08/01/200912/350832US

PCT/US/2009/030669WO/2009/089498

)2010.01 (G11C20637415/12/2008

התאמת רוחבי פולס שורת מילה במערכות זיכרון

ADAPTIG WORD LINE PULSEWIDTHS IN MEMORY SYSTEMS


QUALCOMM INCORPORATED17/12/200761/014257US04/12/200812/328156US

PCT/US/2008/086834WO/2009/079457

)2010.01 (H04W20637513/01/2009

איתור תקשורת אלחוטית המשתמש בסוגים מרובים של מזהי צומת

WIRELESS COMMUNICATIONPAGING UTILIZING MULTIPLETYPES OF NODE IDENTIFIERSQUALCOMM INCORPORATED

14/01/200861/020973US13/06/200861/061543US12/01/200912.352501US

PCT/US/2009/030857WO/2009/091741

)2010.01 (C07D20637806/02/2009

-PYRROLO[2,1(DIHYDRO) איזוקווינולינים]a–1,2[פירולו)דיהידרו(a]ISOQUINOLINESN.V. ORGANON

08/02/200808151199.0EP08/02/200861/027,062US

PCT/EP/2009/051366WO/2009/098283

)2010.01 (C07J20637923/12/2008

–21–נור–19–ידרוקסיה–17תולדת–?–סטרואיד–חומצה קרבוקסילית

בו, לקטון ותרופה הכוללת, שימוש תולדה זו

17-HYDROXY-19-NOR-21-CARBOXYLICACID-STEROID ?-LACTONEDERIVATIVE, USE THEREOF, ANDMEDICAMENT CONTAINING THEDERIVATIVEBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

29/12/2007102007063503.8DEPCT/EP/2008/011159WO/2009/083266


)2010.01 (A61F20638012/12/2008

התקנים המתרחבים באופן עצמאי ושיטות עבורם

SELF-EXPANDING DEVICES ANDMETHODS THEREFOR

INTERSECT ENT, INC18/12/200761/014653US04/06/200861/058803US

PCT/US/2008/086718WO/2009/079418

)2010.01 (C07J20638123/12/2008

–'3–17–)לפרופני–'1(–17תולדותשימוש, און–3–אן–4–אוקסידואסטרא

בה ותרופה המכילה תולדה זו

17-(1'-PROPENYL)-17-3'-OXIDOESTRA-4-EN-3-ONE DERIVATIVE, USE THEREOF,AND MEDICAMENT CONTAINING SAIDDERIVATIVEBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

29/12/2007102007063500.3DEPCT/EP/2008/011161WO/2009/083268

)2010.01 (A61K20638220/01/2009

פאראמיקוסווירוסים אונקוליטים מוסגלים המקודדים ציטוקינים של ציפורים

ATTENUATED ONCOLYTICPARAMYXOVIRUSES ENCODINGAVIAN CYTOKINESBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

29/01/200808001643.9EP29/01/200861/024333US

PCT/EP/2009/000308WO/2009/095167

)2010.01 (C07J06383223/12/2008


–)פרופניל–'1(–17–מתילן–16,15תולדת, און–3–אן–4–אוקסידואסטרא–'3, 17

שימוש בה ותרופה המכילה תולדה זו

15,16-METHYLENE-17-(1'-PROPENYL)-17-3-OXIDOESTRA-4-EN-3'-ONEDERIVATIVE, USE THEREOF, ANDMEDICAMENT CONTAINING SAIDDERIVATIVEBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

29/12/2007102007063496.1DEPCT/EP/2008/011164WO/2009/083271

)2010.01 (G09B20638415/06/2010

תרופות המבוססות על צמחי מרפא ההגדרה של תוספי מזוןהנמכרות תחת

MEDICINES BASED ON HERBS SOLDUNDER THE DEFINITION OF FOODADDITIVES

ASHER מרקוביץ אשר MARKOVICH

)2010.01 (B22F20638619/12/2008

ת תותבת חיתוך עם חור שיטה ליציר להידוק

METHOD OF MAKING A CUTTINGINSERT WITH A HOLE FORCLAMPINGSANDVIK I NTELLECTUALPROPERTY AB

27/12/20070702869-9SEPCT/SE/2008/051523WO/2009/085002

)2010.01 (C07C20639017/12/2008

–5–אמינו–2תהליך להכנת נגזרות חומצה ציאנובנזואית

PROCESS FOR PREPARING 2-AMINO-5-CYANOBENZOIC ACIDDERIVATIVESE.I. DU PONT DE NEMOURS ANDCOMPANY

19/12/200761/008458US


PCT/US/2008/087151WO/2009/085816

)2010.01 (C07D20639125/12/2008

שיטה לייצור נגזרות פירידין מותמר בהטרוציקל

METHOD FOR MANUFACTURINGHETEROCYCLE-SUBSTITUTEDPYRIDINE DERIVATIVESEISAI R&D MANAGEMENT CO., LTD.

26/12/200761/016791USPCT/JP/2008/073545WO/2009/081970

)2010.01 (A47G20639219/12/2008

מסגרת הכוללת תאורה מובנית ואספקת חשמל

FRAME HAVING INTEGRATEDLIGHTING AND POWER SUPPLY

COOL MOUNTAIN COLLECTION AG21/12/200707123945.3EP

PCT/EP/2008/068044WO/2009/080758

)2010.01 (A61K20639321/11/2008

יות קפסולות מוצקות שומנ–מיקרוהמכילות הורמון לצמיחה בליבה הפנימית

המוצקה

SOLID LIPID MICROCAPSULESCONTAINING GROWTH HORMONEIN THE INNER SOLID CORE

MERCK PATENT GMBH21/12/200707024906.5EP

PCT/EP/2008/009849WO/2009/080164

)2010.01 (C07D20639425/11/2008

בנזילפירידזינון כמעכבי–2נגזרות שלMETקינאז

2-BENZYLPYRIDAZINONEDERIVATIVES AS MET KINASEINHIBITORS


MERCK PATENT GMBH21/12/2007102007061963.6DE

PCT/EP/2008/009970WO/2009/083076

)2010.01 (C07D20639515/01/2009

BETA-LACTAMASE לאקטאמאז–מעכבי בטא INHIBITORSMERCK SHARP & DOHME CORP.

18/01/200861/011533USPCT/US/2009/031047WO/2009/091856

)2010.01 (C07D20639619/12/2008

ANTITUMORAL חומרים ותכשירים לטיפול בגידולים COMPOUNDSPHARMA MAR, S.A.

20/12/200707123882.8EPPCT/EP/2008/068049WO/2009/080761

)2010.01 (C07C20639719/12/2008

ANTITUMORAL חומרים ותכשירים לטיפול בגידולים COMPOUNDSPHARMA MAR, S.A.

20/12/200707123882.8EPPCT/EP/2008/068065WO/2009/080769

)2010.01 (C07D20639917/12/2008

תולדות אמינו טריאזול כאגוניסטיםALXשל

AMINOTRIAZOLE DERIVATIVES AS ALXAGONISTS

ACTELION PHARMACEUTICALS LTD.18/12/2007PCT/IB07/055199IB23/10/2008PCT/IB08/054369IB


PCT/IB/2008/055375WO/2009/077990

)2010.01 (B41F20640009/12/2008

שיטה להכנת תבניות הדפסה עבורהדפסה פלקסוגרפית ומערכת לשימוש

בשיטה

METHOD OF PREPARING PRINTINGFORMS FOR FLEXOGRAPHICPRINTING AND A SYSTEM USED INTHE METHODTETRA LAVAL HOLDINGS &FINANCE S.A.

17/12/20070702805-3SEPCT/SE/2008/000689WO/2009/078780

)2010.01 (F01K20640114/11/2008

התקן ומערכת להזרקת אנרגיה, שיטה לתוך מדיום

METHOD, DEVICE AND SYSTEM FORINJECTING ENERGY INTO A MEDIUM

KLAUS WOLTER17/12/2007102007061167.8DE26/02/2008102008011218.6DE22/04/2008102008020270.3DE

PCT/EP/2008/065600WO/2009/077275

)2010.01 (C07D20640219/12/2008

BICYCLIC נגזרת הטרוציקלית ביצקלית HETEROCYCLICDERIVATIVEDAINIPPON SUMITOMO PHARMACO., LTD.

19/12/20072007-328087

JP

06/08/20082008&202960JPPCT/JP/2008/073184WO/2009/078481


)2010.01 (E05B20640329/12/2008

MORTISE מנעול בריח כיסי LOCKGOLTEKמ"בע 2005גולדטק מיגון MIGUN 2005 LTD.

26/12/200761/006140USPCT/IB/2008/003639WO/2009/087464

)2010.01 (C07D20640422/01/2009

תרכובות המכילות קבוצה ציקלובוטוקסית

COMPOUNDS COMPRISING ACYCLOBUTOXY GROUP

UCB PHARMA S.A.24/01/200808001308.9EP24/01/200861/023207US

PCT/EP/2009/050719WO/2009/092764

)2010.01 (H01H20640611/12/2008

ELECTRICAL מתג חשמלי לשליטה בפנס SWITCH, AS FORCONTROLLING A FLASHLIGHTSTREAMLIGHT, INC.

18/12/200711/958804USPCT/US/2008/086433WO/2009/079339

)2010.01 (C12N20640721/11/2008

' של פאג וקטורים היברידים מהונדסיםלתכנון ויצירת פפטיד אנושי שאינו נוגדן

ל' או ספרית חלבון פאג –באמצעות איחויpIX13' של פאגM

ENGINEERED HYBIRD PHAGEVECTORS FOR THE DESIGN ANDTHE GENERATION OF A HUMANNON-ANTIBODY PEPTIDE ORPROTEIN PHAGE LIBRARY VIAFUSION TO pIX OF M13 PHAGECENTOCOR ORTHO BIOTECH INC.

19/12/200761/014773US


PCT/US/2008/084281WO/2009/085464

)2010.01 (C12Q20640821/11/2008

פפטיד אנושי שאינו נוגדן או ספרית חלבון'פאג

A HUMAN NON-ANTIBODY PEPTIDEOR PROTEIN PHAGE LIBRARY

CENTOCOR ORTHO BIOTECH INC.19/12/200761/014777US

PCT/US/2008/084317WO/2009/085468

)2010.01 (C12N20640919/12/2008

חלופית של שלד חלבוני' תצוגת פאגל ' של פאגpIX–איחוי באמצעות איחוי

31M

ALTERNATIVE SCAFFOLD PROTEINFUSIONS PHAGE DISPLAY VIAFUSION TO pIX OF M13 PHAGE

CENTOCOR ORTHO BIOTECH INC.19/12/200761/014778US

PCT/US/2008/087696WO/2009/086116

)2010.01 (C40B20641021/11/2008

תכנון ויצירה של ספריות תצוגה אנושיותלpIX' חדשות של פאג –באמצעות איחוי

pIXל נוגדנים ושיטות, וקטורים,pVII–או

DESIGN AND GENERATION OFHUMAN DE NOVO pIX PHAGEDISPLAY LIBRARIES VIA FUSION TOpIX, OR pVII, VECTORS, ANTIBODIESAND METHODSCENTOCOR ORTHO BIOTECH INC.

19/12/200761/014786USPCT/US/2008/084255WO/2009/085462

)2010.01 (B60Q20641116/06/2010


WARNING מנורת משולש אזהרה לרכב TRIANGLE LIGHTFIXTURE FOR CAR

YOSEF יוסף כריספין KRISPIN

)2010.01 (C10M20641219/12/2007

שיטה, חומר סיכה אוניברסלי סינתטיע,ומוצר את,י תהליך"המוגדר להחליף

סיכת הגפרית החסרה כאשר משתמשים בדלקי דיזל בעלי ריכוז גפרית נמוך

UNIVERSAL SYNTHETICLUBRICANT, METHOD ANDPRODUCT-BY-PROCESS TO REPLACETHE LOST SULFUR LUBRICATIONWHEN USING LOW-SULFUR DIESELFUELSBESTLINE INTERNATIONALRESEARCH, INC.

PCT/US/2007/088252WO/2009/078882

)2010.01 (C07D20641318/12/2008

אמינופירימידין כאנטגוניסטים–4תולדות היסטמין4Hלקולטן

4-AMINOPYRIMIDINE DERIVATIVESAS HISTAMINE H4 RECEPTORANTAGONISTSPALAU PHARMA S.A.

21/12/200707382006.0EP26/02/200861/031534US

PCT/EP/2008/067950WO/2009/080721

)2010.01 (C07K20641406/09/2001

NOVEL חומצות גרעין ופוליפפטידים חדשים RECEPTOR NUCLEIC ACIDSAND POLYPEPTIDESBIOGEN IDEC MA INC.

18/09/200060/233152US21/09/200060/234140US13/02/200160/268499US


14/08/200160/312185USPCT/US/2001/028006WO/2002/024909

)2010.01 (C12Q20641525/12/2008

DEVICESהתקנים ושיטות לדגימת דם מופחתת כאב AND METHODS FORREDUCED-PAIN BLOOD SAMPLING

RAPIDXמ"רפידאקס בע LTD.25/12/200761/016580US04/01/200861/018901US

PCT/IL/2008/001669WO/2009/081405

)2010.01 (C07D20641622/12/2008

בנזופורופירימידינונים כמעכבי פרוטיאין קינאז

BENZOFUROPYRIMIDINONES ASPROTEIN KINASE INHIBITORS

EXELIXIS, INC.21/12/200761/008907US25/03/200861/070971US

PCT/US/2008/087939WO/2009/086264

)2010.01 (C07K20641812/05/2004

ילים פוליאתילן פפטידים דימרים שמכ, גליקול הנקשרים לקולטן אריתרופואטים תכשירים שמכילים אותם ושימוש בהם

PEPTIDE DIMERS WHICH COMPRISEPOLYETHYLENE GLYCOL THATBIND TO THE ERYTHROPOIETINRECEPTOR, PHARMACEUTICALCOMPOSITIONS THEREOF AND USETHEREOFAFFYMAX, I NC.

12/05/200360/469993US12/05/200360/470244US

PCT/US/2004/014889WO/2004/101606


)2010.01 (C07D20641923/12/2008

3–N–אוקסאדיאזולונים–1,3,4–פנילש רפואילשימו5מותמרים בחמצן בעמדה

5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICALUSEBIAL-PORTELA & CA, S.A.

27/12/200761/009302USPCT/PT/2008/000054WO/2009/084970

)2010.01 (C07D20642016/12/2008

הכנתן ויישומן בטיפול, נגזרות אזטידיןAZETIDINE DERIVATIVES, THEIRPREPARATION AND THEIRAPPLICATION IN THERAPYSANOFI-AVENTIS

18/12/20070708830FR06/05/20080802492FR

PCT/FR/2008/001748WO/2009/106708

)2010.01 (H04W20642131/10/2008

POSITIONING איתור המשתמש באות פיילוט משופר USING ENHANCEDPILOT SIGNALQUALCOMM INCORPORATED

18/12/200761/014706US21/12/200761/016101US21/03/200861/038660US01/05/200812/113900US27/10/200812/259253US

PCT/US/2008/082107WO/2009/079103

)2010.01 (B01D20642219/12/2008


עמודתי–תהליך הפרדה סדרתי רב להפרדת נגזרת מתכת יונית

MULTI-COLUMN SEQUENCEDSEPARATION PROCESS FORSEPARATING AN IONIC METALDERIVATIVEAPPLEXION

20/12/20070708966FRPCT/FR/2008/001797WO/2009/106734

)2010.01 (A61K20642317/12/2008

שימוש בהרכב רעיל לעצבים שלCLOSTRIDIUMקומפלקס רעלן BOTULINUMלהפחית תופעות לואי או

למנען

USE OF A NEUROTOXICCOMPONENT OF A CLOSTRIDIUMBOTULINUM TOXIN COMPLEX TOREDUCE OR PREVENT SIDE EFFECTS

MERZ PHARMA GMBH & CO. KGaA21/12/200707024961.0EP21/12/200761/009010US

PCT/EP/2008/010782WO/2009/080272

)2010.01 (C07D20642419/12/2008

EFFICIENT תרופות אספירין יעילות–פרו ASPIRIN PRODRUGSTHE PROVOST, FELLOWS ANDSCHOLARS OF THE COLLEGE OFTHE HOLY AND UNDIVIDEDTRINITY OF QUEEN ELIZABETH,NEAR DUBLIN

21/12/20072007/0934IEPCT/EP/2008/068114WO/2009/080795

)2010.01 (F02D20642516/06/2010

ידי חום כמוס–מנוע אנדותרמי מופעל על ושימושים שלו

ENDOTHERMAL MOTOR POWEREDBY LATENT HEAT AND USESTHEREOF

MOSHE משה יהושע שפר YEHOSHUA SHAFFER


)2010.01 (H01L26206418/12/2008

METHOD התקן ושיטה לטיפול בפיסות סיליקון AND DEVICE FOR TREATINGSILICON WAFERSGEBR. SCHMID GMBH & CO.

19/12/2007102007063202.0DEPCT/EP/2008/010894WO/2009/077201

)2010.01 (F03B20642717/12/2008

BUOYANT מפעיל צף ACTUATORCARNEGIE WAVE ENERGY LIMITED

17/12/20072007906886AUPCT/AU/2008/001853WO/2009/076712

)2010.01 (A01G20642817/12/2008

PLASTIC מחזיר שכבת גידול מפלסטיק MULCH RETRIEVERROCCA MANUFACTURING PTY LTD.

17/12/20072007906889AU15/10/20082008905335AU

PCT/AU/2008/001916WO/2009/076729

)2010.01 (B01D20642917/12/2008

APPARATUS יוניזציה–מכשיר ומערכת לדה AND SYSTEM FORDEIONIZATION

אוניברסיטת בן גוריון בנגב הרשות למחקר ופיתוח

BEN-GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY


17/12/200761/006047USPCT/IB/2008/055380WO/2009/077992

)2010.01 (G06F20643022/01/2009

שיטה ומכשיר לתהליכי יישום שירותאימות במהלך הקצאה חוזרת של שירות

באגדי זמינות גבוהה

METHOD AND APPARATUS FORAUTHENTICATION SERVICEAPPLICATION PROCESSES DURINGSERVICE REALLOCATION IN HIGHAVAILABILITY CLUSTERSTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

25/01/200812/020185USPCT/IB/2009/050244WO/2009/093194

)2010.01 (H04W20643105/11/2008

גישה באמצעות רשתות גישה שאינןGPP3

ACCESS THROUGH NON-3GPPACCESS NETWORKSTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

11/04/200861/044242USPCT/SE/2008/051261WO/2009/126083

)2010.01 (C08K20643208/10/2008

FLAME תכשירים המערבי להבות RETARDANT COMPOSITIONSCHEMTURA CORPORATION

17/12/200761/008056US09/09/200812/283168US

PCT/US/2008/079181WO/2009/079077


)2010.01 (C07C20643322/12/2008

שיטה עבור יצור תרכובתציקלופרופאנקארבוקסילית חומצית

ואמצעי עבור זה

METHOD FOR PRODUCINGCYCLOPROPANECARBOXYLIC ACIDCOMPOUND AND INTERMEDIATETHEREFORSUMITOMO CHEMICAL COMPANY,LIMITED

10/01/20082008-002988

JP

PCT/JP/2008/073901WO/2009/087941

)2010.01 (C12M20643416/12/2008

ביוריאקטור עבור צמיחת תא ושיטות קשורות

BIOREACTOR FOR CELL GROWTHAND ASSOCIATED METHODSTHE CHARLOTTE-MECKLENBURGHOSPITAL AUTHORITY

17/12/200711/957747USPCT/US/2008/086986WO/2009/079504

)2010.01 (A61K20643517/12/2008

ל טיפול בהפרעות מהלכים טיפוליים חיסוניות דלקתיות

THERAPEUTIC REGIMENS FOR THETREATMENT OFIMMUNOINFLAMMATORYDISORDERSCOMBINATORX, INC.

17/12/200761/014307USPCT/US/2008/013805WO/2009/078998

)2010.01 (G01N20643702/02/2009

ASSAY בדיקה לאבחון סטרפטוקוק פנומוניה FOR DIAGNOSINGSTREPTOCOCCUS PNEUMONIAESANOFI PASTEUR LIMITED

01/02/200861/063376US


PCT/CA/2009/000119WO/2009/094779

)2010.01 (A47B20643817/06/2010

THE כרית הנקה ויקי VICKY' NURSING PILLOWMOMMEYמ"מאמי ויקי בע VICKY LTD

)2010.01 (C12M20643917/12/2008

ד SYSTEMא.נ.מערכת ושיטה לעריכת AND METHOD FOREDITING AND MANIPULATING DNA

YEDAמ"ידע חברה למחקר ופיתוח בע RESEARCH ANDDEVELOPMENT CO. LTD.

17/12/200761/006042USPCT/IL/2008/001629WO/2009/078016

)2010.01 (C12N20644030/09/2005

ב USE בהבשלת ביציותIL–17–שימוש OF IL-17 FOR MATURATION OFOOCYTESMERCK SERONO S.A.

30/09/200460/614667USPCT/US/2005/035372WO/2006/039592

)2010.01 (A61K20644118/12/2008

והכנתםPEGתכשירי אינטרפרון בטאPEG-INTERFERON-BETAFORMULATIONS AND THEIRPREPARATIONMERCK SERONO S.A.

20/12/200707150258.7EP


07/01/200861/010,258USPCT/EP/2008/067876WO/2009/080699

)2010.01 (G06F20644218/12/2008

שיטה, מערכת לבקרה וסיוע בתחזוקה ומנגנון

MAINTENANCE ASSISTANCE ANDCONTROL SYSTEM METHOD ANDAPPARATUS

MOBIDEOמ"בע) ישראל(מובידאו AEROSPACE LTD19/12/200761/006125US

PCT/IL/2008/001637WO/2009/078023

)2010.01 (C08B20644311/12/2008

יסכארידיות של חומצה תולדות פולשימושן כחומרים, הכנתן, ליפואית

קוסמטיים לעור ומכשירים רפואיים

POLYSACCHARIDE DERIVATIVES OFLIPOIC ACID, THEIR PREPARATION,USE AS SKIN COSMETICS ANDMEDICAL DEVICESSIGEA S.R.L.

21/12/2007MI2007A002416ITPCT/EP/2008/010534WO/2009/080220

)2010.01 (C07D20644425/02/2009

תהליך לרזולוציה של תולדות איזוקווינוליניות

PROCESS FOR THE RESOLUTION OFISOQUINOLINE DERIVATIVESRECORDATI INDUSTRIA CHIMICA EFARMACEUTICA S.P.A

28/02/2008MI2008A000319ITPCT/EP/2009/052234WO/2009/106547

)2010.01 (G02B20644605/12/2008


שיטה להכנתה ושימוש, מראת הדמייהל ייזרבה במערכת הדמיית

IMAGING MIRROR, METHOD FORMAKING SAME AND USE THEREOFIN A LASER IMAGING SYSTEMTHALES

18/12/20070708840FR28/03/20080801711FR

PCT/EP/2008/066938WO/2009/077361

)2010.01 (H01L20644718/12/2007

וולטאי עם גישת קצה–מודול פוטו, שיטת חברור, וולטאים–למיתרים פוטו מערכת ושיטה

PHOTOVOLTAIC MODULE WITHEDGE ACCESS TO PV STRINGS,INTERCONNECTION METHOD,APPARATUS AND SYSTEMDAY4ENERGY INC.

PCT/CA/2007/002301WO/2009/076740

)2010.01 (A61K20644817/12/2008

משטר מינון הקשור לאסטריםפאליפרידונים להזרקה עם פעילות

ממושכת

DOSING REGIMEN ASSOCIATEDWITH LONG ACTING INJECTABLEPALIPERIDONE ESTERS

JANSSEN PHARMACEUTICA, N.V.19/12/200761/014918US05/12/200861/120276US

PCT/EP/2008/067738WO/2009/080651

)2010.01 (F16N20644915/12/2008

HELICOPTERן טפטוף למסוקפ DRIP PANPHOENIX PRODUCTS, INC.

19/12/200761/014960US08/12/200812/330348US

PCT/US/2008/086807WO/2009/085687


)2010.01 (A61K20645014/01/2009

שימוש במלח של חומצהאצטילסליצילית לטיפול בזיהומים

ויראלים

USE OF AN ACETYLSALICYLIC ACIDSALT FOR THE TREATMENT OF VIRALINFECTIONS

ACTIVAERO GMBH14/01/2008102008004386.9DE

PCT/DE/2009/000033WO/2009/089822

)2010.01 (G02B20645105/12/2008

LASER מערכת מכוונת לייזר POINTING SYSTEMTHALES

18/12/20070708842FRPCT/EP/2008/066926WO/2009/077360

)2010.01 (B32B20645213/12/2008

חומר מרוכב משוריין עם גוף רך בעלע י"משקל נמוך ועמידות גבוהה המיוצר

שימוש בטיפולים מקומיים על בסיס סיליקון

LOW WEIGHT AND HIGHDURABILITY SOFT BODY ARMORCOMPOSITE USING SILICONE-BASED TOPICAL TREATMENTS

HONEYWELL INTERNATIONAL INC.21/12/200711/962663US

PCT/US/2008/086735WO/2009/085673

)2010.01 (C07D20645316/12/2008


–4,3–אוקסו–4–מותמרים–3אמידים]D][5,3,2,1–1,5[–אימידאזו–דיהידרוחומצה קרבוקסילית והשימוש–8–טטראזין

בהם

3-SUBSTITUTED-4-OXO-3,4-DIHYDRO-IMIDAZO-[5,1-D][1,2,3,5]TETRAZINE-8-CARBOXYLIC ACID AMIDES ANDTHEIR USEPHARMINOX LIMITED

18/12/200761/014520USPCT/GB/2008/004140WO/2009/077741

)2010.01 (A45D20645617/12/2008

תכשירים ומכשירים לצביעה, תרכובות זמנית של אזור שאר מקומי

AGENTS, COMPOSITIONS ANDDEVICES FOR TEMPORARYCOLORING LOCAL HAIR AREASS.O.S. COLOR LTD.

17/12/200761/006068USPCT/IL/2008/001630WO/2009/078017

)2010.01 (C07K20645722/12/2008

בעלי קישור שעבר שינויFcוריאנטים שלFcRnל

Fc VARIANTS WITH ALTEREDBINDING TO FcRn

XENCOR INC.26/12/200761/016793US25/02/200861/031353US18/04/200861/046353US02/05/200861/050172US10/07/200861/079779US22/09/200861/099178US

PCT/US/2008/088053WO/2009/086320

)2010.01 (C07K20646019/01/2009

NOVEL אמיד חדשות–)פניל–אמינו–N–(2תולדות N-(2-AMINO-PHENYL)-AMIDE DERIVATIVESF. HOFFMANN-LA ROCHE AG


29/01/200808150805.3EPPCT/EP/2009/050525WO/2009/095324

)2010.01 (G06F20646102/12/2008

מוביל, שיטה לאבטחת קפיצה מותניתמערכת מאובטחת ומעבד, תוכנית, מידע

אבטחה לשיטה זו

METHOD FOR SECURING ACONDITIONAL JUMP, INFORMATIONCARRIER, PROGRAM, SECUREDSYSTEM AND SECURITYPROCESSOR FOR THIS METHODVIACCESS

28/12/20070709165FRPCT/EP/2008/066568WO/2009/083371

)2010.01 (A61K20646218/12/2008

וירוס וסיקולר סטומטיטיס מוחלש מותאםבו, גנטית תכשירים ושיטות לשימוש

GENETICALLY MODIFIEDATTENUATED VESICULARSTOMATITIS VIRUS, COMPOSITIONSAND METHODS OF USE THEREOFWYETH LLC

21/12/200761/015868USPCT/US/2008/087375WO/2009/082664

)2010.01 (B65D20646317/06/2010

מערך אסימטרי של נרתיקים מתכלים הניתנים להפרדה, לנוזלים

BIODEGRADABLE ASYMMETRICARRAY OF SEPARABLE POUCHESFOR LIQUIDS

TIPAמ"בע. טיפה קורפ CORP. LTD


)2010.01 (A61K20646409/01/2009

–2שימוש בתולדת, הרכב רוקחי, אימינופירולידין לייצור הרכב רוקחי

וערכה לטיפול או שיפור של מחלות לב

PHARMACEUTICAL COMPOSITION,USE OF 2-IMMINOPYRROLIDINEDERIVATIVE FOR PRODUCTION OFPHARMACEUTICAL COMPOSITION,AND KIT FOR TREATMENT ORAMELIORATION OF HEARTDISEASESEISAI R&D MANAGEMENT CO., LTD.

11/01/200861/020426US11/01/20082008/004318JP

PCT/JP/2009/050184WO/2009/088063

)2010.01 (A01N46520619/12/2008

תכשירים המכילים פרוגסטינים שאינם סטרואיידים לשימוש כאמצעי מניעה

COMPOSITIONS COMPRISINGNONSTEROIDAL PROGESTINS FORUSE AS A CONTRACEPTIVETEVA WOMEN'S HEALTH, INC.

20/12/200761/008287USPCT/US/2008/013933WO/2009/082478

)2010.01 (C07D20646618/12/2008

תכשירים, פירימידינים]a–5,1[פיראזולו המכילים אותם ושימושים בהם

PYRAZOLO [1,5-a]PYRIMIDINES,COMPOSITIONS COMPRISING THESAME AND USES THEREOFVERTEX PHARMACEUTICALSINCORPORATED

19/12/200761/014824USPCT/US/2008/087362WO/2009/085913

)2010.01 (A61K20646722/12/2008

FORMULATION פורמולציהBIOINVENT INTERNATIONAL AB


28/12/200761/017290USPCT/EP/2008/011043WO/2009/083225

)2010.01 (H04W20646807/01/2009

במערכות תקשורתTDDפעולת אלחוטיות

TDD OPERATION IN WIRELESSCOMMUNICATION SYSTEMS


PCT/US/2009/030342WO/2009/089287

)2010.01 (C07D20646919/12/2008

ם שלושיטה להכנת פיפרוניל ואנלוגיPROCESS FOR THE PREPARATIONOF FIPRONIL AND ANALOGUESTHEREOFVETOQUINOL

19/12/200761/014769US08/01/200808/50084FR

PCT/IB/2008/003576WO/2009/077853

)2010.01 (C07F20647026/12/2008

נגזרות פירידין מותמרות בטבעת, הטרוציקלית וקבוצת פוספונאוקסימתיל

וגורמים נגד פטריות הכלולילם אותן

HETEROCYCLIC RING ANDPHOSPHONOXYMETHYL GROUPSUBTITUTED PYRIDINEDERIVATIVES, AND ANTIFUNGALAGENTS CONTAINING SAME

EISAI R&D MANAGEMENT CO., LTD.

27/12/20072007-336977

JP

27/12/200761/017053USPCT/JP/2008/073697WO/2009/084621


)2010.01 (C12Q20647116/12/2008

A רידיוםשיטה לגילוי קריפטוספו METHOD OF DETECTINGCRYPTOSPORIDIUMSYDNEY WATER CORPORATION,INCORPORATED UNDER THESYDNEY WATER ACT, 1994

17/12/20072007906896AUPCT/AU/2008/001845WO/2009/076708

)2010.01 (E03D20647217/06/2010

SYSTEM מערכת ושיטה לחיסכון ביתי של מים AND METHOD FOR SAVINGHOME WATER

SARA שרה שמר SHEMER

)2010.01 (A61K20647319/12/2008

תכשירים המכילים מלחי אלסמיטרוצין יציבים

STABLE ELSAMITRUCIN SALTFORMULATIONSSPECTRUM PHARMACEUTICALS,INC.

19/12/200761/015183USPCT/US/2008/087683WO/2009/086108

)2010.01 (G06T20647415/12/2008

METHOD שיטה ומכשיר לעיבוד תמונות OF AND APPARATUS FORPROCESSING IMAGES

RAMOTמ"רמות ליד אוניברסיטת תל אביב בע AT TEL-AVIV UNIVERSITYLTD.

20/12/200761/008309US


PCT/IL/2008/001623WO/2009/081394

)2010.01 (A61K20647618/12/2008

נגזרות בנזותיאזול ובנזואוקסאזול ושיטות לשימושן

BENZOTHIAZOLE ANDBENZOXAZOLE DERIVATIVES ANDMETHODS OF USEABBOTT LABORATORIES

20/12/200761/015513US17/12/200812/337433US

PCT/US/2008/087413WO/2009/085945

)2010.01 (A01N20647720/12/2008

–דיהידרוקסי–4,3(–9–אמינו–6[–3{–4–2–פורין–מימן9–)יל–2–פורן–טטרהידרו

של–1–פיפרידין–}יניל–2–פרופ–]יל אסטריםחומצה קרבוקסילית מותמרים כאגוניסטים

2Aשל אדנוזין רצפטור

SUBSTITUTED 4-{3-[6-AMINO-9-(3,4-DIHYDROXY-TETRAHYDRO-FURAN-2-YL)-9H-PURIN-2-YL]-PROP-2-YNYL}-PIPERIDINE-1-CARBOXYLICACID ESTERS AS A2AR AGONISTS

PGXHEALTH, LLC20/12/200761/015303US

PCT/US/2008/087875WO/2009/082720

)2010.01 (C07D20647812/01/2009

תהליכים להכנה ולניקוי של פאליפרידון פלמיטאט

PROCESSES FOR THE PREPARATIONAND PURIFICATION OFPALIPERIDONE PALMITATE

TEVAמ"טבע תעשיות פרמצבטיות בע PHARMACEUTICALINDUSTRIES LTD.

10/01/200861/020222US18/03/200861/037586US23/05/200861/055690US01/08/200861/085503US26/08/200861/091808US

PCT/US/2009/000205


WO/2009/089076

)2010.01 (C07D20647923/10/2007

צורות קריסטליניות של פלונוסטרון הידרוכלוריד

CRYSTALLINE FORMS OFPALONOSETRON HYDROCHLORIDE

SICOR INC23/10/200660/853840US28/11/200660/861488US29/11/200660/861847US01/02/200760/899102US01/02/200760/899109US20/03/200760/919165US14/08/200760/955679US

PCT/US/2007/022539WO/2008/051564

)2010.01 (C07D20648030/12/2008

תהליכים להכנת מופירוצין קלציום קריסטליני

PROCESS FOR PREPARINGCRYSTALLINE CALCIUMMUPIROCIN DIHYDRATEPLIVA HRVATSKA D.O.O.

24/01/200861/023350USPCT/GB/2008/004307WO/2009/092991

)2010.01 (A61N20648115/02/2009

מכשיר לטיפול בעור לשימוש אישיA SKIN TREATMENT APPARATUSFOR PERSONAL USE AND THEMETHOD OF USING SAME

SYNERONמ"סינרון מדיקל בע MEDICAL LTD20/02/200861/030007US

PCT/IL/2009/000178WO/2009/104178


)2010.01 (H01R20648216/12/2008

CONNECTOR מכלול חיבור בעל שרוול אחיזה ASSEMBLY WITHGRIPPING SLEEVEAMPHENOL CORPORATION

20/12/200712/003109USPCT/US/2008/086941WO/2009/085735

)2010.01 (A61K20648319/07/2005

תרכובות ושיטות לשימוש בחלבון דמוי4אנגיופויטין

COMPOSITIONS AND METHODS OFUSING ANGIOPOIETIN-LIKE 4PROTEINGENENTECH, INC.

20/07/200460/589875USPCT/US/2005/025650WO/2006/014678

)2010.01 (C12N20648414/01/2009

מודלים עכבריים הנושאים מוטציה שבה הוצא הגן לגלוטאמיניל ציקלאז

MOUSE MODELS CARRYING AKNOCK-OUT MUTATION OF THEGLUTAMINYL CYCLASE GENEPROBIODRUG AG

14/01/200861/020784USPCT/EP/2009/050387WO/2009/090190

)2010.01 (A61B20648511/01/2008

שיטה והתקן לקביעת תכונה של רקמה חיה

A METHOD AND DEVICE FORDETERMINING A PROPERTY OFLIVING TISSUESOLIANIS HOLDING AG

PCT/CH/2008/000016WO/2009/086643


)2010.01 (A61K20648728/01/2009

PHARMACEUTICAL תכשירי רוקחות COMPOSITIONSBIOVAIL LABORATORIESINTERNATIONAL S.R.L.

28/01/200861/023951USPCT/EP/2009/050924WO/2009/095395

)2010.01 (A23D20648827/11/2008

SUNFLOWER שמן חמניות עם יציבות בחום גבוה OIL WITH HIGH HEATSTABILITYCONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS

21/12/2007P200703417ESPCT/ES/2008/070220WO/2009/080858

)2010.01 (A01M20648923/01/2009

APPARATUS התקן לבקרה על מזיקים FOR PEST CONTROLBASF SE

25/01/200861/023553USPCT/EP/2009/050765WO/2009/092783

)2010.01 (H04W20649006/01/2009

שיטה לניידות במצב סרק נטולת איתות משולבת2GPP3–וGPP3עבור רשת

A METHOD OF SIGNALING-FREEIDLE MODE MOBILITY FOR ANINTEGRATED 3GPP AND 3GPP2NETWORKALCATEL-LUCENT USA INC.

07/01/200811/970139USPCT/US/2009/000072WO/2009/089005


)2010.01 (C07D20649205/02/2009

תרופות, הטרוציקליים ספיציקלייםשימוש בהן, המכילות תרכובות אלו

ושיטה לייצורם

SPIROCYCLIC HETEROCYCLES,MEDICAMENTS CONTAINING SAIDCOMPOUNDS, USE THEREOF ANDMETHOD FOR THEIR PRODUCTIONBOEHRINGER INGELHEIMINTERNATIONAL GMBH

07/02/200808101353.4EPPCT/EP/2009/000805WO/2009/098061

)2010.01 (G06F20649317/12/2008

AUTOMATED חתימות אוטומטיות למסמך משפטי FORENSIC DOCUMENTSIGNATURESGEORGETOWN UNIVERSITY

21/12/200711/963186US12/05/200812/118942US

PCT/US/2008/087201WO/2009/085845

)2010.01 (C12N20649416/12/2008

TRICHOME פרומוטורים ייחודיים לטריכום SPECIFIC PROMOTERSKEYGENE N.V.

21/12/200707123967.7EPPCT/NL/2008/050803WO/2009/082208

)2010.01 (B01F20649520/06/2010

מתקן בעל מספר מיכלים לערבוב בתוכו מספר של מרכיבים לפני שימוש

MULTI-COMPARTMENT APPARATUSFOR IN-SITU MIXING OF APLURALITY OF COMPONENTSBEFORE USE


AMIT עמית גולדבלט GOLDBLAT

)2010.01 (C08L20649620/06/2010

שיטות להסרת חומציות, תכשירי ליגניןמזרם ליגנין ושיטות להפקת חומר

ליגנותאית

LIGNIN COMPOSITIONS, METHODSFOR DEACIDIFICATION OF A LIGNINSTREAM AND METHODS FORPROCESSING A LIGNOCELLULOSICMATERIAL

ס בע' אייץ HCLמ"אל קלינטג CLEANTECH LTD.

)2010.01 (C07K20649720/12/2005

ים חלבוני פולינוקליאוטידים המקודדקונקסין או ואריאנטים שלהם ושימושים

בהם

POLYNUCLEOTIDES ENCODINGCONNEXIN PROTEINS OR VARIANTSTHEREOF AND USES THEREOF

MUSC FOUNDATION FOR RESEARCHDEVELOPMENT

21/12/200460/638366US15/04/200560/671796US

PCT/US/2005/046442WO/2006/069181

)2010.01 (C07K20649820/12/2005

פוליפפטידים שהם פראגמנטים של קונקסין או ואריאנטים שלהם

CONNEXIN POLYPEPTIDEFRAGMENTS OR VARIANTSTHEREOFMUSC FOUNDATION FOR RESEARCHDEVELOPMENT

21/12/200460/638366US15/04/200560/671796US

PCT/US/2005/046442


WO/2006/069181

)2010.01 (C12Q20649919/12/2008

וס שיטות ומערבות לזיהוי סטאפילוקוק אוריאוס עמידים למתיצילין

METHODS AND KITS FOR THEDETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUSAUREUSBIOEMRIEUX SA

21/12/200761/008680USPCT/US/2008/013922WO/2009/085221

)2010.01 (C07D20650018/12/2008

שיטה לייצור סיטאגליפטין ומלחים רוקחיים מתאימים שלהם

PROCESS FOR THE PREPARATION OFSITAGLIPTIN ANDPHARMACEUTICALLY ACCEPTABLESALTS THEREOFDR. REDDY'S LABORATORIES, LTD

20/12/20073076/CHE/2007IN18/01/2008159/CHE/2008IN14/05/20081188/CHE/2008IN04/06/200861/058764US05/06/200861/058975US18/09/200861/097910US

PCT/US/2008/087491WO/2009/085990

)2010.01 (A61B20650130/01/2009

הפחתת המינון ושיפור תמונה בטומוגרפיהדרך ניצול של סביבת האובייקט כאילוצים

דינמיים

DOSE REDUCTION AND IMAGEENHANCEMENT IN TOMOGRAPHYTHROUGH THE UTILIZATION OFTHE OBJECT'S SURROUNDINGS ASDYNAMIC CONSTRAINTSTHE REGENTS OF THE UNIVERSITYOF CALIFORNIA

30/01/200861/024762USPCT/US/2009/032733


WO/2009/097580

)2010.01 (A61K20650219/12/2008

–שיטות לשימוש וזיהוי מאפננים של דמוי4דלתא

METHODS FOR USING ANDIDENTIFYING MODULATORS OFDELTA-LIKE 4VASGENE THERAPEUTICS, INC.

20/12/200712/005054USPCT/US/2008/013899WO/2009/085209

)2010.01 (H04L20650309/01/2009

ל SYSTEM צפיפות רשתמערכת ושיטה להתאים AND METHOD TO ADAPTTO NETWORK CONGESTIONQUALCOMM INCORPORATED

10/01/200861/020368US09/12/200812/331234US

PCT/US/2009/030668WO/2009/089497

)2010.01 (B01F20650419/12/2008

METHOD שיטה והתקן לערבוב AND APPARATUS FORMIXINGPHILADELPHIA MIXING SOLUTIONS,LTD

21/12/200761/016126USPCT/US/2008/087584WO/2009/082677

)2010.01 (F01P20650519/12/2008

APPARATUS התקן ושיטה לאחסון אנרגית חום AND METHOD FORSTORING HEAT ENERGY


RESEARCH FOUNDATION OF THECITY UNIVERSITY OF NEW YORK

21/12/200761/008635US31/01/200861/063467US17/03/200861/069778US17/03/200861/069779US23/07/200861/083005US23/07/200861/083051US04/08/200861/086055US15/09/200861/097043US18/11/200861/115831US

PCT/US/2008/087820WO/2009/082713

)2010.01 (F24J20650719/12/2008

SOLAR רפלקטור לאנרגיה סולרית ENERGY REFLECTORAGC GLASS EUROPE

21/12/200707150319.7EPPCT/EP/2008/067990WO/2009/080741

)2010.01 (G01C20650814/11/2008

להנחתת כלי טיס בעל כנף התקן ושיטה מסתובבת

APPARATUS AND METHOD FORLANDING A ROTARY WINGAIRCRAFTBAE SYSTEMS PLC

21/12/20070725091.3GB21/12/200707255029.6EP

PCT/GB/2008/051065WO/2009/081177

)2010.01 (A01G20650927/10/2008

פונית לגידול ירקות ודגים–מערכת אקוהAQUAPONIC SYSTEM FORVEGETABLE AND FISHPRODUCTIONFORSCHUNGSVERBUND BERLINE.V.


28/08/200808163189.7EPPCT/EP/2008/064546WO/2010/022800

)2010.01 (G07C20651018/12/2008

שיטה ליצירת הוכחה לנוכחות או פעילותשל גוף באזור מזוהה למשך זמן הגדול

ומערכת לבחינתה, מסף נתון

METHOD OF PRODUCING A PROOFOF PRESENCE OR OF OPERATION OFAN ENTITY IN AN IDENTIFIED ZONEFOR A DURATION GREATER THAN AGIVEN THRESHOLD, ANDMONITORING SYSTEMEADS SECURE NETWORKS

21/12/20070709066FRPCT/FR/2008/001785WO/2009/106729

)2010.01 (A47G20651121/06/2010

APPARATUS מיתקן לחסימת חולדות בצנרת ביוב FOR OBSTRUCTINGRATS IN SEWAGE PIPES

GERARD ררד אוריילי'ג O'REILLY

)2010.01 (C11D20651217/06/2009

לעבודות קלות הרכבי ניקוי נוזליים ושיטות לייצורם והשימוש בהם

LIGHT DUTY LIQUID CLEANINGCOMPOSITIONS AND METHODS OFMANUFACTURE AND USE THEREOFCOLGATE-PALMOLIVE COMPANY

17/06/200812/140806USPCT/US/2009/047604WO/2009/155314


)2010.01 (C12N20651321/12/2007

שיטה משופרת לשינוי גנטי בשימושהכנסה באמצעות פוליאתלין גליקול

של בסיסים גרעיניים שעברו שינוי גנטי לתוך התוכן החי בתאי צמחים

AN IMPROVED MUTAGENESISMETHOD USING POLYETHYLENEGLYCOL MEDIATED INTRODUCTIONOF MUTAGENIC NUCLEOBASES INTOPLANT PROTOPLASTSKEYGENE N.V.

21/12/2007NL2007/000326WOPCT/NL/2007/000326WO/2009/082190

)2010.01 (C07D20651417/12/2008

הכנתן, תולדות טריאזול אוקסאדיאזול ותכשירי רוקחות המכילים אותן

TRIAZOLE OXADIAZOLESDERIVATIVES, THEIR PREPARATIONAND PHARMACEUTICALCOMPOSITIONS CONTAINING THEMMERCK SERONO S.A.

21/12/200707150311.4EP20/02/200861/066385US

PCT/EP/2008/067776WO/2009/080663

)2010.01 (B01F20651519/12/2008

GAS אימפלר ריקוע גז FOIL IMPELLERPHILADELPHIA MIXING SOLUTIONS,LTD

21/12/200761/016246USPCT/US/2008/087576WO/2009/082676

)2010.01 (C07K20651601/04/2005

תכשיר מנסיוב של עז לטיפול במחלות אוטואימוניות

GOAT SERUM COMPOSITION FORTHE TREATMENT OF AUTOIMMUNEDISORDERSAIM SCO LIMITED

05/04/20040407710.3GB


17/05/20040410966.6GBPCT/GB/2005/050046WO/2005/097183

)2010.01 (H01P20651716/12/2008

התקן להעברת אותות למאתר משושה ניידת

DEVICE FOR CONVEYING SIGNALSFOR MOBILE ANTENNA POSITIONER

THALES21/12/20070709053FR

PCT/EP/2008/067650WO/2009/083440

)2010.01 (C07K20651827/01/2005

Fc–זקיק–מעורר–ןחלבונים מאוחים הורמו(Fc–FSH(הטרודימרים

HETERODIMERIC FOLLICLESTIMULATING HORMONE - Fc (FSH-Fc) FUSION PROTEINSSYNTONIX PHARMACEUTICALS, INC

28/01/200460/540236USPCT/US/2005/003034WO/2005/073383

)2010.01 (H02M20651919/12/2008

פזי–מעגל תיקון פקטור כח לספק כח תלתPOWER FACTOR CORRECTIONCIRCUIT FOR THREE-PHASE POWERSUPPLYTHALES

21/12/20070709029USPCT/EP/2008/068066WO/2009/083504

)2010.01 (H01Q20652019/12/2008


רחב קיטובית כיוונית–רשת משושה פסDIRECTIONAL MULTIPLE-POLARISATION WIDE-BANDANTENNA NETWORKTHALES

21/12/20070709050FRPCT/EP/2008/068090WO/2009/083511

)2010.01 (A01N20652106/06/2005

METHODS שיטה להפחתת נזק מנמטודים OF REDUCINGNEMATODE DAMAGESYNGENTA PARTICIPATIONS AG

07/06/200404013338.1EPPCT/EP/2005/006057WO/2005/120232

)2010.01 (E04G20652320/11/2008

FORMWORK שלד לעמודים פריזמטים FOR PRISMATICCOLUMNSFATEC, S.A.

30/01/2008P200800237ESPCT/ES/2008/000725WO/2009/095508

)2010.01 (C07C20652420/04/2009

DIMETHYLMINOBUTYRIC-4 דימתילאמינובוטירית–4תולדות חומצה ACIDDERIVATIVESF. HOFFMANN-LA ROCHE AG

29/04/200808155323.2EPPCT/EP/2009/054635WO/2009/132978

)2010.01 (C40B20652529/12/2008


התפתחות נויריט כבדיקה לתרכובות לשיפור זיכרון

NEURITE OUTGROWTH AS ANASSAY FOR MEMORY ENHANCINGCOMPOUNDSHELICON THERAPEUTICS, INC.

27/12/200761/017134USPCT/US/2008/088477WO/2009/086532

)2008.04 (B82B20652628/09/2001

–רשתות מיקרוסקופיות של מיכלים וננו צינורות

MICROSCOPIC NETWORKS OFCONTAINERS AND NANOTUBES

NANOXIS AB28/09/20000003506-3SE

PCT/SE/2001/002116WO/2002/026616

)2010.01 (C07D20653022/12/2008

6קווינולים איזו–)H2(–1תהליך להכנת מותמרים

PROCESS FOR THE PREPARATIONOF 6-SUBSTITUTED-1-(2H)-ISOQUINOLINONESSANOFI AVENTIS

26/12/200707291622.4EP28/05/200861/056550US

PCT/EP/2008/010998WO/2009/080335

)2010.01 (C07D20653112/12/2008

–2–תיאדיאזול–)N–(1,3,4פירידיל טבעתיתהליכים, בנזן סולפואמידים–איל

להכנתם ושימוש שלהם כתרופות

CYCLIC PYRIDYL-N-(1,3,4)-THIADIAZOL -2-YL-BENZENESULFONAMIDES, PROCESSES FORTHEIR PREPARATION AND THEIRUSE AS PHARMACEUTICALSSANOFI AVENTIS

26/12/200707291626.5EPPCT/EP/2008/010559WO/2009/080223


)2010.01 (A61K20653218/12/2008

A שיטה לטיפול במחלות נוירודגנרטיביות METHOD OF TREATINGNEURODEGENERATIVE DISEASES

הרשות, גוריון בנגב-אוניברסיטת בן למחקר ופיתוח

BEN GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY

21/12/200761/008580USPCT/IL/2008/001639WO/2009/081395

)2010.01 (A61B20653318/09/2003

,METHOD מכשיר ומערכת לאפיון שינה, שיטה APPARATUS AND SYSTEMFOR CHARACTERIZING SLEEP

בע-רמות ליד אוניברסיטת תל RAMOTמ"אביב AT TEL-AVIV UNIVERSITYLTD.

19/09/200260/411829US10/01/200360/439029US

PCT/IL/2003/000753WO/2004/026133

)2010.01 (A47D20653422/06/2010

EDGE-ILLUMINATED פנל מואר קצוות PANELבעסולארל SOLARLEDמ"ד LTD

)2010.01 (A47J20653522/06/2010

מתקן להחזקת תבניות ומתקנים לשכלול השימושים בתבניות גמישות

FORM HOLDING DEVICE ANDDEVICES EXTENDING THE USES OFFLEXIBLE FORMS

SARIמ"שרי קליין בע KLEIN LTD.


)2010.01 (G01B20653822/06/2010

GUITAR גיטרה ושיטה לנגן בה AND METHOD OF USINGSAME

OMB גיטרס.בי.אם. או GUITARS

)2010.01 (F41A20654622/06/2010

A תוסף למחסנית MAGAZINE ADD-ONYOSEF יוסף עמר AMAR

)2010.01 (A47J20654723/12/2008

LIQUID מיכשור לחימום נוזל HEATING APPARATUSSTRIX LIMITED

24/12/20070725235.6GBPCT/GB/2008/004249WO/2009/081156

)2010.01 (C07K20655223/12/2008

138CDשיטות וגורמים לשיפור כיוון של המציינים תאים גידוליים

METHODS AND AGENTS FORIMPROVING TARGETING OF CD138EXPRESSSING TUMOR CELLSIMMUNOGEN, INC.

26/12/200761/016614US08/08/200861/087590US


08/08/200861/087466USPCT/EP/2008/068270WO/2009/080832

)2010.01 (C07K20655323/12/2008

ל 138CD–אימונוקוניוגטים מכוונים ימושים בהםוש

IMMUNOCONJUGATES TARGETINGCD138 AND USES THEREOF

IMMUNOGEN, INC.26/12/200761/016620US08/08/200861/087466US08/08/200861/087590US

PCT/EP/2008/068267WO/2009/080830

)2010.01 (C07K20655423/12/2008

ל AGENTS והשימוש בו138CD–גורם מכוון TARGETING CD138 ANDUSES THEREOFBIOTEST AG

26/12/200761/016630USPCT/EP/2008/068266WO/2009/080829

)2010.01 (H04S20655506/01/2009

MATRIX מפענח מערך DECODERDOLBY LABORATORIES LICENSINGCORPORATION

11/01/200861/010896USPCT/US/2009/030204WO/2009/089209

)2010.01 (F01P20655622/06/2010


התקן ליצירת הספק חשמלי המבוסס על המרת חום לרוח בעלת מהירות קבועה

APPARATUS FOR ELECTRICALPOWER GENERATION BASED ONCONVERTING HEAT TO WIND WITHCONSTANT VELOCITY

MICHAEL בסקי'מיכאל אופצ OPACHEVSKY

)2010.01 (H04N20655725/12/2008

NOISE הפחתת רעש בתמונות REDUCTION OF IMAGESMEDIC VISION-BRAINTECHNOLOGIES LTD

25/12/200761/016578USPCT/IL/2008/001679WO/2009/081410

)2010.01 (A62B20655823/06/2010

HEAT בגד קירור PROTECTION SUITDAVID דוד בן יאיר BEN JAIR

)2010.01 (F04B20656918/12/2008

מערכת סיכה למסבים עבור משאבה גאוטרמית

WATER LUBRICATED LINE SHAFTBEARING AND LUBRICATIONSYSTEM FOR A GEOTHERMAL PUMPORMAT TECHNOLOGIES INC.

27/12/200711/965326USPCT/IB/2008/003534WO/2009/090479


)2010.01 (C01B20658024/12/2008

2COMETHODSשיטות להפרדת OF SEQUESTERING CO2CALERA CORPORATION

28/12/200761/017405US29/05/200861/057173US17/06/200861/073319US22/07/200861/082766US12/08/200861/088340US13/08/200861/088347US30/09/200861/101626US11/12/200861/121872US23/12/2008PCT/US2008/088242US23/12/2008PCT/US2008/088246US

PCT/US/2008/088318WO/2009/086460

)2010.01 (H04L20658103/03/2009

KEY מערכת לחלוקת מפתחות DISTRIBUTION SYSTEMNDS LIMITED

10/03/200861/068712USPCT/IB/2009/050842WO/2009/112966

)2010.01 (G06F20658225/03/2009

ידי מעבדים סימולציית תכנון על מקביליים

DESIGN SIMULATION USINGPARALLEL PROCESSORS

ROCKETICK TECHNOLOGIES LTD27/03/200861/039817US10/07/200861/079461US07/08/200861/086803US03/11/200861/110676US

PCT/IL/2009/000330WO/2009/118731

)2010.01 (C12N20658519/03/2002


EVOLVING פיתוח פונקציה מולקולרית חדשה NEW MOLECULARFUNCTIONPRESIDENT AND FELLOWS OFHARVARD COLLEGE

19/03/200160/277081US19/03/200160/277094US20/07/200160/306691US19/03/200210/101030US

PCT/US/2002/008546WO/2002/074929

)2010.01 (C12N20658619/03/2002

EVOLVING פיתוח פונקציה מולקולרית חדשה NEW MOLECULARFUNCTIONPRESIDENT AND FELLOWS OFHARVARD COLLEGE

19/03/200160/277081US19/03/200160/277094US20/07/200160/306691US19/03/200210/101030US

PCT/US/2002/008546WO/2002/074929

)2010.01 (G01R20658725/12/2008

י גילוי"ע, הפחתת צריכת חשמל מהרשת חתימות אלקטרוניות של מכשירים

REDUCING POWER CONSUMPTIONIN A NETWORK BY DETECTINGELECTRICAL SIGNATURES OFAPPLIANCES

GREENLETמ"גרינלט טכנולוגיות בע TECHNOLOGIES LTD26/12/200761/016604US

PCT/IL/2008/001672WO/2009/081407

)2010.01 (B01L20658825/12/2008

DEVICE מערכת לחקירת תאים חיים FOR THE STUDY OF LIVINGCELLSSENG ENTERPRISES LTD.


26/12/200761/006130US13/11/2008PCT/IL2008/001492WO

PCT/IL/2008/001678WO/2009/081409

)2010.01 (C07K20659123/12/2008

פוליפפטידים ופולינוקלאוטידים לשינוי–עמידות צמחים לעקות ביוטיות וא

ולניצול מים ודשן,הביומס, יבול, ביוטיות של צמחים

ISOLATED POLYPEPTIDES,POLYNUCLEOTIDES USEFUL FORMODIFYING WATER USEREFFICIENCY, FERTILIZER USEEFFICIENCY, BIOTIC/ABIOTICSTRESS TOLERANCE, YIELD ANDBIOMASS IN PLANTS

בע'אבוג EVOGENEמ"ן LTD.27/12/200761/009166US20/08/200861/136238US

PCT/IL/2008/001657WO/2009/083958

)2010.01 (G09D20659224/06/2010

שיטה לחיזוי זמני הגעה לתחנות בתחבורה ציבורית

A METHOD FOR PREDICTING THEARRIVAL TIMES AT PUBLICTRANSPORTATION STATIONS

TRANSSPOTמ"טרנספוט בע LTD

)2010.01 (G09F20659324/06/2010

י מערכות שיטה להצגת פרסומות על גב תצוגה ניידות

A METHOD FOR DISPLAYINGADVERTISEMENTS ON MOBILEDISPLAY SYSTEMS

TRANSSPOTמ"טרנספוט בע LTD


)2010.01 (C07D20659409/01/2009

ב פירידואינדולים –1(–מותמריםכאנטגוניסטים להורמון המרכז)אזינון מלנין

(1-AZINONE)-SUBSTITUTEDPYRIDOINDOLES AS MCHANTAGONISTS

ALBAN Y MOLECULAR RESEARCH,INC.

11/01/200861/020530US29/04/200861/048677US

PCT/US/2009/030646WO/2009/089482

)2010.01 (A61K20659617/12/2008

COMPOSITION תכשיר לטיפול בדלקת סטרילית FOR TREATINGSTERILE INFLAMMATIONOY NEUROFOOD AB

28/12/200720075971FIPCT/FI/2008/050750WO/2009/083643

)2010.01 (H04L20661025/12/2008

מערכת ותוכנה להפצת מידעINFORMATION DISTRIBUTIONSYSTEM AND PROGRAM FOR THESAMEOGAWA KEIKO

27/12/20072007-337732

JP

PCT/JP/2008/073556WO/2009/084573

)2010.01 (C07D20661126/01/2009

אימידאזולאינילמתיל אריל סולפונאמידים חדשים

NOVEL IMIDAZOLINYLMETHYLARYL SULFONAMIDES

F. HOFFMANN-LA ROCHE AG


04/02/200861/025841USPCT/EP/2009/050841WO/2009/098136

)2010.01 (C07D20661226/01/2009




PCT/EP/2009/050839WO/2009/098135

)2010.01 (C07D20661325/12/2008

) פניל מותמר(–4תהליך לייצור–אוקסאזין]C–2,1][1,4[הקסאהידרופירידו

און–6

PROCESS FOR THE PRODUCTION OF4-(SUBSTITUTED PHENYL)HEXAHYDROPYRIDO[2,1-C][1,4]OXAZIN-6-ONEEISAI R&D MANAGEMENT CO., LTD.

26/12/200761/016796USPCT/JP/2008/073513WO/2009/081959

)2010.01 (C07D20661502/02/2009

PIPERIDINE תולדות פיפרידין סולפונאמיד SULFONAMIDEDERIVATIVESF. HOFFMANN-LA ROCHE AG

12/02/200808151328.5EPPCT/EP/2009/051135WO/2009/100994

)2010.01 (C12Q20661722/12/2008


סמנים גנטיים של סכיזופרניה והפרעה דו קוטבית

GENETIC MARKERS FORSCIHIZOPHRENIA AND BIPOLARDISORDERSUREGENE LLC

24/12/200761/016563USPCT/US/2008/088061WO/2009/082743

)2010.01 (C12M20661828/12/2008

התקנים המבוססים על הטבעהמולקולארית בפולימרים לאנליזת

מולקולות קטנות וחלבון

SMALL MOLECULES AND PROTEINANALYSIS DEVICES BASED ONMOLECULAR IMPRINTEDPOLYMERS

INFIGOמ"אינפיגו דיאגנטוסטיקס בע DIAGNOSTICS LTD27/12/200761/016829US10/02/200861/027462US

PCT/IL/2008/001688WO/2009/083975

)2010.01 (C12Q20661902/01/2009

GENETIC סמנים גנטיים של מחלות נפש MARKERS OF MENTALILLNESSSUREGENE LLC

02/01/200861/018534US17/01/200861/021756US

PCT/US/2009/030057WO/2009/089120

)2010.01 (A42B20662024/12/2008

קסדת בטחון המותאמת להסרה מהירה ונוחה בזמן חירום

SAFETY HELMET ADAPTED FORQUICK AND EASY EMERGENCYREMOVALNUTRICOM LTD.

24/12/200761/016501USPCT/IB/2008/055533WO/2009/083916


)2010.01(C07K20662119/03/1999

מעקבי קזפאז ותכשירי רוקחות המכילים אותן

CASPASE INHIBITORS ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THE SAMEVERTEX PHARMACEUTICALSINCORPORATED

19/03/199860/078770USPCT/US/1999/005919WO/1999/047545

)2010.01 (C07C20662205/12/2008

גליקופפטידים חדשים סינטטיים חלקית כחומרים אנטיבקטריאלים

NOVEL SEMI-SYNTHETICGLYCOPEPTIDES ASANTIBACTERIAL AGENTSLEAD THERAPEUTICS, INC.

26/12/200761/016783USPCT/US/2008/085716WO/2009/085562

)2010.01 (B01J20662329/12/2008

נ וזל בעזרת ניטור עיבוד בבטיחות שלעדים–והקטנה של נפיצות של סוגי גז שנוצרים ממנו או מוכלים בו

SAFELY PROCESSING A FLUID VIAMONITORING AND DECEREASINGEXPLOSIVENESS OF VAPOR-GASSPECIES FORMED THEREFROM ORCONTAINED THEREIN

ELCONמ"בע) 2003(אלקון מרכז מחזור RECYCLING CENTER (2003)LTD.

27/12/200761/009214USPCT/IB/2008/055567WO/2009/083931

)2010.01 (A47J20662423/12/2008

LIQUID מכשירים לחימום נוזל HEATING DEVICES


STRIX LIMITED24/12/20070725236.4GB09/05/20080808446.9GB22/08/20080815436.1GB

PCT/GB/2008/004252WO/2009/081159

)2010.01 (C22C20662724/12/2008

ה מחוזק תהליך ליצור חלק ממתכת בסיבים קרמיים

PROCESS FOR MANUFACTURING AMETAL PART REINFORCED WITHCERAMIC FIBRESMESSIER DOWTY SA

28/12/20070709171FRPCT/EP/2008/068293WO/2009/083572

)2010.01 (C22C20662824/12/2008

תהליך ליצור חלק ממתכת המחוזק בסיבים קרמיים

PROCESS FOR MANUFACTURING AMETAL PART REINFORCED WITHCERAMIC FIBRESMESSIER DOWTY SA

28/12/20070709172FRPCT/EP/2008/068294WO/2009/083573

)2010.01 (C22C20662924/12/2008

תהליך ליצור חלקים עם שימה העשויה מחומר מורכב ממארג מתכת

METHOD FOR MAKING PARTS WITHAN INSERT MADE OF A METAL-MATRIX COMPOSITE MATERIAL

MESSIER DOWTY SA28/12/20070709173FR

PCT/EP/2008/068292WO/2009/083571


)2010.01 (C12Q20663101/12/2008

BIOMARKERS סמנים ביולוגיים לחיזוי של נזק לכליות FOR THE PREDICTIONOF RENAL INJURY

בע'קומפיוג COMPUGENמ"ן LTD.27/12/200761/016837US

PCT/IL/2008/001561WO/2009/083950

)2010.01 (C07F20663223/12/2008

הוג'תכשירים המכילים מדכאי הדגטןלשימוש בהארכת הישרדות מסר

COMPOSITIONS COMPRISING AHEDGEHOG INHIBITOR FOR USE INEXTENDING CANCER SURVIVALINFINITY PHARMACEUTICALS, INC.

27/12/200761/017160US27/12/200711/965688US01/12/200861/118969US

PCT/US/2008/088222WO/2009/086416

)2010.01 (F41H20663319/01/2009

אלמנטים ננעלים ביניהם עבור מחיצת הגנה ושיטה

INTERLOCKING ELEMENT FORPROTECTIVE DIVIDE AND METHOD


28/01/2008189088ILPCT/IL/2009/000073WO/2009/095903

)2010.01 (B60L20663424/12/2008

SOBRIETY התקן הפעלה מבוסס פיכחון INTERLOCK DEVICEYAKI אלכסנדר שיינפלד NESHER

27/12/200761/016828USPCT/IL/2008/001664


WO/2009/083964

)2010.01 (A61N20663524/12/2008

מכשיר תדר רדיו לחימום רקמות ביולוגיות באמצעות מתקן רוטט

RF DEVICE FOR HEATINGBIOLOGICAL TISSUE USING AVIBRATING APPLICATOR

ALMAמ"אלמה לייזרס בע LASERS LTD27/12/200711/964759US

PCT/IB/2008/055532WO/2009/083915

)2010.01 (C02F36206626/12/2008

–שיטה להגברת ריכוז מושבות של מיקרואורגניזם בתהליך הסרת זיהום על ידי

עיקול אנארובי

A METHOD FOR INCREASING THECONCENTRATION OF COLONIES OFMICRO ORGANISMS IN A PROCESSFOR REMOVING CONTAMINANTSBY ANAEROBIC DIGESTIONMERCOSUL COMERCIAL LTDA.

27/12/2007PI0705361-4

BR

PCT/BR/2008/000404WO/2009/082801

)2010.01 (A61B20664428/12/2008

SYSTEM מערכת ושיטה לרישום נתוני דימות AND METHOD FORREGISTRATION OF IMAGING DATA

בע'ריל אימג REALמ"ינג IMAGING LTD31/12/200761/006223US

PCT/IL/2008/001683WO/2009/083973

)2010.01 (A61B20664512/12/2008


של עורית–התקנים לאטימת החדרה תת קטטר לכלי דם

PERCUTANEOUS CATHETERDIRECTED INTRAVASCULAROCCLUSION DEVICESAGA MEDICAL CORPORATION

28/12/200711/966397USPCT/US/2008/086601WO/2009/085665

)2010.01 (A43B20664731/03/2000

HEELING ציוד ושיטה של שימוש בעקב APPARATUS AND METHODHEELING SPORTS LIMITED

01/04/199960/127459USPCT/US/2000/008633WO/2000/059323

)2010.01 (A43B20664831/03/2000

HEELING ציוד ושיטה של שימוש בעקב APPARATUS AND METHODHEELING SPORTS LIMITED

01/04/199960/127459USPCT/US/2000/008633WO/2000/059323

)2010.01 (H04J20664914/01/2009

RESOURCE הפיכת הקצבת משאבים למקרי ALLOCATIONRANDOMIZATIONQUALCOMM INCORPORATED

14/01/200861/021005US13/01/200912/352746US

PCT/US/2009/030917WO/2009/091772

)2010.01 (H04L20665114/01/2009


חוקי פיקוח תוכנית ותשלומים שמבוסס על פרוטוקול ניידי

POLICY CONTROL AND CHARGING(PCC) RULES BASED ON MOBILITYPROTOCOLQUALCOMM INCORPORATED

14/01/200861/021013US13/01/200912/352734US

PCT/US/2009/030922WO/2009/091776

)2010.01 (A61H20665223/12/2008

, טיפול אולטרהסוני של רקמה שומנית בשילוב עם ואקום

ULTRASOUND TREATMENT OFADIPOSE TISSUE WITH VACUUMFEATURE

ULTRASHAPEמ"אולטרה שייפ בע LTD27/12/200712/005322US

PCT/IB/2008/055506WO/2009/083900

)2010.01 (A61H20665323/12/2008

APPARATUS אונדהתקן ושיטה לטיפול אולטרהס AND METHOD FORULTRASOUND TREATMENT


PCT/IB/2008/055508WO/2009/083902

)2010.01 (A61B20665425/12/2008

COMBINATION טיפול משולב THERAPYULTRASHAPEמ"אולטרה שייפ בע LTD

01/01/200811/968169USPCT/IB/2008/055537WO/2009/083919


)2010.01 (A61B20665525/12/2008

TIME-REVERSALוד אולטרהסאונד באמצעות היפוך זמןמיק ULTRASOUNDFOCUSING


PCT/IB/2008/055538WO/2009/087530

)2010.01 (F28D20665626/12/2008

צינורות חום הכוללים מחליפי חום בעלי תעלות–מיקרו

HEAT PIPES INCORPORATINGMICROCHANNEL HEATEXCHANGERSQUANTACOOL LLC

28/12/200761/017198US10/11/200812/291544US

PCT/US/2008/014081WO/2009/085307

)2010.01 (C07D20665723/12/2008

נגזרות אוקסינדול מותמר ושימושן לטיפול במחלות התלויות בווסופרסין

SUBSTITUTED OXINDOLE-DERIVATIVES AND THE USETHEREOF FOR THE TREATMENT OFVASOPRESSIN-DEPENDENTILLNESSES

ABBOTT GMBH & CO. KG27/12/200761/009276US

PCT/EP/2008/068254WO/2009/083559

)2010.01 (B01D20665823/12/2008

שחזור של כהלים גבוהים מתמיסותתמימיות מהולו

RECOVERY OF HIGHER ALCOHOLSFROM DILUTE AQUEOUSSOLUTIONSGEVO, INC.

27/12/200761/017141US


16/01/200861/021567US16/01/200861/021495US16/01/200861/021558US

PCT/US/2008/088187WO/2009/086391

)2010.01 (H04N20666023/10/2008

פרסומות טלויזיונית מטרתיות המבוססות על התנהגות בזמן אמת

TARGETED TELEVISIONADVERTISEMENTS BASED ONONLINE BEHAVIORALMONDNET, INC.

31/12/200711/968117USPCT/US/2008/081037WO/2009/088554

)2010.01 (B65D20666128/06/2010

ו או מגבת עם כיסים/תיק רחצה לבגדים לצרכי רחצה ואישיים

TOTE FOR LAUNDRY AND/ORTOWEL WITH POCKETS FORWASHING & PERSONAL NEEDS

AVRAHAM אברהם כהן COHEN

)2010.01 (G06T20666328/12/2008

מכשיר ומערכת לניתוח תמונות, שיטה תרמיות

METHOD APPARATUS AND SYSTEMFOR ANALYZING THERMAL IMAGES

בע'ריל אימג REALמ"ינג IMAGING LTD31/12/200761/006220US

PCT/IL/2008/001685WO/2009/083974

)2010.01 (A61K20666416/01/2009


ל הכנת תולדות תהליך ותוצרי ביניים מתילפנטנואית–2–יל–4–ביפניל–5חומצה

PROCESS AND INTERMEDIATES FORTHE PREPARATION OF 5-BIPHENYL-4-YL-2-METHYLPENTANOIC ACIDDERIVATIVESNOVARTIS AG

17/01/200808150353.4EPPCT/EP/2009/050510WO/2009/090251

)2010.01 (C07D20666531/12/2008

, פירידין]a–2,1[בנזואילאימידאזו–2תולדות הכנתן ושימוש רפואי בהן

2-BENZOYLIMIDAZO[1,2-a]PYRIDINEDERIVATIVES, PREPARATIONTHEREOF AND THERAPEUTIC USETHEREOFSANOFI-AVENTIS

02/01/20080800007FRPCT/FR/2008/001837WO/2009/112652

)2010.01 (C07D20666631/12/2008

–פירידינ]a–2,1[פנילאימידאזו–Nתרכובותהכנתן ויישום רפואי, קרבוקסאמיד–2

שלהן

N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2- CARBOXAMIDE COMPOUNDS,PREPARATION ANDTHERAPEUTIC USE THEREOFSANOFI-AVENTIS

02/01/200808/00008FRPCT/FR/2008/001839WO/2009/115651

)2010.01 (C07D20666731/12/2008

–2,1[הטרוארוילאימידאזו–2תולדותa[הכנתן ושימושן הרפואי, פירידין

2-HETEROAROYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES,PREPARATION AND THERAPEUTICUSE THEREOFSANOFI-AVENTIS

02/01/20080800009FR


PCT/FR/2008/001840WO/2009/106752

)2010.01 (C07D20666831/12/2008

–פירידינ]a–2,1[פנילאימידאזו–Nתולדותהכנתן ויישום רפואי, קרבוקסאמיד–2

שלהן

N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2- CARBOXAMIDE DERIVATIVES,THEIRPREPARATION AND THEIRTHERAPEUTIC APPLICATIONSANOFI-AVENTIS

02/01/20080800002FRPCT/FR/2008/001833WO/2009/106748

)2010.01 (C07D20666931/12/2008

הטרוציקליק אימידאזו–6תולדות]2,1–a[קרבוקסאמיד–2–ידיןפיר ,

הכנתן ושימושן הרפואי

6-HETEROCYCLIC IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDEDERIVATIVES, PREPARATION ANDTHERAPEUTIC USE THEREOFSANOFI-AVENTIS

02/01/20080800005FRPCT/FR/2008/001836WO/2009/106750

)2010.01 (F24H20667028/06/2010

מערכת לחיסכון בצריכת המים ההתחלתית בעת התקלחות

SYSTEM FOR SAVING THE INITALWATER CONSUMPTION WHILETAKING A SHOWER

YAIR יאיר יעקב YAACOV


)2010.01 (C07D20667131/12/2008

–2,1[אימידאזו–הטרוציקליק–Nתולדותa[הכנתן ויישום, קרבוקסאמיד–2–פירידינ

רפואי שלהן

N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDEDERIVATIVES, THEIR PREPARATIONAND THEIR THERAPEUTICAPPLICATIONSANOFI-AVENTIS

02/01/20080800003FRPCT/FR/2008/001834WO/2009/106749

)2010.01 (C07D20667231/12/2008

–הטרוציקליק–6–הטרוציקליק–Nתולדות, קרבוקסאמיד–2–פירידיןa[–2,1[אימידאזו

הכנתן ושימושן הרפואי

N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDEDERIVATIVES, PREPARATION ANDTHERAPEUTIC USE THEREOFSANOFI-AVENTIS

02/01/200808/00006FRPCT/FR/2008/001838WO/2009/106751

)2010.01 (C07D20667331/12/2008

–2–פירידינ]A–2,1[תולדות אימידאזו הכנתן ויישום רפואי שלהן, קרבוקסאמיד

IMIDAZO[1,2-A]PYRIDINE -2-CARBOXAMIDE DERIVATIVES,THEIR PREPARATION AND THEIRTHERAPEUTIC APPLICATIONSANOFI-AVENTIS

02/01/20080800004FRPCT/FR/2008/001835WO/2009/112651

)2010.01 (C07D20667426/01/2009


N–[3–דיהידרו–5,4(–4–כלורו–2–ברומו–H1–פניל–)ילמתיל–2–אימידאזול[–

מתאנסולפונאמיד כאגוניסט חלקיאדרנרגי לטיפול בחוסרA1–לאלפא

שליטה בסוגרים

N-[3-BROMO-2-CHLORO-4-(4,5-DIHYDRO-1H-IMIDAZOL -2-YLMETHYL)-PHENYL]-METHANESULFONAMIDE ASALPHA-1 A ADRENERGIC PARTIALAGONIST FOR THE TREATMENT OFINCONTINENCEF. HOFFMANN-LA ROCHE AG

04/02/200861/025839USPCT/EP/2009/050838WO/2009/098134

)2010.01 (G07D20667528/06/2010

מערכת מקוונת לניהול קניון וירטואלי תוך שימוש ברשתות חברתיות

ONLINE VIRTUAL SHOPPING MALLUSING SOCIAL MEDIA SITES

F.Bמ"בע. שופ.בי.אפ SHOP LTD

)2010.01 (A63H20667628/06/2010

COMBAT ערכה ושיטה לשחקו, מתקני משחק קרב GAME APPARATUS, KITAND METHOD

BORIS בוריס בורוכוב BOROCHOV

)2010.01 (C12P20667828/06/2010

A שיטה להפקת סוכרים הניתנים לתסיסה METHOD FOR THE PRODUCTIONOF FERMENTABLE SUGARS



)2010.01 (C07D66792026/07/2007

, מאפנני פעילות קולטן הכימוקין ותהליכים לייצורם

MODULATORS OF CHEMOKINERECEPTORS AND PROCESSES FORTHE PREPARATION OF THE SAMEBRISTOL-MYERS SQUIBB COMPANY

28/07/200660/834235US21/03/200760/896026US25/07/200711/782742US

PCT/US/2007/074377WO/2008/014360

)2010.01 (H04L20668030/01/2009

FREQUENCY הערכת שגיאות תדירות ERROR ESTIMATIONQUALCOMM INCORPORATED

01/02/200861/025641US08/08/200812/188619US

PCT/US/2009/032533WO/2009/099913

)2010.01 (H04W20668123/01/2009

ניהול כוח הדרום במערכת תקשורת אלחוטית

POWER HEADROOM MANAGEMENTIN WIRELESS COMMUNICATIONSYSTEMSQUALCOMM INCORPORATED

25/01/200861/023785US22/01/200912/357698US

PCT/US/2009/031816WO/2009/094525

)2010.01 (H04W20668214/01/2009


רכת ושיטה לאפשר כוונון כוח תחנת מעבסיס מבוססות על משואות שכנות בתוך

מערכת

SYSTEM AND METHOD TO ENABLEBASE STATION POWER SETTINGBASED ON NEIGHBORING BEACONSWITHIN A NETWORKQUALCOMM INCORPORATED

17/01/200861/021767US13/01/200912/353092US

PCT/US/2009/030948WO/2009/091795

)2010.01 (A61P20669020/01/2009

מעכבי חלבון קנאז והשימוש בהם להכנת תרופות

PROTEIN KINASE INHIBITORS ANDTHEIR USE IN THE PREPARATION OFMEDICAMENTSMERCK SERONO S.A.

22/01/200861/011872USPCT/US/2009/000291WO/2009/094123

)2010.01 (A61K20669107/01/2009

SLDLRבדלקת כבד SLDLR IN LIVER INFECTIONS

בעידע YEDAמ"חברה למחקר ופיתוח RESEARCH ANDDEVELOPMENT CO. LTD.

07/01/2008188628ILPCT/IL/2009/000023WO/2009/087622

)2010.01 (A47K20669229/06/2010

SHOWER מערכת סיבון למקלחת SOAP SCRUBBING SYSTEMELIMELECH אלימלך קורן KOREN


)2010.01 (A63H20669329/06/2010

A צעצוע רובה כדורי שלג SNOWBALL GUN TOYMICHAEL מיכאל פירון PERRON

01/07/200961/222122US

)2010.01 (B24D20669423/12/2008

רפידת תיווך בין פריט שוחק לבין כלי תמיכה

INTERFACE PAD FOR USE BETWEENAN ABRASIVE ARTICLE AND ASUPPORT TOOLSaint-Gobain ABRASIFS

31/12/200761/009631USPCT/US/2008/088160WO/2009/088772

)2010.01 (H04W20669730/12/2008

ה מהירה למסרים שיטה ומערכת לתגוב דיגיטליים

A METHOD AND A SYSTEM FORRAPID AWARENESS, RECOGNITION,AND RESPONSE TO DIGITALMESSAGES

BKLKמ"בקלק בע LTD31/12/200761/006222US

PCT/IL/2008/001699WO/2009/083981

)2010.01 (E04G20669917/10/2008

RICATED רכיבי בנין מיוצרים מראש וציוד הרכבה BUILDING COMPONENTSAND ASSEMBLY EQUIPMENTSLEO, ANO

08/01/200811/971018US09/10/200812/248051US

PCT/CA/2008/001809WO/2009/086617


)2010.01 (H04L20670114/01/2009

עבודת ביניים יעילה בין שירותי–מעגל ומוחלפי–מולטימדיה מוחלפי

חבילה שמגדירים מאפיין גודל חבילה מירבי

EFFICIENT INTERWORKINGBETWEEN CIRCUIT-SWITCHED ANDPACKET-SWITCHED MULTIMEDIASERVICES DEFINING A MAXIMUMPACKET SIZE ATTRIBUTEQUALCOMM INCORPORATED

14/01/200861/020982US15/01/200861/021163US13/01/200912/353183US

PCT/US/2009/030959WO/2009/091805

)2010.01 (A61F20670218/05/2009

טיפול בכאבי מחזור על ידי מתן דרך העור של תרופות נגד דלקת שאינן סטרואידיות

TREATMENT OF DYSMENORRHEAVIA TRANSDERMALADMINISTRATION OFNONSTEROIDAL ANTI-INFLAMMATORY DRUGSTEIKOKU PHARMA USA, INC.

21/05/200861/055061USPCT/US/2009/044379WO/2009/143070

)2010.01 (H04W20670330/01/2009

לתמיכה בביטולUTRANשיפור תאי–התאבכות בין

UTRAN ENHANCEMENTS FOR THESUPPORT OF INTER-CELLINTERFERENCE CANCELLATIONQUALCOMM INCORPORATED

01/02/200861/025701US28/01/200912/361124US

PCT/US/2009/032541WO/2009/099915


)2010.01 (C07D20670414/10/2008

תולדות הטרוציקליות מאוחדות ושיטותסילשימוש מט–כמעכבי

FUSED HETEROCYCLICDERIVATIVES AND METHODS OFUSE AS C-MET INHIBITORSAMGEN INC

ONA AMGEN CENTER DRIVE15/01/200812/009123US

PCT/US/2008/011724WO/2009/091374

)2010.01 (G06F20670518/12/2003

HPNAHPNAנתב HUB

COPPERGATEמ"קופרגייט תקשורת בע COMMUNICATIONSLTD.

27/12/200210/330703USPCT/IL/2003/001087WO/2004/059896

)2010.01 (G06F20670618/12/2003

HPNAHPNAנתב HUB

COPPERGATEמ"קופרגייט תקשורת בע COMMUNICATIONSLTD.

27/12/200210/330703USPCT/IL/2003/001087WO/2004/059896

)2010.01 (B22F20670813/10/2008

VALVE חלקיקי מתכת שפופרת ושיטת ייצורם METAL PARTICLES ANDMETHOD FOR PREPARING THE SAMENINGXIA ORIENT TANTALUMINDUSTRY CO. LTD

11/01/2008200810002930.5CNPCT/CN/2008/001723WO/2009/086721


)2010.01 (G09B20672430/06/2010

IN מאמינים בנתינה GIVING WE TRUSTSARA שרה ליבא ביו BIEBA BEYO

)2010.01 (G06F20672523/03/2009

תמיכת חקוי מתקן בתוך מערכת לעיבוד מערך נתונים

DEVICE EMULATION SUPPORTWITHIN A HOST DATA PROCESSINGAPPARATUSARM LIMITED

23/05/20080809492.2GBPCT/GB/2009/000771WO/2009/141574

)2010.01 (A61K20672605/01/2009

פרומיולציה אינסולין לשיחרור אינסולין כפונקציה של רמת הגלוקוזה ברקמה

INSULIN FORMULATIONS FORINSULIN RELEASE AS A FUNCTIONOF TISSUE GLUCOSE LEVELSBIODEL, INC.

04/01/200861/019187USPCT/US/2009/030153WO/2009/089181

)2010.01 (H04W20672729/01/2009

ברה אלחוטי על ידי ניהול של צמתי הע שימוש בטבלת ניתוב

MANAGEMENT OF WIRELESSRELAY NODES USING ROUTINGTABLEQUALCOMM INCORPORATED

30/01/200861/024764AR28/01/200912/361448AR

PCT/US/2009/032474


WO/2009/097458

)2010.01 (H04W20672829/01/2009

ניהול של צמתי העברה אלחוטי על ידי שימוש במזהה

MANAGEMENT OF WIRELESSRELAY NODES USING IDENTIFIERS


PCT/US/2009/032471WO/2009/097456

)2010.01 (G01N20673431/12/2007

TUBE צינור אימות VERIFIERORIDIONמ"בע) 1987(אורדיון מדיקל MEDICAL (1987) LTD.

PCT/IL/2007/001632WO/2009/083943

)2010.01 (A61B20673501/01/2009

שיטה ומערכת לגילוי ודירוג סרטן הערמונית

METHOD AND SYSTEM FORDETECTING AND GRADINGPROSTATE CANCER


02/01/200861/006241US10/09/200861/095632US

PCT/IL/2009/000006WO/2009/083988

)2010.01 (G06F20673604/01/2009

ULTRASONIC על קולי לספרתימארח וממיר DIGITIZER AND HOSTEPOSמ"אפוס פיתוח בע DEVELOPMENT LTD

03/01/200861/006267US


PCT/IL/2009/000014WO/2009/083993

)2010.01 (A61K20673930/06/2010

INJECTABLE תכשיר רוקחות הניתן להזרקה PHARMACEUTICALCOMPOSITION

DAVID דוד סגל SEGAL

)2010.01 (F28F20674114/01/2009

HEAT מחלף חום EXCHANGERBABCOCK & WILCOX POWERGENERATION GROUP, INC.

14/01/200861/020882USPCT/US/2009/030978WO/2009/091816

)2010.01 (A61B20674217/06/2009

ו FIBER שיטת עקיבהמערכת עקיבה סיב אופטי OPTIC TRACKING SYSTEMAND METHOD FOR TRACKINGMAKO SURGICAL CORPORATION

18/06/200861/132446USPCT/US/2009/047624WO/2009/155325

)2010.01 (C02F32067424/12/2008

A מערכת להתפלת מים DESALINATION SYSTEMHAAG FAMILY TRUST

07/01/20082008900077AU13/06/20082008902987AU

PCT/AU/2008/001911


WO/2009/086587

)2010.01 (B01D20674401/07/2010

HIDDEN מערכת טיהור אויר חבויה NBC FILTRATION SYSTEM

BETH-EIמ"תעשיות בית אל זכרון יעקב בע ZIKHRON YA'AKOVINDUSTRIES LTD.

)2009.01 (C12N20675326/01/2003

EXPANSION גידול אוכלוסיות תאי גזע מתחדשות OF RENEWABLE STEMCELL POPULATIONS

בע- גמידה GAMIDA-CELLמ"סל LTD.24/01/200260/350360US30/04/200260/376183US19/08/200260/404137US17/11/2002152904IL

PCT/IL/2003/000064WO/2003/062369

)2010.01 (B65B20675409/09/2004

PUMP מכסה לבקבוק עם משאבה BOTTLE CAPSHLOMO שלמה חיימי HAIMI

02/12/200310/725007USPCT/IL/2004/000830WO/2005/054058

)2010.01 (B05D20675501/07/2010

שיטה ומערכת לצביעה אלקטרוסטטית של גליל פח

METHOD AND SYSTEM FORELECTROSTATIC PAINTING OF AROLLED TIN SHEET

ROLמ"רול פרופיל בע PROFIL LTD.


)2010.01 (A61K20675712/09/2001

תרכובות אימוניות היעילות למניעה אושיפור של זיהום פנאומוניה המכיל לפחות

רפטקוקוס פנאומוניה וייתכן שני חלבוני סט שגם חלבון המופילוס שפעתי

IMMUNOGENIC COMPOSITIONSUSEFUL FOR THE PREVENTION ORAMELIORATION OFPNEUMOCOCCAL INFECTIONCOMPRISING AT LEAST TWOSTREPTOCOCCUS PNEUMONIAEPROTEINS AND OPTIONALLY ANHAEMOPHILUS INFLUENZAEPROTEINSMITHKLINE BEECHAMBIOLOGICALS S.A.

15/09/20000022742.1GBPCT/EP/2001/010570WO/2002/022168

)2010.01 (C07D20675806/02/2009

FURO-AND פירידינים]C–2,3[תיאנו–ו–פורו THIENO [3,2-C]PYRIDINESOSI PHARMACEUTICALS, INC.

06/02/200861/063800US03/12/200861/119553US

PCT/US/2009/033311WO/2009/100282

)2010.01 (A61K20675909/02/2009

FSHLIQUIDתכשירים נוזליים של FORMULATION OF FSHBIOGENERIX AG

08/02/200808151231.1EPPCT/EP/2009/051451WO/2009/098318


)2010.01 (C12Q20676029/09/2003

וי עלייה בכולסטרול במהלך שיטות לחיז טיפול המדכא את מערכת החיסון

METHODS TO PREDICTCHOLESTEROL ELEVATIONSDURING IMMUNOSUPPRESSANTTHERAPYNOVARTIS AG

30/09/200260/415123USPCT/EP/2003/010798WO/2004/029618

)2010.01 (A61P20676126/02/2009

AMINOQUINOLINES-2 אמינוקוינולינים–2F. HOFFMANN-LA ROCHE AG

07/03/200808152425.8EPPCT/EP/2009/052253WO/2009/109502

)2010.01 (A43D20676205/01/2009

FOOT מכשיר למדידת כף רגל MEASURING DEVICEAETREX WORLDWIDE INC.

07/01/2008188645ILPCT/IL/2009/000018WO/2009/087618

)2010.01 (C07D20676326/01/2009




PCT/EP/2009/050837WO/2009/098133


)2010.01 (C07D20676420/11/2007

תרכובות ותכשירים כמעכבי פרוטאין קינאז

COMPOUNDS AND COMPOSITIONSAS PROTEIN KINASE INHIBITORS

IRM LLC08/12/200660/869299US28/08/200760/966449US

PCT/US/2007/085304WO/2008/073687

)2010.01 (C07D20676509/02/2009

יל–2–אוקסאזול–דיהידרו–5,4תולדות אמין

4,5-DIHYDRO-OXAZOL-2-YL-AMINEDERIVATIVES

SIENA BIOTECH S.P.A.18/02/200808151546.2EP

PCT/EP/2009/051452WO/2009/103626

)2010.01 (B65D20676601/07/2010

שקית לשימוש רב פעמי הניתנת לעיצוב מחדש לצורך אחסון פריט

A REUSABLE ANDRECONFIGURABLE BAG FOR ITEMSTORGE

NETA נטע וטרמן WATERMANN

)2010.01 (C07K20676702/01/2009

או פרגמנטים,Bנוגדנים מרוקנים תאיתכשירים המכילים אותם ושימוש, שלהם

פול בסינדרום המאפיין על ידי בהם לטי עייפות

B CELL DEPLETING ANTIBODIES, ORFRAGMENTS THEREOF,COMPOSITIONS COMPRISING THESAME AND USE THEREOF FORTREATING CHRONIC FATIGUESYNDROME


BERGEN TEKNOLOGIOVERFORINGAS

02/01/200808000006.0EP02/01/200861/018551US

PCT/EP/2009/000003WO/2009/083602

)2010.01 (B65D20677008/01/2009

מיכל מורכב ושיטה לייצורCOMPOSITE CONTAINER ANDMETHOD FOR MANFACTURINGSAMEDISPENSING TECHNOLOGIES B.V.

08/01/20081034895USPCT/NL/2009/000001WO/2009/088285

)2010.01 (H04W20677110/11/2008

BACKHAUL איתות בקהול להימנעות התאבכות SIGNALING FORINTERFERENCE AVOIDANCEQUALCOMM INCORPORATED

01/02/200861/025670US22/04/200861/047021US29/10/200812/260849US

PCT/US/2008/083043WO/2009/099471

)2010.01 (A23L20677213/01/2009

,A3,7–הידרוקסי–7–דקההידרו(–'1[–5 1,1––נפטאלן]A[קיצלופרופא–H1–טטרהמתיל

–2,4,6–]מתילבוטיל–'3–)יל–4בנזנדיקרבוסאלדהיד–1,3–טריהידרוקסי

כתרופה

) 5-[1'-(DECAHYDRO-7-HYDROXY-1,1,3A,7-TETRAMETHYL-1H-CYCLOPROPA[A]NAPHTALEN-4-YL)-3'-METHYLBUTYL]-2,4,6-TRIHYDROXY-1,3-BENZENEDICARBOXALDEHYDE ASMEDICAMENTSPIERRE FABRE MEDICAMENT

18/01/20080800276FRPCT/FR/2009/000038


WO/2009/106769

)2010.01 (C12N20677415/01/2009

מ שופרים מיונקים ושימושים וקטורי ביטוי שלהם

IMPROVED MAMMALIANEXPRESSION VECTORS AND USESTHEREOFABBOTT LABORATORIES

15/01/200861/021282US10/10/200861/104546US

PCT/US/2009/031136WO/2009/091912

)2010.01 (A61J20677504/07/2010

, ומחבר זכרIVמתאם רפואי כולל ספיקושיטה, קיט עבור ערבוב ונתינה תרופה

עבורו

MEDICAL ADAPTER WITH IV SPIKEAND MALE CONNECTOR, KIT FORDRUG RECONSTITUTION ANDADMINISTRATION KIT, ANDMETHOD THEREFOR

MEDIMOPמ"מדימופ פרויקטים רפואיים בע MEDICAL PROJECTS LTD.

)2010.01 (A61J20677604/07/2010

מתאם לבקבוקון עם מיצב למזרק מובנהVIAL ADAPTER WITH BUILT-INSYRINGE STABILIZER

MEDIMOPמ"מדימופ פרויקטים רפואיים בע MEDICAL PROJECTS LTD.

)2010.01 (F24C20677704/07/2010


ELECTRIC חימום חשמליים ורהיטים עם חימוםגופי HEATERS ANDFURNITURE WITH HEATING

BUYANSKY מאיר בויאנסקי MEIR

)2010.01 (B60L20677804/07/2010

ה אשר מגיע, נוסעת מכוח החשמלמכוניתמן המצברים וממחזרת חזרה למצברים

חלק גדול מהכוח

ELECTRICITY POWERED CARWHOSE POWER REACHES OF THEBETTERY AND SENDS BACK MUCHOF ELECTRICITY BACK TOBATTERY

DAVID דוד כהן COHEN

)2010.01 (B23P20677904/07/2010

METHOD שיטה והתקן לחיתוך אלמנט AND SYSTEM FORCUTTING AN ELEMENT

CAMTEKמ"קמטק בע LTD.08/07/200961/223733US

)2010.01 (B60H20678004/07/2010

A מערכת איוורור רכב ושיטה עבורה VEHICULAR VENTILATIONSYSTEM AND METHOD THEREFOR

MOSHE משה סגל SEGAL


)2010.01 (A01K20678110/11/2003

מפריסי פרסה טרנסגניים עם גנום בעלמוטציה לא טבעית עם ייצור פריונים

ושיטה לייצור נוגדנים, תפקודיים מופחת מהם

TRANSGENIC BOVINE WITH AGENOME COMPRISING A NON-NATURAL MUTATION WITHREDUCED FUNCTIONAL PRIONPRODUCTION, AND A METHOD FORPRODUCING ANTIBODIESTHEREFROMKYOWA HA KKO KIRIN CO., LTD.

08/11/200260/425056US26/09/200360/506901US

PCT/US/2003/035720WO/2004/044156

)2010.01 (C12N20678331/03/2006

ותכשיריC–20שבטי נגד–נוגדן מוראין חד רוקחות המכילים אותן

A MURINE ANTI-C20 MONOCLONALANTIBODY AND PHARMACEUTICALCOMPOSITIONS CONTAINING THESAMEBIOMEDICS INC

31/03/20052005-103093

JP

28/12/20052005&378466JPPCT/JP/2006/306925WO/2006/106959

)2010.01 (A61K20678417/12/2008

קנבינואיד–תכשירי רוקחות המכילים פיטו פסיכוטית–בצירוף עם תרופה אנטי

PHARMACEUTICAL COMPOSITIONSCONTAINING A PHYTO-CANNABINOID IN COMBINATIONWITH AN ANTI- PSYCHOTICMEDICINEOTSUKA PHARMACEUTICAL CO.,LTD.

04/01/20080800390.7GBPCT/GB/2008/004217WO/2009/087351


)2010.01 (G06F20678509/01/2009

רבקיד ערוצים המשתמש–וד אודיובחלוקה מותאמת עם נקודת גישה

אקראית ויכולת לחיזוי פרמטרים מרובים

LOSSLESS MULTI-CHANNEL AUDIOCODEC USING ADAPTIVESEGMENTATION WITH RANDOMACCESS POINT(RAP) AND MULTIPLEPREDICTION PARAMETER SET(MPPS) CAPABILITYDTS, INC.

30/01/200812/011899USPCT/US/2009/000124WO/2009/097076

)2010.01 (C12N20678623/01/2009

מערכת ושיטה לחדירה רבת מימדים לצמחים

SYSTEM AND METHOD FOR LARGE-SCALE INFILTRATION OF PLANTS

BAYER INNOVATION GMBH01/02/200808001863.3EP

PCT/EP/2009/000412WO/2009/095183

)2010.01 (C07D20678805/01/2009

תכשירים, חומרים כימיים מסוימים ושיטות

CERTAIN CHEMICAL ENTITIES,COMPOSITIONS AND METHODS

INTELLIKINE, INC.04/01/200861/009971US26/09/200861/194294US05/12/200861/201146US

PCT/US/2009/000038WO/2009/088986

)2010.01 (C07D20678905/01/2009

תכשירים, חומרים כימיים מסוימים ושיטות

CERTAIN CHEMICAL ENTITIES,COMPOSITIONS AND METHODS


INTELLIKINE, INC.04/01/200861/009971US26/09/200861/194294US05/12/200861/201146US

PCT/US/2009/000042WO/2009/088990

)2010.01 (H04W20679028/01/2009

VIRTUAL גווני–תכנון וירטואלי במערכת רב SCHEDULING INHETEROGENEOUS NETWORKSQUALCOMM INCORPORATED

01/02/200861/025515US27/01/200912/360544US

PCT/US/2009/032294WO/2009/099844

)2010.01 (A61K20679129/12/2008

CAPSULE פורמיולציית כמוסה FORMULATIONTAKEDA PHARMACEUTICALCOMPANY LIMITED

10/01/20082008-003634

JP

PCT/JP/2008/073875WO/2009/087938

)2010.01 (A47J20679203/01/2008

APPARATUS מתקן להכנת משקה FOR PRODUCING ABEVERAGEESSENCE-SBT SA

PCT/IT/2008/000005WO/2009/084061


)2010.01 (G07D20679304/07/2010

אופטימיזציה וסימולציה של זמינות מקומות חניה

OPTIMIZING AND SIMULATINGAVAILABILITY OF PARKING SPACES

URI רן ברנדס MISHAL

)2010.01 (A61K20679408/01/2009

COMPOSITIONS תכשירים לשימוש מקומי FOR TOPICAL USEבע.ד.מ .M.Dמ"לדרמן יועצים LEDERMAN CONSULTING LTD

08/01/200861/006347USPCT/IL/2009/000035WO/2009/087632

)2010.01 (A01G20679530/12/2008

MULTI-STEP שלבית ליצירת מוצרי אצות–שיטה רב METHOD FORPRODUCING ALGAE PRODUCTSTHE UNIVERSITY OF AKRON

04/01/200861/018957USPCT/US/2008/088504WO/2009/088839

)2010.01 (F41F20679730/01/2009

התקן לטעינה של תרמיל פגז במרגמה בעלת טעינה אחורית

ARRANGEMENT FOR SUPPORTINGMORTAR INTO BREECH-LOADINGWEAPON BARRELPATRIA LAND & ARMAMENT OY

31/01/200820085074FIPCT/FI/2009/050077WO/2009/095539


)2010.01 (F41F20679830/01/2009

ן לטעינה של תרמיל פגז בתותח בעל התק טעינה אחורית

ARRANGEMENT FOR SUPPORTINGSHELL INTO BREECH-LOADINGWEAPON BARRELPATRIA LAND & ARMAMENT OY

31/01/200820085075FIPCT/FI/2009/050081WO/2009/095543

)2010.01 (F41F20679930/01/2009

SUPPORT רכיב תמיכה ושיטה לתמיכה בפגז MEMBER FORSUPPORTING SHELL, AND METHODPATRIA LAND & ARMAMENT OY

31/01/200820085080FIPCT/FI/2009/050076WO/2009/095538

)2010.01 (F41F20680030/01/2009

התקן להגשה של תרמיל בנשק בעל טעינה אחורית

ARRANGEMENT FOR SUPPORTINGSHELL INTO BREECH-LOADINGWEAPON BARRELPATRIA LAND & ARMAMENT OY

31/01/200820085076FIPCT/FI/2009/050079WO/2009/095541

)2010.01 (A01N20680109/01/2009

טיפול אינטראטאכאל של כאב נוירופתיA2Aעם אגוניסטים לרצפטור

INTRATHECAL TREATMENT OFNEUROPATHIC PAIN WITH A2ARAGONISTSPGXHEALTH, LLC

09/01/200861/019912USPCT/US/2009/030565WO/2009/089425


)2010.01 (F41F20680230/01/2009

רכיב ושיטה לתמיכה בפגז לתוך קנה נשקSUPPORT MEMBER FORSUPPORTING SHELL INTO WEAPONBARREL, AND METHODPATRIA LAND & ARMAMENT OY

31/01/200820085077FIPCT/FI/2009/050080WO/2009/095542

)2010.01 (A61B20680305/07/2010

התקן דנטאלי לטיפול בנחירות ודום נשימה חסימתי

ORAL DENTAL APPLIANCE FORTREATMENT OF SNORING ANDOBSTRUCTIVE SLEEP APNEA

SAPOZNIK יוסי ספוזניק YOSSI

)2010.01 (A23L20680405/07/2010

תכשיר מרפא לחשבת מינרלים חסרים בפה

ORAL REMEDIAL MINERALREPLENISHMENT (OMR)PREPARATION

SOPHIA סופיה בראון BRAUN

)2010.01 (C09D20680507/02/2009

תכשיר הניתן להדפסה ליצור ציפוי מוליך חשמל ושיטות ליצורו

PRINTABLE COMPOSITION FORPRODUCING ELECTROCONDUCTIVECOATINGS, AND METHOD FOR THEPRODUCTION THEREOFBAYER MATERIALSCIENCE AG


13/02/2008102008008837.4DEPCT/EP/2009/000870WO/2009/100865

)2010.01 (H04B20680608/01/2009

–מכשיר תקשורת רדיו נייד רב משדר מקלט ושיטה קשורה

MULTI-TRANSCEIVER PORTABLERADIO COMMUNICATIONS DEVICEAND RELATED METHODHARRIS CORPORATION

09/01/200811/971570USPCT/US/2009/030402WO/2009/089323

)2010.01 (G06T20680715/01/2009

שיטה ומצלמה לרכישה בזמן אמת שלת מימדיות–לתמידע ויזואלי מסצנות

METHOD AND CAMERA FOR THEREAL-TIME ACQUISITION OFVISUAL INFORMATION FROMTHREE-DIMENSIONAL SCENESUNIVERSIDAD DE LA LAGUNA

15/01/2008P200800126ESPCT/ES/2009/000031WO/2009/090291

)2010.01 (C07D20680820/01/2009

פירידון בעלות פעילות–תולדות אינדוליל1בודקת לפעילותו המעכבת של קינאז

INDOLYL-PYRIDONE DERIVATIVESHAVING CHECKPOINT KINASE 1INHIBITORY ACTIVITYVERNALIS (R&D) LTD.

22/01/20080801090.2GB11/10/20080818695.9GB

PCT/GB/2009/000149WO/2009/093012


)2010.01 (A61L20680906/01/2009

ANALGESIC פוספאט אפטיטי משכך כאבים–דבק סידן APATITIC CALCIUM-PHOSPHATE CEMENTUNIVERSITE DE NANTES OF

07/01/200808290010.1EP07/01/200861/019446US

PCT/EP/2009/050081WO/2009/087148

)2010.01 (C07D20681112/01/2009

–4,3[אזולו תולדות חדשות פירd[פירימידין כגורמים נגד סרטן

NOVEL PYRAZOLO [3,4-d]PYRIMIDINE DERIVATIVES AS ANTI-CANCER AGENTSNATCO PHARMA LIMITED

11/01/2008109/CHE/2008INPCT/IN/2009/000037WO/2009/098715

)2010.01 (C07K20681209/01/2009

IAPINHIBITORSמעכבים של OF IAPGENENTECH, INC.

11/01/200861/020682USPCT/US/2009/030674WO/2009/089502

)2010.01 (H04W20681322/04/2009

תזמון שידור ללווין או מלווין)DL/UL(עבור ניצול רוחב פס מלא

UL/DL SCHEDULING FOR FULLBANDWIDTH UTILIZATIONTELEFONAKTIEBOLAGET L MERICSSON (PUBL)

30/04/200812/112220USPCT/SE/2009/050421WO/2009/134195


)2010.01 (E04F20681405/07/2010

אלמנט חזית ושיטה לאבטחתו לקירFACADE ELEMENT AND METHODFOR SECURING THE SAME TO AWALL

TERMODANמ"טרמודן בע LTD

)2010.01 (C07D20681516/01/2009

CYCLIC חוסמי תעלות טריאזו ודיאזו ציקליים TRIAZO AND DIAZOCHANNEL BLOCKERSUNIVERSITY OF GREENWICH

16/01/20080800741.1GBPCT/GB/2009/050033WO/2009/090431

)2010.01 (C07D20681615/01/2009

–דיהידרו–6,3שיטה לייצור תולדותטריאזין מתולדות מטפורמין–5,3,1

ופאראלדהיד

METHOD FOR THE PRODUCTION OF3,6-DIHYDRO-1,3,5-TRIAZINEDERIVATIVES FROM METFORMIN ANDPARALDEHYDE DERIVATIVESPOXEL SAS

02/02/2008102008007314.8DEPCT/EP/2009/000212WO/2009/095159

)2010.01 (C07D20681720/02/2009

–דיהידרו–7,6אתיל–R)–*6*N(תרכובתH5–6,5(אינדנו–D(דיאמין–6,2–תיאזול

והשימוש כאנטיפסיכוטיים

COMPOUND (R)-N*6*-ETHYL-6,7-DIHYDRO-5H-INDENO(5,6-D)THIAZOLE-2,6-DIAMINE AND THEUSE AS ANTIPSYCHOTICSASTRAZENECA AB


21/02/200861/030332USPCT/SE/2009/050188WO/2009/105026

)2010.01 (C07D20681816/02/2009

PYRROLOPYRAZINE מעכבי פירולופיראזין קינז KINASEINHIBITORSF. HOFFMANN-LA ROCHE AG

25/02/200861/031035US22/01/200961/146514US

PCT/EP/2009/051759WO/2009/106444

)2010.01 (C07D20681909/01/2009

PYRROLOPYRIMIDINES פירולופירימידינים ופירולופירידינים ANDPYRROLOPYRIDINESNOVARTIS AG

11/01/200808150182.7EPPCT/EP/2009/050225WO/2009/087225

)2010.01 (A61K20682014/01/2009

H3תרכובות –]D–5,4[טריאזולו]3,2,1]–קינאזMTORשימושן כמעכבי, פירימידין

קינאז וייצורן–3PI–ו

3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIRUSE AS MTOR KINASE AND PI3KINASE INHIBITORS AND THEIRSYNTHESESWYETH LLC

15/01/200861/021084US07/03/200861/034680US

PCT/US/2009/030939WO/2009/091788


)2010.01 (C07K20682115/07/2004

) גורם גידול עצבי(NGFנוגדנים נגדNGFכמעכבי מסלול, המנטרל פעילות

ספציפיים

HUMAN ANTI-NGF NEUTRALIZINGANTIBODIES AS SELECTIVE NGFPATHWAY INHIBITORS

MEDAREX INC.15/07/200360/487431US

PCT/US/2004/022876WO/2005/019266

)2010.01 (C07K20682215/07/2004

) גורם גידול עצבי(NGFנוגדנים נגדNGFכמעכבי מסלול, המנטרל פעילות

ספציפיים


MEDAREX INC.15/07/200360/487431US

PCT/US/2004/022876WO/2005/019266

)2010.01 (C07K20682315/07/2004

גורם גידול(NGFנוגדנים נגדכמעכבי מסלול, המנטרל פעילות)עצביNGFספציפיים


MEDAREX INC.15/07/200360/487431US

PCT/US/2004/022876WO/2005/019266

)2010.01 (A21D20682519/01/2009

MICROWAVABLE בצק עוגייה להכנה במיקרו ואריזה עבורו COOKIE DOUGHAND PACKAGING THEREFORNESTEC S.A.

25/01/200861/023637USPCT/EP/2009/050532WO/2009/092679


)2010.01 (A62B20682706/07/2010

מיתקן לאימונים פיזיותראפיים וספוטיביים לכיסא גלגלים

DEVICE FOR SPORTIVE ANDPHYSIOTHERAPY TRAININGADAPTED FOR WHEELCHAIR

ZIVIYA פינחס גורן GOREN

)2010.01 (G04B20682806/07/2010

3D לוח שעון תלת ממד SHOW CLOCK FACEYOSEF יוסף לוי LEVY

)2009.01 (A61K20682921/04/2000

של–4יחידת אלפה–אנטגוניסט של תת אינטגרין לטיפול בלייפת

METHOD FOR THE TREATMENT OFFIBROSIS USING AN ANTAGONISTOF THE INTEGRIN ALPHA-4SUBUNITBIOGEN IDEC MA INC.

22/04/199960/130847US01/06/199960/137214US

PCT/US/2000/010781WO/2000/064474

)2009.01 (A61K20683021/04/2000

א–אנטגוניסט של תת של–4לפה יחידת אינטגרין לטיפול בלייפת

METHOD FOR THE TREATMENT OFFIBROSIS USING AN ANTAGONISTOF THE INTEGRIN ALPHA-4SUBUNIT


BIOGEN IDEC MA INC.22/04/199960/130847US01/06/199960/137214US

PCT/US/2000/010781WO/2000/064474

)2010.01 (C07H20683130/07/2004

תולדות גלוקופיראנוסיל ותכשירי רוקחות המכילים אותן

GLUCOPYRANOSYL DERIVATIVESAND PHARMACEUTICALCOMPOSITIONS CONTAINING THESAMEMITSUBISHI TANABE PHARMACORPORATION

01/08/200360/491534USPCT/JP/2004/011312WO/2005/012326

)2010.01 (G01N20683207/11/2002

10F2P161נוגדנים הנקשרים לאפיטופ של ושימושים בהם

ANTIBODIES BINDING AN 161P2F10BEPITOPE AND USES THEREOF

AGENSYS, INC.07/11/200110/005480US31/01/200210/062109US

PCT/US/2002/036002WO/2003/040340

)2010.01 (A61B20683305/10/2008

התקן ושיטה לחיבור תפר לעצםMEDICAL APPARATUS ANDMETHOD FOR ATTACHING ASUTURE TO A BONE

בע.ג.א.ת .T.A.Gמ"מכשירים רפואיים MEDICAL PRODUCTSCORPORATION LTD.

28/02/200861/064333US23/06/200861/129394US

PCT/IL/2008/001316WO/2009/107121


)2010.01 (A61K20683408/01/2009

שיטות והרכבים למתן פומי של חלבונים ופפטידים בעלי פעילות רפואית

METHODS AND COMPOSITIONS FORORAL ADMINISTRATION OFPROTEIN AND PEPTIDETHERAPEUTIC AGENTS

OSHADIמ"אושדי דראג אדמיניסטריישן בע DRUG ADMINISTRATIONLTD.

08/01/2008188647IL14/07/200861/080,295US

PCT/IL/2009/000036WO/2009/087633

)2010.01 (A61K20683508/01/2009

שיטות והרכבים למתן פומי של אינסוליןMETHODS AND COMPOSITIONS FORORAL ADMINISTRATION OFINSULIN

OSHADIמ"אושדי דראג אדמיניסטריישן בע DRUG ADMINISTRATIONLTD.

08/01/2008188647IL14/07/200861/080,295US02/10/200861/102,020US

PCT/IL/2009/000037WO/2009/087634

)2010.01 (H04H20683612/06/2008

SYSTEM שיטה ומערכת להערכת זמן צפייה AND METHOD FOROVERTIME VIEWINGNDS LIMITED

09/01/200861/010513USPCT/IB/2008/052322WO/2009/087496

)2010.01 (H04W20683728/01/2009


VIRTUAL גווני–תכנון וירטואלי במערכת רב SCHEDULING INHETEROGENEOUS NETWORKSQUALCOMM INCORPORATED

01/02/200861/025515US27/01/200912/360548US

PCT/US/2009/032287WO/2009/099843

)2010.01 (H04W20683823/12/2008

בחירה תחנת בסיס משרת במערכת וטיתתקשורת אלח

SERVING BASE STATION SELECTIONIN A WIRELESS COMMUNICATIONNETWORKQUALCOMM INCORPORATED

01/02/200861/025645US09/12/200812/331156US

PCT/US/2008/088256WO/2009/097070

)2010.01 (H02K20683906/07/2010

HYDRAULIC מערכת כוח הידראולית POWER SYSTEMSANמ"סאן הייטק בע HITEC LTD

)2010.01 (A23D20684004/06/2009

DEVICE מכשיר ושיטה למיצוי שמן זית AND METHOD FOREXTRACTING OLIVE OILOLIVE X-PRESS LTD

22/06/200861/074642USPCT/IL/2009/000564WO/2010/007610


)2010.01 (B01D20684106/07/2010

מתקן סינון ושיטה לטיפול במדיית סינון גרנולרית

A FILTRATION APPARATUS ANDMETHOD FOR TREATINGGRANULAR FILTRATION MEDIUM

LIQUIDמ"בע) 2001(קסלר אילן ניהול ופיתוח AUTOMATION LTD

)2010.01 (A61J20684217/01/2008

אלמנט מתאם מזרק במערכת ערבוב תרופות

SYRINGE ADAPTER ELEMENT INDRUG MIXING SYSTEM

TEVAמ"טבע מדיקל בע MEDICAL LTD.

PCT/IL/2008/000077WO/2009/090627

)2010.01 (C07K20684306/01/2009

נגזרות אינסולין חדשות בעלות פרופיל זמן פעולה מושהה ביותר

NOVEL INSULIN DERIVATIVESHAVING AN EXTREMELY DELAYEDTIME-ACTION PROFILESANOFI-AVENTIS DEUTSCHLANDGMBH

09/01/2008102008003566.1DE14/04/200861/044662US24/05/2008102008025007.4DE

PCT/EP/2009/000018WO/2009/087082

)2010.01 (C07K20684406/01/2009

נגזרות אינסולין חדשות בעלות פרופיל זמן פעולה מושהה ביותר

NOVEL INSULIN DERIVATIVESHAVING AN EXTREMELY ANEXTREMELY DELAYED TIME-ACTIONPROFILESANOFI-AVENTIS DEUTSCHLANDGMBH


09/01/2008102008003568.8DE14/04/200861/044659US24/05/2008102008025008.2DE

PCT/EP/2009/000017WO/2009/087081

)2010.01 (C07D20684506/01/2009

METHOD שיטה לסינתזת טטראהידרוביופטרין OF SYNTHESIZINGTETRAHYDROBIOPTERINBIOMARIN PHARMACEUTICAL INC.

07/01/200861/019528US22/04/200861/046909US

PCT/US/2009/000030WO/2009/088979

)2010.01 (A61K20684608/01/2009

N-ALKOXYAMIDEיהאלקוקסיאמיד כחומרי הדמ–Nתצמידי CONJUGATES ASIMAGING AGENTSLANTHEUS MEDICAL IMAGING, INC.

08/01/200861/019627USPCT/US/2009/000096WO/2009/089022

)2010.01 (G06F20684705/01/2009

תרגום כתובות דינמי באמצעות ניהול מסגרת

DYNAMIC ADDRESS TRANSLATIONWITH FRAME MANAGEMENT

IBM CORPORATION11/01/200811/972725US

PCT/EP/2009/050051WO/2009/087134

)2010.01 (G06F20684807/01/2009


חילוץ תכונת מטמון והדרכותEXTRACT CACHE ATTRIBUTEFACILITY AND INSTRUCTIONTHEREFOREIBM CORPORATION

11/01/200811/972675USPCT/EP/2009/050107WO/2009/087160

)2010.01 (C11D20684907/07/2010

סבון להקלה וטיפול בגוף עקב עקיצות ורגישות

SOAP FOR RELIEF AND TREATINGAND SENSITIVITY BODY

ZAHAR זהר אלדין ביאן ALLDEEN BIYAN

)2010.01 (F16K20685007/07/2010

ע HANDי יד ורגל"ברז המופעל AND FOOT OPERATEDFAUCET

YAIR יאיר משולם MESHULAM

)2010.01 (A01G20685108/01/2009

שיטה לייצור ההתקן, התקן השקייה ואמצעים לייצורו, האמור

WATERING DEVICE, METHOD FORMANUFACTURING SAID DEVICE,AND MEANS THEREFORTERRIGIO AB

09/01/20080800045-7SEPCT/SE/2009/050006WO/2009/088354


)2010.01 (F24J20685207/07/2010

התקן לדיכוי הסעה טבעית עבור קולטי שמש

SUPPRESSOR OF NATURALCONVECTION FOR SOLARCOLLECTORS

LEVIN לוין אלכסנדר ALEXANDER

)2010.01 (A43B20685307/07/2010

שיטה והתקן נעלים משולב סוליה הניתנת להסרה

METHOD APPARATUS COMBININGREMOVABLE SHOE SOLE

URIA אריק בן משה MORAN

)2010.01 (A01N20685423/01/2009

תרכובות טריציקליות כמאפננות של4PDEוכמעכביa–TNFסינתזה של

TRICYCLIC COMPOUNDS ASMODULATORS OF TNF-a SYNTHESISAND AS PDE4 INHIBITORSHIGH POINT PHARMACEUTICALS,LLC

25/01/200861/023617USPCT/US/2009/031819WO/2009/094528

)2010.01 (A61K20685505/12/2003

שימוש באגוניסט כולינרגי בררני לקולטן7aניקוטיני לייצור תרופה

USE OF CHOLINERGIC AGONISTSELECTIVE FOR AN a7 NICOTINICRECEPTOR IN THE MANUFACTUREOF A MEDICAMENTTHE FEINSTEIN INSTITUTE FORMEDICAL RESEARCH

02/12/200260/431650USPCT/US/2003/038708


WO/2004/052365

)2010.01 (B62J20685703/02/2009

רכבי שטח בעלי סידור לאחיזת יד עבור נוסע

ATV HAVING A HAND GRIPARRANGEMENT FOR A PASSENGER

POLARIS INDUSTRIES INC.04/02/200812/012587US

PCT/US/2009/000677WO/2009/099588

)2010.01 (A47L20685827/01/2009

A תהליך ומכשיר לניקוי סובסטראטים PROCESS AND A DEVICE TO CLEANSUBSTRATESUNILEVER PLC,

21/02/20080373/MUM/2008INPCT/EP/2009/050869WO/2009/103595

)2010.01 (H01L20685928/04/2008

PROCESS תהליך לייצור תאים סולרים FOR THE MANUFACTUREOF SOLAR CELLSSOLVAY FLUOR GMBH

23/01/200861/022958USPCT/EP/2008/055173WO/2009/092453

)2010.01 (A61K20686012/02/2009

ANTI-TUMOUR פאראמיקסו וירוסים נוגדי גידול EFFECTIVEPARAMYXOVIRUSBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

14/02/200808075121.7EP19/02/200861/029650US


PCT/EP/2009/051659WO/2009/101149

)2010.01 (E05B20686107/07/2010

על–ליטה אלקטרוהתקן ידית לש מכנית דלת

ELECTRO-MECHANICAL DOORCONTROL HANDLE DEVICE

PLASANמ"פלסן סאסא בע SASA LTD.

)2010.01 (A61B20686215/01/2009

ידי שימוש קביעת מאפיין פיזיולוגי על במדידות לחץ דם חוזרות

DETERMINATION OFPHYSIOLOGICAL PARAMETERSUSING REPEATED BLOOD PRESSUREMEASUREMENTS

BENJAMIN בנימין גביש GAVISH15/01/200861/021141US

PCT/IL/2009/000061WO/2009/090646

)2010.01 (H04W20686304/02/2009

מנגנון התחלה מתאים לבקרת זיהוי תאב DRXבמצבUE–חדש

SUITABLE TRIGGER MECHANISM TOCONTROL NEW CELLIDENTIFICATION IN UE WHEN INDRX MODEQUALCOMM INCORPORATED

04/02/200861/026125US03/02/200912/364880US

PCT/US/2009/033085WO/2009/100136

)2010.01 (H04L20686405/02/2009


POLICY בקרת מדיניות לזרמי נתונית עטופים CONTROL FORENCAPSULATED DATA FLOWSQUALCOMM INCORPORATED

06/02/200861/026712US07/02/200861/026981US14/03/200861/036585US04/02/200912/365592US

PCT/US/2009/033155WO/2009/100180

)2010.01 (H04W20686527/01/2009

חות"ניהול התאבכות שמבוסס על דו מדידת פילוט משופר

INTERFERENCE MANAGEMENTBASED ON ENHANCED PILOTMEASUREMENT REPORTSQUALCOMM INCORPORATED

01/02/200861/025644US26/01/200912/359612US

PCT/US/2009/032161WO/2009/099811

)2010.01 (H01H20686619/01/2009

מתגים עטופים המשתמשים בתחליף כספית ושיטות לייצורם

ENCAPSULATED SWITCHESEMPLOYING MERCUTY SUBSTITUTEAND METHOD OF MANUFACTURETHEREOFTHERMO FISHER SCIENTIFIC INC.

22/01/200861/022758US07/10/200812/247136US

PCT/US/2009/031384WO/2009/094316

)2010.01 (A01N20686715/01/2009

–3(–7הכנה והפרדה אננטיומרית שלנואן]4.4[דיאזאספירו–7,1–)פירידיניל

וצורות מלח חדישות של הרצמאט

PREPARATION AND ENANTIOMERICSEPARATION OF 7-(3-PYRIDINYL)-1,7-DIAZASPIRO[4.4] NONANE ANDNOVEL SALT FORMS OF THERACEMATE AND ENANTIOMERS


TARGACEPT, INC.15/01/200861/021197US

PCT/US/2009/000242WO/2009/091561

)2010.01 (H04W20686804/02/2009

UPLINK משוב תקציב עיכוב למעלה DELAY BUDGET FEEDBACKQUALCOMM INCORPORATED

04/02/200861/026046US03/02/200913/364967US

PCT/US/2009/033105WO/2009/100150

)2010.01 (C12M20686927/01/2009

METHOD שיטה ומכשיר לתהליך פוטוכימי AND DEVICE FOR APHOTOCHEMICAL PROCESSECODUNA OG

31/01/2008A152/2008AT03/06/2008A889/2008AT

PCT/AT/2009/000026WO/2009/094680

)2010.01 (F41F20687030/01/2009

סידור ושיטה לטעינת פגז לנשק בעל טעינה אחורית

ARRANGEMENT AND METHOD FORSUPPORTING SHELL INTO BREECH-LOADING WEAPON BARRELPATRIA LAND & ARMAMENT OY

31/01/200820085083FIPCT/FI/2009/050072WO/2009/095535

)2010.01 (F41F71206830/01/2009


התקן ושיטה לתמיכה בטעינת פגז לנשק בעל טעינה אחורית

SUPPORT MEMEBR FORSUPPORTING SHELL INTO BREECH-LOADING WEAPON BARREL, ANDMETHODPATRIA LAND & ARMAMENT OY

31/01/200820085081FIPCT/FI/2009/050075WO/2009/095537

)2010.01 (H01L20687223/01/2009

פרוסה למצע נושא–שיטה להרכבת התקן בצורה הפיכה

METHOD FOR REVERSIBLYMOUNTING A DEVICE WAFER TO ACARRIER SUBSTRATEBREWER SCIENCE, INC.

24/01/200861/023379USPCT/US/2009/031862WO/2009/094558

)2010.01 (C09K20687315/02/2008

BIOMATERIAL חומר ביולוגי ושיטת הכנתו AND PREPARATIONMETHOD THEREOFBODY ORGAN BIOMEDICAL CORP

09/01/2008200810002062.0CNPCT/CN/2008/070309WO/2009/086743

)2010.01 (A61N20687427/01/2009

אלקטרודה גמישה ונקבובית בעלת שטח גדול לחימום

FLEXIBLE AND POROUS LARGE-AREA ELECTRODE FOR HEATING

ONCOTHERM KFT27/01/200808001487.1EP

PCT/EP/2009/000597WO/2009/092619


)2010.01 (C07D20687509/02/2009

BICYCLOAMINE תולדות ביציקלואמין DERIVATIVEEISAI R&D MANAGEMENT CO., LTD.

13/02/20082008-031939

JP

13/02/200861/028378USPCT/JP/2009/052164WO/2009/101917

)2010.01 (C01D20687604/09/2008

ש ל מלח מצוי במידה גבישים כדורייםמילימטר שזורמים חופשי 100–500

ותהליך להכנתם

FREE FLOWING 100-500 MM SIZESPHERICAL CRYSTALS OF COMMONSALT AND PROCESS FORPREPARATION THEREOFCOUNCIL OF SCIENTIFIC ANDINDUSTRIAL RESEARCH

07/01/200860/DEL/2008INPCT/IN/2008/000568WO/2009/087645

)2010.01 (C01D20687725/09/2008

שיטה משופרת להכנת מלח מצוי בטוהר מלח במחבות מלח סולריות–גבוה ממי

AN IMPROVED PROCESS OF THEPREPARATION OF COMMON SALT OFHIGH PURITY FROM BRINES INSOLAR SALT PANSCOUNCIL OF SCIENTIFIC ANDINDUSTRIAL RESEARCH

07/01/200857/DEL/2008INPCT/IN/2008/000614WO/2009/087646

)2010.01 (A61K68782008/03/2004

שימוש בוירוס מיקסומה לטיפול תרופתי בסרטן ובהדבקת וירוס כרונית

USE OF MYXOMA VIRUS FOR THETHERAPEUTIC TREATMENT OFCANCER AND CHRONIC VIRALINFECTION


ROBARTS RESEARCH INSTITUTE07/03/200360/452521US18/03/200360/455393US

PCT/CA/2004/000341WO/2004/078206

)2010.01 (G02C20687912/02/2009

TELESCOPIC משקפיים טלסקופיים SPECTACLESTOPSIGHT OPTICS LTD.

14/02/200861/028527USPCT/IL/2009/000175WO/2009/101628

)2010.01 (C07K20688009/01/2009

ושיטות לטיפול11–אנטגוניסטים קדהרין בדלקת פרקים

CADHERIN-11 ANTAGONISTS ANDMETHODS FOR THE TREATMENT OFINFLAMMATORY JOINT DISORDERSSYNOVEX CORPORATION

11/01/200861/010734USPCT/US/2009/000162WO/2009/089062

)2010.01 (A61K20688108/01/2009

הרכבים לטיפול במחלה רירית הנגרמתאתי נוגדי גידולים או טיפו"ע ל המדכא

המערכת החיסונית

FORMULATIONS FOR THETREATMENT OF MUCOSITISINDUCED BY ANTITUMOR ORIMMUNOSUPPRESSIVE THERAPYINDENA S.P.A.

11/01/2008MI2008A38ITPCT/EP/2009/000050WO/2009/087091

)2010.01 (G01S20688326/01/2009


שיטה לתמיכה במיקום משתמש מבניות–במערכות ניסוי תוך

METHOD TO SUPPORT USERLOCATION IN- IN-STRUCTURECOVERAGE SYSTEMALCATEL-LUCENT USA INC.

29/01/200812/010668USPCT/US/2009/031981WO/2009/097237

)2010.01 (C07D20688622/01/2009

–2,1–פלואורו–6תהליך להכנת נגזרת אילידן–3–אינדול–3H–אוקסו–2–דיהידרו

PROCESS FOR THE MANUFACTUREOF A 6-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENEDERIVATIVEBOEHRINGER INGELHEIMINTERNATIONAL GMBH

25/01/200808150661.0EPPCT/EP/2009/000377WO/2009/092580

)2010.01 (A01K20688708/01/2009

SIMULANT לחומר נפץ ראשוני מדמה MATERIAL FORPRIMARY EXPLOSIVES


10/01/2008188714ILPCT/IL/2009/000034WO/2009/087631

)2010.01 (C07C20688827/08/2004

P1Sתרכובת המסוגלת לקשור קולטן ושימושה הרוקחי

COMPOUND CAPABLE OF BINDINGS1P RECEPTOR ANDPHARMACEUTICAL USE THEREOFONO PHARMACEUTICAL CO., LTD.

29/08/20032003-306088

JP

02/04/20042004&110573JP 08/06/20042004&169958JP


05/07/20042004&198523JPPCT/JP/2004/012768WO/2005/020882

)2010.01 (C12N20688913/10/2004

שילוב ספציפי למיקום של חומצות אמינות פעילות לתוך חלבוניםמחמזרו

SITE-SPECIFIC INCORPORATION OFREDOX ACTIVE AMINO ACIDS INTOPROTEINSTHE SCRIPPS RESEARCH INSTITUTE

14/10/200360/511532USPCT/US/2004/034089WO/2005/038002

)2010.01 (C04B20689026/12/2008

שיטה לייצורו, מוצר בעל מבנה מעוצב ומוצר מרוכב

MOULDED CONSTRUCTIONPRODUCT, A METHOD FOR THEPRODUCTION THEREOF AND ACOMPOSITE PRODUCTOBSCHESTVO S OGRANICHENNOYOTVESVENNOSTYU "VLAKOS-NN"

09/01/20082008100344RU12/02/20082008105270RU

PCT/RU/2008/000806WO/2009/088322

)2010.01 (A61K20689109/01/2009

PAI–1מעכבים רפואיים של פונקצית ושיטות לשימוש בהם

THERAPEUTIC INHIBITORS OF PAI-1FUNCTION AND METHODS OF THEIRUSEINTREXON CORPORATION

09/01/200861/020137US14/07/200861/080640US

PCT/US/2009/000155WO/2009/089059


)2009.01 (A61K20689217/07/2003

קשור לגלוקוז? שימוש באינטרפרוןלהכנת תרופה לטיפול ומניעה של דלקת

פקיעת כליה

USE OF GLYCOSYLATEDINTERFERON - ? IN THEMANUFACTURE OF A MEDICAMENTFOR TREATING AND PREVENTINGGLOMERULONEPHRITISBIOGEN IDEC MA INC.

17/07/200260/396393USPCT/US/2003/022440WO/2004/006756

)2010.01 (C07D20689305/03/2009

–3–בנזיל–1תולדותהידרוקסימתילאינדאזול חדשות ושימוש

בהן לטיפול במחלות המבוססות על ביטוי ,MCP–1של

1CR3CX40–וP

NOVEL 1-BENZYL-3-HYDROXYMETHYLINDAZOLEDERIVATIVES AND USE THEREOF INTHE TREATMENT OF DISEASESBASED ON THE EXPRESSION OFMCP-1, CX3CR1 AND P40AZIENDE CHIMICHE RIUNITEANGELINI FRANCESCO A.C.R.A.F.S.p.A.

07/03/200808425139.6EPPCT/EP/2009/052585WO/2009/109613

)2010.01 (A61M20689406/02/2009

INSERTER הרכב אמצעי החדרה ASSEMBLYUNOMEDICAL A/S

08/02/2008PA200800185DK08/02/200861/027125US13/02/2008PA200800202DK13/02/200861/028259US13/02/2008PA200800203DK13/02/200861/028262US20/02/200861/030022US21/02/2008PA200800240DK25/02/2008PA200800262DK


25/02/200861/031227US07/08/200812/187971US09/09/200861/95379US

PCT/EP/2009/051399WO/2009/098306

)2010.01 (F21V20689508/07/2010

LIGHTING מערכת תאורה SYSTEMELTAM אלתם עין השופט EIN HASHOFET

)2010.01 (C12P20689608/07/2010

מקדים חומרי הזנה לתסיסה ותהליכים להכנתם

FERMENTATION FEEDSTOCKPRECURSOR AND METHODS FORTHE PRODUCTION THEREOF

ס בע' אייץ HCLמ"אל קלינטג CLEANTECH LTD.26/06/201061/358894US

)2010.01 (H04W97206808/07/2010

מודול הרחבת מסך עבור התקן תקשורת נייד

DISPLAY EXTENSION MODULE FORPORTABLE TELECOMMUNICATIONDEVICE

MOSHE משה דרמר DERMER

)2010.01 (C12N20689809/01/2009


אינטגרין מבני אדם–a–9נוגדן מאונש נגד ושימושים בו

HUMANIZED ANTI-HUMAN a9-INTEGRIN ANTIBODY AND USESTHEREOFJURIDICAL FOUNDATION THECHEMO-SERO- THERAPEUTICRESEARCH INSTITUTE

11/01/20082008-004975

JP

31/10/20082008&282496JPPCT/JP/2009/050187WO/2009/088064

)2010.01 (A61M20689909/01/2009

ה–מערכת ושימוש בו לטיפול בפתולוגי של מערכת העצבים המרכזית

AN APPARATUS AND USE THEREOFFOR TREATING CENTRAL NERVOUSSYSTEM PATHOLOGYWAKE FOREST UNIVERSITYHEALTH SCIENCES

09/01/200861/019968US18/07/200861/081997US

PCT/US/2009/030581WO/2009/089435

)2010.01 (C12N00206907/01/2009

תוספת תרבות המכיל פוליאמין ומקור ברזל ושימוש בו

A CULTURE ADDITIVE CONTAININGA POLYAMINE AND IRON SOURCEAND USES THEREOFCELLCA GMBH

09/01/200808000244.7EPPCT/EP/2009/000035WO/2009/087087

)2010.01 (A61K20690109/01/2009

–ו 6,3מפעילים של פרוקספאזות תלייניות7

ACTIVATORS OF EXECUTIONERPROCASPASES 3,6 AND 7THE REGENTS OF THE UNIVERSITYOF CALIFORNIA


11/01/200861/020608USPCT/US/2009/030680WO/2009/089508

)2010.01 (A61M20690229/12/2008

מערכות למתן תרופה לחולים עם דלקת פרקים שיגרונית

SYSTEMS FOR ADMINISTERINGMEDICATION FOR RHEUMATOIDARTHRITIS PATIENTSUCB PHARMA SA

11/01/200861/010779US18/07/200861/135262US18/09/200861/192551US

PCT/IB/2008/003984WO/2009/090499

)2010.01 (C07F20690308/01/2009

סל–תהליך לדה קטיבית פרוטונציה–2–פלואורו–1ופונקציונליזציה של

כלורובנזים–3–התמרה

PROCESS FOR THE SELECTIVEDEPROTONATION ANDFUNCTIONALIZATION OF 1-FLUORO-2-SUBSTITUTED-3-CHLOROBENZENESDOW AGROSCIENCES LLC

11/01/200861/010918USPCT/US/2009/030372WO/2009/089310

)2010.01 (C07D20690423/12/2008

נגזרות של חומצת אמינו מסוג בטא לטיפול בסכרת

BETA--AMINO ACID DERIVATIVESFOR TREATMENT OF DIABETES

MERCK PATENT GMBH24/01/200808001305.5EP

PCT/EP/2008/011099WO/2009/092432


)2010.01 (C07D20690523/12/2008

של –3–פירידין]C–3,2[פירולו(–4נגזרותYL(פירימידין

אמין–2–

4-(PYRROLO[2,3-C]PYRIDINE-3-YL)PYRIMIDIN -2- AMINE DERIVATIVES

MERCK PATENT GMBH22/01/2008102008005493.3DE

PCT/EP/2008/011098WO/2009/092431

)2010.01 (C02F20690611/01/2009

DESALINATION מערכת התפלה ואלמנטים בה SYSTEM ANDELEMENTS THEREOF

בע.אי.די.איי .I.D.Eמ"טכנולוגיות TECHNOLOGIES LTD.10/01/200861/006386US

PCT/IL/2009/000046WO/2009/087642

)2010.01 (A61K20690912/01/2009

אבקה מזופורית של תחמוצת אבץ ותהליך להכנתה

MESOPOROUS ZINC OXIDE POWDERAND METHOD FOR PRODUCTIONTHEREOFANTARIA LIMITED

11/01/200861/006398US02/07/20082008903390AU

PCT/US/2009/030732WO/2009/089527

)2010.01 (A45D20691009/06/2008

HAIR-CLIPPER גוזז שיערDENIVALDO GONCALVES DA SILVA

09/01/2008MU8800115-6

BR

PCT/BR/2008/000160WO/2009/086609


)2010.01 (A61K20691112/01/2009

UVVISIBLYתכשירים להגנה מפני קרינת TRANSPARENT UVPHOTOPROTECTIVE COMPOSITIONSANTARIA LIMITED

11/01/200861/006398USPCT/US/2009/030725WO/2009/089523

)2010.01 (F21V20691208/07/2010

LIGHT גוף תאורה מבוסס לדים MIXING LAMPTOMERין'זלוצ) איגור(יגאל VALACH

)2010.01 (H04W20691309/01/2009

שיטה והתקן לשימוש במידע יכולת שירות לאיתור מישור משתמש

METHOD AND APPARATUS FORUSING SERVICE CAPABILITYINFORMATION FOR USER PLANELOCATIONQUALCOMM INCORPORATED

11/01/200861/020635US07/10/200812/246815US

PCT/US/2009/030651WO/2009/089486

)2010.01 (C07D20691428/01/2009

נגזרות פיפראדין ספירוציקליות מותמרות3–כליגנדים לקולטן היסטמין

SUBSTITUTED SPIROCYCLICPIPERIDINE DERIVATIVES ASHISTAMINE-3 (H3) RECEPTORLIGANDSCEPHALON, INC.

30/01/200861/062909US


PCT/US/2009/032195WO/2009/097309

)2010.01 (H04B20691611/02/2009

SIGNAL והתקנים לרשתות קוויותאות AND DEVICES FOR WIREDNETWORKSAPOLLO FIRE DETECTORS LIMITED

11/02/20080802502.5GBPCT/GB/2009/000385WO/2009/101404

)2010.01 (G01C17206919/03/2009

סריקהLADARמימדית–הדמייה תלת מהירה עם מבנה קרן דיגיטלית קומפקטי

RAPID SCAN LADAR 3D IMAGINGWITH COMPACT DIGITAL BEAMFORMATIONRAYTHEON COMPANY

19/03/200812/077476USPCT/US/2009/001762WO/2009/117142

)2010.01 (G06F20692021/11/2003

שיטה להפחתת האפשרות של טעויות תרופות

METHOD FOR REDUCING THEPOSSIBILITY OF MEDICATIONERRORSCAREFUSION 303, INC.

27/12/200210/331034USPCT/US/2003/037324WO/2004/061745

)2010.01 (G06F20692121/11/2003

SYSTEM מערכת לשימוש עם התקן מטופל רפואי FOR USE WITH A PATIENTMEDICAL DEVICECAREFUSION 303, INC.


27/12/200210/331034USPCT/US/2003/037324WO/2004/061745

)2010.01 (G06F20692221/11/2003

מערכת להפחתת האפשרות של טעויות תרופות

SYSTEM FOR REDUCING THEPOSSIBILITY OF MEDICATIONERRORSCAREFUSION 303, INC.

27/12/200210/331034USPCT/US/2003/037324WO/2004/061745

)2010.01 (H02G20692303/02/2009

מתקן עבור חיזור התקנת קופסא לפתח במעטפת הקיר

DEVICE FOR SECURING ANINSTALLATION BOX TO AN OPENINGIN A WALL SHELLHAGER ELECTRO GMBH & CO. KG

04/02/2008102008008164.7DE22/08/2008102008039383.5DE

PCT/DE/2009/000166WO/2009/097845

)2010.01 (H02B20692403/02/2009

במיוחד קופסת חלוקה, התקנת קופסא עבור חיווט על פני השטח

INSTALLATION BOX, INPARTICULAR DISTRIBUTION BOXFOR SURFACE WIRINGHAGER ELECTRO GMBH & CO. KG

04/02/2008102008163.9DEPCT/DE/2009/000165WO/2009/097844

)2010.01 (A62D20692530/12/2009


שיטה ופורמולציה עבור ניטרול כימיקלים רעליים וחומרים

METHOD AND FORMULATION FORNEUTRALIZING TOXIC CHEMICALSAND MATERIALSE-Z-EM, INC.

22/01/200812/017749USPCT/US/2008/088547WO/2009/094098

)2010.01 (H01R20692622/01/2009

תקע חיבור לכבלים קואקסיאלים רביםושיטה להתקנת תקע חיבור לכבלים

קואקסיאלים רבים כזה

MULTIPLE COAXIAL CABLE PLUGCONNECTION AND METHOD FORINSTALLING SUCH A MULTIPLECOAXIAL CABLE PLUGCONNECTIONHUBER+ SUHNER AG

14/03/2008382/08CHPCT/CH/2009/000029WO/2009/111895

)2010.01 (A61K69272010/02/2009

DRUG מערכת לנתינת תרופות עם אפקט מייצב DELIVERY SYSTEM WITHSTABILISING EFFECTBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

13/02/200808002633.9EP08/08/200808162105.4EP21/11/200808105842.2EP

PCT/EP/2009/000904WO/2009/100871

)2010.01 (A61F20692815/01/2009

INTERSPINOUS מרווח בין חוליות עמוד השדרה SPACERVERTIFLEX, INC.

15/01/200861/011199USPCT/US/2009/031150WO/2009/091922


)2010.01 (A61M20692922/01/2009

DILATOR מרחיבVERTIFLEX, INC.

23/01/200861/062448USPCT/US/2009/031710WO/2009/094463

)2010.01 (C07D20693026/01/2009

–METפירידינים דחוסים פעילים כמעכביC

FUSED PYRIDINES ACTIVE ASINHIBITORS OF C-METF. HOFFMANN-LA ROCHE AG

25/01/20080801416.9GBPCT/GB/2009/000211WO/2009/093049

)2010.01 (C07K20693128/01/2009

אוIIתכשיר הכולל נוגדן הנקשר לאתר2HERומשתנים חומציים שלו

COMPOSITION COMPRISINGANTIBODY THAT BINDS TO DOMAINII OF HER2 AND ACIDIC VARIANTSTHEREOFGENENTECH, INC.

30/01/200861/024825USPCT/US/2009/032220WO/2009/099829

)2010.01 (A61K20693212/02/2009

הרכבים ושיטות למתן גורמים, התקנים מועילים מרובים

DEVICES, FORMULATIONS, ANDMETHODS FOR DELIVERY OFMULTIPLE BENEFICIAL AGENTSINTARCIA THERAPEUTICS, INC.

13/02/200861/065692USPCT/US/2009/000916WO/2009/102467


)2010.01 (C07D20693316/01/2009

METHOD שיטה להכנת תרכובת אדנין FOR PREPARING ADENINECOMPOUNDDAINIPPON SUMITOMO PHARMACO., LTD.

17/01/20082008-007974

JP

PCT/JP/2009/050550WO/2009/091032

)2010.01 (C07D20693422/01/2009

–2,1–פלואורו–6צורות מלח של נגזרת, אילידן–3–אינדול–3H–אוקסו–2–דיהידרו

תהליך לייצורן ותכשירי רוקחות המכילים אותן

SALT FORMS OF A 6-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE DERIVATIVE, PROCESSFOR THEIR MANUFACTURE ANDPHARMACEUTICAL COMPOSITIONSCONTAINING SAMEBOEHRINGER INGELHEIMINTERNATIONAL GMBH

25/01/200808150660.2EPPCT/EP/2009/000378WO/2009/092581

)2010.01 (C07C20693630/01/2009

הכנתן, אלקאנול–פניל–2–אמינו–2נגזרות ותכשירים רוקחיים המכילים אותן

2-AMINO-2-PHENYLALKANOLDERIVATIVES, PREPARATIONTHEREOF AND PHARMACEUTICALCOMPOSITIONS CONTAINING SAMEOROXCELL

31/01/20080800521FR30/07/200861/084829US

PCT/FR/2009/000106WO/2009/112703


)2010.01 (H04W20693730/01/2009

SERVING בחירת תא משרת בתקשורת אלחוטית CELL SELECTION INWIRELESS COMMUNICATIONSQUALCOMM INCORPORATED

30/01/200861/024880US29/01/200912/362289US

PCT/US/2009/032586WO/2009/097500

)2010.01 (B41M20693827/10/2008

ABRASION מדיה חסינה לשחיקה RESISTANT MEDIAW. R. GRACE & CO.-CONN.

04/12/200761/005277US14/01/200861/011021US

PCT/US/2008/012179WO/2009/073070

)2010.01 (C07C20693925/06/2004

SUBSTITUTED תרכובות טטרראציקלין מותמרות TETRACYCLINECOMPOUNDSPARATEK PHARMACEUTICALS, INC.

09/07/200360/486017US25/11/200360/525287US16/12/200360/530123US

PCT/US/2004/020249WO/2005/009943

)2010.01 (C08J20694016/01/2009

ציפויים וצבעים מימיים בעלי, כורכי לטקסהפשרה ושיטות לשימוש–יציבות בקפאון

בהם

LATEX BINDERS, AQUEOUSCOATINGS AND PAINTS HAVINGFREEZE-THAW STABILITY ANDMETHODS FOR USING SAMERHODIA OPERATIONS

18/01/200861/022206US21/01/200861/022443US21/11/200861/199936US


PCT/US/2009/000309WO/2009/091592

)2010.01 (A61M20694116/01/2009

CATHETER קטטרPLAQUE TEC LTD

18/01/20080800981.3GBPCT/GB/2009/000106WO/2009/090390

)2010.01 (F16B20694212/01/2009

התקן ושיטה לפיצוי על הצטברות שגיאות אפיצות

APPARATUS AND METHOD FORTOLERANCE STACK-UPCOMPENSATIONGENERAL DYNAMICS LANDSYSTEMS, INC.

11/01/200812/007519USPCT/US/2009/000183WO/2009/089069

)2010.01 (B65D20694312/07/2010

PORTABLE דיספנסר נייד DISPENSERMOR מור ראובני REUVENI

)2010.01 (G07D20694412/07/2010

COMPUTERIZED מערכת ממוחשבת לעריכת מכרזים SYSTEM FORTENDERS

MICHAEL מיכאל נשר NESHER


)2010.01 (C07D20694512/02/2009

MODULATORS מאפננים לאמילואיד בטא FOR AMYLOID BETAF. HOFFMANN-LA ROCHE AG

22/02/200808151825.0EPPCT/EP/2009/051613WO/2009/103652

)2010.01 (B60R20694612/07/2010

מתקן נגד גניבה עבור רכבים הניתניםע י שרשרת"לנעילה

AN ANTI-THEFT DEVICE FOR CHAINLOCKABLE VEHICLES

GUY גיא שמש SHEMESH

)2010.01 (G06F20694712/07/2010

CONSTRAINED אילוץ אנונימיות בנתוני הפקה ANONYMIZATIONOF PRODUCTION DATA

הרשות, גוריון בנגב-אוניברסיטת בןחלמחקר ופיתו

BEN GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY

)2010.01 (A61K20694828/01/2009

צורה פולימורפית של תולדתלט]A–3,4[טריאזול]4,2,1[ יפול פירידין

במחלות זיהומיות

POLYMORPHIC FORM OF A[1,2,4]TRIAZOLE[4,3-A] PYRIDINEDERIVATIVE FOR TREATINGINFLAMMATORY DISEASESPFIZER LIMITED


04/02/200861/025879USPCT/IB/2009/050351WO/2009/098612

)2010.01 (C07D20694925/02/2009

AMINOQUINOLINE-2 אמינוקווינולין–2תולדות DERIVATIVESF. HOFFMANN-LA ROCHE AG

07/03/200808152421.7EPPCT/EP/2009/052193WO/2009/109491

)2010.01 (C07D20695016/03/2009

AMINOPIPERIDINYL תולדות אמינופיפרידיניל ושימושן DERIVATIVESAND USES THEREOFF. HOFFMANN-LA ROCHE AG

25/03/200861/039286USPCT/EP/2009/053055WO/2009/118254

)2010.01 (C07D20695105/02/2009

ALKYL-PIPERAZINE-3 פיפראזין ושימושן–אלקיל–3תולדות DERIVATIVESAND USES THEREOFF. HOFFMANN-LA ROCHE AG

15/02/200861/028978USPCT/EP/2009/051293WO/2009/101018

)2010.01 (C07D20695216/01/2009

תולדת אמינודיהידרותיאזין דחוסהCONDENSEDAMINODIHYDROTHIAZINEDERIVATIVEEISAI R&D MANAGEMENT CO., LTD.


18/01/20082008-008680

JP

18/01/200861/021939US31/07/20082008&197204JP31/07/200861/085024US

PCT/JP/2009/050511WO/2009/091016

)2010.01 (B60P20695312/07/2010

ASSIST מדרגת עזר STEPבע- מאג MAG-EHמ"עה LTD.

)2010.01 (G09B20695404/02/2009

הקלטה אוטומטית של ממשק התקן וירטואלי

AUTOMATED RECORDING OFVIRTUAL DEVICE INTERFACE

MOBILE COMPLETE, INC.11/02/200812/029445US

PCT/US/2009/033055WO/2009/102595

)2010.01 (C07D20695919/01/2009

תרכובות בעלות פעילות של אנטגוניסט2CRTH

COMPOUNDS HAVING CRTH2ANTAGONIST ACTIVITY

OXAGEN LIMITED18/01/20080800874.0GB10/11/20080820526.2GB

PCT/GB/2009/000142WO/2009/090414

)2010.01 (C12P20696019/01/2001


SOLVENTLESS תהליך מיצוי ללא ממיס EXTRACTIONPROCESSMARTEK BIOSCIENCESCORPORATION

19/01/200060/177125USPCT/US/2001/001806WO/2001/053512

)2010.01 (C12P20696119/01/2001

SOLVENTLESS תהליך מיצוי ללא ממיס EXTRACTIONPROCESSMARTEK BIOSCIENCESCORPORATION

19/01/200060/177125USPCT/US/2001/001806WO/2001/053512

)2010.01 (H04W20696213/07/2010

MOBILE מכשיר תקשורת נייד COMMUNICTIONS DEVICENOAM נועם עפרי OFARI

)2010.01 (B08B20696313/07/2010

מינון והפרדה,ן לקלסיפיקציהשיטה ומתקחומרים יבשים ואבקות בשדה

אלקטרוסטאטי של טעינה כתרית

METHOD AND DEVICE FORCLASSIFICATING, SORTING ANDSEPARATING DRY POWDERPRODUCTS IN ELECTROSTATICFIELD OF CORONA CHARGE

RINGמ"רינג הנדסה בע ENGINEERING LTD.


)2010.01 (H02N20696418/01/2009

SOLAR התקן ושיטה להמרת אנרגיה סולרית ENERGY CONVERSIONDEVICE AND METHOD

TECHNIONמ"מוסד הטכניון למחקר ופתוח בע RESEARCH ANDDEVELOPMENT FOUNDATION LTD.

16/01/200861/021478USPCT/IL/2009/000068WO/2009/090652

)2010.01 (B08B20696513/07/2010

מינון והפרדה, שיטה ומתקן לקלסיפיקציהואבקות בעזרת רטט מכאניחומרים יבשים

METHOD AND APPARATUS FORCLASSIFICATING, SORTING ANDSEPARATING DRY POWDERPRODUCTS USING MECHANICALVIBRATIONS

RINGמ"רינג הנדסה בע ENGINEERING LTD.

)2010.01 (B22F20696608/01/2009

אבקת מתכת או אבקת סגסוגת שיוצבו ושיטה וכלי תגובה ליצורן

PHLEGMATIZED METAL POWDER ORALLOY POWDER AND METHOD ANDREACTION VESSEL FOR THEPRODUCTION THEREOFTRADIUM GMBH

23/01/2008102008005781.9DEPCT/EP/2009/050163WO/2009/092631

)2010.01 (C12N20696712/01/2009


חלקיקים רקומביננטים דמויי וירוסהשפעת המיוצרים בצמחים

טרנסגנים המבטאים המאגלוטינין

RECOMBINANT INFLUENZA VIRUS-LIKEPARTICLES (VLPS) PRODUCED INTRANSGENIC PLANTS EXPRESSINGHEMAGGLUTININMEDICAGO INC.

21/01/20082615372CA22/01/200861/022775US11/07/2008PCT/CA08/001281CA

PCT/CA/2009/000032WO/2009/076778

)2010.01 (A61B20696816/01/2009

TISSUE מפצל רקמות SPLITTERVERTIFLEX, INC.

16/01/200861/011478USPCT/US/2009/031225WO/2009/091960

)2010.01 (A61K20696923/01/2009

ס שיטה להכנת תחבושות באמצעות תרסי חשמלי

METHOD FOR MAKING PATCHES BYELECTROSPRAY

DBV TECHNOLOGIES,23/01/20080850406FR

PCT/FR/2009/050094WO/2009/095591

)2010.01 (A61K20697013/01/2009

ושיטות לטיפול בגידולים ממקור תכשירים המאטופויטי

COMPOSITIONS AND METHODS FORTHE TREATMENT OF TUMOR OFHEMATOPOIETIC ORIGINGENENTECH, INC.

31/01/200812/023811USPCT/US/2009/030851WO/2009/099719


)2010.01 (A01H20697130/01/2009

SEEDLESS חציל טריפלואידי ללא גרעינים TRIPLOID EGGPLANTRIJK ZWAAN ZAADTEELT ENZAADHANDEL B.V.

01/02/200808001894.8EP05/11/200808019332.9EP

PCT/EP/2009/000636WO/2009/095266

)2010.01 (A61B20697214/01/2009

APPARATUS התקן ושיטה לתיקון שברים AND METHODS FORFRACTURE REPAIRPAUL HINDRICHS

14/01/200861/020778US22/08/200861/090999US

PCT/US/2009/030971WO/2009/091811

)2010.01 (H04W20697313/01/2009

BACKUP איתור גיבוי לתקשורת אלחוטית PAGING FOR WIRELESSCOMMUNICATIONQUALCOMM INCORPORATED

14/01/200861/020973US12/01/200912/352246US

PCT/US/2009/030856WO/2009/091740

)2010.01 (H04W20697413/01/2009

איתור ורישום בתקשורת אלחוטיתהמשתמשים בסוגים מרובים של מזהי

צומת

WIRELESS COMMUNICATIONPAGING AND REGISTRATIONUTILIZING MULTIPLE TYPES OFNODE IDENTIFIERSQUALCOMM INCORPORATED


14/01/200861/020973US13/06/200861/061543US12/01/200912/352507US

PCT/US/2009/030861WO/2009/091743

)2010.01 (C12N20697516/01/2009

ייצור של אנזימים סולפטאזייםליזוזומליים אנושיים מזורחנים ברמה

ושימושים בהם, גבוהה

MANUFACTURE OF ACTIVE HIGHLYPHOSPHOYLATED HUMANLYSOSOMAL SULFATASE ENZYMESAND USES THEREOFBIOMARIN PHARMACEUTICAL INC.

18/01/200861/022179US23/09/200861/099373US31/10/200861/110246US

PCT/US/2009/031276WO/2009/091994

)2010.01 (C07K20697607/12/2004

חומצת גרעין מקודדת רצפטור חלבוני פרוסטהגלנדיני חדש ושיטות להכנתם

NUCLEIC ACID ENCODING A NOVELPROSTAGLANDIN RECEPTORPROTEIN AND METHODS OF USETHEREOFAVENTIS PHARMACEUTICALS INC.

30/12/200310/747994USPCT/US/2004/040853WO/2005/066209

)2010.01 (B01D20697729/10/2008

משטח הפצת זרימה לטיפול במים על ידי אוסמוסה הפוכה

A FLOW DISTRIBUTOR PLATE FORTHE TREATMENT OF WATER BYREVERESE OSMOSISGRAHAM, WILLIAM

16/01/20080800774.2GBPCT/IB/2008/054465WO/2009/090510


)2010.01 (A61K20697814/01/2009

הרכבי אבקת חלבון ושיטות להכנתםPOWDERED PROTEINCOMPOSITIONS AND METHODS OFMAKING SAMEABBOTT GMBH & CO. KG

15/01/200861/021298USPCT/EP/2009/050385WO/2009/090189

)2010.01 (C07K20697912/11/2004

ILIL-18–18פרוטאינים קושרים מסוג BINDING PROTEINSABBOTT LABORATORIES

12/11/200310/706689USPCT/US/2004/037971WO/2005/047307

)2010.01 (C07K20698009/02/2001

אנושי18–נוגדנים הקושרים אינטרלויקין ושיטות להכנתם ושימושים בהם

ANTIBODIES THAT BIND HUMANINTERLEUKIN-18 AND METHODS OFMAKING AND USINGABBOTT LABORATORIES

10/02/200060/181608USPCT/US/2001/004170WO/2001/058956

)2010.01 (A61L20698118/01/2009

תחבושת לכוויות המבוססת על קולגן קולואידי ושנוצר ממדוזות

COLLOIDAL COLLAGEN BURNWOUND DRESSING PRODUCEDFROM JELLYFISH

בע-קול COLL-MEDמ"מד LTD.16/01/200861/021381US

PCT/IL/2009/000071WO/2009/090655


)2010.01 (E06B20698214/07/2010

BLIND משקוף עיוור עבור חלון או דלת FRAME FOR A WINDOW OR ADOOR

) 2006(אלומינה סיסטמס דיבלופמנטמ"בע

ALUMINA SYSTEMS DEVELOPMENT(2006) LTD.

)2010.01 (E06B20698326/02/2006

BLIND משקוף עיוור עבור חלון או דלת FRAME FOR A WINDOW OR ADOOR

) 2006(אלומינה סיסטמס דיבלופמנטמ"בע

ALUMINA SYSTEMS DEVELOPMENT(2006) LTD.

)2010.01 (B01J20698505/01/2009

MONOLITHIC זרז מונוליטי ושימושים בו CATALYST AND USESTHEREOFHYDROGEN CATALYST LTD

14/01/200861/006435USPCT/IL/2009/000017WO/2009/090631

)2010.01 (G07C20698630/01/2009

METHOD שיטה ומכשיר לניהול בקרת גישה AND DEVICE FORMANAGING ACCESS CONTROLEVVA SICHERHEITSTECHNOLOGIEGMBH

30/01/2008A 145/2008AT


PCT/AT/2009/000033WO/2009/094683

)2010.01 (C03C20698727/01/2009

GLASS חומרי גלם להכנת זכוכית FRITSBASF SE

30/01/200812/022294USPCT/US/2009/032107WO/2009/097264

)2010.01 (C09D20698827/01/2009

–דיו מוליך עם מתאמים מתכתיים אורגניים

CONDUCTIVE INKS WITH METALLO- ORGANIC MODIFIERS

BASF SE30/01/200812/022358US

PCT/US/2009/032109WO/2009/097266

)2010.01 (C09D20698927/01/2009

CONDUCTIVE דיו מוליך INKSBASF SE

30/01/200812/022403USPCT/US/2009/032112WO/2009/097269

)2010.01 (C12Q20699019/01/2009

בסרטן1GSTPגילוי של היפרמתילציה הערמונית

DETECTION OF GSTP1HYPERMETHYLATION IN PROSTATECANCERVERIDEX, LLC

22/01/200861/022600USPCT/US/2009/031379WO/2009/094312


)2010.01 (C12Q20699119/01/2009

שלIII–וIIמיקום מולקולרי של שלבים סרטן המעי הגס ופרוגנוזה

MOLECULAR STAGING OF STAGE IIAND III COLON CANCER ANDPROGNOSISVERIDEX, LLC

22/01/200861/022539USPCT/US/2009/031389WO/2009/094318

)2010.01 (A61B20699214/07/2010

ANOMALY זיהוי אנומליות באפליקציות הדמיה LESION DETECTION INIMAGING APPLICATIONS

בע.פי.וי.יד .D.V.Pמ"טכנולוגיות TECHNOLOGIES LTD.

)2010.01 (C07K20699323/05/2006

METHOD שיטה לטיהור נוגדנים FOR THE PURIFICATIONOF ANTIBODIESF. HOFFMANN-LA ROCHE AG

25/05/200505011302.6EPPCT/EP/2006/004863WO/2006/125599

)2010.01 (C07K20699410/02/1997

TNF? הקושרים, נוגדנים של בני אדם ממקור אנושי

HUMAN ANTIBODIES THAT BINDHUMAN TNFa

ABBOTT BIOTECHNOLOGY LTD.09/02/199608/599226US25/11/199660/031476US

PCT/US/1997/002219


WO/1997/029131

)2010.01 (A61M20699516/01/2009

ערכת להכנסת קטטר מבוקרת מרחוקמREMOTELY CONTROLLEDCATROLLED CATHETER INSERTIONSYSTEM

CATHETER קטטר רובוטיקס ROBOTICS INC.16/01/200860/021507US13/05/200861/052790US

PCT/US/2009/031357WO/2009/092059

)2010.01 (C08L20699614/07/2010

שיטות להסרת חומציות, תכשירי ליגניןמזרם ליגנין ושיטות להפקת חומר

ליגנותאית

LIGNIN COMPOSITIONS, METHODSFOR DEACIDIFICATION OF A LIGNINSTREAM AND METHODS FORPROCESSING A LIGNOCELLULOSICMATERIAL


)2010.01 (C12N20699725/01/2009

C– VEGFתכשירים ושיטות לוויסות ביטוי

COMPOSITIONS AND METHODS FORMODULATING VASCULARENDOTHELIAL GROWTH FACTOR C(VEGF -C ) EXPRESSION


24/01/201061/023105USPCT/IL/2009/000100WO/2009/093253


)2010.01 (A61K20699815/01/2009

VACCINE חיסון למלת האלצהיימר FOR ALZHEIMER'SDISEASE


16/01/200861/021348USPCT/IL/2009/000066WO/2009/906050

)2010.01 (H03M20699914/01/2009

DIRECT ישירRFממיר דיגיטלי לאנלוגי מורכב RF COMPLEX ANALOG TODIGITAL CONVERTERLOCKHEED MARTIN CORPORATION

16/01/200812/014846USPCT/US/2009/030990WO/2009/091822

)2010.01 (H04W20700015/01/2009

WIRELESS שידור מידע בתקשורת אלחוטית COMMUNICATIONINFORMATION RELAYQUALCOMM INCORPORATED

16/01/200861/021537US16/01/200861/021545US14/01/200912/353893US

PCT/US/2009/031147WO/2009/091919

)2010.01 (A61K20700114/01/2009

ד ופאמין פורמולציות למתן אגוניסטים של שלא דרך המעיים

PARENTERAL FORMULATIONS FORTHE ADMINISTRATION OFDOPAMINE AGONISTSVEROSCIENCE, LLC

14/01/200861/020930US23/06/200812/144620US

PCT/US/2009/000268WO/2009/091576


)2010.01 (A61F20700215/01/2009

INTRAUTERINE רחמי לחסימת חצוצרות–התקן תוך FALLOPIAN TUBEOCCLUSION DEVICEYALE UNIVERSITY

15/01/200861/006454US14/01/200912/353770US

PCT/US/2009/000241WO/2009/091560

)2010.01 (B01D20700515/07/2010

המכילה, מערכת למיחזור מים אפוריםבתוכה את כל הרכיבים הנדרשים לצורך

פעולת המיחזור

GRAY WATER RECYCLING SYSTEM,CONTAINING ALL COMPONENTSREQUIRED FOR RECYCLINGOPERATION

PEL פל דויד DAVID

)2010.01 (F03G20700615/07/2010

השיטה של ייצור אנרגיה מן התנועה שלהרכבת וכן תכשיר ליישומ

A METHOD OF THE ENERGYGENERATING FROM THE MOTIONOF TRAINS, AND A DEVICE FOR ITSIMPLEMENTATION

ZOLDAN זולד אלכסנדר ALEXANDER

)2010.01 (C12N20700713/02/2002


שיפוץ ואכלוס מחדש של רקמות שעברוניקוי מתאית וחלקיקים מתים באמצעות

תאי גזע

RENOVATION AND REPOPULATIONOF DECELLULARIZED TISSUES ANDCADAVERIC ORGANS BY STEMCELLSROBERT J. HARIRI

14/02/200160/268560USPCT/US/2002/004187WO/2002/063962

)2010.01 (C12N20700813/02/2002

שיפוץ ואכלוס מחדש של רקמות שעברוניקוי מתאית וחלקיקים מתים באמצעות

תאי גזע

RENOVATION AND REPOPULATIONOF DECELLULARIZED TISSUES ANDCADAVERIC ORGANS BY STEMCELLSROBERT J. HARIRI

14/02/200160/268560USPCT/US/2002/004187WO/2002/063962

)2010.01 (A61K20700919/02/2009

EXTRACTS תמצית פרי המרולה OF SCLEROCARYABIRREA

MANAGEMENT חברה ישראלית, ערדום-ניהול ואחזקה AND HOLDINGS-ARDOM

19/02/200861/064125USPCT/IL/2009/000192WO/2009/104184

)2010.01 (H04L20701016/01/2009

תקשורת אלחוטית ושיטה לביטול מערכת אוטומטי של צומת ומפתח

WIRELESS COMMUNICATIONSYSTEM AND METHOD FORAUTOMATIC NODE AND KEYREVOCATIONKONINKLIJKE PHILIPSELECTRONICS N.V.

18/01/200861/022057US25/07/200861/083828US


PCT/IB/2009/050160WO/2009/090616

)2010.01 (A61K20701117/12/2008

שימוש בתולדות איזותיוציאנט כגורמים מיאלומה–אנטי

USE OF ISOTHIOCYANATEDERIVATIVES AS ANTI-MYELOMAAGENTSINDENA S.P.A.

18/01/200808100658.7EPPCT/EP/2008/010768WO/2009/089889

)2010.01 (G01N20701227/10/2000

איבחון וריפוי סרטן באמצעות מולקולותל 28SGP–הקשורות

DIAGNOSIS AND THERAPY OFCANCER USING SGP28-RELATEDMOLECULESAGENSYS, INC.

28/10/199960/162610USPCT/US/2000/029607WO/2001/031343

)2010.01 (A61K20701307/02/2009

הפסקת עמידות חיסונית עם חומצות מיניות לא טבעיות המקודדות גנטיתא

BREAKING IMMUNOLOGICALTOLERANCE WITH A GENETICALLYENCODED UNNATURAL AMINOACIDTHE SCRIPPS RESEARCH INSTITUTE

08/02/200861/065147US08/02/200861/065148US12/02/200861/065590US12/02/200861/065515US 25/07/200861/135947US25/07/200861/135969US31/07/200861/137676US31/07/200861/137635US29/12/200861/203947US29/12/200861/203948US


PCT/US/2009/000813WO/2009/099672

)2010.01 (A61N20701424/02/2009

נתינה מוגברת של תרופה לרקמות עיניות באמצעות יונתופוריזה

ENHANCED DELIVERY OF ATHERAPEUTIC TO OCULAR TISSUESTHROUGH IONTOPHORESISEYEGATE PHARMA S.A.S.

25/02/200861/031267US25/04/200861/047950US

PCT/US/2009/034977WO/2009/108626

)2010.01 (C03C20701525/02/2009

זיגוג המגן מפני השמש בעל מקדם העברת אור משופר

SOLAR-PROTECTION GLAZINGHAVING AN IMPROVED LIGHTTRANSMISSION COEFFICIENTSAINT-GOBAIN GLASS FRANCE

27/02/20080851263FRPCT/FR/2009/050299WO/2009/112759

)2010.01 (C07D20701616/01/2009

PHENYLACETAMIDE תולדות פנילאצטאמיד DERIVATIVEASTELLAS PHARMA INC.

18/01/20082008-008671

JP

PCT/JP/2009/050508WO/2009/091014

)2010.01 (B01J20701704/02/2009

מיקרוקפסולות המכילות חומר פעיל שטח ליפופילי ושמן

MICROCAPSULES COMPRISING ALIPOPHILIC SURFACTANT AND OIL


BASF SE05/02/200808101289.0EP

PCT/EP/2009/051272WO/2009/098232

)2010.01 (H04N20701816/01/2009

שיטה להצפנת תמונה ושיטה לפענוח תמונה

IMAGE CODING METHOD ANDIMAGE DECODING METHOD

PANASONIC CORPORATION18/01/200808000979.8JP

PCT/JP/2009/000150WO/2009/090884

)2010.01 (A01G20701916/02/2009

SCREENINGךהתקנת סיכו INSTALLATIONBONAR TECHNICAL FABRICS N.V.

27/02/200808003521.5EPPCT/EP/2009/051790WO/2009/106450

)2010.01 (C07D20702012/02/2009

PROCESS נילידים מותמריםתהליך להכנת ביפנילא FOR PREPARINGSUBSTITUTED BIPHENYLANILIDESBAYER CROPSCIENCE AG

25/02/200808151892.0EPPCT/EP/2009/000986WO/2009/106234

)2010.01 (C12N12070222/12/1997

NF–KAPPAמאקטב קולטן BRECEPTOR ACTIVATOR OF NF-KAPPA BIMMUNEX CORPORATION

23/12/199660/059978US


07/03/199708/813509US14/10/199760/064671US

PCT/US/1995/023866WO/1998/028424

)2010.01 (C12N20702222/12/1997

Bליגנדה עבור מאקטב קולטן KAPPA–NF

LIGAND FOR RECEPTORACTIVATOR OF NF-KAPPA BIMMUNEX CORPORATION

23/12/199660/059978US07/03/199708/813509US14/10/199760/064671US

PCT/US/1997/023775WO/1998/028426

)2010.01 (H04B20702306/08/2003

מיתוג ערוצים לתמיכה בשירותי מולטימדיה לשידור רחב ולמנויים

CHANNEL SWITCHING FORSUPPORT OF MULTIMEDIABROADCAST AND MULTICASTSERVICESINTERDIGITAL TECHNOLOGYCORPORATION

07/08/200260/402161USPCT/US/2003/024543WO/2004/015876

)2010.01 (C12N20702413/02/2002

ג POST-PARTUM זע מבודדים משיליה אנושיתתאי MAMMALIANDPLACENTAL STEM CELLSANTHROGENESIS CORPORATION

14/02/200160/268560US05/12/200110/004942US

PCT/US/2002/004282WO/2002/064755


)2010.01 (C12N20702513/02/2002

תאי גזע מבודדים משיליה אנושית

POST-PARTUM MAMMALIANPLACENTA, ITS USE ANDPLACENTAL STEM CELLSTHEREFROMANTHROGENESIS CORPORATION

14/02/200160/268560US05/12/2001004942US

PCT/US/2002/004282WO/2002/064755

)2010.01 (H04L20702606/08/2003

מיתוג ערוצים לתמיכה בשירותי מולטימדיה לשידור רחב ולמנויים

CHANNEL SWITCHING FORSUPPORT OF MULTIMEDIABROADCAST AND MULTICASTSERVICESINTERDIGITAL TECHNOLOGYCORPORATION

07/08/200260/402161USPCT/US/2003/024543WO/2004/015876

)2010.01 (G01N20702719/01/2009

א ו תנאים שיטה לגילוי חתימות של מחלה בנוזלי הגוף

METHODS FOR DETECTINGSIGNATURES OF DISEASE ORCONDITIONS IN BODILY FLUIDSPRESIDENT AND FELLOWS OFHARVARD COLLEGE

18/01/200861/022033US18/06/200861/073434US

PCT/US/2009/031395WO/2009/092068

)2010.01 (A61K20702815/08/2003


PHARMACEUTICAL אלפאTNFהרכב רוקחי לנוגדן נוגד NATI-TNF-ALPHA ANTIBODY FORMULATIONABBOTT BIOTECHNOLOGY LTD.

16/08/200210/222140USPCT/IB/2003/004502WO/2004/016286

)2009.01 (C07K20702924/03/2000

ל IL–12–נוגדנים אנושיים המתחברים אנושי ושיטות ליצורם

HUMAN ANTIBODIES THAT BINDHUMAN IL-12 AND METHODS FORPRODUCINGGENETICS INSTITUTE, LLC.

25/03/199960/126603USPCT/US/2000/007946WO/2000/056772

)2010.01 (A61K20703018/01/2009

גליקוליפידים–תרפיה משולבת של בטאשורות ונוגדנים לטיפול בהפרעות הק

לחיסון

COMBINATION THERAPY OF BETA-GLYCOLIPIDS AND ANTIBODIESFOR THE TREATMENT OF IMMUNE-RELATED DISORDERS

THEמ"הדסית שירותי מחקר רפואי ופיתוח בע BRIGHAM AND WOMEN'SHOSPITAL, INC.

18/01/200861/021959USPCT/IL/2009/000072WO/2009/090656

)2010.01 (C07D20703115/01/2009

צורות קריסטל של דימתוקסי דוקטאקסל ושיטות להכנתן

CRYSTALLINE FORMS OFDIMETHOXY DOCETAXEL ANDMETHODS FOR PREPARING THESAMEAVENTIS PHARMA S.A.

17/01/20080800243FRPCT/FR/2009/000042WO/2009/115655


)2010.01 (C12N20703213/03/2009

אוליגונוקלאוטידים פוספודיאסטריים סינטטיים ושימושים רפואיים שלהם

SYNTHETIC PHOSPHODIESTEROLIGONUCLEOTIDES ANDTHERAPEUTICAL USES THEREOFGENTIUM SPA

19/03/200808425175.0EP07/05/200861/051088US

PCT/EP/2009/053002WO/2009/115465

)2010.01 (E01F20703327/02/2009

שיטה, מבנה למניעת נפילת אבניםלמניעת נפילת אבנים ושיטה לעיצוב

מבנה זה

A STRUCTURE FOR PREVENTINGROCKFALL, A ROCKFALLPREVENTION METHOD, AND AMETHOD FOR DESIGNING SAIDSTRUCTUREOFFICINE MACCAFERRI S.P.A.

27/02/20082008-045936

JP

PCT/IB/2009/050809WO/2009/107104

)2010.01 (C07F20703426/01/2009

CRYSTALLINE תרכובות סינאמיד קריסטלי או מלחים CINNAMIDECOMPOUNDS OR SALTS THEREOFEISAI R&D MANAGEMENT CO., LTD.

28/01/20082008-016692

JP

PCT/JP/2009/051162WO/2009/096349

)2010.01 (C07D20703504/02/2009

BENZYLPIPERIZINE תרכובת של בנזילפיפריזין COMPOUND


DAINIPPON SUMITOMO PHARMACO., LTD.

05/02/20082008-025676

JP

PCT/JP/2009/051854WO/2009/099087

)2010.01 (H04M20703715/07/2010

COMBINED רשת טלפון משולבת TELEPHONE NETWORKל TZACHIויצחי LEVI

)2010.01 (C07D20703804/02/2009

COMPOUNDS תרכובותPULMAGEN THERAPEUTICS(SYNERGY) LIMITED

06/02/20080802192.5GB09/12/20080822437.0GB

PCT/GB/2009/000298WO/2009/098448

)2010.01 (C07K20703911/12/1997

נוסחאות פרמצטיות המכילות תרכובתשאינה מסיסה במים להעברת תרופות

מתמשכת

PHARMACEUTICAL FORMULATIONSCOMPRISING A WATER-INSOLUBLECOMPLEX FOR SUSTAINED DRUG

DELIVERYPRAECIS PHARMACEUTICALSINCORPORATED

11/12/199608/762747USPCT/US/1997/022881WO/1998/025642


)2010.01 (H04W20704012/02/2009

התקן ושיטה לתזמון על פני נקודות חיבור מרובים

APPARATUS AND METHOD FORSCHEDULING OVER MULTIPLE HOPS


PCT/US/2009/033978WO/2009/102906

)2010.01 (H01R20704116/01/2009

ELECTRICAL הרכבת מחבר חשמלי CONNECTORASSEMBLYAMPHENOL CORPORATION

17/01/200861/021841USPCT/US/2009/000316WO/2009/091598

)2010.01 (H04B20704217/01/2008

שיטה וסידור עבור טיפול במקלט רדיו ברשת תקשורת אלחוטית

METHOD AND ARRANGEMENT FORHANDLING A RADIO RECEIVER IN AWIRELESS COMMUNICATIONNETWORK

TELEFONAKTIEBOLAGET L MERICSSON (PUBL)

PCT/SE/2008/050052WO/2009/091303

)2010.01 (H02P20704311/03/2009

INLET מכלול לדכא רוח נכנס WIND SUPPRESSORASSEMGLYWIND TAMER CORPORATION

16/01/200812/009057USPCT/US/2009/036795WO/2009/092118


)2010.01 (C07D20704512/01/2009

SOLID אורטאטקסל במצבי גבישיות שונים FORMS OF ORTATAXELINDENA S.P.A.

18/01/200808000904.6EPPCT/EP/2009/000112WO/2009/090024

)2010.01 (C07D20704618/01/2008

דיאלקוקסי קווינאזולין–6,7נגזרותשימושיות לטיפול בהפרעות הקשורות

לסרטן

6,7-DIALKOXY QUINAZOLINEDERIVATIVES USEFUL FORTREATMENT OF CANCER RELATEDDISORDERSNATCO PHARMA LTD

PCT/IN/2008/000036WO/2009/090661

)2010.01 (A47D20704715/07/2010

ת ושיטה של מרכז פעילות מערכ לתינוקות

A SYSTEM AND METHOD FOR ABABY ACTIVITY CENTER

YANOOKAמ"ינוקא התפתחות בע EVOLUTION LTD.

)2010.01 (G09B20704815/07/2010

AUTOMATED רשת ספריות ממוכנות אוטומטיות LIBRARY KIOSKNETWORK

MOSHE משה להב LAHAV


)2010.01 (A01N20704915/01/2009

סינתזה של לקטונים מחומצה המשמשים כחומרי ריפוירסורסיליקית

SYNTHESIS OF RESORCYLIC ACIDLACTONES USEFUL ASTHERAPEUTIC AGENTSUNIVERSITE DE STRASBOURG

15/01/200861/011163USPCT/US/2009/031149WO/2009/091921

)2010.01 (A01N20705006/02/2009

–תרכובות מלתיון מייוצבות במיקרו קפסולה

STABILIZED MALATHIONMICROCAPSULE FORMULATIONS

CHEMINOVA A/S06/02/200808101318.7EP06/02/200861/006923US

PCT/DK/2009/050037WO/2009/097860

)2010.01 (A61B20705118/07/2010

כף מידה דנטלית למטבעים לשתלים ושיטה

DENTAL IMPRESSION TRAY FORIMPLANTS AND A METHODTHEREOF

.DR טרופ-ר אילת רובינוביץ"ד AYELET RUBINOVITCH-TROP

)2010.01 (A61M20705217/12/2008

DRUG שסתום וידוא לאספקת תרופות PORT VERIFICATION VALVEPRO-IV LTD

22/01/200861/006578USPCT/IL/2008/001616


WO/2009/093231

)2010.01 (G06Q20705321/01/2009

שיטה ומערכת לפרשנות שפה מצביתMETHOD AND SYSTEM FORSITUATIONAL LANGUAGEINTERPRETATIONGEACOM, INC.

17/01/200812/009229USPCT/US/2009/031547WO/2009/092096

)2010.01 (C30B20705414/07/2004

SINGLE יהלום גביש יחיד ושיתה לייצורו CRYSTAL DIAMOND ANDMETHOD OF MAKING THEREOFCARNEGIE INSTITUTION OFWASHINGTON

14/07/200360/486435USPCT/US/2004/022610WO/2005/007935

)2010.01 (C07C20705530/01/2009

תהליך עבור ייצור של תרכובת בנזאלדהייד

PROCESS FOR PRODUCTION OFBENZALDEHYDE COMPOUNDSUMITOMO CHEMICAL COMPANY,LIMITED

14/02/20082008-032763

JP

PCT/JP/2009/052014WO/2009/101898

)2009.01 (H04W20705717/01/2002


מית עבור תקשורת הקצאת רוחב פס דינ רבת כניסות

DYNAMIC BANDWIDTHALLOCATION FOR MULTIPLEACCESS COMMUNICATION USINGSESSION QUEUESTANTIVY COMMUNICATIONS, INC.

31/01/200109/773252USPCT/US/2002/001512WO/2002/061993

)2010.01 (H04W20705819/05/2000

–קדימות ובקרת זרימה של ערוץ רב משתמשים בעלי ספקטרום מפוזר

PRIORITIZATION AND FLOWCONTROL OF A SPREADSPERCTRUM MULTIUSER CHANNELINTERDIGITAL TECHNOLOGYCORPORATION

20/05/199960/135073USPCT/US/2000/013918WO/2000/072608

)2009.01 (H04J20705913/06/2002

בדרגה נמוכה יותרHBהעברה של אות מבקשHBמאות

TRANSMITTAL OF HEARTBEATSIGNAL AT A LOWER LEVEL THANHEARTBEAT REQUESTTANTIVY COMMUNICATIONS, INC.

13/06/200160/297925US29/11/200109/997621US07/05/200260/378697US12/06/200210/171080US

PCT/US/2002/018878WO/2002/102095

)2010.01 (C12N20706015/05/2001

שבטי ממקור אנושי כנגד–נוגדן חדהמעבירות אות מעוררAILIMמולקולות

ושימוש רוקחי בנוגדן זה

HUMAN MONOCLONAL ANTIBODYAGAINST A COSTIMULATORYSIGNAL TRANSDUCTIONMOLECULE AILIM ANDPHARMACEUTICAL USE THEREOF


JAPAN TOBACCO INC.

18/05/20002000-147116

JP

30/03/20012001&99508JPPCT/JP/2001/004035WO/2001/087981

)2010.01 (E01B20706122/02/2008

מערכת להידוק מסילה והידוק מסילה על גבי מצע

SYSTEM FOR FASTENING A RAIL,AND FASTENING OF A RAIL ON ASUBSTRATEVOSSLOH-WERKE GMBH

PCT/EP/2008/052209WO/2009/103349

)2010.01 (B64G20706216/01/2009

DEVICE מכשיר לגילוי פריטי חלל FOR DETECTING SPACEOBJECTSINSTITUTE FOR Q-SHU PIONEERS OFSPACE, INC

17/01/20082008-008452

JP

PCT/JP/2009/050560WO/2009/091037

)2010.01 (A01N20706317/02/2009

OIL-BASED יף על בסיס שמןתרכיזי תרח SUSPENSIONCONCENTRATESBAYER CROPSCIENCE AG

25/02/200808151880.5EPPCT/EP/2009/001087WO/2009/106247


)2010.01 (C07D20706409/03/2009

–דיאזא–4,1דות חדשות תולנוניל אוקסאדיאזוליל]2.2.3[ביציקלו

המשמשות כמאפננות של קוטלני אצטילקולין ניקוטיני

NOVEL 1,4-DIAZA-BICYCLO[3.2.2]NONYLOXADIAZOLYL DERIVATIVESUSEFUL AS MODULATOR OFNICOTINIC ACETYLCHOLINERECEPTORSNEUROSEARCH A/S

11/03/2008PA200800372DK12/03/200861/035876US

PCT/EP/2009/052732WO/2009/112460

)2010.01 (A41D20706516/01/2009

LOAD וסט טקטי נושא מטען BEARING TACTICAL VESTARCHANGEL ARMOR, LLC

16/01/200861/006499US12/09/200861/096458US

PCT/US/2009/031289WO/2009/092006

)2010.01 (A01N20706615/01/2009

תכשירים המכילים,IAPתרכובות מדכאי שים בהןאותן ושימו

IAP INHIBITOR COMPOUNDS,COMPOSITIONS COMPRISING THESAME AND USES THEREOFTETRALOGIC PHARMACEUTICALCORPORATION

24/01/200861/023237USPCT/US/2009/031093WO/2009/094287

)2010.01 (C07D20706724/02/1998

מערכת למתן טרנסדרמלי של ביופרנאורפין לשימוש לטיפול בכאב

TRANSDERMAL DELIVERYSYSTEMS OF BUPRENORPHINE FORUSE IN TREATING PAINEURO-CELTIQUE S.A.


24/02/199760/038919US29/09/199760/939068US

PCT/US/1998/003584WO/1998/036728

)2009.01 (C12Q20706802/03/2003

LABELING מגיבים מסומנים ומטרות מסומנות REAGENTS ANDLABELED TARGETS

ENZO LIFE SCIENCES, INC.12/03/200210/096075US

)2010.01 (A47D20706918/07/2010

AN שולחן בר הרחבה EXTENDABLE TABLEDOR דור חריף HARIF

23/11/200961/263424US

)2010.01 (C07K20707012/08/2003

פפטדים כגורמי המסה לחלבוני פקטורגידול משנה בטה ותכשירים רוקחיים

המכילים אותם

PEPTIDES AS SOLUBILIZINGEXCIPIENTS FOR TRANSFORMINGGROWTH FACTOR ? PROTEINS ANDPHARMACEUTICAL COMPOSITIONSCOMPRISING THEMWYETH HOLDINGS CORPORATION

13/08/200260/402733USPCT/US/2003/025177WO/2004/014940


)2010.01 (C12Q20707121/01/2009

SELECTIVE גירוי של אור סלקטיבי להתרבות תאים PHOTOSTIMULATION TOINDUCE CELL PROLIFERATIONTHE GENERAL HOSPITALCORPORATION

18/01/200861/022202USPCT/US/2009/031599WO/2009/092112

)2010.01 (A44C20707223/01/2009

חפץ מסופק עם אלמנט גרפיקה מועבר לשבב תמיכה ושיטה לייצור חפץ כזה

OBJECT PROVIDED WTH AGRAPHICS ELEMENT TRANSFERREDONTO A SUPPORT WAFER ANDMETHOD OF PRODUCING SUCH ANOBJECTCOMMISSARIAT A L'ENERGIEATOMIQUE

25/01/20080850475FRPCT/EP/2009/050779WO/2009/092794

)2010.01 (A44C20707323/01/2009

פריט שכולל רכיב גרפי שהועבר לשבב תמיכה ושיטה לייצור פריט זה

OBJECT COMPRISING A GRAPHICSELEMENT TRANSFERRED ONTO ASUPPORT WAFER AND METHOD OFPRODUCING SUCH AN OBJECTCOMMISSARIAT A L'ENERGIEATOMIQUE

25/01/20080850472FRPCT/EP/2009/050785WO/2009/092799

)2010.01 (C07D20707421/01/2009


תרכובות טריצקליות עם פעילותאנטגוניסטית לפקטור משחרר

קורטיקוטרופין ותכשירים רוקחיים המכילים אותן

TRICYCLIC COMPOUNDS HAVINGCORTICOTROPIN-RELEASINGFACTOR ANTAGONISTIC ACTIVITYAND PHARMACEUTICALCOMPOSITIONS CONTAINING THEMTAKEDA PHARMACEUTICALCOMPANY LIMITED

22/01/200861/006554USPCT/JP/2009/051299WO/2009/093747

)2010.01 (C12Q20707516/01/2009

GENERIC סמנים גנטיים של מחלות נפש MARKERS OF MENTALILLNESSSUREGENE LLC

17/01/200861/021756USPCT/US/2009/031322WO/2009/092032

)2010.01 (A61M20707619/07/2010

ROBOTIC הנעה רובוטית של צנתר DRIVE FOR CATHETERBIOSENSE WEBSTER, INC.

12/08/200912/539707US

)2010.01 (H02M20707723/01/2009

HIGH מהפך מתח גבוה VOLTAGE INVERTERADVANCED FUSION SYSTEMS LLC

24/01/200861/062154USPCT/US/2009/031904WO/2009/094589


)2010.01 (C07D20707820/01/2009

הכנה, תולדות אזאבייצקלית קרבקסאמיד שלהם ושימוש בהם לטיפול

AZABICYCLIC CARBOXAMIDEDERIVATIVES, PREPARATIONTHEREOF AND THERAPEUTIC USETHEREOFSANOFI-AVENTIS

22/01/200808/00308FRPCT/FR/2009/000052WO/2009/112678

)2010.01 (C07D20707920/01/2009

–קרבוקסמידים ואזא–2–דולנגזרות של אינקרבוקסאמידים מותמרות–2–אינדול

הכנתן ושימושן, בקבוצת סילאן התראפיוטי

DERIVATIVES OF INDOLE 2-CARBOXAMIDES AND AZAINDOLE2-CARBOXAMIDES SUBSTITUTEDBY A SILANYLE GROUP,PREPARATION THEREOF ANDTHERAPEUTIC USE THEREOFSANOFI-AVENTIS

23/01/200808/00343FRPCT/FR/2009/000054WO/2009/109710

)2010.01 (C07D20708020/01/2009

, תולדות אזאבייציקלית קרבקסאמיד הכנה שלהם ושימוש בהם לטיפול

AZABICYCLIC CARBOXAMIDEDERIVATIVES, PREPARATIONTHEREOF AND THERAPEUTIC USETHEREOFSANOFI-AVENTIS

22/01/20080800310FRPCT/FR/2009/000053WO/2009/112679

)2010.01 (H04B20708117/08/2004


מקלט לביטול ערבול רצוף אשר מעבד עם מגוון ברירות

SUCCESSIVE INTERFERENCECANCELLATION RECEIVERPROCESSING WITH SELECTIONDIVERSITYQUALCOMM INCORPORATED

23/09/200310/670079USPCT/US/2004/027039WO/2005/036799

)2010.01 (G02B20708226/03/2009

אופטיקה מתאמת סדר נמוך על ידי מראה פתח–שניונית מתרגמת של טלסקופ אל

LOW ORDER ADAPTIVE OPTICS BYTRANSLATING SECONDARYMIRROR OF OFF-APERTURETELESCOPERAYTHEON COMPANY

26/03/200861/039620US25/03/200912/410772US

PCT/US/2009/038369WO/2009/120847

)2009.01 (C12N20708329/01/2009

משטחים סינתטיים לתרבות קרדיומיוציטים המופקים מתאי גזע

SYNTHETIC SURFACES FORCULTURING STEM CELL DERIVEDCARDIOMYOCYTESGERON CORPORATION

30/01/200861/062921USPCT/US/2009/032411WO/2009/097411

)2010.01 (C07D20708420/01/2009

נגזרות ביציקליות של קרבוקסאמידיםהכנתן ושימושן, אזאביציקליים

התראפיוטי

BICYCLIC DERIVATIVES OFAZABICYCLIC CARBOXAMIDES,PREPARATION THEREOF ANDTHERAPEUTIC USE THEREOFSANOFI-AVENTIS

22/01/20080800309FRPCT/FR/2009/000051


WO/2009/112677

)2009.01 (C12N20708529/01/2009

משטחים סינתטיים לתרבות תאי אבי אוליגודנדרוציט המפוקים מתאי גזע

SYNTHETIC SURFACES FORCULTURING STEM CELL DERIVEDOLIGODENDROCYTE PROGENITORCELLSGERON CORPORATION

30/01/200861/063010USPCT/US/2009/032425WO/2009/097421

)2010.01 (H04L20708605/02/2009

איתות שידור לא רציף בערוצי בקרה של קישור למעלה

DISCONTINUOUS TRANSMISSIONSIGNALING OVER AN UPLINKCONTROL CHANNELQUALCOMM INCORPORATED

08/02/200861/027254US26/03/200861/039548US04/02/200912/365872US

PCT/US/2009/033221WO/2009/100200

)2010.01 (C07D20708730/01/2009

MESOIONIC חומרי הדברה מזויוניים PESTICIDESE.I. DU PONT DE NEMOURS ANDCOMPANY

06/02/200861/063789US09/04/200861/043428US

PCT/US/2009/032584WO/2009/099929

)2010.01 (A61K20708819/07/2010


תכשיר לטיפול מקומי במצבים דלקתיים של עור עם עקצוץ

TOPICAL COMPOSITION FORTREATING INFLAMMATORYPRURITIC SKIN CONDITIONS

בע.ש.ב .B.Sמ"מדיקלי MEDICLY LTD

)2010.01 (C07D20708927/01/2009

שימוש משולב של מעכב אנגיוגנזה וטקסאן

COMBINED USE OF ANGIOGENESISINHIBITOR AND TAXANE

EISAI R&D MANAGEMENT CO., LTD.29/01/200861/024359US

PCT/JP/2009/051244WO/2009/096377

)2010.01 (G01N20709022/01/2009

סיווג חולי מחלות קרדיווואסקולריות עלפי פרוגנוזה הנמדדת לפי רמות הסמן

40–YKL

CLASSIFICATION OF INDIVIDUALSSUFFERING FROMCARDIOVASCULAR DISEASESACCORDING TO SURVIVALPROGNOSES AS FOUND BYMEASURING THE LEVELS OFBIOMARKER YKL-40RIGSHOSPITALET

23/01/2008PA200800089DKPCT/DK/2009/050015WO/2009/092382

)2010.01 (F41F20709130/01/2009

והתקן, סידור להגשת פגז לקנה תותח תמיכה עבורו

ARRANGEMENT FOR SUPPORTINGSHELL INTO WEAPON BARREL, ANDSUPPORT MEMBERPATRIA LAND & ARMAMENT OY

31/01/200820085082FIPCT/FI/2009/050073


WO/2009/095536

)2010.01 (F04D20709219/03/2004

חלק איוורור עם מערך מאווררים במערכות טיפול באוויר

FAN ARRAY FAN SECTION IN AIR-HANDLING SYSTEMS

HUNTAIR, INC.20/03/200360/456413US

PCT/US/2004/008578WO/2004/085928

)2010.01 (A23L20709320/07/2010

, התקן ושיטה להכנת יוגורט מוקפא סורבה וגלידה

APPARATUS AND METHOD FORPREPARING FROZEN YOGURT,SHERBET AND ICE CREAM

AVRAHAM אברהם כץ KATZ

)2010.01 (B01D20709419/02/2008

ניהול ביצועים של תהליך הפרדת קרומיםON-LINE PERFORMANCEMANAGEMENT OF MEMBRANESEPARATION PROCESSABB RESEARCH LTD

PCT/IB/2008/000359WO/2009/104035

)2010.01 (H01L20709505/12/2008


מפעל סולרי לריכוז נמוך ושיטה להעלאת–יצור החשמל של המודולים הפוטו

וולטאיים של מפעל זה

LOW CONCENTRATION SOLARPLANT AND METHOD FORMAXIMIZING THE ELECTRICITYPRODUCTION OF THEPHOTOVOLTAIC MODULESTHEREOFABENGOA SOLAR NEWTECHNOLOGIES, S.A.

30/01/2008P200800242ESPCT/ES/2008/000763WO/2009/095509

)2010.01 (C12P20709605/02/2009

פוליפפטידיים מוסגלים של לפטין ושימושיהם

MODIFIED LEPTIN POLYPEPTIDESAND THEIR USES

AMBRX, INC.08/02/200861/027414US

PCT/US/2009/033277WO/2009/100255

)2010.01 (G06F20709721/01/2009

עריכת מסמך באמצעות משטח עריכה ארעי

EDITING A DOCUMENT USING ATRANSITORY EDITING SURFACE

MICROSOFT CORPORATION25/02/200812/037059US

PCT/US/2009/031482WO/2009/108417

)2010.01 (G06F20709823/01/2009

מערכת אוטומטית ושיטה לניטור ביצוע ויישומים שלה, עמודת כרומטוגרפיה

AUTOMATED SYSTEM ANDMETHOD FOR MONITORINGCHROMATOGRAPHY COLUMNPERFORMANCE, ANDAPPLICATIONS THEREOFBIOGEN IDEC MA INC.

25/01/200861/023747US


PCT/US/2009/000469WO/2009/094203

)2010.01 (C07D20709927/01/2009

קווינולין מותמרות–אמינו–2–תולדות תיו–המשמשות כמעכבות של בתא6בעמדה )BACE(סקרטאז

6-SUBSTITUTED-THIO-2-AMINO-QUINOLINE DERIVATIVES USEFULAS INHIBITORS OF-?-SECRETASE(BACE)

JANSSEN PHARMACEUTICA, N.V.28/01/200861/024039US

PCT/US/2009/032126WO/2009/097278

)2010.01 (C07D20710029/01/2009

קווינולין המשמשות–אמינו–2תולדות)BACE(כמעכבות של בתא סקרטאז

2-AMINO-QUINOLINE DERIVATIVESUSEFUL AS INHIBITORS OF B-SECRETASE (BACE)JANSSEN PHARMACEUTICA, N.V.

29/01/200861/024244USPCT/US/2009/032393WO/2009/097401

)2010.01 (A61F20710123/01/2009

ELASTOMERIC חומרים אלסטומרים MATERIALSCLOPAY PLASTIC PRODUCTSCOMPANY, INC.

24/01/200861/023107USPCT/US/2009/031779WO/2009/094506

)2010.01 (H04W20710211/02/2009

QUALITY המשכיות איכות שירות OF SERVICE CONTINUITY



PCT/US/2009/033807WO/2009/102797

)2010.01 (H04L20710311/02/2009

HARQבקרת שידור נתונים מבוססת על במערכת תקשורת אלחוטית

CONTROL OF DATA TRANSMISSIONBASED ON HARQ IN A WIRELESSCOMMUNICATION SYSTEMQUALCOMM INCORPORATED

12/02/200861/028159US10/02/200912/368968US

PCT/US/2009/033810WO/2009/102798

)2010.01 (H04W20710412/02/2009

מציוד משתמשCQIהפעלת שידורעבור ציוד משתמש במצבBצומתל

FACH_CELL

TRIGGERING OF CQI TRANSMISSIONFROM UE TO NODE B FOR A UE INCELL_FACH STATE

QUALCOMM INCORPORATED12/02/200861/028068US12/02/200861/028168US11/02/200912/369261US

PCT/US/2009/033929WO/2009/102872

)2010.01 (H04L20710505/02/2009

מערכת ושיטה לריבוב משופר לערוצי בקרה של קישור למעלה

ENHANCED MULTIPLEXINGSYSTEM AND TECHNIQUE FORUPLINK CONTROL CHANNELSQUALCOMM INCORPORATED

08/02/200861/027242US04/02/200912/365845US

PCT/US/2009/033218WO/2009/100217


)2010.01 (H04L20710606/02/2009

QMULTIPLEXING–וIריבוב מעל ענפי OVER I AND QBRANCHESQUALCOMM INCORPORATED

08/02/200861/027143US06/03/200861/034227US05/02/200912/366010US

PCT/US/2009/033348WO/2009/100302

)2010.01 (A01G20710721/01/2008

שיטה והתקן לקביעת פרמטר לחץ של דגימת צמח

METHOD AND DEVICE FORDETERMINING A PRESSUREPARAMETER OF A PLANT SAMPLEZIMMERMANN, DIRK

PCT/EP/2008/000424WO/2009/092389

)2010.01 (A61F20710830/01/2009

–סיבית ביו–פיגום המורכב ממיקרוספרה נספגת לריפוי פצעים

FIBER-MICROSPHEREBIORESORBABLE COMPOSITESCAFFOLD FOR WOUND HEALINGKCI LICENSING, INC.

01/02/200812/012274USPCT/US/2009/032648WO/2009/097534

)2010.01 (H05K20710901/09/2009

סידור מעגל חשמלי בעל קבלים חופפים

AN ELECTRICAL CIRCUITARRANGEMENT WITH OVERLAPPINGCAPACITORS


ROHDE & SCHWARZ GMBH & CO. KG16/10/2008102008051920.0DE

PCT/EP/2009/006321WO/2010/043285

)2010.01 (C07D20711030/01/2009

תהליך להכנתם, פירזולופירימידינים ושימוש בהם כתרופה

PYRAZOLOPYRIMIDINES, APROCESS FOR THEIR PREPARATIONAND THEIR USE AS MEDICINEMERZ PHARMA GMBH & CO. KGaA

01/02/200808250396.2EP01/02/200861/063421US

PCT/EP/2009/000616WO/2009/095254

)2010.01 (C07F71112012/02/2009

אלקילפוספונטים דיאריל ושיטות להכנתםDIARYL A LKYLPHOSPHONATESAND METHODS FOR PREPARINGSAMEFRX POLYMERS, INC.

12/02/200812/029629USPCT/US/2009/033881WO/2009/102843

)2010.01 (G01N20711222/01/2009

40 YKLכסמן כללי למחלה לא ספציפית

YKL-40 AS A GENERAL MARKER FORNON-SPECIFIC DISEASE

RIGSHOSPITALET23/01/2008PA200800089DK15/09/2008PA200801292DK15/09/2008PA200801293DK15/09/2008PA200801294DK

PCT/DK/2009/050014WO/2009/092381


)2010.01 (A61K20711322/01/2009

תכשירים של אריטרופויטין ופיברונקטין להתחדשות של עצם

ERYTHROPIETIN AND FIBRONECTINCOMPOSITIONS FOR BONEREGENERATION

REMEDORמ"רימידור ביומד בע BIOMED LTD24/01/200861/006633US

PCT/IL/2009/000087WO/2009/093240

)2010.01 (G06F20711420/07/2010

IMPROVED ות משופרות להכנסת נתוניםשיט DATA ENTRY SYSTEMSBENJAMIN בנימין פירוז גסביאן FIROOZ GHASSABIAN

)2010.01 (G01N20711517/07/2009

את דחיסותSITU–INשיטה לקבועומכשיר לביצוע, השכבות של חורמ גרגרי

התהליך

METHOD FOR IN-SITUDETERMINING THE COMPACTNESSOF GRAINY MATERIAL LAYERSAND DEVICE FOR PERFORMING THEPROCESSSUBERT, ISTVAN

17/07/2008P0800441HUPCT/HU/2009/000059WO/2010/007454

)2010.01 (C12P20711821/01/2009

תהליך עבור ייצור של תרכובת חומצהמנדלית מותמרות אורטו בעלת פעילות

אופטית

PROCESS FOR PRODUCTION OFOPTICALLY ACTIVE ORTHO-SUBSTITUTED MANDELIC ACIDCOMPOUND


SUMITOMO CHEMICAL COMPANY,LIMITED

22/01/20082008-011300

JP

PCT/JP/2009/051297WO/2009/093745

)2010.01 (G06F20711910/02/2009

אספקת מיעון בלתי ישיר של נתוניםקלט כאשר רשימת/יצוע פלטבמערכת לב

הכתובות הבלתי ישירות של הנתונים היא בלתי רציפה

PROVIDING INDIRECT DATAADDRESSING IN AN INPUT/OUTPUTPROCESSING SYSTEM WHERE THEINDIRECT DATA ADDRESS LIST ISNON-CONTIGUOUSIBM CORPORATION

14/02/200812/031038USPCT/EP/2009/051485WO/2009/101067

)2010.01 (G06F20712009/02/2009

כיוונית באמצעות–העברת נתונים דו קלט יחידה/פעולת פלט

BI-DIRECTIONAL DATA TRANSFERWITHIN A SINGLE I/O PORATION

IBM CORPORATION14/02/200812/030954US

PCT/EP/2009/051450WO/2009/101053

)2010.01 (G06F20712109/02/2009

PROCESSING פלט/עיבוד נתונים לפיקוח פעולות קלט OF DATA TO MONITORINPUT/OUTPUT OPERATIONSIBM CORPORATION

14/02/200812/031023USPCT/EP/2009/051446WO/2009/101051


)2010.01 (G06F20712209/02/2009

פקודה ותגובה של מחשב לקביעת מצב פלט/פעולת קלט

COMPUTER COMMAND ANDRESPONSE FOR DETERMINING THESTATE OF AN I/O OPERATIONIBM CORPORATION

14/02/200812/030989USPCT/EP/2009/051461WO/2009/101056

)2010.01 (G06F20712321/07/2010

מערכת ושיטה לאיחוד של מזהי משתמש בכריית מידע רשת

SYSTEM AND METHOD FORUNIFICATION OF USER IDENTIFIERSIN WEB HARVESTING

VERINTמ"ורינט מערכות בע SYSTEMS LTD.

)2010.01 (B01D20712421/07/2010

מכשיר להוצאת מלחים מתמיסה באופן אלקטרומגנטי

DEVICE FOR ELECTROMAGNETICDESALINATION OF SOLUTION

VLADIMIR ולדימיר טורופוב TOROPOV

)2010.01 (A61K20712619/05/2005

שיטות ותכשירים קשורים להפחתת שומןMETHOD AND RELATEDCOMPOSITIONS FOR REDUCTION OFFATTHE REGENTS OF THE UNIVERSITYOF CALIFORNIA

19/05/200460/572879USPCT/US/2005/017957WO/2005/112942


)2010.01 (C07D20712724/01/2008

ALDH-2 בטיפול התמכרותALDH–2מעכבי INHIBITORS IN THETREATMENT OF ADDICTIONTHE ENDOWMENT FOR RESEARCHIN HUMAN BIOLOGY, INC.

PCT/US/2008/051862WO/2009/094028

)2010.01 (A61K20712823/01/2009

PHARMACEUTICAL צורת מינון רוקחית DOSAGE FORMGRUNENTHAL GMBH

25/01/200808001415.2EP25/01/200808001416.0EP17/10/200808018221.5EP

PCT/EP/2009/000438WO/2009/092601

)2010.01 (C07K20712922/01/2009

RON ושימושים בהםRONנוגדני ANTIBODIES AND USESTHEREOFBIOGEN IDEC MA INC.

22/01/200861/022779USPCT/US/2009/000376WO/2009/094148

)2010.01 (C07C20713029/01/2009

N'N'–קילביפניל דימותמרים אמינואל2Dאנטגוניסטים של קולטני פרוסטגלנדין

N,N-DISUBSTITUTEDAMINOALKYLBIPHENYLANTAGONISTS OF PROSTAGLANDIND2 RECEPTORSAMIRA PHARMACEUTICALS, INC.


01/02/200861/025597US31/10/200861/110496US

PCT/US/2009/032499WO/2009/099902

)2010.01 (C07D20713105/03/2009

–3–בנזיל–1תולדות חדשותהידרוקסימתילאינדאזול ושימוש בהן

בטיפול במחלות המבוססות על הביטוי ,MCP–1של 1CR3CX40–וP

NOVEL 1-BENZYL-3-HYDROXYMETHYLINDAZOLEDERIVATIVES AND USE THEREOF INTHE TREATMENT OF DISEASESBASED ON THE EXPRESSION OFMCP-1, CX3CR1 AND P40AZIENDE CHIMICHE RIUNITEANGELINI FRANCESCO A.C.R.A.F.S.p.A.

07/03/200808425139.6EPPCT/EP/2009/052590WO/2009/109618

)2010.01 (C03B20713310/03/2009

מערכת לערבוב ושיטה להפיכת זכוכיות מותכות להומוגניות

STIRRING SYSTEM AND METHOD FORHOMOGENIZING GLASS MELTS

UMICORE AG & CO. KG03/04/2008102008017045.3DE

PCT/EP/2009/052756WO/2009/121684

)2010.01 (C07K20713422/01/2009

נוגדנים אנושיים המיועדים לפקטור וון ווילברנד

HUMANIZED ANTIBODIES SPECIFICFOR VON WILLEBRAND FACTORGLENMARK PHARMACEUTICALSS.A.

23/01/200861/023025US14/04/200861/044787US

PCT/IB/2009/000124WO/2009/093138


)2010.01 (C07K20713501/02/2009

פוליפפטידים ופוליניוקליאטידים והשימוש, בהם כיעד לתרופות לייצור תכשירים

תכשירים ביולוגים ותרופות

POLYPEPTIDES ANDPOLYNUCLEOTIDES, AND USESTHEREOF AS A DRUG TARGET FORPRODUCING DRUGS AND BIOLOGIS

COMPUGENמ"קומפיוגן בע LTD31/01/200861/025054US10/03/200861/035168US09/04/200861/043599US

PCT/IL/2009/000123WO/2009/095925

)2010.01 (F41F20713630/01/2009

רכיבים ושיטה, סידור לגשת פגז לתוך קנה של הסידור

ARRANGEMENT FOR SUPPORTINGSHELL INTO WEAPON BARREL,SUPPORT ELEMENT AND METHODPATRIA LAND & ARMAMENT OY

31/01/200820085078FIPCT/FI/2009/050078WO/2009/095540

)2010.01 (A61K20713711/02/2009

–מוצרים ברי השתלה המכילים חלקיקי ננו

IMPLANTABLE PRODUCTSCOMPRISING NANOPARTICLES

MAGFORCE NANOTECHNOLOGIES AG11/02/2008102008008522.7DE11/04/200861/071084US

PCT/DE/2009/000196WO/2009/100716

)2010.01 (C12N20713822/01/2009


ם לאנליזה של חלבונים אוכלוסיות תאי והשימוש בם

CELL POPULATIONS FORPOLYPEPTIDE ANALYSIS AND USESOF SAME


24/01/200861/006634US29/08/200861/136356US

PCT/IL/2009/000089WO/2009/093242

)2010.01 (A61B20713921/01/2009

METHOD שיטה ומכשיר לניטור הנקה AND DEVICE FORMONITORING BREASTFEEDING


22/01/200861/006558US14/05/200861/053069US

PCT/IL/2009/000085WO/2009/093238

)2010.01 (C01G20714022/07/2010

PRODUCTION הפקת נפט סינטטי קל מפסולת צמיגים OF LIGHT SYNTHETICOIL FROM SCRAP TIRES

WASTOILמ"ווסטאויל אקו בע ECO LTD

)2010.01 (C02F20714122/07/2010

A מערכת לאספקת מי ים ושיטה עבורה SEA WATER-SUPPLY SYSTEM ANDMETHOD THEREFOR

SHACHAR שחר כרמי CARMI


)2010.01 (G07B20714222/07/2010

DIRECT כסף ישיר MONEYEREZ ארז אלחיאני ELHAYANI

)2010.01 (B23D20714321/01/2009

סיבית למספר–מערכת לחיתוך רצועה רב רב של סיבים באורך נתון זהה

SYSTEM FOR CUTTINGMULTIFILAMENT STRAND TO APLURALITY OF FILAMENTS OF THESAME GIVEN LENGTH

POLYSSIVEמ"פוליסיב בע LTD22/01/200861/006563US

PCT/IL/2009/000081WO/2009/093236

)2010.01 (A23C20714422/01/2009

COMPOSITION ושומן מפוזר תכשיר המכיל חלבון COMPRISING PROTEINAND DISPERSE FATHAMLET PROTEIN A/S

22/01/2008PA200800079DK22/01/200861/022542US

PCT/EP/2009/050696WO/2009/092754

)2010.01 (C07K20714621/10/2005

נוגדנים המסוגלים להתחרות עם נוגדניםRA22–ILשבטיים נגד–חד

ANTIBODIES CAPABLE OFCOMPETING WITH ANTI-IL-22RAMONOCLONAL ANTIBODIESZYMOGENETICS INC.

22/10/200460/621553USPCT/US/2005/037821


WO/2006/047249

)2010.01 (G08G20714722/07/2010

מערכת חיישנית מבוזרת המסוכרנת באופן דינמי

DYNAMICALLY SYNCHRONIZEDDISTRIBUTED SENSOR NETWORK

PEARLSמ"פניני חכמה מחקר ופיתוח בע OF WISDOM RESEARCH &DEVELOPMENT LTD,

)2010.01 (G01D20714828/01/2009

METHOD שיטה לקביעת זווית סיבוב FOR DETERMINING A TWISTANGLESIEMENS AKTIENGESELLSCHAFT

01/02/2008102008007372.5DEPCT/EP/2009/050930WO/2009/905398

)2010.01 (C07D20714920/03/2003

–2–)מתוקסיפניל–4–אתוקסי–3(–1[–2–(+)אצטילאמינו–4–]מתילסולפונילאתיל

פולימורף רוקחי, דיאון–3,1–ינדוליןאיזואסולבאט או הידראט שלו, מלח, מקובל

, לשימוש בטיפול במחלה אוטואימוניתבאופן ברירתי יחד עם תרופה נוגדת דלקת

(+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL] -4-ACETYLAMINOISOINDOLINE-1,3-DIONE, OR A PHARMACEUTICALACCEPTABLE POLYMORPH, SALT,SOLVATE, OR HYDRATE THEREOFFOR USE IN TREATING ANAUTOIMMUNE DISEASE,OPTIONALLY IN COMBINATIONWITH AN ANTI-INFLAMMATORYCELGENE CORPORATION

20/03/200260/366515US07/01/200360/438450US

PCT/US/2003/008738WO/2003/080049


)2010.01 (A61K20715030/01/2009

מטרים תרופה המכיל תצמיד קושר תרופה

PRODRUG COMPRISING A DRUGLIKER CONJUGATE

ASCENDIS PHARMA AS01/02/200808150973.9EP05/12/200808170872.9EP

PCT/EP/2009/051079WO/2009/095479

)2010.01 (C07D20715112/02/2009

תהליך להכנה רגיוסלקטיבית של תולדות–4–פיראזול–הלואלקיל–3–אלקיל–1

חומצה קרבוקסילית

METHOD FOR THE REGIOSELECTIVESYNTHESIS OF 1-ALKYL-3-HALOALKYL-PYRAZOLE-4CARBOXYLIC ACID DERIVATIVESBAYER CROPSCIENCE AG

25/02/200808151891.2EPPCT/EP/2009/000958WO/2009/106230

)2010.01 (E03B20715223/01/2009

תהליך ומכשיר לאיסוף מים מתוקים מתחת לפני הים

PROCESS AND DEVICE FOR THECOLLECTION OF UNDERSEAFRESHWATERMICHEL PERIL

23/01/20080800358FR23/01/20080800359FR

PCT/FR/2009/000076WO/2009/115657

)2010.01 (C07K20715323/01/2009

ב בררני של אתר קישור משני של עיכוIGFBP–4נגדA–PAPPפעילות

SELECTIVE EXOSITE INHIBITION OFPAPP-A ACTIVITIY AGAINST IGFBP-4

AARHUS UNIVERSITET


25/01/200861/023631DK01/02/2008PA200800148US01/02/200861/025545US

PCT/EP/2009/050796WO/2009/092806

)2010.01 (F22B20715429/01/2009

HYBRID מפריד מוכלא SEPARATORALSTOM TECHNOLOGY LTD.

18/02/200861/029391US28/05/200812/127846US

PCT/US/2009/032353WO/2009/105316

)2010.01 (C07K20715522/01/2009

פפטידים המגנים על רקמות ואנלוגים של–פפטידים למניעה וטיפול במחלות או אי

סדרים הקשורים לנזק לרקמות

TISSUE PROTECTIVE PEPTIDES ANDPEPTIDE ANALOGS FORPREVENTING AND TREATINGDISEASES AND DISORDERSASSOCIATED WITH TISSUE DAMAGEARAIM PHARMACEUTICALS, INC.

22/01/200861/062012US22/01/200861/062022US22/01/200861/062045US03/07/200861/133912US30/12/200861/203890US

PCT/US/2009/000424WO/2009/094172

)2010.01 (C07F20715616/02/2006

BORON-CONTAINING מולקולות קטנות המכילות בור SMALLMOLECULESANACOR PHARMACEUTICALS, INC

16/02/200560/654060USPCT/US/2006/005542WO/2006/089067


)2010.01 (A61M20715722/01/2009

INHALER משאףVECTURA DELIVERY DEVICESLIMITED

24/01/200808100881.5EPPCT/EP/2009/050730WO/2009/092768

)2010.01 (A61M20715814/01/2009


24/01/200808100886.4EPPCT/EP/2009/050340WO/2009/092650

)2010.01 (A61M20715914/01/2009


24/01/200808100892.2EPPCT/EP/2009/050344WO/2009/092652

)2010.01 (A61M20716022/01/2009


24/01/200808100906.0EPPCT/EP/2009/050733WO/2009/092770


)2010.01 (C07K20716126/01/2009

שיטות ותכשירים המשתמשים–FGFבפוליפפטידים מאוחים של

KLOTHO

METHODS AND COMPOSITIONSUSING KLOTHO-FGF FUSIONPOLYPEPTIDES

NOVARTIS AG28/01/200861/063015US

PCT/EP/2009/050850WO/2009/095372

)2010.01 (A61B20716205/02/2009

MICROWAVE מתקן מיקרוגל APPLICATORUK INVESTMENT ASSOCIATES LLC

09/02/20080802455.6GBPCT/GB/2009/050113WO/2009/098513

)2010.01 (A61F20716306/02/2009

LENS מחסנית למערכת העברת עדשה DELIVERY SYSTEMCARTRIDGEALCON, INC.

07/02/200861/026805USPCT/US/2009/033401WO/2009/100337

)2010.01 (C07D20716420/02/2008

,FOLATES תכשירים ושימושם, פולאטים COMPOSITIONS ANDUSES THEREOFGNOSIS S.P.A

PCT/EP/2008/052037WO/2009/103334


)2010.01 (C07D20716509/02/2009

PROCESS 226תהליך להכנת תולדות פירידון FOR PREPARINGPYRIDONE DERIVATIVES 226ASTRAZENECA AB

11/02/200861/027582USPCT/GB/2009/050124WO/2009/101432

)2010.01 (A61K20716601/06/2000

תכשירי רוקחות לטיפול במחלות עמילוידיות

PHARMACEUTICAL COMPOSITIONSFOR TREATING AMYLOID DISEASES

NEURALAB LIMITED01/06/199960/137010US

PCT/US/2000/015239WO/2000/072876

)2010.01 (C12N20716723/01/2009

רקומביננטים מוחלשים ללא אלפאוירוסים יכולת שיכפול ביתושים ושימושים בהם

ATTENUATED RECOMBINANTALPHAVIRUSES INCAPABLE OFREPLICATING IN MOSQUITOES ANDUSES THEREOFTHE BOARD OF REGENTS OF THEUNIVERSITY OF TEXAS SYSTEM

24/01/200861/062229USPCT/US/2009/000458WO/2009/131604

)2010.01 (A61J20716827/01/2009

MOUTHPIECE פומית ושיטה להכנתה AND METHOD FORTHE PRODUCTION THEREOFMEDELA HOLDING AG

05/02/2008157/08SEPCT/CH/2009/000032


WO/2009/097702

)2010.01 (A61K20716930/01/2009

שיטה לקביעת רגישות לגורם נגד סרטןMETHOD FOR DETERMINATION OFSENSITIVITY TO ANTI-CANCERAGENTKEIO UNIVERSITY

31/01/20082008-021124

JP

01/09/20082008&223384JPPCT/JP/2009/000374WO/2009/096196

)2010.01 (A61K20717023/01/2009

METHODS שיטות לטיפול בדלקות ויראליות OF TREATING VIRALINFECTIONSCHIMERIX, INC.

25/01/200861/023633US01/10/200861/101810US

PCT/US/2009/000447WO/2009/094190

)2010.01 (C07C20717108/01/2009

SUBSTITUTEDם מותמריםסיקלוהקסנוני CYCLOHEXENONESFIRMENICH SA

01/02/2008PCT/IB2008/050389IBPCT/IB/2009/050070WO/2009/095804

)2010.01 (G06Q20717222/01/2009

סחר פיננסי מערכת להפקת מסמך מותאם

SYSTEM FOR GENERATING ACUSTOMIZED FINANCIAL TRADEARTICLE


SUPERDERIVATIVES, INC.23/01/2008US61/006582US

PCT/IL/2009/000090WO/2009/093243

)2010.01 (A61K20717326/01/2009

פורמולציות עמידות התמכרות שיש להן אינטראקציות אלכוהול מופחתות

ABUSE RESISTANT MELTEXTRUDED FORMULATION HAVINGREDUCED ALCOHOL INTERACTIONABBOTT GMBH & CO. KG

24/01/200861/023288USPCT/EP/2009/050853WO/2009/092818

)2010.01 (C12N20717422/01/2009

,PEPTIDES תכשירים ושימושים שלהם, פפטידים COMPOSITIONS, ANDUSES THEREOFFUNDACAO DE AMPARO APESQUISA DO ESTADO DE SAOPAULO

22/01/200861/022747USPCT/IB/2009/050237WO/2009/093189


-ז"לחוק הפטנטים תשכ26הודעה לפי סעיף1976

NOTICE UNDER SECTION 26 OF THEPATENTS LAW, 5727-1967

הבקשות שפרטיהן מתפרסמים להלן קובלוכל המעונין. לחוק הפטנטים17לפי סעיף

מהבקשות להתנגד למתן פטנט על פי בקשהתוך שלושה חדשים, המתפרסמות רשאי

להגיש לרשם הפטנטים, מתאריך יומן זהלחוק הפטנטים30הודעת התנגדות לפי סעיף

ואילך לתקנות57בדרך הקבועה בתקנה .1968–ח"תשכ, הפטנטים

The applications, particulars of which are setout below, have been accepted pursuant toSection 17 of the Patents Law. Any personwishing to oppose the grant of a patent on anyof the applications published here, may,within three months from the date of thisjournal, give to the Commissioner of Patentsnotice under Section 30 of the Patents Law, inthe manner prescribed in regulations 57 et seqof the Patents Regulations, 5728-1968

פרטי הבקשות במידה ויישימים מובאים לפי:סדר זה

Particulars of the applications, whereapplicable, are given in the following order:

[11] מספר הבקשה [21] Number of application[54] שם האמצאה Title of invention

[22] תאריך הבקשה Application dateמדינת–יך של בקשות החוץ מספר ותאר

האגוד[31] [32] [33] Number and date of foreignapplication – convention country.

[51]* סיווג בינלאומי* Int.Cl.[61] בקשה לפטנט מוסף Application for patent of addition

[62] בקשת חלוקה Divisional application[71] המבקש Applicant[72] הממציא Inventor

[87] פרסום של בקשה הבינלאומית' מס International Publication Number[74] מען למסירת מסמכים Address for service

[57])בשפה בה ערוך הפירוט(תקציר האמצאה Abridgement of invention (in thelanguage in which the specification is drawnup)

בקשות הפטנטים שפורסמו ביומן: הערה**זה סווגו בהתאם לגרסת הסיווג הבינלאומי

.שהייתה בתוקף בעת הכנת הבקשות לפרסום

*Note:, patent applications published in thisjournal were classified according to theInternational Classification version that wasin force when this journal was prepared.


123129]21][11[

WWWWWWמיעו� ADDRESSING]54[

30.01.1998]22[Int. Cl.(2010.01) G06F 17//30, G06Q 20//00]51[NET - EXPRESS]71[

AVIV רובי רוט, גיל דייגי, אביב רפואה REFUAH, GIL DAYAGI,ROBY ROTH

]72[

,מ"בע) 1995(ארליך.אי.י'ג11רחוב מנחם בגין,15קומה, מגדל איילון

רמת גן

G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,11 MENACHEM BEGIN ST.,RAMAT GAN 52521

]74[

A method of WWW page retrieval from a web site, comprising: receiving informationassociated with control of a web site, wherein said received information is not aWWW address and comprises characters typed for entry by a user into a URL entryfield in a browser operable on an electronic device having web browsing capabilitiesin which a standard URL address would be entered; said information being receivedby a software not associated with said web site; responsive to said information andsaid determined geographical location, by said software; sending the page address tothe browser for retrieving said page responsive to said page address; and therebycausing said page to be directly displayed to the user using the browser, without anyadditional user intervention beyond the entry of said information.

]57[

בקשות חלוקה מבקשה זו.שטר� פורסמו

207660,The applications fordivision from thisapplication have not yetbeen published

__________________

131229]21][11[

תרכובות בעלות עיכוב המרה אנזימטית, להתערבות רפואית במניעת סיבוכי סכרת

.תכשירי� רוקחיי� ושימושי� שלה�

COMPOUNDS HAVINGENZYMATIC CONVERSIONINHIBITION FOR THERAPEUTICINTERVENTION IN PREVENTINGDIABETIC COMPLICATIONS,PHARMACEUTICALPREPARATIONS AND USESTHEREOF

]54[


05.02.1998]22[US]33[05.02.1997]32[08/794433]31[

Int. Cl.(2010.01) A61K 31//197, 31//198, 31//275, 31//5375]51[FOX CHASE CANCER CENTER,U.S.A.

]71[

WO/1998/033492]87[,לצר וכהן צדק, פרל, איתן

7רחוב שנקר צליההר12688.ד.ת,

EITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,HERZLIYA 46733

]74[

Disclosed is a class of compounds which inhibit the enzymatic conversion of fructose-lysine into fructose-lysine-3-phosphate in an ATP dependent reaction in a newlydiscovered metabolic pathway. According to the normal functioning on this pathway,fructose-lysine-3-phosphate (FL3P) is broken down to form free lysine, inorganicphosphate and 3-deoxyglucosone (3DG), the latter being a reactive protein modifyingagent. 3DG can be detoxified by reduction to 3-deoxyfructose (3DF), or it can reactwith endogenous proteins to form advanced glycation end-product modified proteins(AGE-proteins), which are believed to be a contributing cause of diabeticcomplications. Also disclosed are therapeutic methods of using such inhibitors toreduce formation of AGE-proteins and thereby lessen, reduce and delay diabeticcomplications, as well as methods for assessing a diabetic's risk of developingcomplications and for determining the efficacy of the disclosed inhibitor therapy bymeasuring the ratio of 3DG to 3DF in a biological sample following an oral dose of afructose-lysine-containing food product.

]57[

__________________

133912]21][11[

שימוש באנטיג� להכנה תרכובת להשרית תגובת ציטוטוקסיי� אפקטורי�Tלימפוציטי�

USE OF AN ANTIGEN IN THEPREPARATION OF ACOMPOSITION FOR INDUCINGAN EFFECTOR CYTOTOXIC TLYMPHOCYTE (CTL) RESPONSE

]54[

10.07.1998]22[CA]33[10.07.1997]32[2209815]31[US10.12.1997 08/988320

Int. Cl.(2010.01) A61K 38//19, 38//22, 39//00, 39//12, A61P 31//04, 31//12, 35//00,C07K 14//08, 14//52, 14//575

]51[

MANNKIND CORPORATION, U.S.A.]71[


WO/1999/002183]87[,לוצאטו את לוצאטו

עומר, גן תעשייה באר שבע5352.ד.ת,

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,P.O.B. 5352,BEER-SHEVA 84152

]74[

A method of inducing a cytotoxic T-lymphocyte (CTL) response to an antigen isdisclosed. The method involves delivering the antigen to the lymphatic system of ananimal regularly over a sustained period of time using, e.g., an osmotic pump. Themethod is advantageous over prior art methods for inducing a CTL response in that itdoes not require repetitive immunizations or the use of adjuvants. The method of thepresent invention can be used for the induction of CTLs in tumor or infectious diseaseimmunotherapy.

]57[


181687,The applications for divisionfrom this application havenot yet been published

__________________

135751]21][11[

תהלי� לזיהוי חומרי� המסוגלי� לעכב–אינטראקציה בי� פרסניליני� ופפטיד של בטא

אמילויד או פרקורסור שלו

PROCESS FOR IDENTIFYINGCOMPOUNDS CAPABLE OFINHIBITING THE INTERACTIONBETWEEN PRESENILINS ANDTHE BETA-AMYLOID PEPTIDEOR ITS PRECURSOR

]54[

23.10.1998]22[FR]33[24.10.1997]32[97/13384]31[US07.08.1998 60/095671

Int. Cl.(2010.01) C07K 14//47, G01N 33//50, 33//542, 33//68]51[AVENTIS PHARMA S.A., FRANCE]71[WO/1999/021886]87[

,לוצאטו את לוצאטו עומר, גן תעשייה

שב5352.ד.ת, עבאר


]74[

The invention concerns novel peptide and nucleotide sequences, and theirpharmaceutical use. More particularly, the invention concerns novel polypeptidescapable of inhibiting at least partially the interaction between presenilin 1 or presenilin2 and theβ-amyloid peptide precursor and/or theβ-amyloid peptide. The invention

]57[


also concerns the preparation of in vitro tests for detecting molecules and in particularmolecules capable of inhibiting said interaction.

__________________

135874]21][11[

עבור מערכת רדיו הניתנת לשיחזורTCMמקלט תצורה ושיטה עבורו

TCM RECEIVER FOR ARECONFIGURABLE RADIOSYSTEM AND METHODTHEREFOR

]54[

03.11.1998]22[US]33[03.11.1997]32[60/064097]31[US03.11.1997 60/064098 US03.11.199760/064132

Int. Cl.(2010.01) H03M 13//25, 13//41, H04B 01//24, 01//40, H04L 01//00, 25//497,27//18, 27//34

]51[

HARRIS CORPORATION, U.S.A.]71[WO/1999/023760]87[

,ברגמן וגולר, וולף ירושלים1352.ד.ת,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,JERUSALEM 91013

]74[

A system for providing a field configurable radio frequency receiver system includinga digital signal processing therefor. The digital processor receives the demodulatedsignals in order to efficiently decode the trellis encoded modulated signals, which arereceived as part of the radio frequency carrier signals.

]57[

__________________


135875]21][11[

ציוד תיקשורת בתדר רדיו הנית� לתיכנות בשדההכולל מעגל תדר ביניי� הנית� לעיצוב ושיטה

עבורו

FIELD PROGAMMABLE RADIOFREQUENCYCOMMUNICATIONS EQUIPMENTINCLUDING A CONFIGURABLEIF CIRCUIT AND METHODTHEREFOR

]54[

03.11.1998]22[US]33[03.11.1997]32[60/064132]31[US03.11.1997 60/064097 US03.11.199760/064098

Int. Cl.(2010.01) H04B 01//28, 01//40, H04L 25//497, 27//00, 27//34]51[HARRIS CORPORATION, U.S.A.]71[WO/1999/023761]87[



]74[

A system and method for providing a field configurable radio frequencycommunications system including an intermediate frequency digital signal processingcircuit therefor. The intermediate frequency digital signal processing circuits includesdigital transmitter and receiver circuit paths, a digital baseband circuit, controlregisters and an interface circuit. The transmitter and receiver circuit paths and thebaseband circuits include digital processing circuits that are configurable bycommands provided to the control register via the interface circuit to select thetransmitter or receiver mode of operation, to select the signaling scheme of waveformemployed, to configure the signal processing functions of the transmitter or receivercircuit paths, and to select the use of any of a plurality of a baseband signal processingfunctions.

]57[

__________________


140223]21][11[

תכשירי רוקחות המכילי� אקסאנדי� לטפול בסובלנות פגומה לגלוקוז

PHARMACEUTICALCOMPOSITIONS CONTAININGEXENDIN FOR TREATINGIMPAIRED GLUCOSETOLERANCE

]54[

07.05.1999]22[US]33[12.06.1998]32[60/089044]31[

Int. Cl.(2010.01) A61K 38//26, A61P 03//08, 05//50, 09//10]51[AMYLIN PHARMACEUTICALS,INC., U.S.A.

]71[

WO/1999/064061]87[,ברגמן וגולר, וולף

ירושלים1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,JERUSALEM 91013

]74[

A composition for the treatment of impaired glucose tolerance (IGT) including acompound which binds to a receptor for glucagon-like peptide-1, and a pharmaceuticalcarrier. The amount of the compound present is an effective amount to improvepancreatic $g(b)-cell sensitivity to blood glucose levels in a human with IGT. Also, amethod for improving the pattern of insulin secretory responses in a human with IGTby administering to the human a composition comprising a compound which binds to areceptor for glucagon-like peptide-1 and a pharmaceutical carrier.

]57[

__________________

140938]21][11[

א המקודדי� לפוליפפטידי� המסוגלי�"רצפי דנל הפוליפפטידי�,LDCAM–להיקשר

המכילי� חלבוני איחוי, המקודדי� על יד�פוליפפטידי� אלו ותהלי� להכנת

הפוליפפטידי�

DNA SEQUENCES ENCODINGPOLYPEPTIDES CAPABLE OFBINDING TO LDCAM,POLYPEPTIDES ENCODED BYTHEM, FUSION PROTEINSCOMPRISING THEPOLYPEPTIDES AND A PROCESSFOR THE PREPARATION OF THEPOLYPEPTIDES

]54[

05.08.1999]22[US]33[07.08.1998]32[60/095663]31[

Int. Cl.(2010.01) C07K 14//47, C12N 15//13, 15//62]51[


IMMUNEX CORPORATION, U.S.A.]71[WO/2000/008057]87[

,ריינהולד כהן ושותפיו'א26רחוב הברזל רמת החייל

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,RAMAT HACHAYAL 69710

]74[

The invention is directed to B7L-1 as a purified and isolated protein, the DNAencoding the B7L-1, host cells transfected with cDNAs encoding B7L-1 and processesfor preparing B7L-1 polypeptides.

]57[

מבקשה זו בקשות חלוקה.שטר� פורסמו


__________________

142581]21][11[

לבתרופה לטיפ MEDICAMENT ול במחלת FOR TREATINGHEART DISEASE

]54[

02.12.1999]22[US]33[09.04.1999]32[09/289409]31[

Int. Cl.(2010.01) A61N 01//32]51[KEVIN R. ORTON, U.S.A.]71[WO/2000/061221]87[



]74[

A method for preparing and use of a substance (18). The preparation involves flowingan alternating electrical current through an electrolytic material. The alternatingcurrent is caused to flow for a period preferably at least 10 minutes, and morepreferably 4-8 hours, so as to change a physical property thereof. The current is thenremoved. The substance has properties which last for a limited time. While active, thesubstances may then be used to provide medical/cosmetic therapy to a recipient byinhaling into the pulmonary tract, or internal injection of the substance into the body ofa human or animal recipient.

]57[


__________________

142691]21][11[

ליצירתAILIMשימוש בנוגד� הנקשר לחלבו�תכשיר רוקחי למניעה או טיפול במחלת השתל

נגד המאכס�

USE OF AN ANTIBODY WHICHBINDS TO AILIM PROTEIN INTHE MANUFACTURE OFMEDICAMENT FORPREVENTING, TREATING ORPROPHYLAXIS OF GRAFTVERSUS HOST REACTION

]54[

30.08.2000]22[JP]33[30.08.1999]32[242672/99]31[JP24.08.2000 254680/00

Int. Cl.(2010.01) A61K 38//17, 39//395, 45//00]51[JAPAN TOBACCO INC., JAPAN]71[WO/2001/015732]87[



]74[

It has been found out that antibodies against AILIM (also called JTT-1 antigen, JTT-2antigen, ICOS and 8F4) exert significant therapeutic effects on joint diseases such asarticular rheumatism and arthrosis deformans, graft-versus-host disease,transplantation immunological rejection, inflammation (hepatitis, inflammatorydiseases, etc.) and symptoms in association with immune sensitization by a foreignantigen and the thus induced hyperproduction of an antibody against the antigen.

]57[

__________________


144306]21][11[

PROCESS תהלי� להכנת ביניי� קוטלי מזיקי� FOR PREPARINGPESTICIDAL INTERMEDIATES

]54[

01.02.2000]22[FR]33[04.02.1999]32[99/01469]31[

Int. Cl.(2010.01) C07C 25/5/61, 31/7/26, 32/3/46, C07D 21/3/72, 40/1/00]51[BASF AGRO B.V. ARNHEM (NL),WADENSWIL-BRANCH,SWITZERLAND

]71[

WO/2000/046210]87[,ריינהולד כהן ושותפיו

'א26רחוב הברזל רמת החייל


]74[

The invention relates to a process for the preparation of a compound of formula (I):wherein W, R1, R2 and R3 are as defined in the description.

]57[

__________________

145142]21][11[

פולינוקלאוטיד רקומביננטי המכיל אלמנטורצ המקודד,PSMרצפי� של הג�, הגברה

לפוליפפטיד הטרולוגי

RECOMBINANTPOLYNUCLEOTIDECOMPRISING AN ENHANCERELEMENT, SEQUENCES OF THEPSM GENE AND SEQUENCEENCODING A HETEROLOGOUSPOLYPEPTIDE

]54[

01.03.2000]22[AU]33[01.03.1999]32[PP8956]31[AU25.01.2000 PQ5268


Int. Cl.(2010.01) A61K 48//00, C12N 15//11, 15//12, 15//67]51[COMMONWEALTH SCIENTIFICAND INDUSTRIAL RESEARCHORGANISATION, AUSTRALIA

]71[




]74[

The invention provides regulatory constructs comprising intron 3 of the prostatespecific membrane antigen gene (PSMA). An isolated nucleic acid molecule encodingthe partial sequence of intron 3 of PSMA, a vector and a recombinant expressioncassette are disclosed. The invention also provides a method of directing expression ofa coding sequence in a prostate cell, a bladder cell, a breast cell and a vascularendothelial cell using the said constructs. This invention further provides a method oftreatment of cancer using the said constructs.

]57[

__________________

145830]21][11[

מסוג גלוקגו�1–תכשירי� המכילי� פפטיד לשימוש בטיפול בפגיעה ברקמת לב

GLUCAGON-LIKE PEPTIDE-1COMPOSITIONS FOR USE INTREATING MYOCARDIALTISSUE INJURY

]54[

27.04.2000]22[US]33[30.04.1999]32[09/302596]31[

Int. Cl.(2010.01) A61K 38//26, A61P 09//10]51[AMYLIN PHARMACEUTICALS,INC., U.S.A.

]71[



]74[

Individuals in need of treatment of ischemia-related reperfusion are treated, preferablyintravenously, with a composition which includes a compound which binds to areceptor for the glucagon-like peptide-1. The invention relates to both the method andcompositions for such treatment.

]57[


__________________

146312]21][11[

–)פירידיניל–אוקסו–2(–3נגזרי חומצהפרופאנואית המעכבי� קישור–אצילאמינו

אינטגריני� לקולטני� שלה� ותכשירי� פרמצבטיי� המכילי� אות�

3-(2-OXO-PYRIDINYL)-ACYLAMINO-PROPANOIC ACIDDERIVATIVES THAT INHIBITTHE BINDING OF INTEGRINS TOTHEIR RECEPTORS ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHE SAME

]54[

05.05.2000]22[US]33[07.05.1999]32[60/132967]31[US10.12.1999 60/170441

Int. Cl.(2010.01) A61K 31//4412, 31//443, A61P 03//10, 09//10, 11//06, 19//02,27//14, C07D 21/3/58, 21/3/62, 21/3/75, 21/5/38, 40/1/04, 40/7/06, 47/1/04

]51[

ENCYSIVE PHARMACEUTICALSINC., U.S.A.

]71[

WO/2000/068188]87[',ר שלמה כהן ושות"ד

124אבן גבירול תל אביב11490.ד.ת,

DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,P.O.B. 11490,TEL AVIV 62038

]74[

A method for the inhibition of the binding ofα4β1 integrin to its receptors, forexample VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compoundsthat inhibit this binding; pharmaceutically active compositions comprising suchcompounds; and the use of such compounds either as above, or in formulations for thecontrol or prevention of diseases states in whichα4β1 is involved.

]57[

__________________

147680]21][11[

ANTISTATIC חומר נוגד חומר סטאטי AGENT]54[

03.08.2000]22[DE]33[16.08.1999]32[19938735.4]31[


DE13.09.1999 19943637.1 Int. Cl.(2010.01) C08K 05//42, C09K 03//16]51[BAYER AKTIENGESELLSCHAFT,GERMANY

]71[




]74[

The invention relates to the use of fluorinated alkylsulphonic acid salts as an antistaticagent, especially in plastics, and to plastics containing fluorinated alkylsulphonic acidsalts and moulded bodies produced from said plastics.

]57[

__________________

148482]21][11[

שיטות להכנת טטרציקליני� מותמרי� בכימיותכמה תרכובות, מבוססות על מתכות מעבר

חדישות כאלה והשימוש בה� להכנת תרופות

METHODS OF PREPARINGSUBSTITUTED TETRACYCLINESWITH TRANSITION METAL-BASED CHEMISTRIES, SOMESUCH NOVEL COMPOUNDS ANDUSE THEREOF IN THEPREPARATION OFMEDICAMENTS

]54[

13.09.2000]22[US]33[14.09.1999]32[60/154701]31[US12.09.2000 60/232091

Int. Cl.(2010.01) A61K 31//65, A61P 31//00, C07C 23/1/12, 23/7/26]51[TRUSTEES OF TUFTS COLLEGE,U.S.A.

]71[

WO/2001/019784]87[טסנ ',קולב ושות. פורד

מרמורק,4שער הגיא רחובות2273.ד.ת,

SANFORD T.COLB & CO.,P.O.B. 2273,REHOVOT 76122

]74[

The present invention relates to novel chemistries which allow for heretoforeunobtainable substituted tetracycline compounds which exhibit significant antibacterialactivity. The methods disclosed herein utilize reactive tetracycline-based precursorcompounds, reactive organic substituent precursors and transition metal catalysts underconditions such that a tetracycline compound substituted with the desired organic

]57[


substituent is formed. In one embodiment of the invention, a substituted tetracyclinecompound may be prepared by combining a reactive tetracycline-based precursorcompound such as an arene tetracycline diazonium salt, and a reactive organicsubstituent precursor, e.g., alkenes, substituted alkenes, vinyl monomers, aromaticsand heteroaromatics, in the presence of a transition metal catalyst, such as palladiumchloride, under conditions such that a tetracycline compound substituted with theorganic substituent is formed. Such compounds may optionally act as intermediates formaking other compounds, e.g., hydrogenation of unsaturated groups on the substituent.


183125,183124,The applications for divisionfrom this application havenot yet been published

__________________

149144]21][11[

חלבוני שטח ויראליי� אחרי מודיפיקציה שנקשרי� לתאי� של ואסקולטורה של גידול

MODIFIED VIRAL SURFACEPROTEINS WHICH BIND TOCELLS OF TUMORVASCULATURE

]54[

27.10.2000]22[US]33[29.10.1999]32[09/429273]31[

Int. Cl.(2010.01) A61K 38//08, 48//00, A61P 35//00, C07K 04//12, 14//15, 14//78,C12N 15//48, 15//62, 15//86

]51[

UNIVERSITY OF SOUTHERNCALIFORNIA, U.S.A.

]71[




]74[

A vector particle having a surface protein which is modified to include a tumorvasculature targeting motif, or TVTM, peptide. Such peptides enable vector particlesto be targeted to endothelial cells, and in particular to endothelial cells of the bloodvessels of tumors, whereby agents which inhibit, prevent, or destroy th growth of suchcells are delivered to the cells, thereby terminating the blood supply to a tumor.

]57[

__________________


150325]21][11[

אבקות של מתכות ברמת ניקיו�–שיטה לייצור ננוזו–וננו, גבוהה אבקות המיוצרות בשיטה

METHOD FOR THEPRODUCTION OF HIGHLYPURE METALLIC NANO-POWDERS AND NANO-POWDERS PRODUCEDTHEREBY

]54[

19.06.2002]22[Int. Cl.(2010.01) B22F 09//16, C22C 33//00]51[

CIMA קיסריה,מ"סימה נאנוטק ישראל בע NANOTECH ISRAEL LTD]71[,ברגמן וגולר, וולף


]74[

A method for producing a metal nano-powder comprising:(a) forming an alloy comprising a first metal and a second metal that is different fromthe first metal;(b) subjecting the alloy to a leaching agent effective to leach out the second metal andform a metal nano-powder;(c) washing and filtering the metal nano-powder;(d) drying the washed and filtered metal nano-powder;(e) coating the dried metal nano-powder with a chemical reagent to form a coatedmetal nano-powder wherein the chemical reagent is selected from the group consistingof sorbitan esters, polyoxyethylene esters, alcohols, glycerin, polyglycols, organicacid, organic acid salts, organic acid esters, thiols, phosphines, low molecular weightpolymers, and combinations thereof; and(f) de-agglomerating the coated metal nano-powder.

]57[

__________________

150484]21][11[

COLLOID וקטורי� קולואידי� סינתטיי� לריפוי גני� SYNTHETIC VECTORSFOR GENE THERAPY

]54[

28.12.2000]22[US]33[30.12.1999]32[09/475305]31[

Int. Cl.(2010.01) A61K 09//127, 31//7088, 48//00, C12N 15//09, 15//88]51[NOVARTIS AG, SWITZERLAND]71[WO/2001/049324]87[




]74[

Non-naturally occurring vector for gene therapy are provided, comprised of chemicallydefined reagents, where the vector is self-assembling and where the vector comprises(1) a core complex comprising a nucleic acid and (2) at least one complex formingreagent, where the vector has fusogenic activity. The vector optionally may containreagents permitting fusion with cell membranes and nuclear uptake. The vector alsomay contain an outer shell moiety that is anchored to the core complex, whereby theouter shell stabilizes the complex, protects it from unwanted interactions and enhancesdelivery of the nucleic acid into a target tissue or cell. The outer shell optionally maybe sheddable, that is, it may be designed such that it dissociates from the vector uponentry into the target cell or tissue.

]57[



__________________

150602]21][11[

הנ, חיסו� לשפעת מפרוטאוזו� ל"שיטה להכנת ושימושו

PROTEOSOME INFLUENZAVACCINE, METHOD FORPREPARING SUCH AND USETHEREOF

]54[

15.02.2001]22[US]33[15.02.2000]32[60/182476]31[

Int. Cl.(2010.01) A61K 39//12]51[ID BIOMEDICAL CORPORATIONOF QUEBEC, CANADA

]71[

WO/2001/060402]87[,ותפיוריינהולד כהן וש



]74[

Improved forms of vaccines which comprise proteosomes and protein antigens aredescribed. Vaccines which contain influenza HA as the antigen are used for illustrationas to demonstrate efficacy. Improvements in the preparation of the vaccinesthemselves and the proteosome component are also included.

]57[


__________________

150837]21][11[

ב בהכנת תרופה לטיפול באיFSHהשימוש פוריות

USE OF FSH FOR PREPARING AMEDICAMENT FOR TREATINGINFERTILITY

]54[

09.01.2001]22[EP]33[27.01.2000]32[00300591.5]31[EP04.04.2000 00302840.4

Int. Cl.(2010.01) A61K 38//24, A61P 05//06]51[MERCK SERONO S.A.,SWITZERLAND

]71[

LOUISE DUERR-MYERS, ERNESTLOUMAYE

]72[

WO/2001/054715]87[,מ"אינטרפארם מעבדות בע

18רחוב הקישון יבנה151.ד.ת,

INTERPHARM LABORATORIESLTD.,18 HAKISHON ST.,P.O.B. 151,YAVNE 81101

]74[

The present invention relates to the use of FSH and/or a biologically-active analoguethereof in the production of a medicament for the treatment of infertility in women.The medicament is for administration at an initial dose in the range of from 100 to 600IU followed by a second dose at least 3 days later in the stimulation phase. In oneembodiment, the medicament is for administration of a dose in the range of from 300to 600 IU on every third day of the first 6 days of the stimulation phase. In anotherembodiment, the initial dose is in the range of from 100 to 500 IU, with the seconddose being administered between three and six, preferably four, days after the initialdose.

]57[


__________________

151527]21][11[

MUTATED שעבר מוטציהG1חלבו� ציקלי� CYCLIN G1 PROTEIN]54[

01.03.2001]22[US]33[02.03.2000]32[09/517832]31[

Int. Cl.(2010.01) A61K 38//17, 48//00, A61P 27//02, 27//12, 35//00, 43//00, C07K14//435, C12N 05//10, 15//12, 15//63, 15//86, 15//861, 15//867

]51[

UNIVERSITY OF SOUTHERNCALIFORNIA, U.S.A.

]71[




]74[

Methods of treating tumors, preventing restenosis, and treating hyperplasias, cornealhaze, and cataracts by administering to an animal a mutated cyclin G1 protein. Themutated cyclin G1 protein may be administered to an animal by administering to ananimal an expression vehicle, such as a retroviral vector comprising a gene constructencoding a mutated cyclin G1 protein.

]57[

__________________

152055]21][11[

USE שימוש בוירוס הרפס ליצור תרופות OF AN ATTENUATEDHERPES VIRUS IN THEMANUFACTURE OFMEDICAMENTS

]54[

12.04.2001]22[GB]33[12.04.2000]32[0009079.5]31[

Int. Cl.(2010.01) A61K 35//76, 39//245, C12N 15//869]51[BIOVEX LIMITED, UNITEDKINGDOM

]71[

WO/2001/077358]87[




]74[

Use of an attenuated herpes virus which lacks a functional vhs gene, or a functionalequivalent thereof, in the manufacture of a medicament for use in a method ofimmunotherapy or vaccination comprising the infection of dentritic cells with saidvirus.

]57[

__________________

152567]21][11[

IL-18 באתרוסקלרוסיסIL–18מעכבי INHIBITORS INATHEROSCLEROSIS

]54[

30.04.2001]22[EP]33[05.05.2000]32[00109606.4]31[

Int. Cl.(2010.01) A61K 39//395, C07K 16//24]51[MERCK SERONO S.A.,SWITZERLAND

]71[

YOLANDE CHVATCHKO, ZIADMALLAT, ALAIN TEDGUI

]72[

WO/2001/085201]87[,מ"אינטרפארם מעבדות בע

18רחוב הקישון יבנה151.ד.ת,

INTERPHARM LABORATORIESLTD.,18 HAKISHON ST.,P.O.B. 151,YAVNE 81101

]74[

The invention relates to the use of an IL-18 inhibitor for the manufacture of amedicament for the treatment and/or prevention of atherosclerosis.

]57[

__________________

153710]21][11[

ספירובנזואזפיני� מותמרי� שאינ� פפטידי�רסי� ותרכובות פרמצבטיות כמעכבי וזופ

NONPEPTIDE SUBSTITUTED]54[


SPIROBENZOAZEPINES המכילות אות� ASVASOPRESSIN ANTAGONISTSAND PHARMACEUTICALCOMPOSITIONS COMPRISINGTHE SAME

02.07.2001]22[US]33[05.07.2000]32[60/216220]31[

Int. Cl.(2010.01) A61K 31//55, A61P 09//10, 09//14, C07D 22/3/00, 22/3/16, 23/1/12,24/1/04, 26/5/30, 40/1/12, 40/3/12, 41/3/12

]51[

ORTHO-MCNEILPHARMACEUTICAL, INC., U.S.A.

]71[




]74[

The invention is directed to nonpeptide substituted benzodiazepines of Formula I,wherein A, X, n, R1, R2, R3, R4, R5, a and b are as described in the specification,which are useful as vasopressin receptor antagonists for treating conditions associatedwith vasopressin receptor activity such as those involving increased vascular resistanceand cardiac insufficiency. Pharmaceutical compositions comprising a compound ofFormula I and methods of treating conditions such as hypertension, congestive heartfailure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis,renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis, orwater retention are also disclosed.

]57[

__________________

153846]21][11[

–שימוש בריאווירוס בשילוב ע� נוגדני אנטיריאווירוס להכנת תכשיר רוקחות לטיפול–אנטי

RASבאי סדרי� של התפתחות תאי מתווכי

USE OF REOVIRUS INCOMBINATION WITH ANTI-ANTI-REOVIRUS ANTIBODIESFOR THE PREPARATION OF A

]54[


PHARMACEUTICALCOMPOSITION FOR TREATINGRAS-MEDIATEDPROLIFERATIVE DISORDERS

20.07.2001]22[US]33[10.08.2000]32[09/636597]31[

Int. Cl.(2010.01) A61K 35//76, 38//13]51[ONCOLYTICS BIOTECH INC.,CANADA

]71[




]74[

The present invention pertains to methods for preventing reovirus recognition in thetreatment of cellular proliferative disorders, and particularly ras-mediated cellularproliferative disorders, in mammals. The mammal may be selected from dogs, cats,sheep, goats, cattle, horses, pigs, mice, humans and non-human primates. The methodcomprises suppressing or otherwise inhibiting the immune system of the mammal and,concurrently or subsequently, administering to the proliferating cells an effectiveamount of one or more reoviruses under conditions which result in substantial lysis ofthe proliferating cells. In particular, the methods provide for reovirus treatment ofimmunosuppressed or immuno-deficient mammals to treat the proliferative disorders.Immunosuppression,immunoinhibition or otherwise inducing an immunodeficient statein a mammal renders the reovirus more effective. The methods may include theselective removal of immune constituents that may interfere with the systemic deliveryof the virus; preventing reovirus recognition by the host immune system; and removalof the virus from an immune suppressed or immune incompetent host followingtreatment with reovirus. Alternatively, reovirus may be administered to a mammalwith a diminished immune response system under conditions which result insubstantial lysis of the proliferating cells. Immune systems may be compromised byone or more of the following: an HIV infection; as a side effect of chemotherapy orradiation therapy; by selective removal of B and/or T cell populations; by removal ofantibodies (anti-antireovirus antibodies or all antibodies), and the like.

]57[

__________________

154234]21][11[

על קוויDCשיטה ומערכת להספקת הספק טלפו� מקומיי�

METHOD AND SYSTEM FORPROVIDING DC POWER ON

]54[


LOCAL TELEPHONE LINES

30.01.2003]22[Int. Cl.(2010.01) H04M 01//00, 19//00]51[MOSAID TECHNOLOGIESINCORPORATED, CANADA

]71[


REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,RAMAT HACHAYAL 69710

]74[

A network for coupling a telephone set to a telephone server, comprising:a wire pair connected for concurrently carrying an analog telephone signal to and fromthe telephone service and a DC power signal;a connection point for connecting the network to the telephone service;a power supply coupler DC coupled at a point of said wire pair for coupling DC powerinto said wire pair;an AC Pass and DC Stop device connected in series between said wire pair and saidconnection point for substantially conducting only AC telephony signals and blockingDC flow from the telephone service into said wire pair, said AC Pass and DC Stopdevice being connected between the point at which said power supply coupler is DCcoupled to said wire pair and said connection point;a load coupler DC coupled to said wire pair for coupling DC power to a load from saidwire pair, independently of the hook state of the telephone set; anda telephone coupler for coupling the telephone set to said wire pair for passing onlyanalog telephony signals between said wire pair and the telephone set while limitingthe DC power supplied to the telephone set to a level suitable for proper telephoneoperation, an off-hook signaling circuit connected to bypass said AC Pass and DCStop device for supplying an off-hook signal to the telephone services when thetelephone set is off-hook, wherein said power supply coupler supplies all of the powerrequired by the load and the telephone set.

]57[

__________________

154259]21][11[

ORGANOPHOSPHORUS תכשירי� אורגנוזרחניי�COMPOSITIONS

]54[

25.08.2001]22[US]33[28.08.2000]32[649422]31[

Int. Cl.(2010.01) A01N 57//10, 57//28, C07F 09//00]51[BASF CORPORATION, U.S.A.]71[



ה 'א26ברזל רחוב רמת החייל


]74[

The efficacy of insecticidal compositions (especially organophosphate insecticides) isenhanced through the blending of the insecticide with fatty acid containing crop oilconcentrate.

]57[

__________________

155058]21][11[

שיטה ומוצר לעיבוד נתוני� באמצעות, התק� מערכי הוראות מרובי�

APPARATUS, METHOD ANDPRODUCT FOR DATAPROCESSING USING MULTIPLEINSTRUCTION SETS

]54[

18.02.2002]22[GB]33[31.05.2001]32[0113199.4]31[

Int. Cl.(2010.01) G06F 09//00, 09//318]51[ARM LIMITED, UNITED KINGDOM]71[WO/2002/097613]87[

ט ',קולב ושות. סנפורד מרמורק,4שער הגיא

רחובות2273.ד.ת,


]74[

A data processing system supports execution of both native instructions and Javabytecodes using a hardware executer for the Java bytecodes where possible ans asoftware instruction interpreter for the Java bytecodes where these are not supportedby the hardware. The sequences of native instructions (26) within the softwareinstruction interpreter that perform the processing for the Java bytecodes beinginterpreted terminate within a sequence terminating instruction BXJ that actsdifferently depending upon whether or not an enabled hardware executer (6) isdetected to be present. If an enabled hardware executer is detected as present, then theexecution of the next Java bytecode is attempted with this. If an active hardwareexecuter is not present, then the next Java bytecode is passed directly to the softwareinstruction interpreter.

]57[


__________________

155260]21][11[

AUTOMATED מערכת שיווק רב שלבית אוטומטית MULTI-LEVELMARKETING SYSTEM

]54[

10.10.2001]22[US]33[13.10.2000]32[60/239988]31[

Int. Cl.(2010.01) G06Q 30//00]51[NDS LIMITED, UNITED KINGDOM]71[WO/2002/031614]87[

ט ',קולב ושות. סנפורד מרמורק,4הגיא שער



]74[

A method for automated multi-level marketing of an electronic item. The methodincludes providing a secured electronic item (220) originating from a distributor (210),and a first user (215) packaging a copy of the secured electronic item with securedpayment details (212) for the first user to receive a payment, thereby producing apackaged secured electronic item. Related apparatus and methods are also described.

]57[


__________________

155482]21][11[

שיטה להעלאת תפוקת מוצר של פוליפפטיד שלע י תאי� פונדקאיי� חיידקיי�"יונקי� המיוצר רקומביננטיי�

METHOD FOR INCREASINGPRODUCT YIELD OF AMAMMALIAN POLYPEPTIDEPRODUCED BY RECOMBINANTBACTERIAL HOST CELLS

]54[

01.11.2001]22[US]33[03.11.2000]32[60/245962]31[

Int. Cl.(2010.01) C12N 01//21, 15//67, C12P 21//00, 21//08, C12R 01//19, 01//42]51[GENENTECH, INC., U.S.A.]71[WO/2002/040697]87[



]74[

The invention provides a method for increasing product yield of a polypeptide ofinterest produced by recombinant host cells, where expression of the polypeptide bythe recombinant host cells is regulated by an inducible system. More specifically, themethod involves culturing the recombinant host cells under conditions of highmetabolic and growth rate and then reducing the metabolic rate of the recombinanthost cells at the time of induction of polypeptide expression. In particular, theinvention provides a method of increasing product yield of an antibody, growth factor,or protease produced by a recombinantE. coli host cell regulated by an induciblesystem.

]57[

__________________

155483]21][11[

מטרי� תרופה ציאנוגונידי� פירידינאיו� ונגזרותדיהידרופירידיניליד� ותכשירי� רוקחיי�

המכילי� אות�

PRODRUGS OFCYANOGUANIDINE PYRIDINIUMAND DIHYDROPYRIDINYLIDENEDERIVATIVES ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM

]54[


14.11.2001]22[US]33[21.11.2000]32[60/252078]31[

Int. Cl.(2009.01) A61K 31/44, 31/4422, A61P 35/00, C07D 211/84, 213/72, C07F09/58

]51[

LEO PHARMA A/S, DENMARK]71[WO/2002/042265]87[



]74[

The invention relates to compounds of formula (I), wherein X1 and X2 independentlyrepresent a bond; a straight, branched and/or cyclic hydrocarbon diradical, optionallysubstituted with one or more hydroxy, halogen, nitro, amino, cyano, aminosulfonyl,alkylsulfonylamino, alkylcarbonyl, formyl, aminocarbonyl or alkylcarbonylamino; aheteroarylene or non-aromatic heterocyclic hydrocarbon diradical, all of which areoptionally substituted with one or more straight, branched and/or cyclic non-aromatichycrocarbon radical, hydroxyl, halogen, amino, nitro, cyano, aminosulfonyl,alkylsulfonylamino, alkylcarbonyl, formyl, aminocarbonyl or alkylcarbonylamino; Y1and Y2 independently represent a bond, an ether diradical (R'-O-R''), an aminediradical (R'-N-R''), O, S, S(O), S(O)2, C(O), NH-CO, CO-NH, SO2-N(R'), methyleneor N(R')-SO2 wherein R' and R'' independently represent straight or branchedhydrocarbon diradicals containing up to 4 carbon atoms; Y3 represents O, O-C(O),C(O)-O, N(R8), R8 being hydrogen or C1-4alkyl; R1 represents hydrogen or straight,branched and/or cyclic alkyl, optionally substituted with phenyl; or an aromatichydrocarbon radical; R2 represents aryl, heteroaryl or a non-aromatic heterocyclichydrocarbon radical, all of which are optionally substituted; tetrahydropyranyloxy, di-(C1-4 alkoxy)phosphinoyloxy or C1-4 alkoxycarbonylamino; R3 represents hydrogen;a straight, branched and/or cyclic hydrocarbon radical, optionally substituted with oneor more amino, hydroxy, carboxy, halogen, nitro, cyano, alcoxy, aminocarbonyl, C1-4alkoxycarbonyl, C1-4alkoxycarbonylamino, sulfo, hydroxysulfonyloxy,dihydroxyphosphinoyloxy, phosphono, sulfamino, aminosulfonyl, aminoacylamino ordialkoxyphosphinoyl; heteroaryl or a non-aromatic heterocyclic hydrocarbon radical,all of which are optionally substituted with one or more straight, branched and/orcyclic hydrocarbon radical, amino, hydroxy, carboxy, halogen, nitro, cyano, alkoxy,aminocarbonyl, C1-4alkoxycarbonyl, C1-4alkoxycarbonylamino, sulfo,hydroxysulfonyloxy, dihydroxyphosphinoyloxy, phosphono, sulfamino,aminosulfonyl, aminoacylamino or dialkoxyphosphinoyl; (a) wherein s is an integerfrom 1 to 200; R6 is hydrogen or an optionally substituted non-aromatic hydrocarbonradical; R7 Is independently hydrogen or methyl; R4 and R5 Independently representhydrogen; a straight, branched and/or cyclic hydrocarbon radical, optionallysubstituted with halogen, hydroxyl, halogen, amino, nitro or cyano; A representshydrogen, an optionally substituted, straight, branched and/or cyclic hydrocarbonradical, hydroxy, halogen, nitro, cyano, heteroaryl, heteroaralkyl or thiol; m and r areindependently integers from 0 to 4; and n is 0 or 1; Z- is a pharmaceutically acceptableanion, such as chloride, bromide, iodide, sulfate, methanesulfonate, p-toluenesulfonate,nitrate or phosphate. The compounds are well suited as prodrugs in human and

]57[


veterinary therapy.

__________________

155493]21][11[

שיטה והתק� להדפסת מידע, מערכת מצלמה בצורת דמות על תמונות

CAMERA SYSTEM METHOD ANDAPPARATUS FOR PRINTINGPROCESSED IMAGE DATA ONPHOTOGRAPHS

]54[

19.10.2001]22[US]33[20.10.2000]32[09/693134]31[

Int. Cl.(2010.01) H03M 13//00]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA

]71[




]74[

A method of printing digital data onto a photograph using infrared ink and using an inkjet printing process as is disclosed. The data can store the details of an image taken bya camera and of a second image which has been transformed by a proprietary imageprocessing program which can be loaded separately into the camera, the data beingrecorded in a fault tolerant form enabling the copying or recovery of the original imageor of the transformed image notwithstanding damage thereto.

]57[

__________________


155657]21][11[

–תולדות בנזנסולפונאמיד אצילאמינואלקילתהלי� להכנת� ותכשירי� רפואיי�, מותמרי�

המכילי� אות�

ACYLAMINOALKYL-SUBSTITUTEDBENZENESULFONAMIDEDERIVATIVES, PROCESS FORTHEIR PREPARATION ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM

]54[

20.10.2001]22[DE]33[03.11.2000]32[10054481.9]31[

Int. Cl.(2010.01) A61K 31//64, A61P 09//00, C07C 31/1/00, 31/1/58, 33/3/12,33/5/42, C07D 21/3/24, 21/5/54, 29/5/02, 40/7/12, 40/7/14, 40/9/12, 40/9/14

]51[

SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[


7רחוב שנקר הרצליה12688.ד.ת,


]74[

The present invention relates to acylaminoalkyl-substituted benzenesulfonamidederivatives of formula (I), in which A, R(1), R(2), X, Y and Z have the meaningsindicated in the claims. The compounds of formula (I) are valuable pharmaceuticalactive compounds which have, for example, an inhibitory action on ATP-sensitivepotassium channels in the cardiac muscle and/or in the vagal cardiac nerve and aresuitable, for example, for the treatment of disorders of the cardiovascular system suchas coronary heart disease, arrhythmias, cardiac insufficiency, cardiomyopathies,decreased contractility of the heart or vagal dysfunction of the heart, or for theprevention of sudden cardiac death. The invention furthermore relates to processes forthe preparation of the compounds of the formula (I), their use and pharmaceuticalpreparations comprising them.

]57[

__________________

156640]21][11[

תלי� להכנת ארילאתאנולדיאמיני�חומר מוצא וחומר ביניי�, מאימידאזואוקסזולי�

PROCESS FOR PREPARINGARYLETHANOLDIAMINES FROM

]54[


�,IMIDAZOOXAZOLES לשימוש בתהלי STARTINGMATERIAL AND INTERMEDIATEUSED IN THE PROCESS

17.12.2001]22[GB]33[31.01.2001]32[0102407.4]31[

Int. Cl.(2010.01) C07C 21/5/14, 22/9/38, 23/3/64, 25/1/02, 25/5/49, 31/1/08, C07D23/3/20, 25/7/04, 49/8/04

]51[

GLAXO GROUP LIMITED, UNITEDKINGDOM

]71[




]74[

An improved process for preparing arylethanoldiamines is described. Compounds ofthis type are known to be useful as agonists at atypical beta-adrenoceptors (also knownas beta-3-adrenoceptors).

]57[



__________________

156889]21][11[

אזאביציקלו–3–) דיכלורופניל–4,3(–1–(+)תכשירי� המכילי� אותו, הקסא�] 3.1.0[

והשימוש שלו

(+) - 1 - (3,4 - DICHLOROPHENYL)- 3 - AZABICYCLO [3.1.0]HEXANE, COMPOSITIONS ANDUSES THEREOF

]54[

11.01.2002]22[US]33[11.01.2001]32[758883]31[

Int. Cl.(2009.01) A61K 31/40, C07D 209/52]51[DOV PHARMACEUTICAL, INC.,U.S.A.

]71[




]74[

The present invention relates to (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane]57[


and pharmaceutically acceptable salts thereof compositions comprising (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable saltthereof, and methods for treating of or preventing relapse of depression, anxietydisorders, eating disorders, or urinary incontinence in a patient comprisingadministering (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or apharmaceutically acceptable salt thereof. The (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or pharmaceutically acceptable salt therof is preferablysubstantially free of its corresponding (-)-enantiomer.

__________________

157327]21][11[

אצתילגלוקוזאמי�–Nשימוש בפולימרי� שלו או פעילות/להכנת תרופות לוויסות מבנה

עורקית

USE OF N-ACETYLGLUCOSAMINEPOLYMERS FOR THEPREPARATION OFMEDICAMENTS FORMODULATION OF VASCULARSTRUCTURE AND/OR FUNCTION

]54[

08.02.2002]22[US]33[12.02.2001]32[781182]31[

Int. Cl.(2010.01) A61K 31//70, C08B 37//00]51[MARINE POLYMERTECHNOLOGIES, INC., U.S.A.

]71[




]74[

The present invention relates to compositions comprising semi-crystalline beta-1-4-N-acetylglucosamine polymers (p-GlcNac) and methods utilizing such polymersmodulation of vascular structure and/or function. The compositions and methodsdisclosed are useful for stimulating, in a p-GlcNac concentration-dependent manner,endothelin-1 release, vasoconstriction, and/or reduction in blood flow out of abreached vessel, as well as for contributing to or effecting cessation of bleeding. Themethods of the present invention comprise topical administration of materialscomprising semi-crystalline p-GlcNac polymers that are free of proteins, andsubstantially free of single amino acids as well as other organic and inorganiccontaminants, and whose constituent monosaccharide sugars are attached in a beta-1-4conformation.

]57[


__________________

157756]21][11[

–שיטות לבדיקת פעילות של מקטעי בקרת שיעתוק

METHODS FOR ASSAYINGACTIVITY OF TRANCRIPTIONALCONTROL ELEMENTS

]54[

08.03.2002]22[US]33[09.03.2001]32[60/274770]31[

Int. Cl.(2009.01) C12N 15/12, 15/52, 15/79, C12Q 01/48, 01/66, 01/68]51[GENE STREAM PTY LTD.,AUSTRALIA

]71[




]74[

The present invention relates generally to expression vectors and their use in geneexpression or gene regulation assays. More particularly, the present invention providesexpression vectors and/or reporter vectors providing kinetics of protein expressionwith improved temporal correlation to promoter activity. Even more particularly, theinvention provides expression vectors comprising a transcribable polynucleotide whichcomprises a sequence of nucleotides encoding an RNA element which modulates thestability of a transcript corresponding to said transcribable polynucleotide. The presentinvention provides, inter alia, novel vectors, useful for identifying and analysing cis-and trans-acting regulatory sequences/factors as well as vectors and geneticallymodified cell lines or organisms that are particularly useful for drug screening anddrug discovery.

]57[

__________________

157926]21][11[

PEPTIDES פפטידי� לאבחו� סכיזופרניה FOR THE DIAGNOSISOF SCHIZOPHRENIA

]54[

21.03.2002]22[IL]33[21.03.2001]32[142159]31[


US21.03.2001 60/278659 Int. Cl.(2010.01) C07K 07//06, 14//47, G01N 33//53, 33//68]51[

YEDA רחובות,מ"ידע חברה למחקר ופיתוח בע RESEARCH ANDDEVELOPMENT CO., LTD.

]71[




]74[

Short peptides are provided, which bind to a body fluid sample obtained from aschizophrenic patient at a substantively higher level than to a body fluid sampleobtained from a non-schizophrenic individual. The peptides are no more than 10 aminoacids long and comprise a continuous sequence of at least 5 amino acids whichconsists of at least one positively charged amino acid at one of its ends. The providedpeptides, which are the putative binding sites of autoantibodies found in high levels inschizophrenic individuals, are thus useful in diagnosis of schizophrenia

]57[

__________________

158545]21][11[

השגחה ומיפוי בזמ� אמת של הווצרות פגיעה מהסרת רקמה בלב

REAL-TIME MONITORING ANDMAPPING OF ABLATION LESIONFORMATION IN THE HEART

]54[

21.10.2003]22[US]33[21.10.2002]32[10/277079]31[

Int. Cl.(2010.01) A61B 18//14]51[BIOSENSE WEBSTER INC., U.S.A.]71[

בע.ד ,מ"קליגלר שירותי קניין רוחני תל אביב33111.ד.ת,

D. KLIGLER I.P. SERVICES LTD,P.O.BOX 33111TEL AVIV 61330

]74[

Apparatus for ablating tissue in an organ of a subject during an ablation procedure,comprising:

]57[


a probe, adapted to be inserted into the organ;an ablation device, adapted to apply a local treatment to the organ so as to ablate tissueof the organ;at least one sensor, adapted to sense a parameter that is indicative of a level ofablation;a display monitor; anda computer, adapted to:drive the ablation device to apply the local treatment to the organ at a plurality of sitesdesignated for ablation,receive respective sensed parameters from the sensor, sensed when the sensor islocated at or adjacent to the plurality of sites designated for ablation,display on the display monitor a map of the organ, anddesignate, on the map, during the ablation procedure, indications of the respectivelevels of ablation at the sites, responsive to the respective sensed parameters,characterized in that the computer is further adapted to calculate and to display on saidmap a weighted average of levels of ablation at each site and at secondary sites in avicinity of the site, wherein the weighting of each secondary site decreases as thedistance of the secondary site from the site increases.

__________________

158593]21][11[

תהלי� להכנת�, תרכובות ארילסולפונאמידסוכרת, ותכשירי� רפואי� לטיפולבהשמנה

CNSוהפרעותIIמסוג

ARYLSULFONAMIDECOMPOUNDS, PROCESS FORPREPARATION THEREOF ANDPHARMACEUTICALCOMPOSITIONS FOR THETREATMENT OF OBESITY, TYPEII DIABETES AND CNS-DISORDERS

]54[

08.05.2002]22[SE]33[11.05.2001]32[0101659-1 ]31[SE11.05.2001 0101660-9US29.05.200160/294132US29.05.200160/294102SE05.06.20010101958-7

Int. Cl.(2010.01) A61K 31//4164, 31//439, 31//445, 31//4965, 31//551, A61P 03//04,03//10, 05//48, 25//00, C07D 21/1/46, 23/3/64, 24/1/04, 29/5/116, 29/5/135, 29/5/155,40/1/12, 40/1/14, 40/3/12, 40/3/14, 40/9/14, 41/3/12, 41/3/14, 45/3/02, 48/7/04,48/7/08

]51[

BIOVITRUM AB, SWEDEN]71[





]74[

The present invention relates to substituted bis-arylsulfonamide and arylsulfonamidecompounds of the general formula (I) or the formula (II), which compounds arepotentially useful for the prophylaxis and treatment of medical conditions relating toobesity, type II diabetes and/or disorders of the central nervous system.

]57[



__________________

159053]21][11[

שת תכשיר תרופתי לאפנ� ליגנדי� של נתיב קרי והכנתו בשימוש מאפנ� אוליגונוקליוטיד, הד�

PHARMACEUTICALCOMPOSITION FORMODULATING BLOODCOAGULATION PATHWAYLIGANDS AND ITSPREPARATION USING ANOLIGONUCLEOTIDEMODULATOR

]54[

28.05.2002]22[US]33[25.05.2001]32[60/293231]31[US07.11.2001 60/331037

Int. Cl.(2010.01) A61K 31//7088, A61P 07//04, C07H 21//00, C12Q 01//68]51[DUKE UNIVERSITY, U.S.A.]71[WO/2002/096926]87[



]74[

The biological activity of nucleic acid ligand is regulated (i.e. enhanced or inhibited)]57[


$i(in vivo) to produce a desired biological effect. This is accomplished through theadministration of a modulator, or regulator, that changes the binding of the nucleicacid ligand for its target or that degrades or otherwise cleaves, metabolizes or breaksdown the nucleic acid ligand while the ligand is still exerting its effect. Modulators ofthe present invention can be administered in real time as needed based on variousfactors, including the progress of the patient, as well as the physician's discretion inhow to achieve optimal therapy. Thus, this invention provides for the first time aregulatable therapeutic regime in the course of nucleic acid ligand therapy.

__________________

159479]21][11[

הכנת� והשמוש בה� לאבחו�, גליקופפטידי� ולטפול בטרשת נפוצה

GLYCOPEPTIDES, THEIRPREPARATION AND USE IN THEDIAGNOSIS OR THERAPEUTICTREATMENT OF MULTIPLESCLEROSIS

]54[

19.06.2002]22[IT]33[22.06.2001]32[FI2001A000114]31[

Int. Cl.(2010.01) C07K 01//16, 09//00, 14//705, 17//08, G01N 33//552, 33//566]51[UNIVERSITA' DEGLI STUDI DIFIRENZE, ITALY

]71[




]74[

Glycopeptides capable of identifying multiple sclerosis antibodies, and therefore usefulas diagnostic tools or for the treatment of said pathology are described.

]57[

__________________

160115]21][11[

הכנה של אננטיומרי� טהורי� של טבעת ביצקליות דחוסות מותמרות באמי�

SYNTHESIS OFENANTIOMERICALLY PURE

]54[


AMINO-SUBSTITUTED FUSEDBICYCLIC RINGS

12.09.2002]22[US]33[12.09.2001]32[60/323201]31[

Int. Cl.(2010.01) C07D 21/5/38, 21/7/22, 22/1/02, 24/1/40, 49/1/02]51[ANORMED CORPORATION,CANADA

]71[




]74[

This invention describes various processes for synthesis and resolution of racemicamino-substituted fused bicyclic ring systems. One process utilizes selectivehydrogenation of an amino-substituted fused bicyclic aromatic ring system. Analternative process prepares the racemic amino-substituted fused bicyclic ring systemvia nitrosation. In addition, the present invention describes the enzymatic resolution ofa racemic mixture to produce the (R)- and (S)- forms of amino-substituted fusedbicyclic rings as well as a racemization process to recycle the unpreferred enantioner.Further provided by this invention is an asymmetric synthesis of the (R)- or (S)-enantioner of primary amino-substituted fused bicyclic ring systems.

]57[

__________________

160318]21][11[

ELECTRO-OPTIC אופטי עבור ברקודי� מחזירי�–קורא אלקטרו READER FORRETRO-REFLECTIVE BARCODES

]54[

16.08.2001]22[Int. Cl.(2010.01) G06K 07//10]51[

,מ"אופטידטק טכנולוגיות זיהוי אופטי בע ירושלים

OPTIDTECH OPTICALIDENTIFICATIONTECHNOLOGIES LTD.

]71[

NAFTALI אבישי דרורי, נפתלי אייזנברג EISENBERG, AVISHAIDRORI

]72[

WO/2003/017193]87[,מ"בע) 1995(ארליך.אי.י'ג

11רחוב מנחם בגין,15קומה, מגדל איילון רמת גן

G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,11 MENACHEM BEGIN ST.,

]74[


RAMAT GAN 52521

A system for identification comprising: a surface (14) comprising retro-reflectiveindicta; a source of light that illuminates the indicta (18) along an illuminationdirection; and a detector (20, 21) that views light reflected from the indicta, whereinthe retro-reflector reflects the light that illuminates it as a plurality of beams at aplurality of angles relative to the illumination direction.

]57[

__________________

160605]21][11[

–C2אול–1–השמוש במערכות אינדא�מותמרות להכנת תרופות למניעת או לטפול

בהשמנה

USE OF C2-SUBSTITUTED INDAN-1-OL SYSTEMS FOR PREPARINGMEDICAMENTS FOR THEPROPHYLAXIS OR TREATMENTOBESITY

]54[

17.08.2002]22[DE]33[31.08.2001]32[10142666.6]31[

Int. Cl.(2010.01) A61K 31//10, 31//16, 31//18, 31//19, 31//215, 31//255, 31//275,31//34, 31//36, 31//38, 31//395, 31//44, 31//495, A61P 03//04

]51[


]71[




]74[

The invention relates to the use of C2-substituted indane-1-ol systems and to theirphysiologically compatible salts and physiologically functional derivatives forproducing medicaments to promote weight loss in mammals and for the prophylaxis ortreatment of obesity. The invention also relates to the use of compounds of formula (I),wherein the groups are defined as per the description, and to the physiologicallycompatible salts and physiologically functional derivatives of said compounds, forproducing a medicament for the prophylaxis or treatment of obesity.

]57[


__________________

161216]21][11[

תמיכה בשיחה באמצעות טלפו� נייד ברשת תקשורת משולבת

SUPPORTING MOBILECOMMUNICATIONS SESSION INA COMBINEDCOMMUNICATIONS NETWORK

]54[

01.04.2004]22[Int. Cl.(2010.01) H04Q 03//00, 11//04]51[

בע. איי.סי.אי ECI פתח תקוה,מ"טלקום TELECOM LTD.]71[בע. איי.סי. אי ,מ"טלקום

30רחוב הסיבים פתח תקוה

ECI TELECOM LTD.,30 HASIVIM ST.,PETACH TIKVA 49517

]74[

A technique is proposed for supporting a mobile communication session in acombined communication network comprising a mobile network and a non-mobile access network. In the mobile network, the mobile communication sessionis associated with a mobile number. The technique comprises:(a) associating, in the non-mobile access network, the mobile number with a non-mobile device of the non-mobile network,(b) providing an access device being in communication with a plurality of non-mobile devices of the non-mobile network and with a controller of a mobilenetwork, operative to represent the non-mobile device of the plurality of non-mobile devices as having the mobile number;(c) selectively conducting the mobile communication session either through amobile device associated with the mobile number in the mobile network, orthrough the non-mobile device associated with the mobile number in the non-mobile network.

]57[

__________________


161248]21][11[

ב בונזודיאוקסול–3,1(–11–)11,17(–שימוש–5–

–) פרופיניל–1(17–הדרוקסי–17–) איל–אסטרא

או� להכנת תרופה לטיפול באי–3–דיא�–9,4 סדרי�

עיקריי� של דכאו�

USE OF (11,17)-11-(1, 3 -BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPYNYL)-ESTRA- 4, 9 - DIEN-3-ONE FORTHE PREPARATION OF AMEDICAMENT FOR THETREATMENT OF MAJORDEPRESSIVE DISORDER

]54[

21.10.2002]22[EP]33[26.10.2001]32[01204072.1]31[

Int. Cl.(2010.01) A61K 31//58, A61P 25//00, C07J 01//00]51[N.V. ORGANON, THENETHERLANDS

]71[




]74[

The present invention relates to the use of the glucocorticoid receptor antagonist(11beta ,17 beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one (Org 34517) for the preparation of a medicament for the treatment ofdepression as well as to pharmaceutical preparations of Org 34517 for said use.

]57[

__________________

161257]21][11[

הכנת� ושימוש� כמעכבי�, נגזרות של נפטירידי�)PDE4(פוספודיאסטרז4של איזואנזי�

NAPHTHYRIDINE DERIVATIVES,THEIR PREPARATION ANDTHEIR USE ASPHOSPHODIESTERASEISOENZYME 4(PDE4)INHIBITORS

]54[

04.11.2002]22[GB]33[05.11.2001]32[0126511.5]31[GB 30.04.2002 0209882.0


Int. Cl.(2010.01) A61K 31//4375, A61P 11//00, C07D 47/1/04]51[NOVARTIS AG, SWITZERLAND]71[WO/2003/039544]87[


באר שבע5352.ד.ת,


]74[

The invention relates to compounds of formula (I), in free or salt form, where R1 is amonovalent aromatic group having up to 10 carbon atoms, and R2 is a cycloaliphaticgroup having up to 8 ring carbon atoms. Compositions containing them, methods fortheir preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors arealso described.

]57[

__________________

617191]21][11[

בחירת צומת שירות לנתוני מנה לשירותי שידור שידור לכל/לרבי�

SELECTING A PACKET DATASERVING NODE FOR MULTI-CAST/BROADCAST SERVICES

]54[

29.10.2002]22[US]33[05.11.2001]32[10/011954]31[

Int. Cl.(2009.01) H04B 07/26, H04L 01/00]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2003/041339]87[ט ',קולב ושות. סנפורד מרמורק,4שער הגיא



]74[

Method and apparatus for selecting a Packet Data Service Node (PDSN) for acommunication in a wireless transmission system supporting broadcast transmissions.

]57[


The packet control function node determines a number of communicable PDSNs andassigns each a unique identifier. The PCF then selects one of the communicablePDSNs based on the multi−cast address of a given communication. One embodimentperforms a modulo operation on a function of the multi−cast address and the numberof communicable PDSNs, wherein the result of the modulo operation corresponds to aunique identifier.

__________________

161731]21][11[

ULTRAVIOLET התק� לחיטוי באמצעות קרינה אולטרה סגולה DISINFECTINGAPPARATUS

]54[

30.10.2002]22[US]33[02.11.2001]32[60/336381]31[US09.10.2002 268567 US30.10.2002284709

Int. Cl.(2010.01) A61L 02//00]51[HONEYWELL INTERNATIONALINC., U.S.A.

]71[




]74[

Ultraviolet radiation is used to disinfect air (105) in a flow tube (110), where the flowtube (110) includes total reflecting features (120) on a portion of its external surfaceand said ultraviolet radiation propagates through a portion of the flow tube via totalinternal reflection.

]57[


__________________

161764]21][11[

ל ,POSH–חומצות גרעי� המקודדות פוליפפטידי� ושימוש�

POSH NUCLEIC ACIDS ANDPOLYPEPTIDES AND USESTHEREOF

]54[

12.11.2002]22[US]33[09.11.2001]32[60/345846]31[US15.03.2002 60/364530

Int. Cl.(2010.01) A61P 31//12, C12N 15//52, 15//62, G01N 33//53]51[PROTEOLOGICS INC., U.S.A.]71[WO/2003/095971]87[

',בן עמי ושות8מנחם פלאוט


BEN-AMI & ASSOCIATES,8 PLAUT ST.,PARK TAMAR,P.O.B. 94,REHOVOT 76100

]74[

The application discloses novel polypeptides and nucleic acids involved in a variety ofbiological processes, including viral reproduction. Related methods and compositionsare also described.

]57[

__________________

161807]21][11[

METHODשיטה לקיבוע חפ. חות� לחפ. בסיס והתק� OF FIXING A SEALING]54[


OBJECT הכולל חפ. בסיס וחפ. חות� TO A BASE OBJECT ANDASSEMBLY OF A BASE OBJECTWITH A SEALING OBJECT

06.11.2002]22[FR]33[07.11.2001]32[01/14577]31[

Int. Cl.(2010.01) H01L 21//58]51[AXALTO S.A., FRANCE]71[WO/2003/041153]87[



]74[

A sealing-object (4) is fixed to a base-object (10). The sealing-object comprises athrough-hole (5). The objects are fixed to each other in the following manner. In apreparation step, a fixing layer (1,2,3) is provided between the base-object and theseali ng-object. In addition an evacuation device (6) equipped with an evacuationchannel (7) is placed onto the sealing-object. The through-hole of the sealing objecthas a first extremity opening out on the evacuation channel and a second extremityopening out on the fixing layer. In a fixing step, the fixing layer is heated which causesthe fixing layer to release gas. The gas is at least partially evacuated via the through-hole of the sealing-object and the evacuation channel of the evacuation device.

]57[

__________________

162280]21][11[

קונסולת משחק וידאו המשולבת ע� מכשיר הדפסה

VIDEO GAME CONSOLEINCORPORATING A PRINTERAPPARATUS

]54[

09.11.1999]22[AU]33[09.11.1998]32[PP7026]31[AU09.11.1998 PP7027AU09.11.1998PP7019


AU09.11.1998PP7017AU09.11.1998PP7020AU09.11.1998PP7021

Int. Cl.(2010.01) A63F 13//00, B41J 02//01, 02//175, G03B 17//02, 19//02, 27//52,29//00, G06C 11//04, G06F 03//12, 13//00, H04M 01//03, H04N 05//765

]51[

DIVISION FROM 142715]62[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA

]71[




]74[

A video game console device including:means to receive video game storage media for execution by said console;a processor for executing said video games stored on said storage media;connectors to enable operational interaction from control devices during executingof said video games; anda printer module including a printhead, ink supply unit, and print media feedmeans;said printer module being operatively associated with said processor to print outonto print media images relevant to said video games.

]57[

__________________

162356]21][11[

COLOURED יהלו� צבוע DIAMOND]54[

13.12.2002]22[GB]33[14.12.2001]32[0130004.5]31[

Int. Cl.(2010.01) C30B 25//10, 29//04]51[ELEMENT SIX LIMITED, UNITEDKINGDOM

]71[




]74[

A diamond layer of single crystal CVD diamond which is coloured, preferably whichhas a fancy colour, and which has a thickness of greater than 1 mm.

]57[


__________________

162448]21][11[

תהלי� לניקוי ובידוד של פקטור פעיל ביולוגית לגירוי מושבת גרנולוציטי�

PROCESS FOR THEPURIFICATION AND ISOLATIONOF BIOLOGICALLY ACTIVEGRANULOCYTE COLONYSTIMULATING FACTOR

]54[

05.12.2002]22[SI]33[19.12.2001]32[P-200100322]31[

Int. Cl.(2010.01) A61K 38//19, A61P 07//02, 29//00, 31//04, 35//00, 37//04, 43//00,C07K 01//22, 14//535

]51[

LEK PHARMACEUTICALS D.D.,SLOVENIA

]71[




]74[

The invention relates to the process for the isolation of biologically active granulocytecolony stimulating factor (G−CSF), which enables the separation of correctly foldedbiologically active monomeric molecules of G−CSF from the incorrectly folded,biologically inactive monomeric, oligo− or polymeric and also from aggregatedmolecules of G−CSF by using immobilised metal affinity chromatography. Theprocess of the invention, if desired the whole process, can be advantageouslyperformed under native conditions. The biologically active G−CSF with a purity ofgreater than 95% is thus obtained. Only two additional chromatographic steps, cationicexchange chromatography and gel filtration, are then preferably applied to remove thetraces of impurities. The entire process results in the production of higher yields ofG−CSF with a purity of greater than 99%. The described process is particularlysuitable for the industrial production of G−CSF.

]57[

__________________


162514]21][11[

ידי–מתק� מולי� למחצה לזיהוי פריטי� על בתוצר איפנו� בי� תדרי חקירה שוני�שימוש

SEMICONDUCTOR DEVICE FORARTICLE IDENTIFICATIONUSING INTERMODULATIONPRODUCT OF DIFFERENTINTERROGATION FREQUENCIES

]54[

23.12.2002]22[US]33[26.12.2001]32[10/033080]31[

Int. Cl.(2010.01) G06K 07//08]51[RAYTHEON COMPANY, U.S.A.]71[WO/2003/058550]87[




]74[

An harmonic intermodulation article identification system comprises a scanning dipoleantenna response to an RF intermodulation harmonic product radiated from RF diodescarried by or embedded in a substrate. The product signature is applied to a spectrumanalyzer that outputs a signature identification to a comparator. In response toreceiving a signature identification, the comparator scans previously stored signatureidentifications for a match. A match indicates the received product identification fromthe analyzer defined a specific substrate such as a document or product tag. A matchby the comparator outputs a signal to display that indicates the identification of asubstrate carrying RF diodes generating the compared product identification.

]57[

__________________

162750]21][11[

]CRYOPROBE]54 קרחי–פרוב

25.06.2001]22[


US]33[05.07.2000]32[09/610488]31[Int. Cl.(2010.01) A61M 05//00]51[

בע- מור קרית מטלון,מ"יישום מחקרים תקוה-פתח

מפרץ חיפה,מ"קלינטיקה בע

MOR-RESEARCH APPLICATIONSLTD.CLEANETICA LTD.

]71[

WO/2002/002026]87[בע"ד ,מ"ר מרק פרידמן

ז,54.ק, מגדל משה אביב 7בוטינסקי'רחגן-רמת

DR. MARK FRIEDMAN LTD.,MOSHE AVIV TOWER, 54THFLOOR,7 JABOTINSKY ST.,RAMAT GAN 52520

]74[

An intralesional method for treating a hypertrophic scar or keloid using a cryoprobe.The method comprises: (a) inserting the cryoprobe into the hypertrophic scar or keloidso that the cryoprobe is positioned within the hypertrophic scar or keloid; and (b)introducing a cryogen into the cryoprobe thereby freezing the hypertrophic scar orkeloid. The cryoprobe has a sealed distal end comprising a cutting tip. Also disclosedis a cryoprobe comprising an elongated, uninsulated housing having a sealed distal endand a proximal end. The housing comprises therein a cryogen inlet tube. Thecryoprobe further comprises a cutting tip at the distal end of the housing and a cryogenvent adjacent to the proximal end and in fluid communication with the interior of thehousing.

]57[

__________________

163139]21][11[

�אוכלוסיה מבוססת הערכות ואמצעי� להערי את האימונוגנטיקה היחסית של חלבוני�

POPULATION BASEDASSESSMENTS AND MEANS TORANK THE RELATIVEIMMUNOGENICITY OFPROTEINS

]54[

26.02.2003]22[US]33[26.02.2002]32[60/360057]31[

Int. Cl.(2010.01) G01N 33//48, 33//53]51[GENENCOR INTERNATIONAL,]71[


INC., U.S.A.WO/2003/073068]87[



]74[

The present invention provides means to assess immune response profiles ofpopulations. In particular, the present invention provides means to qualitatively assessthe immune response of human populations wherein the immune response directedagainst any protein of interest is analyzed. The present invention further providesmeans to rank proteins based on their relative immunogenicity. In addition, the presentinvention provides means to create proteins with reduced immunogenicity for use invarious applications.

]57[

__________________

163406]21][11[

שיטה והתק� להנחיית תנועה של חייה המשוטטת בצורה חופשית באמצעות גירוי מוחי

METHOD AND APPARATUS FORGUIDING MOVEMENT OF AFREELY ROAMINGANIMALTHROUGH BRAINSTIMULATION

]54[

10.02.2003]22[US]33[08.02.2002]32[60/355050]31[

Int. Cl.(2010.01) A61B 05//00]51[THE RESEARCH FOUNDATION OFTHE STATE UNIVERSITY OF NEWYORK, U.S.A.

]71[


רושליםי1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,JERUSALEM 91013

]74[


Movement of a freely roaming animal (190), such as a rat, is guided using electricstimulation of the animal's brain. Cues are provided to the animal to move forward bystimulating a reward center of the brain. Cues are provided to the animal to change itsdirection by stimulating portions of the animal's brain that control right and leftmovements, such as a cortical representation of whiskers of the animal.Multi−channel, remotely controlled equipment (140, 145, 150, 350) may be carried bythe animal to enable independent energizing of electrodes attached to different regionsof the animal's brain. A transmitter carried by the animal may report back data to allowmonitoring. A component may be carried by the animal for carrying out a mission,such as for search and rescue or surveillance. Groups of animals may be controlled inreal−time by coordinating their movements and tracking their locations.

]57[

__________________

163541]21][11[

DETERMINING קביעת משתני ביצועי טיסה FLIGHTPERFORMANCE PARAMETERS

]54[

12.08.2004]22[Int. Cl.(2010.01) B64D 47//00, G05D 01//00]51[

AVIV תל אביב, אביב צידון TZIDON]71[,פרל כהן צדק לצר

5שנקר'רח,1ים-מרכז גב הרצליה12704.ד.ת,

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,P.O.B. 12704,HERZLIYA 46733

]74[

A method for enhancing estimation of parameters for an aircraft simulator having asimulation model and covariance matrix, the method comprising:providing a first estimation of predetermined parameters;performing maneuvers with an aircraft;collecting actual flight data over a time representing the maneuvers of said aircraft;dividing the actual flight data into segments with quasi-constant velocity;feeding recorded flight control data of each segment into the simulation model;comparing output from the simulation model with actual flight data to determine errorvector; andupdating the covariance matrix and the estimation of the desired parameters using theerror vector.

]57[

__________________


163708]21][11[

FUNGICIDAL תכשירי� קוטלי פטריות MIXTURES]54[

19.03.2003]22[DE]33[21.03.2002]32[10212704]31[

Int. Cl.(2010.01) A01N 43//40, 43//653, C07D 24/9/00]51[BASF AKTIENGESELLSCHAFT,GERMANY

]71[




]74[

The invention relates to a fungicidal mixture that comprises (1) 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazolo-3-thion (prothioconazole) or the salts or adducts thereof and at least one furtherfungicidal composition, selected from (2) boscalid or (3) carboxine or (4) metrafenoneor (5) a compound of formula (V) or (6) a compound of formula (VI) or (7)quinoxyfen or (8) dithianon or (9) thiram or (10) mepiquat chlorides or (11)cyazofamid or (12) fenoxanil or (13) a compound of formula (XIII) or (14) thiophanatemethyl or (15) carbendazim or (16) metalaxyl or (17) fludioxonil or (18) thiabendazoleor (19) quintozene or (20) prochloraz or (21) anthraquinone in a synergisticallyeffective amount.

]57[



__________________

163710]21][11[

SELECTIVE דיפפטידי� כמעכבי� בררניי� של קליקריי� DIPEPTIDEINHIBITORS OF KALLIKREIN

]54[

04.03.2003]22[GB]33[08.03.2002]32[0205527.5]31[

Int. Cl.(2010.01) A61K 38//04, 38//55, A61P 01//04, 07//02, C07K 05//06]51[VANTIA LIMITED, UNITEDKINGDOM

]71[





]74[

Compounds of general formula (1), or a pharmaceutically acceptable salt thereof:wherein R1 is selected from H, lower alkyl, R4-CO, R4-O2CCH2, R5-OCO and R5-SO2;R2 is selected from lower alkyl, cycloalkyl optionally substituted with an alkyl oralkyloxy group, (C5-C12)cycloalkylalkyl optionally substituted with an alkyl oralkyloxy group, aralkyl optionally substituted with up to three groups chosen from F,CI, Br, I, OH, lower alkyl, O-(lower alkyl), O-benzyl, NH2, NO2, NH-acyl, CN andCF3, and aralkyloxymethyl optionally substituted with up to three groups chosen fromF, CI, Br, OH, lower alkyl and O-(lower alkyl); or R1 and R2 together are ano-xylylene group optionally substituted on the aromatic ring with a group selected fromF, CI, Br, OH, lower alkyl and O-(lower alkyl); R3 is selected from H, OH and O-lower alkyl; R4 is selected from H, lower alkyl and phenyl; and R5 is selected fromlower alkyl, phenyl and benzyl. The compounds are useful as pharmaceuticalcompositions.

]57[

__________________

163736]21][11[

שיטות, הכנות אבקתיות המכילות טיאוטרופיו�להכנת� ושימוש בה� להכנת תרופות המתאימות

לשאיפה

TIOTROPIUM CONTAININGPOWDERED PREPARATIONS,METHOD OF THEIRPREPARATION AND USESTHEREOF FOR THEMANUFACTURE OF AMEDICAMENT SUITABLE FORINHALATION

]54[

28.03.2003]22[EP]33[04.04.2002]32[02007634.5]31[

Int. Cl.(2010.01) A61K 09//00, 09//14, 09//72, 31//46, A61P 11//00, C07D 49/8/02]51[BOEHRINGER INGELHEIMPHARMA GMBH & CO. KG,GERMANY

]71[

WO/2003/084509]87[


,כהן ושותפיוריינהולד'א26רחוב הברזל רמת החייל


]74[

The invention relates to powdered preparations containing tiotropium for inhalation,processes for preparing them as well as their use for preparing a pharmaceuticalcomposition for treating respiratory complaints, particularly for treating COPD(chronic obstructive pulmonary disease) and asthma.

]57[

__________________

163959]21][11[

חומצה בנזואית–תולדות פניל סולפוניל אמינו ותכשירי רוקחות המכילי� אות�

DERIVATIVES OF PHENYL-SULFONYLAMINO- BENZOICACID AND PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM

]54[

11.03.2003]22[EP]33[11.03.2002]32[02075998.1]31[

Int. Cl.(2010.01) A61K 31//167, 31//18, A61P 31//18, C07C 23/5/84, 23/7/40, 31/1/44]51[TIBOTEC PHARMACEUTICALSLTD., IRELAND

]71[




]74[

The present invention concerns a compound having the formula (I) a N-oxide form, astereochemical isomer, racemic mixture, salt prodrug, ester or metabolite thereof. Itfurther relates to processes for their preparation as well as pharmaceuticalcompositions, their use as medicines, and diagnostic kits comprising them. The presentinvention also concerns combinations of the present entry inhibitors with anti-retroviral agents. It further relates to their use in assays as reference compounds or asreagents. The compounds of the present invention are useful for preventing or treatinginfection by HIV and for treating AIDS.

]57[


__________________

164087]21][11[

התק� נעילה ושיטה להתאמת, מערכת נעילה מערכת נעילה

LOCK SYSTEM, LOCK SYSTEMDEVICE AND METHOD OFCONFIGURING A LOCK SYSTEM

]54[

12.03.2003]22[SE]33[19.03.2002]32[0200827-4 ]31[

Int. Cl.(2010.01) E05B 49//00, G05B 11//01, 23//00, 23//02, G06F 13//368]51[ASSA ABLOY AB, SWEDEN]71[HILKKA PALOMAKI, FRANCKCHINELLATO, HENNEKARLHEINZ, DIETERKUCHENBECKER, ROLFNORBERG, LARS NILSSON, JUHAMURTOLA, MICHEL NOXFELD

]72[

WO/2003/078769]87[עורכי דין ועורכי, קבוצת איתן מהולל

,פטנטיםא 10בן שדרות אבא

הרצליה2081.ד.ת,

EITAN MEHULAL LAW GROUP,10 ABBA EBEN BLVD.,P.O. B. 2081,HERZLIYA 46120

]74[

A method of configuring a lock system comprising a plurality of lock system devicescomprises the following steps: defining a plurality of command and status messages,wherein each of the messages has a specific function when received by a device,defining a plurality of device types, wherein each of the types can send predeterminedcommand and status messages, sending a claiming message from each device, whereinthe claiming message from a specific device comprises information relating to thepredetermined messages that said specific device can send, and storing, in each of thedevices, the information relating to the predetermined messages that every other devicecan send. By this method, a simple lock system can be set up without involvement ofthe person installing the system. A lock system and a lock system device using this

]57[


method are also provided.

__________________

164210]21][11[

שיטה ומערכת למיו� ראשוני לקביעת סדרהטיפול למיקסו� מספר הניצולי� מאירוע רב

נפגעי�

TRIAGE METHOD AND SYSTEMFOR DETERMINING AN ORDEROF TREATMENT TO MAXIMIZESURVIVORS OF A MASSCASUALTY INCIDENT

]54[

21.03.2003]22[US]33[17.10.2004]32[60/367527]31[US17.10.2004 60/406225 US17.10.2004385829

Int. Cl.(2010.01) A61B 05//00]51[THINKSHARP, INC., U.S.A.]71[WO/2003/082097]87[



]74[

The present invention is a method and system of triage that assesses a severity scorefor each casualty, and determines a treatment prioritization plan to maximize thenumber of survivors. The present invention includes a score-based mathematicalalgorithm for resource-constrained triage, where an optimal number of survivors isdetermined through a methodology that can be mathematically modeled and solved, amethodology that considers victim survival probabilities, victim deterioration rates,and resource availability. First, each casualty is assessed and an RPM severity score isassigned based upon a sum of coded values for respiratory rate, pulse rate, and bestmotor response. Next, treatment priorities are determined from analytical ormathematical techniques, such as dynamic or linear programming, in consideration of

]57[


survival probabilities associated with each RPM score, and deterioration-with-timerates for each RPM score for victims awaiting transport and treatment and theavailability and timing of transport and treatment services.

__________________

164324]21][11[

תרופות המכילות תולדות קווינולינו� יחד ע�תסרטניו–תרופות אנטי

MEDICAMENTS COMPRISINGQUINOLINONE DERIVATIVES INCOMBINATION WITH ANTI-CANCER DRUGS

]54[

04.04.2003]22[US]33[05.04.2002]32[116117]31[

Int. Cl.(2010.01) A61K 31//4704, 31//4741, 31//506, A61P 35//00, C07D 23/9/54,40/1/04, 40/1/14, 40/5/14, 40/9/14, 41/3/14, 47/1/04, 49/1/22

]51[

NOVARTIS VACCINES ANDDIAGNOSTICS, INC., U.S.A.

]71[




]74[

Organic compounds having the formulas (I) and (II) are provided where the variableshave the values described herein. Medicaments include an anti-cancer drug selectedfrom 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of thecompound, a pharmaceutically acceptable salt of the compound, or a pharmaceuticallyacceptable salt of the tautomer in treatin along with an anti-cancer drug selected from5-FU or CPT-11. The medicaments may be used in treating cancer. The use of acompound of formula (I) or formula (II), a tautomer of the compound, apharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable

]57[


salt of the tautomer in treating cancer in conjunction with an anti-cancer drug selectedfrom 5-FU or CPT-11 is also provided.

__________________

164584]21][11[

בנזימידאזול) פיפרידיניל–4(–1נגזרות שלברות שימוש בתור אנטגוניסטי� להיסטאמי�

3Hותכשירי� פרמצבטיי� המכילי� אות�

1-(4-PIPERIDINYL)BENZIMIDAZOLE DERIVATIVESUSEFUL AS HISTAMINE H3ANTAGONISTS ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHE SAME

]54[

16.04.2003]22[US]33[18.04.2002]32[60/373,731]31[

Int. Cl.(2010.01) A61K 31//4545, 31//4985, 45//00, A61P 37//08, 43//00, C07D40/1/14, 40/5/14, 41/3/14, 41/7/14, 47/1/04, 47/3/00, 48/7/04, 49/8/04, 51/3/04

]51[

SCHERING CORPORATION, U.S.A.]71[WO/2003/088967]87[

',ר שלמה כהן ושות"ד 124אבן גבירול

תל אביב11490.ד.ת,


]74[

Disclosed are histamine H3 antagonists of the formula (I) wherein R1 is optionallysubstituted benzimidazolyl or a derivative thereof; R2 is optionally substituted aryl orheteroaryl; M1and M

2are C(R

3( or N; Q is -N(R8(-,- S- or -O-; and the remaining

variables are as defined in the specification. Also disclosed are pharmaceuticalcompositions comprising the compounds of formula I and methods of treating variousdiseases or conditions, such as allergy, allergy-induced airway responses, andcongestion (e.g., nasal congestion) using the compounds of formula I. Also disclosedare methods of treating said diseases or conditions using the compounds of formula Iin combination with an H1receptor antagonist.

]57[


__________________

164656]21][11[

מ ידע עמית לעמית בקר רשת רדיו עבור החלפת על ציוד לקוח

RADIO NETWORK CONTROLLERPEER-TO-PEER EXCHANGE OFUSER EQUIPMENTMEASUREMENTS INFORMATION

]54[

25.06.2003]22[US]33[27.06.2002]32[60/392122]31[

Int. Cl.(2010.01) H04B 07//26, 17//00]51[INTERDIGITAL TECHNOLOGYCORPORATION, U.S.A.

]71[




]74[

A drifting (WTRU) wireless transmit/receive unit has an associated (D-RNC) driftradio network controller (38) and an associated (S-RNC) servicing radio networkcontroller (40). The D-RNC (38) sends a request message to the S-RNC (40)requesting measurements of the drifting WTRU. The S-RNC (40) receives the requestmessage and sends an information message with the requested measurements to the D-RNC (38). The D-RNC (38) receives the information message.

]57[

__________________

164857]21][11[


–דיאזא–4,8–תיאה–1תרכובותשיטה להכנת�, או�–3–דקא�]5.4[ספירו

.ותכשירי� פארמצבטיי� המכילי� אות�

1-THIA-4,8,DIAZA-SPIRO[4.5]DECAN-3-ONECOMPOUNDS, PROCESS FORPREPARATION THEREOF ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM

]54[

01.05.2003]22[US]33[03.05.2002]32[60/377433]31[

Int. Cl.(2010.01) A61K 31//438, 31//439, 31//4523, A61P 25//02, 25//28, C07D48/7/10, 49/1/10, 49/1/107, 49/7/10, 51/3/10

]51[

ISRAEL נס ציונה, המכון למחקר ביולוגי בישראל INSTITUTE FORBIOLOGICAL RESEARCH

]71[




]74[

There are provided methods for the treatment of diseases involving dysfunction of theperipheral and central nervous system comprising administering one or more spirocompounds. Also provided are pharmaceutical compositions useful in such methods,compounds for use in the preparation of such pharmaceutical compositions, processesfor preparing compounds useful in the practice of such methods, and some novel suchcompounds per se.

]57[

__________________

164860]21][11[

מערכת דיקור ע� מנגנו� הדק לבקרה על עומק החדירה

LANCING DEVICE WITHTRIGGER MECHANISM FORPENETRATION DEPTHCONTROL

]54[

27.10.2004]22[US]33[31.10.2003]32[698775]31[

Int. Cl.(2010.01) A61B 17//00]51[LIFESCAN, INC., U.S.A.]71[

כ ,הן ושותפיוריינהולד'א26רחוב הברזל רמת החייל


]74[


A lancing device comprising:a housing;a lancing mechanism operatively attached to the housing,a pressure tip for engaging a target site and creating a target site bulge, the pressure tipmoveably attached to the housing; anda trigger mechanism for detecting a target site bulge of a predetermined height and,thereafter, triggering an immobilization of the pressure tip with respect to the housing,thereby preventing subsequent change in target site bulge location relative to saidhousing.

]57[

__________________

164945]21][11[

שיטה לסדור שפת פנלי� באמצעות ציפוי עבור הקמת תעלות למזוג אויר

METHOD OF EDGING BY MEANSOF THE COATING OF PANELSFOR THE CONSTRUCTION OFAIR CONDITIONING DUCTING

]54[

01.11.2004]22[ES]33[03.11.2003]32[ES200302563]31[

Int. Cl.(2010.01) B29C 65//00, F16L 21//00]51[SAINT-GOBAIN CRISTALERIA,S.A., SPAIN

]71[

NOE JUARRANZ MORATILLA,ESTHER SORIANO HOYUELOS

]72[

,לצר וכהן צדק, פרל, איתן7רחוב שנקר



]74[

The invention refers to an edging suitable for application to the edges of mineral woolpanels, especially glass wool, of the type that is used in the manufacture of ducting forair conditioning, this coating being aimed at preventing the lifting off of the fibresfrom the panel by the rubbing action arising from its effect on this area of the panelfrom the air moving inside the inside. The edging is obtained by the direct applicationof a coating on the area that it is required to protect, consisting of paint, varnish or anyother suitable substance, heving fast drying properties and being applied by sprayers,rollers or similar devices.

]57[


__________________

165106]21][11[

שיטות לתרבית רציפה של ספורוזואה תו� תאימינית של ההתפתחות–אובליגטורי בפזה הלא

להכנת וקצינה נגד פרוטוזואה

METHODS FOR CONTINUOUSCULTURING OF THE OBLIGATEINTRACELLULAR SPOROZOEAIN THE ASEXUAL PHASE OFDEVELOPMENT FORPREPARING ANANTIPROTOZOAL VACCINE

]54[

20.05.2003]22[US]33[21.05.2002]32[60/382,428]31[

Int. Cl.(2010.01) A61K 39//002, 39//012, A61P 33//02, C12N 01//10, C12Q 01//02]51[SCHERING-PLOUGH LTD.,SWITZERLANDPATHOGENES, INC, U.S.A.

]71[

WO/2003/099325]87[',תר שלמה כהן ושו"ד



]74[

The invention relates to a method of excysting and growing protozoal oocysts by invitro tissue culture resulting in production of a continuous culture of merozoites. Theinvention also provides an economical and reliable supply of culturedEimeria sp. forvaccine production, assays and research. Domesticated avians that have beenvaccinated using the providedEimeria sp. are also provided.

]57[

__________________

165128]21][11[

חיות ליצירת מודל חוליית� שאינו אד� בעלרקמת מטרה נורמאלית בעלת פנוטיפ בוגר

מודלי�, ורקמות מטרה חולות מחוליית� תור�של רקמה ומכרסמי� פגועי מערכת חיסו� המיוצרי� בשיטות אלו ושיטות להערכת

ההשפעה של טיפול רפואי כנגד רקמת המטרה החולה

METHODS FOR GENERATING ANON-HUMAN VERTEBRATEANIMAL MODEL HAVINGTARGET NORMAL TISSUE OFMATURE PHENOTYPE ANDTARGET DISEASED TISSUESFROM A DONOR VERTEBRATEANIMAL, TISSUE MODELS AND

]54[


IMMUNODEFICIENT RODENTSPRODUCED THEREOF, ANDMETHODS FOR ASSESSING THEEFFECT OF A THERAPEUTICTREATMENT DIRECTEDAGAINST A TARGET DISEASEDTISSUE

30.05.2003]22[US]33[30.05.2002]32[60/384715]31[

Int. Cl.(2010.01) A01K 33//00, 67//027, A01N 65//00, A61K 35//12, 49//00, G01N33//15

]51[

RAVEN BIOTECHNOLOGIES, U.S.A.]71[WO/2003/101187]87[




]74[

The invention relates to the use of fetal tissues to generate a tissue model in a non-human animal. The tissue model comprises target tissues allowed to progress throughdevelopment in vivo in a non-human host in order to obtain tissues having a maturephenotype that can be used to assess toxicity and/or efficacy of an agent.

]57[

בקשות חלוקה מבקשה זו.פורסמו שטר�


__________________

165193]21][11[

חדנוגדני� אימונומודולטורי שבטיי�–� והשימוש בה� לטיפול בסרט�

HUMANIZEDIMMUNOMODULATORYMONOCLONAL ANTIBODIESAND USE THEREOF FOR THETREATMENT OF NEOPLASTICDISEASE

]54[

22.05.2003]22[IL]33[23.05.2002]32[149820]31[

Int. Cl.(2010.01) A61K 39//395, C07K 16//28, C12N 15//13]51[ תקוה- פתח,מ"מור יישום מחקרים בע

יבנה,מ"קיורטק בעMOR RESEARCH APPLICATIONS,LTD.

]71[


CURETECH LTD.ג, בריטה הרדי BRITTA לאה קלפר, ונס'סטיבן טרן HARDY, STEVEN TARRAN

JONES, LEAH KLAPPER]72[

WO/2003/099196]87[',ר וב ושות"ד

2 פקריס' רח רחובות2189.ד.ת,

WEBB & CO.,2 PEKERIS ST., P.O.B. 2189,REHOVOT 76121

]74[

The present invention provides to a humanized monoclonal antibody havingimmunostimulatory effects. This antibody binds specifically to B lymphoblastoid cells,induces proliferation and activation of peripheral blood lymphocytes, and is capable ofeliciting an anti-tumor effect upon administration to subjects suffering from cancer.

]57[



__________________

165218]21][11[

, תהלי� להכנת�, נגזרות פירידי� קרבוקסיאמידשימושי� שלה� להכנת מדבירי מזיקי�

רי� מדבירי� מזיקי� המכילי� אות�ותכשי

PYRIDINE CARBOXAMIDEDERIVATIVES, A PROCESS FORTHEIR PREPARATION, THEIRUSE FOR PREPARINGPESTICIDES AND PESTICIDALCOMPOSITIONS COMPRISINGTHEM

]54[

06.05.2003]22[EP]33[16.05.2002]32[02010910.4]31[

Int. Cl.(2010.01) A01N 43//40, 43//50, 43//54, 43//653, 43//836, C07D 21/3/82,40/1/06, 40/5/06, 40/9/06, 41/3/06, 41/7/06

]51[

BAYER CROPSCIENCE AG,GERMANY

]71[




]74[

The invention relates to a 3-pyridylcarboxamide derivative of formula (I). Wherein thevarious symbols are as defined in the description, compositions thereof, their use forthe control of pests, and to processes for their preparation.

]57[


__________________

165858]21][11[

תכשיר רוקחי לטיפול בממאירי� אנושיי� ע� מחסור בארגיני� ושימוש שלו

PHARMACEUTICAL PREPARATIONFOR TREATING HUMAN

MALIGNANCIES WITH ARGININEDEPRIVATION AND USES THEREOF

]54[

20.06.2003]22[US]33[20.06.2002]32[60/390757]31[WO09.09.2002 PCT/CN02/00635

Int. Cl.(2010.01) A61K 38//43, 38//50, C07K 14//47]51[BIO-CANCER TREATMENTINTERNATIONAL LIMITED, CHINA

]71[



EITAN, PEARL, LATZER AND COHENZEDEK,P.O.B. 12688,HERZLIYA 46733

]74[

The present invention provides an isolated and substantially purified recombinanthuman arginase having sufficiently high enzymatic activity and stability to maintainAdequate Arginine Depletion in a patient. The present invention also provides apharmaceutical composition comprising the modified invention enzyme and methodfor treatment of diseases using the pharmaceutical composition.

]57[

__________________

165958]21][11[


שיטה לשליטה במגבר אופטי המצוי במסלול אופטי

METHOD OF CONTROLLINGOPTICAL AMPLIFIER LOCATEDALONG AN OPTICAL LINK

]54[

23.12.2004]22[Int. Cl.(2010.01) H04B 10//08]51[

בע. איי.סי. אי תק,מ"טלקום ECIוהפתח TELECOM LTD.]71[בע. איי.סי. אי ,מ"טלקום



]74[

A method of performing error-free shut down of an optical power amplifier in anoptical link comprising a transmitting side of said link, an optical fiber span and areceiving side of said link, wherein said optical power amplifier is a receiving sidepower amplifier;the method comprising:transmitting at least a first diagnostic signal via a first auxiliary optical channel fromthe transmitting side towards the receiving side of the link;shutting down said optical power amplifier in case of simultaneously detecting at theside of said link associated with the optical power amplifier, absence of said firstdiagnostic signal and at least one of the following events:loss (LOS) of input signal in a main band carrying information optical channels;power reduction in both the main band and a short band of signal at the input of saidamplifier;disappearance of a second diagnostic signal, if transmitted via a second auxiliaryoptical channel from the receiving side of the link towards the transmitting side of thelink,determining whether a fault that resulted in shutting down of the receiving side poweramplifier has occurred remotely or close to said amplifier; the determination beingbased on a specific combination of the events detected simultaneously with theabsence of said first diagnostic signal, wherein reduction of noise in the main band andthe short band of signal indicates a fault close to the receiving power amplifier.

]57[

__________________

166158]21][11[

חד מיימניי� וממיסי, נתרניי�–מלחי� דו אתנול להעברת נשאי� פעילי�

DISODIUM SALTS,MONOHYDRATES ANDETHANOL SOLVATES FORDELIVERING ACTIVE AGENTS

]54[

05.04.2000]22[US]33[05.04.1999]32[60/127754]31[US01.03.2000 60/186143


US01.03.200060/186142US21.03.200060/191286

Int. Cl.(2010.01) A61K 47//16, C07C 23/5/00, 23/5/60]51[DIVISION FROM 145546]62[NOVARTIS AG, SWITZERLAND]71[WO/2000/059863]87[




]74[

The inventors have discovered that the disodium salt of certain delivery agents hassurprisingly greater efficacy for delivering active agents than the correspondingmonosodium salt. Furthermore, the inventors have discovered that the disodium saltsof these delivery agents form solvates with ethanol and hydrates with water. Thedelivery agents have formula (I) wherein R1, R2, R3, and R4 are indepedentlyhydrogen, halogen, C1-C4 alkyl, or C1-C4 alkoxy; and R5 is a substituted orunsubstituted C2-C16 alkylene, substituted or unsubstituted C2-C16 alkenylene,substituted or unsubstituted C1-C12 alkyl(arylene), or substituted or unsubstitutedaryl(C1-C12 alkylene). The hydrates and solvates of present invention also havesurprisingly greater efficacy for delivering active agents, such as heparin andcalcitonin, than their corresponding monosodium salts and free acids. The presentinvention provides an alcohol solvate, such as ethanol solvate, of a disodium salt of adelivery agent of formula (I) above. Preferred delivery agents include, but are notlimited to,N-(5-chlorosalicyloyl)-8-aminocaprylic acid (5-CNAC),N-(10-[2-hydroxybenzoyl]amino)decanoic acid (SNAD), and sodiumN-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC). The invention also provides methods ofpreparing the disodium salt, ethanol solvate, and hydrate and compositions containingthe disodium salt, ethanol solvate, and/or hydrate.

]57[

__________________

166174]21][11[

COMPENSATING תיקו� של פיזור כרומטי בסיבי� אופטיי� FORCHROMATIC DISPERSION INOPTICAL FIBERS

]54[

15.07.2003]22[US]33[16.07.2002]32[60/396321]31[

Int. Cl.(2010.01) G02B 26//06]51[


CHROMATIC MICRO OPTICS, INC.,U.S.A.

]71[




]74[

An optical chromatic dispersion compensator (60) betters optical communicationsystem performance. The dispersion compensator (60) includes a collimating means(61) that receives a spatially diverging beam of light from an end of an optical fiber(30). The collimating means (61) converts the spatially diverging beam into a mainlycollimated beam that is emitted therefrom. An optical phaser (62) receives the mainlycollimated beam from the collimating means (61) through an entrance window (63),and angularly disperses the beam in a banded pattern that is emitted from the opticalphaser (61). A light-returning means (66) receives the angularly dispersed light andreflects it back through the optical phaser (62) to exit the optical phaser near theentrance window (63) thereof.

]57[

__________________

166424]21][11[

תכשירי� לשחרור מושהה המכילי� למוטריגי� וציפוי חיצוני בעל אחד או יותר פתחי�

SUSTAINED RELEASEFORMULATIONS COMPRISINGLAMOTRIGINE AND AN OUTERCOATING WITH ONE OR MOREORIFICES

]54[

28.07.2003]22[GB]33[29.07.2002]32[0217493.6]31[GB29.07.2002 0217492.8 GB13.06.20030313801.3

Int. Cl.(2010.01) A61K 09//00, 09//22, 09//28, 31//53]51[GLAXO GROUP LIMITED, UNITEDKINGDOM

]71[

WO/2004/001274]87[





]74[

A sustained release formulation of lamotrigine or a pharmaceutically acceptablederivative thereof and methods of treatment and uses thereof.

]57[

__________________

166443]21][11[

PRODUCTION תהלי� ייצור לבנזוניטריל טטראפלואר PROCESS OFTETRAFLUORINATEDBENZONITRILE

]54[

23.07.2003]22[JP]33[24.07.2002]32[2002-214632]31[US30.07.2002 60.399136

Int. Cl.(2010.01) B01J 29//74, C07C 25/3/30, 25/5/50]51[SHOWA DENKO K.K., JAPAN]71[WO/2004/009535]87[




]74[

The invention enables reduction of catalyst in producing tetrafluorobenzonitrile bydecyanation of one cyano group of tetrafluorodicyanobenzene by using a syntheticzeolite, particularly Zeolite 3A, 4A or 5A, in the reaction. Therefore the inventionprovides an industrially useful process capable of producing tetrafluorobenzonitrile, auseful agrochemical and drug intermediate, by hydrogenolysis oftetrafluorodicyanobenzene to decyanate one cyano group with the use of catalyst insmall amounts.

]57[

__________________

166580]21][11[

שיטה ומערכת להעברת נתוני� במערכת תקשורת

METHOD AND SYSTEM FOR ADATA TRANSMISSION IN ACOMMUNICATION SYSTEM

]54[


22.08.2003]22[US]33[23.08.2002]32[60/405422]31[US06.12.2002 10/313553 US06.12.200210/313594

Int. Cl.(2009.01) H04B 07/005, 07/26, H04L 12/56]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

Methods and apparatus for a data transmission in a communication system aredisclosed. Each of a subset of plural access terminals desiring to transmit user data inan interval transmits a request to transmit in the interval to an access network. Theaccess network makes a decision to schedule at least one of the subset of the pluralaccess terminals to transmit in the interval in accordance with the request. At least oneaccess point of the access network transmits the decision to the plural access terminals.

]57[

__________________

166599]21][11[

–)2S–5Z(צורה גבישית מוצקה של חומצה–מתילהפט–2–)אתינימידואילאמינו(–7–אמינו

אנואית–5

CRYSTALLINE SOLID FORM OF(2S-5Z) -2-AMINO-7-(ETHANIMIDOYLAMINO)-2-METHYLHEPT-5-ENOIC ACID

]54[

22.08.2003]22[US]33[23.08.2002]32[60/405526]31[

Int. Cl.(2010.01) A61K 31//155, 31//198, A61P 01//00, 01//02, 01//04, 01//12, 01//18,03//08, 03//10, 05//24, 07//00, 09//00, 11//00, 17//00, 21//04, 25//00, C07C 25/7/14,C07D 25/7/00

]51[

PHARMACIA CORPORATION,U.S.A.

]71[

WO/2004/018412]87[





]74[

(2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid is crystallized asan anhydrous, stoichiometric 1.5 HCl salt and a scaleable crystallization method isdisclosed. The salt form was characterized and the absolute configuration of the chiralcenter was confirmed as 'S'. (2S,5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid was high melting and appears acceptably non-hygroscopic for use in apharmaceutical composition.

]57[

__________________

166632]21][11[

פטופרוטאי�–נוגד� הקושר אנטיג� של אלפהל"וחלבו� איחוי הכולל את הנ

ANTIBODY THAT BINDS ANALPHA-FETOPROTEIN ANTIGENAND FUSION PROTEINCOMPRISING SUCH

]54[

01.08.2003]22[US]33[01.08.2002]32[60/399707]31[

Int. Cl.(2010.01) C07K 16//18, 16//46, C12N 15//13, 15//62]51[IMMUNOMEDICS, INC., U.S.A.]71[WO/2004/013180]87[



]74[

The present invention provides humanized, chimeric and human anti-alpha-fetoproteinantibodies, fusion proteins, and fragments thereof. The antibodies, fusion proteins, andfragments thereof, as well as combinations with other suitable antibodies, are usefulfor the treatment and diagnosis of hepatocellular carcinoma, hepatoblastoma, germ cell

]57[


tumors carcinoma and other AFP-producing tumors.

__________________

166696]21][11[

PROCESS קטואצטאל–תהלי� להכנת תרכובות גמא FOR PRODUCINGGAMMA-KETOACETALCOMPOUNDS

]54[

19.08.2003]22[JP]33[20.08.2002]32[2002-238786]31[JP09.05.2003 2003-131270

Int. Cl.(2010.01) C07D 20/7/325, 31/9/00, 31/9/06]51[DAIICHI SANKYO COMPANYLIMITED, JAPAN

]71[



]74[

A process for producing high-purity gamma -keto acetals in high yield by a simple and easy means ,as represented by the following scheme) :I(

wherein Ar is aryl ;X is halogeno ;Raand Rbare each alkyl or the like ;and W is alkylene.

]57[

__________________

166833]21][11[

ARYLTHIAZOLE-2תהלי� להכנת�, ארילתיאזול–2תרכובות COMPOUNDS,]54[


ושימוש� בהכנת תרופות לטיפול במחלותהמווסתות על ידי אגוניסטי� של

PPARALPHAו–PPARGAMMA

PROCESS FOR THEIRPREPARATION AND USETHEREOF IN THE PREPARATIONOF MEDICAMENTS FOR THETREATMENT OF DISEASESMODULATED BY PPARALPHAAND PPARGAMMA AGONISTS

21.08.2003]22[EP]33[30.08.2002]32[02019146.6]31[

Int. Cl.(2010.01) A61K 31//426, A61P 03//10, C07D 27/7/24, 41/7/12]51[F. HOFFMANN-LA ROCHE AG,SWITZERLAND

]71[




]74[

The present invention relates to compounds of formula (I) wherein Rl to R10, X, Y andn are as defined in the description and claims, and pharmaceutically acceptable saltsand esters thereof. The compounds are useful for the treatment of diseases such asdiabetes.

]57[

__________________

166883]21][11[

,SIGNAL הפרעה וכוח רעש, מדידת סיגנלי� INTERFERENCE ANDNOISE POWER MEASUREMENT

]54[

26.08.2003]22[US]33[06.09.2002]32[10/236414]31[

Int. Cl.(2009.01) H04B 07/185]51[THE DIRECTV GROUP, INC., U.S.A.]71[WO/2004/023676]87[

ט ',לב ושותקו. סנפורד מרמורק,4שער הגיא



]74[

Systems and methods are presented for measuring power levels of primary and]57[


interfering signals as well as noise, particularly for satellite transmitted signals. Atypical method comprises the steps of receiving a signal comprising a primary signal,an interference signal and noise, demodulating the primary signal to remove a carrierfrequency, decoding the primary signal to obtain symbols, estimating a power level ofthe primary signal based upon the demodulated and decoded primary signal.Additionally, an ideal primary signal can be generated from the carrier power andfrequency and the symbols and subtracted from the received signal to produce thenoise and interference signal. The noise and interference power is then estimated fromthe noise and interference signal.

__________________

167063]21][11[

DOOR מנעול צילינדר לדלת CYLINDER LOCK]54[

28.08.2003]22[US]33[28.08.2002]32[229156]31[

Int. Cl.(2010.01) E05B 13//00, 47//06]51[ILAN הרצליה, אילן גולדמן GOLDMAN]71[




]74[

A cylinder lock for use in a door lock, comprising an outer plug, an inner plug, a rotarycam adapted to move a deadbolt of the door lock, and a clutch adapted to engage forrotation the outer plug to the rotary cam. The cylinder lock further comprises anelectronic blocking device (EBD) and a drive means adapted to actuate the clutch uponan unblocking command from the EBD generated upon receiving therein anunblocking signal emitted from the outer side of the door, thereby enabling moving thedeadbolt by rotation of the outer plug. The cylinder lock comprises an inner handle

]57[


attached thereto at the inner side of the door, the EBD and the drive means beingentirely accommodated within the inner handle. The signal is emitted by an electronickey or panel and may be a mechanical vibration signal, a light signal, or a radio signal.

__________________

167175]21][11[

כלי קידוח בעל לוחות חיתו� חלופיות ולוחות חיתו� חלופיות עבור כלי הקידוח

DRILLING TOOL WITHALTERNATING CUTTINGPLATES AND ALTERNATINGCUTTING PLATES FOR SAIDDRILLING TOOL

]54[

19.08.2003]22[DE]33[09.09.2002]32[10241841]31[DE13.05.2003 10321635.9

Int. Cl.(2010.01) B23B 51//00, 51//02]51[KOMET GROUP HOLDING GMBH,GERMANY

]71[



]74[

The invention relates to a dual-cutting drilling tool. The drilling tool comprises a basebody (14) which is rotatable about a drill axis (36) and in which two plate seats (16)are arranged on the front face thereof for receiving identically configured alternatingcutting plates (16). The alternative cutting plates are respectively provided on a maincutting edge (28) thereof with an adjacent first face (30), forming a cutting wedge, anda free surface (24). The main cutting edges (28) of the alternating cutting plates (20)complement each other in the region of a central, offset cutting part (28'), forming across-cutting edge which is interrupted by a center hole (60). The aim of the inventionis to reduce the risk of breakage in the center area of the alternating cutting plates andto provide better guidance for the tool. According to the invention, slanting guidinginclinations (56) are provided on the free surface of the alternating cutting plates (20),extending from an apex line (54) to the center corner (46) of the plates. The freesurfaces (24) are positively inclined in a radially outer region in the direction ofadvancement and are negatively inclined in the region of the guiding inclinations (56)

]57[


thereof.

__________________

167434]21][11[

פירולידי�–2,5–) גליציל מותמר(–Nתרכובותמותמר לשימוש כמעכבי דיפפטידיל פפטידאז

IV– (DPP – IV(ותכשירי רוקחות המכילי� אות�

N-(SUBSTITUTED GLYCYL)-2,5-DISUBSTITUTED PYRROLIDINESFOR USE AS INHIBITORS OFDIPEPTIDYL PEPTIDASE-IV(DPP-IV) ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHE SAME

]54[

15.09.2003]22[US]33[19.09.2002]32[10/246831]31[US11.09.2003 10/659860

Int. Cl.(2010.01) A61K 31//401, 31//4439, 31//506, A61P 03//10, C07D 20/7/08,20/7/16, 40/1/06, 40/1/12, 40/3/06, 40/3/12, 41/3/14, C07F 05//02

]51[

ABBOTT LABORATORIES, U.S.A.]71[WO/2004/026822]87[




]74[

The present invention relates to compounds of formula I which inhibit dipeptidylpeptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes,especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia,obesity, atherosclerosis, and various immunomodulatory diseases. Or pharmaceuticallyacceptable salts or prodrugs thereof, wherein X,R,R1,R2 and R3 have the definitionsgiven in the description.

]57[


__________________

167564]21][11[

, תרכיז פולימרי נגד חיידקי� נגד נגיפי�תהליכי� להכנת חומרי� פולימריי� ממנו

ומוצרי� המיוצרי� ממנו

ANTIMICROBIAL ANDANTIVIRAL POLYMERICMASTER BATCH, PROCESSESFOR PRODUCING POLYMERICMATERIAL THEREFROM ANDPRODUCTS PRODUCEDTHEREFROM

]54[

21.03.2005]22[Int. Cl.(2010.01) A61K 33//34, 47//00, A61P 31//12, C08K 03//22]51[THE CUPRON CORPORATION,U.S.A.

]71[



]74[

A polymeric master batch for preparing an antimicrobial and antifungal and antiviralpolymeric material comprising a slurry of thermoplastic resin, an antimicrobial andantifungal and antiviral agent consisting essentially of water insoluble particles ofionic copper oxide that releases Cu++, a polymeric wax and an agent for occupying thecharge of said ionic copper oxide wherein said agent is selected from the groupconsisting of a chelating agent, a phenolic antioxidant and a metal deactivator.

]57[

__________________

167566]21][11[

שיטות להכנת יריעות חד ודו שכבתיות מחומרפוליאתיל� בעל משקל מולקולרי גבוה במיוחד

וחפצי� עמדיי ירי המיוצרי� מה�

METHODS OF PREPARATION OFMONOLAYERS AND BILAYERSCOMPRISING ULTRA HIGHMOLECULAR WEIGHTPOLYETHYLENE ANDBALLISTIC RESISTANTARTICLES MANUFACTUREDTHEREFROM

]54[

21.03.2005]22[US]33[16.08.2004]32[60/601645]31[


US08.11.2004 60/626206 Int. Cl.(2010.01) B32B 27//00, C08F 10//02, C08J 05//18, F41H 01//02]51[DSM IP ASSETS B.V., THENETHERLANDS

]71[

YUVAL שלום גבע, יובל פוקס FUCHS, SHALOM GEVA]72[',ר וב ושות"ד

2פקריס' רח רחובות2189.ד.ת,

WEBB & CO.,2 PEKERIS ST., P.O.B. 2189,REHOVOT 76121

]74[

A multilayered material comprising a plurality of unidirectional monolayers of ultrahigh molecular weight polyethylene and being essentially devoid of bonding matrices,with the direction of each monolayer being rotated at an angle with respect to thedirection of an adjacent unidirectional monolayer.

]57[



__________________

167714]21][11[

ודולציה אריל סולפונאמידי� ושימוש בה� למ9CCRשל

ARYL SULFONAMIDES ANDUSES THEREOF FORMODULATION OF CCR9

]54[

17.11.2003]22[US]33[18.11.2002]32[60/427670]31[

Int. Cl.(2010.01) A61K 31//4164, 31//421, 31//4245, 31//496, 31//50, 31//505,31//5375, A61P 29//00, C07D 21/3/50, 21/3/61, 21/3/70, 21/3/84, 21/3/89, 23/3/64,23/7/08, 23/9/26, 24/1/12, 40/1/12, 41/3/04

]51[

CHEMOCENTRYX, INC., U.S.A.]71[WO/2004/046092]87[



]74[

Compounds of formula (I) (in which the variables L, X, Y and Z are as defined in theclaims) are provided that act as potent antagonists of the CCR9 receptor, and whichhave been further confirmed in animal testing for inflammation, one of the hallmarkdisease states for CCR9. The compounds are generally aryl sulphonamide derivativesand are useful in pharmaceutical compositions, methods for the treatment of CCR9-mediated diseases, and as controls in assays for the identification of CCR9 antagonists.

]57[


__________________

167923]21][11[

METHOD שיטה להכנת חפצי� מוקצפי� בעלי צורה גסה FOR PREPARATION OFBULK SHAPED FOAM ARTICLES

]54[

09.10.2003]22[US]33[14.10.2002]32[10/271054]31[

Int. Cl.(2010.01) C04B 20//10, 22//00, 38//00]51[ נשר,מ"סלריס בע

חיפה, גדעון גראדרCELLARIS LTD.GIDEON GRADER

]71[




]74[

A process for the preparation of bulk foams which comprises contacting ceramic foamparticles with a hydrophobic material to form impregnated and/or coated ceramic foamparticles (103) with hydrophobic properties. The impregnated and/or coated ceramicfoam particulate material (103) is mixed (108) with a ceramic binding material with orwithout an organic binder in an aqueous composition solution to form a castable andpressable mixture (109). The castable and pressable mixture (109) is cast (110), andoptionally pressed (111), in a mold to form a wet green body (113), which is in turndried (114) to form a dried green body (115), and is then fired and sintered (116) toform a bulk shape foam article.

]57[

__________________

168000]21][11[

LOW חומר נפ. בעל בעירות נמוכה FLAMMABILITYEXPLOSIVE COMPOSITION

]54[

12.04.2005]22[Int. Cl.(2010.01) C06B 23//00]51[

,מ"רפאל מערכות לחימה מתקדמות בע חיפה

RAFAEL ADVANCED DEFENSESYSTEMS LTD.

]71[

GILרחל, מנשה צליק, תמר קימל, גיל שרון SHARON, TAMAR KIMMEL,MENASHE ZALIK, RACHEL

]72[


STEINER שטיינר,לוצאטו את לוצאטו



]74[

Explosive composition of reduced flammability, characterized in that it comprises anexplosive material, a silicone rubber binder and a fire retardant component chosenfrom the group consisting of boric acid, borates and other boron compounds.

]57[

__________________

168050]21][11[

,IL–1אנטגוניסטי� מבוססי� על קולט� ושיטות ליצור� ומגיבי� להכנת�

IL-1 RECEPTOR BASEDANTAGONISTS AND METHODSOF MAKING THEM ANDREAGENTS FOR USE THEREIN

]54[

24.10.2003]22[US]33[28.10.2002]32[10/282162]31[

Int. Cl.(2010.01) C07K 14//715]51[REGENERONPHARMACEUTICALS, INC., U.S.A.

]71[




]74[

The present invention provides a fusion polypeptide capable of binding interleukin -1(IL-1) to form a nonfunctional complex. It also provides a nucleic acid sequenceencoding the fusion polypeptide and methods of making and uses for the fusionpolypeptide.

]57[

__________________

168386]21][11[

COMPOSITIONS תכשירי� ושימושי� בליקופ� AND USES OFLYCOPENE

]54[


04.12.2003]22[EP]33[06.11.2002]32[02024244.9]31[

Int. Cl.(2010.01) A61K 31//015, 31//07, 31//355, 31//375, 36//00]51[DSM IP ASSETS B.V., THENETHERLANDS

]71[




]74[

Lycopene can be used in the primary prevention and incidence risk reduction of non-cancerous symptoms and/or pathologies (i.e., the prophylactic supplementation of thehealthy subjects), in the treatment or the coadjuvant treatment of non-canceroussymptoms and/or pathologies (i.e. the supplementation as therapy or accompanying arunning therapy) and in the secondary prevention of non-cancerous symptoms and/orpahtologies (i.e., the supplementation after a successful therapy for the prevention ofthe relapse), which are associated with, favored by or caused by androgen signalling orwhich are sensitive to a reduction of androgen signalling.

]57[

__________________

168483]21][11[

MULTI-LAYER רירית–שכבתית תו�–מערכת ריפוי רב TRANSMUCOSALTHERAPEUTIC SYSTEM

]54[

04.11.2003]22[DE]33[13.11.2002]32[10252726.1]31[

Int. Cl.(2010.01) A61K 09//00, 09//70, 47//30]51[LTS LOHMANN THERAPIE-SYSTEME AG, GERMANY

]71[




]74[

The invention relates to a film-type therapeutic system (1) comprising at least twointerconnected layers, for the transmucosal administration of active ingredients. Saidsystem comprises a layer (2) which is mucoadhesive in an aqueous environment, and asingle-layer or multi-layer rear layer (3). At least one of said layers contains activeingredients, and the cited mucoadhesive layer (2) is capable of swelling in aqueousmedia, but is insoluble or only slightly soluble.

]57[


__________________

168487]21][11[

–וקוינזולי�–איסוקוינולי�,–קוינולי�תכשירי� קוטלי פיטריות, אוקסיאלקילאמידי�

נת� ושימוש בה� תהלי� להכ, הכוללי� אות� למאבק בפטריות

QUINOLIN-, ISOQUINOLIN- ANDQUINAZOLIN-OXYALKYLAMIDES ,FUNGICIDAL COMPOSITIONSCOMPRISING THEM, PROCESSFOR THEIR PREPARATION ANDMETHODS OF USING THEM TOCOMBAT FUNGI

]54[

27.10.2003]22[GB]33[26.11.2002]32[0227555.0]31[

Int. Cl.(2010.01) A01N 43//42, 43//54, C07D 21/5/20, 21/5/60, 21/7/24, 23/9/74]51[SYNGENTA LIMITED, UNITEDKINGDOM

]71[




]74[

Fungicidal compounds of the general formula (1) wherein one of X and Y is N or N-oxide and the other is CR or both of X and Y are N.

]57[

__________________

168784]21][11[

–1,3תרכובת ציקלית דחוסה ע�דיהידרואימידזול ותכשירי� רפואיי� המכילי�

אות�

FUSED 1,3-DIHYDROIMIDAZOLERING COMPOUNDS ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHE SAME

]54[

02.12.2003]22[


JP]33[04.12.2002]32[2002-352186]31[Int. Cl.(2010.01) A61K 31//52, 31//522, A61P 03//00, 43//00, C07D 47/1/00, 47/1/04,47/3/34

]51[

EISAI R&D MANAGEMENT CO.,LTD., JAPAN

]71[




]74[

A novel compound having excellent DPPIV inhibitory activity. It is a compoundrepresented by the general formula (I) (wherein T1 means an optionally substituted,mono- or bicyclic, 4- to 12-membered heterocycle containing one or two nitrogenatoms therein; the structure shown by (II) means a double bond or single bond; X3

means oxygen or sulfur; X1 means optionally substituted C2-6 alkynyl, etc.; Z1 meansnitrogen or -CR3=; Z2 and Z3 each independently means nitrogen, -CR1=, carbonyl, or -NR2-; and R1, R2, R3, and X2 each independently means optionally substituted C1-6 alkyl, etc.), a salt thereof, or a hydrate of either.

]57[

__________________

169092]21][11[

ע� מתמיר1Bתולדות אוורמקטי�שימוש� בהכנת '',4או'4אלקוקסימתיל בעמדה

�קוטלי חרקי� המכילי� אות�, קוטלי חרקי�

AVERMECTIN B1 DERIVATIVESHAVING AN ALKOXYMETHYLSUBSTITUENT IN THE 4"- OR 4'-POSITION, USE THEREOF IN THEPREPARATION OF PESTICIDESAND PESTICIDES COMPRISINGTHE SAME

]54[

19.12.2003]22[GB]33[20.12.2002]32[0229804.0]31[

Int. Cl.(2010.01) A61K 31//70, A61P 33//00, C07H 17//08]51[


SYNGENTA PARTICIPATIONS AG,SWITZERLAND

]71[




]74[

What is described are a compound of the formula (I): wherein n is 0 or 1; A-B is -CH=CH- or -CH2-CH2-; R1 is C1-C12-alkyl, C3-C8-cycloalkyl or C2-C12-alkenyl; R2 isfor example C1-C12-alkyl, C2-C12-alkenyl or C2-C12-alkinyl; which are optionallysubstituted with one to five substituents selected from the group consisting of OH,halogen, CN,-N3, -N02, C3-C8-Cycloalkyl, norbornylenyl-, C3-C8Cycloalkenyl; C3-C8-halocycloalkyl, Cl-C12-alkoxy, C1-C6-alkoxy-C1-C6-alkoxy, C3-C8-cycloalkoxy, C1-C12-haloalkoxy, C1-C12-alkylthio, C3-C8-cycloalkylthio, C1-C12-haloalkylthio, Cl-C12

alkylsulfinyl, C3-C8-cycloalkylsulfinyl, C1-C12-haloalkylsulfinyl, C3-C8-halocycloalkylsulfinyl, Cl-C12-alkylsulfonyl, C3-C8-cycloalkylsulfonyl, C1-C12-haloalkylsulfonyl, C3-C8-halocycloalkylsulfonyl, -NR4R6, -X-C(=Y)-R4, -X-C(=Y)-Z-R4, -P(=O)(OCl-C6-alkyl)2, aryl, heterocyclyl, aryloxy, arylthio and heterocyclyloxy;R3 is for example H, C1-C12-alkyl or C1-C12-alkyl which is optionally substituted and,where applicable, to E/Z isomers, mixtures of E/Z isomers and/or tautomers, in eachcase in free form or in salt form; a process for preparing and using these compoundsand their tautomers; pesticides whose active compound is selected from thesecompounds and their tautomers; and a process for preparing these compounds andcompositions, and the use of these compounds and compositions.

]57[

__________________

169106]21][11[

METHOD שיטה ומערכת לתקשורת קבוצה AND SYSTEM FORGROUP COMMUNICATIONS

]54[

18.12.2003]22[US]33[31.12.2002]32[10/334521]31[

Int. Cl.(2010.01) H04L 29//06, H04W 04//06]51[MOTOROLA, INC., U.S.A.]71[WO/2004/062218]87[

REINHOLD,יוריינהולד כהן ושותפ COHN AND PARTNERS,]74[



26A HABARZEL ST.,RAMAT HACHAYAL 69710

A method and system for group communications between a plurality of endpoints(102, 106, 108 etc.) in a system (100) is described. The method includes the steps of:a) receiving at a group entity (104) from an initiating endpoint (102), using atransactional protocol, a first message requesting a session between a plurality ofendpoints (106, 108 etc.) affiliated with a group that correlates to the group entity(104); b) causing the session to be accepted; c) causing the presence of the session tobe communicated, using a broadcast protocol, to the plurality of endpoints (106, 108etc.) affiliated with the group; and d) communicating from the group entity (104) to theinitiating endpoint (102), using the transactional protocol, the acceptance of thesession.

]57[

__________________

169182]21][11[

י� לריכו� בדי� המכילי� תערובת של תכשיר פולימרי� קטיוני� ומשני ראולוגיה

FABRIC SOFTENERCOMPOSITIONS CONTAINING AMIXTURE OF CATIONICPOLYMERS AND RHEOLOGYMODIFIERS

]54[

12.12.2003]22[US]33[16.12.2002]32[10/320067]31[

Int. Cl.(2009.01) C11D 03/00]51[COLGATE-PALMOLIVECOMPANY, U.S.A.

]71[

WO/2004/061065]87[',זליגסון גבריאלי ושות

31יבנה' רח תל אביב1426.ד.ת,

SELIGSOHN GABRIELI & CO.,31 YAVNE ST.,P.O.B. 1426,TEL AVIV 61013

]74[


An aqueous fabric softening composition is described having its rheological propertiesof flow elasticity and viscosity capable of being readily modified as neededindependently of each other to satisfy a consumer preference, said compositioncomprising: a) from about 0.01% to about 25%, by weight, of a cationic fabricsoftener; b) an effective amount of a mixture of cationic polymers capable ofmodifying the aforesaid rheological properties, said mixture comprising: (iii) fromabout 0.01% to about 90%, by weight, of a cationic linear homopolymer that isderivable from the polymerization of acrylic acid and/or methacrylic acid or a linearcopolymer that is derivable from the polymerization of acrylic acid and/or methacrylicacid and acrylamide or methacrylamide, said homopolymer or copolyer having amolecular weight of from about 10,000 to about 30 million; and (iv) from about 10%to about 99.99%, by weight, of a cationic cross-linked polymer that is derivable fromthe polymerization of, from 5 to 100 mole percent of cationic vinyl addition monomer,from 0 to 95 mole percent of acrylamide, and from 70ppm to 300ppm of a difunctionalvinyl addition monomer cross linking agent, the respective amounts of (i) and (ii) insaid mixture being selected to provide the desired rheological properties of viscosityand flow elasticity in said softening composition; and c) balance water.

]57[

__________________

169234]21][11[

מערכת ושיטה לשליטה וניהול מפגשי� בי� ערכת תקשורתנקודות סיו� במ

SYSTEM AND METHOD FORCONTROLLING AND MANAGINGSESSIONS BETWEEN ENDPOINTSIN A COMMUNICATIONSSYSTEM

]54[

18.12.2003]22[US]33[31.12.2002]32[10/334577]31[

Int. Cl.(2010.01) H04L 29//06, 29//08]51[MOTOROLA, INC., U.S.A.]71[WO/2004/062176]87[



]74[

In a communications system having a plurality of endpoints (240, 242, 246) eachincluding a logical entity and its physical counterpart, a system for controlling andmanaging session between at least two endpoints. The system including a registrationmanager (202), an application layer router (204), a session controller (206), a groupdatabase manager (208), and at least one group entity (210).

]57[


__________________

169437]21][11[

שיטות להערכת אינטראקציות ושיטה לזיהוי �ביומולקולות מטרה ושאינ� מטרה מתו

מצעות יצירת מגע של מולקולה תערובת בא לוכדת ע� דגימה

METHOD FOR ASSESSINGINTERACTIONS AND A METHODFOR IDENTIFYING TARGET ANDNON-TARGET BIOMOLECULESIN A MIXTURE OFBIOMOLECULES BYCONTACTING A CAPTUREMOLECULE WITH A SAMPLE

]54[

16.01.2004]22[US]33[16.01.2003]32[60/441398]31[

Int. Cl.(2010.01) G01N 33//68]51[CAPROTEC BIOANALYTICSGMBH, GERMANY

]71[




]74[

Capture compounds and collections thereof and methods using the compounds for theanalysis of biomolecules are provided. In particular, collections, compounds andmethods are provided for analyzing complex protein mixtures, such as the proteome.The compounds are multifunctional reagents that provide for the separation andisolation of complex protein mixtures. Automated systems for performing the methodsalso are provided.

]57[




__________________

169451]21][11[

תהלי� להכנת גבישי� של זוניסאמיד חופשיי�יסאמיד דיכלורואתא� וגבישי� של זונ–1,2–מ

טהורי� בדרגה גבוהה

PROCESS FOR THEPREPARATION OF 1,2-DICHLOROETHANE FREECRYSTALS OF ZONISAMIDE ANDTHE HIGHLY PURE CRYSTALSOF ZONISAMIDE

]54[

28.07.2003]22[US]33[13.01.2003]32[10/340601]31[

Int. Cl.(2010.01) C07D 26/1/20]51[DAINIPPON SUMITOMO PHARMACO. LTD., JAPAN

]71[




]74[

process for the preparation of crystals of zonisamide containing residual 1,2-dichloroethane of not more than 5 ppm, by adding an aqueous C2-4 alcohol to crystalsof zonisamide containing residual 1,2-dichloro-ethane of more than 5 ppm, removingthe 1,2-dichloroethane by azeotropic distillation, followed by collecting theprecipitated crystals from the residual mixture, and the highly pure crystals ofzonisamide containing residual 1,2-dichloroethane of not more than 5 ppm, which isuseful as an antiepileptic agent.

]57[

__________________

169900]21][11[

PROCESS תהלי� ליצירת נגזרות פירידיני� אמינו קטליי� FOR PREPARINGPYRIDINE-SUBSTITUTED AMINOKETAL DERIVATIVES

]54[

27.01.2004]22[DE]33[11.02.2003]32[10305391.3]31[

Int. Cl.(2010.01) C07D 21/3/38]51[SANOFI-AVENTIS DEUTSCHLAND]71[


GMBH, GERMANYWO/2004/072026]87[

,פרל כהן צדק לצר5שנקר'רח,1ים-מרכז גב



]74[

The present invention relates to an efficient process for preparing derivatives of 1-(pyridinyl)-1, 1-dialkoxy-2-aminoethane of the formula (I), with which compounds ofthe formula (I) can be prepared in high purity and yield and in the form of the free basewithout isolating the acetylpyridine oxime of the formula (XI) which is a criticalproduct from a safety point of view as a solid.

]57[

__________________

169954]21][11[

תרכובות אמיד המותמרות ע� שלוש קבוצותתכשירי� רפואיי�, תהלי� להכנת�, ציקליות

ושימוש� לייצור תרופה לטיפול, המכילי� אות� רצויGK–במצב שהפעלת

TRICYCLO SUBSTITUTEDAMIDE COMPOUNDS, PROCESSFOR THEIR PREPARATION,PHARMACEUTICALCOMPOSITIONS CONTAININGTHEM AND USE THEREOF INTHE MANUFACTURE OFMEDICAMENTS FOR THETREATMENT OF A CONDITIONWHERE ACTIVATION OF GK ISDESIRABLE

]54[

03.02.2004]22[US]33[11.02.2003]32[60/446683]31[US11.08.2003 60/494434 US20.10.200360/512800

Int. Cl.(2010.01) A61K 31//427, 31//4439, 31//454, 31//495, 31//497, A61P 03//10,C07D 27/7/46, 29/5/185, 30/7/46, 30/9/06, 33/3/24, 40/5/12, 40/9/12, 41/3/12, 41/7/12,41/7/14

]51[

PROSIDION LIMITED, UNITEDKINGDOM

]71[



LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,P.O.B. 5352,

]74[


BEER-SHEVA 84152

Compounds of Formula (I): or pharmaceutically acceptable salts thereof, are useful inthe prophylactic and therapeutic treatment of hyperglycemia and diabetes.

]57[

__________________

169963]21][11[

CIGARETTE סיגריה בעלת צינורית נקבובית למעבר ח� HAVING POROUSHEAT TRANSFER TUBE

]54[

13.02.2004]22[US]33[14.02.2003]32[10/366349]31[

Int. Cl.(2010.01) A24D 03//04]51[PHILIP MORRIS PRODUCTS S.A.,SWITZERLAND

]71[




]74[

A smoking article includes a cylinder of smoking material, a filter attached to thecylinder of smoking material, and a tube of preferably porous and/or perforatedmaterial adapted to collapse at an open end upon exposure to thermal energy andpreferably extending from one end portion of the smoking material to the junction ofthe filter and the cylinder of smoking material. Thermal energy generated by a burningportion of the tobacco filler material within the cylinder of smoking material istransferred by convection through the open portion of the tube after the end portion ofthe tube has collapsed closed by the heat from the burning portion of the tobacco.

]57[

__________________


170175]21][11[

METHODS שיטות להכנת תולדות בנזאמידי� ציקלי FOR PRODUCINGCYCLIC BENZAMIDINEDERIVATIVES

]54[

10.02.2004]22[JP]33[19.02.2003]32[2003-040949]31[

Int. Cl.(2010.01) C07C 25/5/54, 30/9/66, 43//225, C07D 20/9/44, 29/5/10, 41/3/10]51[EISAI R&D MANAGEMENT CO.,LTD., JAPAN

]71[




]74[

A process for producing a fluorinated cyclic benzamidine derivative (A) or saltthereof, characterized by comprising the step of reacting a specific novel compoundwith ammonia or an imide; a process for producing a morpholine-substituted phenacylderivative (B) or salt thereof, characterized by comprising reacting a specific novelcompound with morpholine, reacting the reaction product with a halogenating reagent,and subjecting the resultant reaction product to a reaction for ketal elimination; aprocess for producing a cyclic benzamidine derivative (C) or salt thereof, characterizedby coupling the compound (A) or salt with the compound (B) or salt in the presence ofan ether or hydrocarbon; and a method of recrystallizing the cyclic benzamidinederivative (C) or salt, characterized by dissolving the compound (C) or salt in a mixedsolvent comprising an alcohol and water or in a mixed solvent comprising an ether andwater and adding water to the solution to precipitate crystals of the compound (C) orsalt.

]57[

__________________

170226]21][11[

שיטה ומתק� לשימוש בערו. תנועה לתקשורת של נתוני פיקוח במערכת תקשורת אלחוטית

METHOD AND APPARATUS FORUSING A TRAFFIC CHANNELFOR COMMUNICATIONS OFCONTROL DATA IN A WIRELESSCOMMUNICATION SYSTEM

]54[


18.02.2004]22[US]33[18.02.2003]32[10/368684]31[

Int. Cl.(2010.01) H04L 12//56, H04W 74//06]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

Various methods and apparatus provide for a method and apparatus for acommunication system to efficiently use the traffic channel resources forcommunications of control data. A controller receiving a transmission indicator of acontrol message for transmission from a base station to a mobile station over a trafficchannel. The controller selects a traffic channel dormant timer based on thetransmission indicator. A network entity may send the transmission indicator to thebase station. The transmission indicator of the control message is determined based onat least one of extent of communications and size of data of the control messagebetween the mobile station and the base station. The controller sets up a traffic channelfor transmission of the control message with the selected traffic channel dormanttimer. The traffic channel is torn down after expiration of the selected traffic channeldormant timer.

]57[

__________________

170304]21][11[

מערכת חישוב הערכת ערכי� לא מסודרי� משוערי�

CHAOS THEORETICALEXPONENT VALUECALCULATION SYSTEM

]54[

26.12.2003]22[JP]33[24.02.2003]32[2003-045386]31[

Int. Cl.(2010.01) G06F 17//10]51[ELECTRONIC NAVIGATIONRESEARCH INSTITUTE, JAPANKAKUICHI SHIOMI, JAPANSUSUMU KOBAYASHI, JAPAN

]71[

WO/2004/075074]87[,ר יצחק הס ושותפיו"ד

279רחוב הירקון תל אביב6451.ד.ת,

DR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,P.O.B. 6451,TEL AVIV 61063

]74[


There is provided a chaologic index value calculation system for analyzing a time-series signal by a chaologic method and calculating the chaologic index value. Thesystem includes: means for receiving input of a predetermined parameter; means forreading a time-series signal; means for cutting out a time-series signal for eachprocessing unit x = x (i) from the time-series signal which has been read in; means forcalculating a chaologic index value of the time-series signal which has been read in;and means for outputting the chaologic index value of the time-series signal calculated.The means for calculating the chaologic index value has means for calculating thechaologic index value for the sampling time in the time-series signal of the cut outprocessing unit x = x (i) and means for calculating the chaologic index value of thetime-series signal for a predetermined time by using the chaologic index value for thesampling time.

]57[

__________________

170335]21][11[

–רצפי דילוג תדר עבור מערכות תקשורת רבות פס

FREQUENCY HOP SEQUENCESFOR MULTI-BANDCOMMUNICATION SYSTEMS

]54[

09.02.2004]22[US]33[18.02.2003]32[10/368736]31[

Int. Cl.(2010.01) H04B 01//713, H04J 11//00]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

Techniques to generate FH sequences having excellent correlation properties and touse these FH sequences in multi-band communication systems (e.g., OFDM systems).In one aspect, FH sequences may be generated based on an algebraic expressiony(k) =log&agr; b/k (modp) wherek is an index,p is an odd prime number, &agr; is a primitiveroot of p, b is an integer, and (modp) denotes modulo-p operation. Different FHsequences may be generated with different values forb, &agr;, and/orp. In anotheraspect, data may be transmitted using FH sequences generated based on the expressiony(k) = log&agr; b/k (modp). In a first scheme, data may be transmitted on 'traffic'channels, each of which may be associated with a respective FH sequence thatdetermines the specific subband to use in each slot. In a second scheme, each datatransmission is sent on subbands determined based on all or a portion of an FHsequence.

]57[


__________________

170338]21][11[

AUTOMATED שיטה ממוכנת להתייחסות שונה לפעימת לב METHOD FORDISCRIMINATING THE CARDIACBEAT

]54[

11.03.2004]22[IT ]33[17.03.2003]32[RM2003A000117]31[

Int. Cl.(2010.01) G06F 17//00]51[MATTEO BONAN, ITALYSALVATORE ROMANO, ITALY

]71[




]74[

The invention concerns an automated method for discriminating the cardiac beat, onthe basis of a blood pressure sampled signal, having a starting point Pstart,characterised in that it operates according to a finite state machine for determining atleast the diastolic point Pdia, the systolic point Psys, and the dicrotic point Pdic of thepressure signal, the method being apt to iteratively repeat on subsequent sections of thepressure signal. The present invention further concerns the instruments necessary toperform the automated method and the apparatus performing the same.

]57[

__________________

170519]21][11[


או במלח מתאי� פרמצטית שימוש בפנופיבראט, באורליסטאט ובנשא מתאי� פרצטית, שלו

ותכשירי�, להכנת תרופות לטיפול בהשמנת יתר רפואיי� המכילי� אות�

USE OF FENOFIBRATE ORPHARMACEUTICALLYACCEPTABLE SALT THEREOF,ORLISTAT ANDPHARMACEUTICALLYACCEPTABLE CARRIER IN THEMANUFACTURE OFMEDICAMENTS FOR THETREATMENT OF OBESITY ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHEM

]54[

12.03.2004]22[EP]33[13.03.2003]32[03290625.7]31[

Int. Cl.(2010.01) A61K 31//192, 31//216, 31//223, 45//06, A61P 03//04]51[FOURNIER LABORATORIESIRELAND LIMITED, IRELAND

]71[




]74[

The present invention relates to the use of a fibrate and orlistat to treat patientssuffering from obesity.

]57[

__________________

170574]21][11[

METHOD כוח–שיטה למדידת רגישות גירוסקופ תלוית FOR MEASURINGFORCE-DEPENDENTGYROSCOPE SENSITIVITY

]54[

12.11.2003]22[US]33[17.03.2003]32[10/390200]31[

Int. Cl.(2010.01) G01C 19//56]51[NORTHROP GRUMMANCORPORATION, U.S.A.

]71[



]74[


force-effect model of the effects of acceleration on the output of a gyro triad isdetermined. Rotation sequences are then devised to permit excitation and observationof force-effect model parameters in order to provide calibration information for theseparameters. A state diagram containing the gyro triad force-effect model parameters isderived from the force-effect model, where moving from one position in the statediagram to another position indicates the gyro triad error which would occur inrotating the gyro triad according to a corresponding motion. Searching for all possibleclosed loop paths achievable through the state diagram, by a multiple-axes rate tablewith a specified number of rotations, separates gyro triad error calibration from theaccelerometer calibration. Closed loop paths having minimal lengths and exhibitinglarger error sensitivity are chosen to perform error parameter calibration and reduceforce-dependent gyroscopic sensitivity.

]57[

__________________

170635]21][11[

חלק איוורור ע� מער� מאווררי� במערכות טיפול באוויר

FAN ARRAY FAN SECTION INAIR-HANDLING SYSTEMS

]54[

19.03.2004]22[US]33[20.03.2003]32[60/456413]31[

Int. Cl.(2010.01) F04D 25//00, 25//16, 27//00]51[HUNTAIR, INC., U.S.A.]71[WO/2004/085928]87[

',זליגסון גבריאלי ושות31יבנה' רח



]74[

A fan array fan section in an air-handling system comprising includes a plurality of fanunits (200) arranged in a fan array and positioned within an air-handling compartment(202). One preferred embodiment may include an array controller (300) programmedto operate the plurality of fan units (200) at substantially peak efficiency. The pluralityof fan units (200) may be arranged in a true array configuration, a spaced pattern array

]57[


configuration, a checker board array configuration, rows slightly offset arrayconfiguration, columns slightly offset array configuration, or a staggered arrayconfiguration.



__________________

170730]21][11[

METHOD שיטה ומערכת לגילוי חומרי� מסוכני� AND ARRANGEMENTFOR DETECTING HARMFULSUBSTANCES

]54[

04.03.2004]22[DE]33[07.03.2003]32[10310394.5]31[

Int. Cl.(2010.01) G01N 27//64]51[AIRSENSE ANALYTICS GMBH,GERMANY

]71[

ANDREAS WALTE, WOLFMUNCHMEYER

]72[

WO/2004/079359]87[בי'ג בע, יי אמ ,מ"פקטור אנד קו

הר חוצבים, רחוב המרפא ירושלים45087.ד.ת,

JMB, FACTOR & CO. LTD.,HAR HOTZVIM HI-TECH PARK,P.O.B. 45087,JERUSALEM 91450

]74[

The aim of the invention is to create a method and a device for detecting harmfulsubstances while eliminating or minimizing the drawbacks of an ion mobilityspectrometer (IMS). Said aim is achieved by a method in which the sample gas flow ismixed with a reference gas before reaching the detectors (2, 3, 4, 5, 6) and is directedto several detectors (3, 4, 5, 6) located next to the IMS (2), the obtained test signalsregarding the ratio between the gas flow in the test gas path (8) prior to the meteringprocess and the gas flow of the reference gas are used for calculating the originalconcentration of the harmful substances in the test gas, whereupon an alarm can betriggered by means of predefined and stored test values via a simple comparison of thesignal amplitudes or a pattern recognition. The test system is cleaned and rinsedfollowing the measurement phase by feeding the reference gas, if necessary also anadditional cleansing gas. Such methods and test systems are used for identifyingharmful substances in ambient air.

]57[


__________________

170793]21][11[

COMPOSITIONS ושיטות לאבחנה של סרט� הערמוניתתרכובות AND METHODSFOR DIAGNOSING PROSTATECANCER

]54[

14.03.2004]22[US]33[12.03.2003]32[60/453514]31[US12.03.2003 60/453515 US28.11.200360/525135US05.01.200460/534111

Int. Cl.(2010.01) C07K 16//24, G01N 33//53, 33//574]51[מכון רפפורט המכון למחקר במדעי

ע חיפה,ש משפחת רפפורט"הרפואהRAPPAPORT FAMILY INSTITUTEFOR RESEARCH IN THE MEDICALSCIENCES

]71[

NATHAN נתן קרין KARIN]72[WO/2004/080273]87[

,מ"בע) 1995(ארליך.אי.י'ג11רחוב מנחם בגין,15קומה, איילוןמגדל

רמת גן


]74[

A method of treating prostate cancer is provided. The method comprisingadministering to a subject in need thereof a therapeutically effective amount of anagent capable of reducing activity and/or expression of MCP-1 or of an effectorthereof, thereby treating the prostate cancer in the subject.

]57[




__________________

170963]21][11[

ANTIFUNGAL תכשירי� נגד פטריות לצפוי ציפור� NAIL COATCOMPOSITIONS

]54[

22.03.2004]22[US]33[21.03.2003]32[60/456684]31[

Int. Cl.(2010.01) A61K 08//41, 08//44, 31//445, 47//14]51[NEXMED HOLDINGS, INC., U.S.A.]71[WO/2004/084826]87[




]74[

A dual action antifungal nail coat composition and method of use for ameliorating orpreventing fungal infection of the nails, and onychomycosis, in particular, is disclosed.Composition embodiments in the form of one-coat type and two-coat type suitable fordaily fungicidal regimens are disclosed. A preferred antifungal nail coat compositioncomprises an effective fungicidal amount of antifungal agent, a permeation enhancingamount of a substantially non-volatile, permeation enhancer, a film-forming amount ofa hydrophilic polymer, and a pharmaceutically acceptable, volatile carrier. Thecomposition provides a substantially water-soluble fungicidal coating on contacting afungally susceptible or infected nail.

]57[

__________________

171053]21][11[

מותמרי�(–8–)הלואצטיל(–5תהלי� להכנת אוני�–2–קוינולי�–)1H(–)אוקסי

PROCESS FOR THEPREPARATION OF 5-(HALOACETYL)-8- (SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES

]54[


01.04.2004]22[US]33[02.04.2003]32[60/459724]31[

Int. Cl.(2010.01) C07D 21/5/26]51[NOVARTIS AG, SWITZERLAND]71[WO/2004/087668]87[

,לוצאטו את לוצאטו ומרע, גן תעשייה



]74[

The invention relates to a process for preparing 5-(alpha-haloacetyl)-8-substitutedoxy -)1 H (- quinolin-2-ones. The process involves (i) reacting (a) 8-hydroxy-)1 H (-quinolin-2-one with an acylating agent and a Lewis acid to form 5-acetyl-8-hydroxy-)1 H (- quinolin-2-one; or (b) 8-hydroxy-) lH (- quinolin-2-one with an acylating agent to

form 8-acetoxy-) lH (- quinolin-2-one, and treating, in-situ, the 8-acetoxy-)1 H (-quinolin-2-one with a Lewis acid to form 5-acetyl-8-hydroxy -)1 H (- quinolin-2-one; or(c) 8-acetoxy -)1 H (- quinolin-2-one with a Lewis acid to form 5-acetyl-8-hydroxy-)lH (- quinolin-2-one; (ii) reacting the 5-acetyl-8-hydroxy -)1 H (- quinolin-2-oneprepared in Step (i) with a compound having the Formula RL in the presence of a baseand a solvent to form 5-acetyl-8-substituted oxy -)1 H (- quinolin-2-one, wherein R is aprotecting group and L is a leaving group; and (iii) reacting the 5-acetyl-8-substitutedoxy -)1 H (- quinolin-2-one with a halogenating agent in the presence of a solvent toform a 5-(alpha-haloacetyl)-8-substituted oxy -)1 H (- quinolin-2-one.

]57[

__________________

171056]21][11[

HYBRID קיבוע משולב מעוג� של שבר בפמור הקריבני INTERLOCKINGPROXIMAL FEMORALFRACTURE FIXATION

]54[

23.03.2004]22[US]33[25.03.2003]32[60/457216]31[US05.03.2004 10/794693

Int. Cl.(2010.01) A61B 17//56, 17//64, 17//74]51[ORTHOMEDITEC מגדל העמיק,מ"אורטומדיטק בע LTD.]71[

MARC מרק ויסמן WAISMAN]72[WO/2004/084761]87[

,מ"בע) 1992(גולד פטנטים וייעוץ כלכלי15יוחנן הסנדלר

GOLD PATENTS LTD.,15 YOHANAN HA'SANDLAR ST.

]74[


P.O.B חיפה25267.ד.ת, 25267HAIFA 31251

A novel internal fixation for fixing an intracapsular fracture of a femoral neck using aminimally invasive procedure is provided. The fixation apparatus (Figure 1) includes atubular member (12) having sharp end (16) and a blunt end (18) that is adapted to beimplanted while slightly crossing the fracture line. Three lag screws (20) are adapted topass through passages (56) in the tubular member (12) and extend outwardly beyondthe sharp end (16) while threads (24) in the lag screws (2) allow for compression ofbone fragments. In extracapsular and subtrochanteric fractures, the internal fixationcan be incorporated with external- interlocking apparatus (100) that comprises pinscrews (104) that are adapted to be inserted through bores (58) laterally provided onthe tubular member (12), so as to interlock the tubular member (12), and additional pinscrews (106) that are nailed to a distal bone fragment (102). A connecting member(114) is adapted to secure the pin screws together and allows reduction, correction andfixation in the intra and post-operative period.

]57[

__________________

171224]21][11[

VIBRATORY התק� הפרדה ויברטורי SEPARATOR]54[

02.10.2005]22[Int. Cl.(2010.01) B07B 01//00, 01//28]51[

KROOSH אשדוד,מ"קרוש טכנולוגיות בע TECHNOLOGIES LTD]71[YURI יונה קרוש, יורי אובדון OBODAN, IONA KRUSH]72[

,מ"קרוש טכנולוגיות בע אשדוד12266.ד.ת,

KROOSH TECHNOLOGIES LTD,P.O.BOX 12266ASHDOD 77521

]74[

A dual-mode vibratory screen separator for sizing of particulate material in alternativesingle-frequency or multi-frequency vibration modes, which includes:a vibratable housing connected to a support via set of elastic elements, anda screen assembly, arranged inside said housing, anda source of single frequency vibratory excitation for exciting the separator so as to

]57[


separate particulate material provided thereto, andat least two activating units arranged in excitation conducting association with saidscreen assembly, each of said at least two activating units includes:at least one actuator element arranged beneath said screen assembly for conductingexcitation energy to said screen assembly, andat least a pair of resilient attachment apparatuses for attaching said at least one actuatorelement to said housing,wherein said screen assembly is connected either to said at least one actuator elementby first attachment means providing generation of single-frequency vibration of saidscreen assembly, or, alternatively, said screen assembly is connected to said vibratablehousing by second attachment means providing generation of multifrequency vibrationof said screen assembly in the direction generally normal to the plane of the sievesurface of said screen assembly.

__________________

171291]21][11[

ג ל הומוגני טרמורוורסבילי המכיל'פיל�ולות קפס, תהלי� לייצורו,2–קאראגינא� קאפא

רכות וצורות שנוצרו ממנו

HOMOGENEOUSTHERMOREVERSIBLE GEL FILMCOMPRISING KAPPA-2CARRAGEENAN, PROCESS FORITS MANUFACTURE, SOFTCAPSULES AND SOLID FORMSMADE THEREOF

]54[

14.04.2004]22[US]33[14.04.2003]32[60/462758]31[US14.04.2003 60/462721 US14.04.200360/462617US14.04.200360/462785US14.04.200360/462783US14.04.200360/462794


US14.04.200360/462792US14.04.200360/462793

Int. Cl.(2010.01) A61K 09//00, 09//14, 31//715]51[FMC CORPORATION, U.S.A.]71[WO/2004/091530]87[




]74[

The present invention is directed to a homogeneous, thermoreversible gel filmcomprising a film forming amount of kappa-2 carrageenan, and optionally at least oneof a plasticizer, a second film former, a bulking agent, and a pH controlling agent; andprocesses for the preparation thereof. The present invention is also directed to softcapsules and solid forms containing the gel film, as well as processes for thepreparation thereof.

]57[

__________________

171388]21][11[

תרופה עבור מחלות רטינליות גור� מניעה אור אלקיל או מלחי�'עצביות המכילי� נגזרות את

מזה

PREVENTIVE AGENT ORREMEDY FOR RETINAL NERVEDISEASES CONTAINING ALKYLETHER DERIVATIVES OR SALTSTHEREOF

]54[

15.04.2004]22[JP]33[17.04.2003]32[2003-112539]31[

Int. Cl.(2010.01) A61K 31//397, 31//40, 31//4025, 31//445, 31//4525, 31//4535, A61P09//10, 27//06, C07D 20/5/04, 20/7/14, 21/1/56, 40/5/12

]51[

TOYAMA CHEMICAL CO., LTD.,JAPAN

]71[


279רחוב הירקוןבתל אבי6451.ד.ת,


]74[

An alkyl ether derivative represented by the following general formula [1] or its salt:wherein R1 and R2 represent each a substituent such as hydrogen, halogeno or alkyl; R3

represents alkylamino, amino or hydroxyl; the ring A represents a 5- or 6-memberedaromatic heterocycle or a benzene ring; m and n are each an integer of from 1 to 6; andp is an integer of from 1 to 3; shows an effect of protecting retinal nerve cells and,

]57[


therefore, is useful as a preventive and/or a remedy for retinal nerve diseases such asglaucoma, diabetic retinopathy, retinal artery obstruction, retinal venous obstruction,macular degeneration and retinopathy of prematurity.

__________________

171417]21][11[

, תולדות ניטרואוקסיות של פלוואסטטי�אטורואסטטי�, סריבאסטטי�, פרואסטטי�

ורוסובאסטטי� כגורמי� המפחיתי� כולסטרול קתית אנטי ע� פעילות משופרת אנטי דל תרומבוטית ואנטי טסית ד�

NITROOXY DERIVATIVES OFFLUVASTATIN, PRAVASTATIN,CERIVASTATIN, ATORVASTATINAND ROSUVASTATIN ASCHOLESTEROL-REDUCINGAGENTS WITH IMPROVED ANTI-INFLAMMATORY,ANTITHROMBOTIC ANDANTIPLATELET ACTIVITY

]54[

24.05.2004]22[EP]33[27.05.2003]32[03101530.8]31[

Int. Cl.(2010.01) A61K 31//21, 31//40, 31//404, 31//44, 31//505, A61P 03//06, 07//02,29//00, C07D 20/7/34, 20/7/416, 20/9/12, 20/9/24, 21/3/55, 23/9/42

]51[

NICOX S.A., FRANCE]71[WO/2004/105754]87[

,ינהולד כהן ושותפיורי'א26רחוב הברזל רמת החייל


]74[

Nitrooxyderivatives of fluvastatin, cerivastatin, atorvastatin and rosuvastatin havingimproved pharmacological activity and enhanced tolerability are described. They canbe employed for treating and/or preventing several diseases, in particular coronarysyndromes, neurodegenerative disorders as well as for reducing cholesterol levels.

]57[

__________________

171519]21][11[

COMPOSITIONS תכשירי� להורדה במשקל FOR]54[


AFFECTING WEIGHT LOSS

21.04.2004]22[US]33[29.04.2003]32[60/466838]31[

Int. Cl.(2010.01) A61K 31//135, 31//138, 31//485, 47//48, A61P 03//04]51[OREXIGEN THERAPEUTICS, INC.,U.S.A.

]71[




]74[

Disclosed are compositions for affecting weight loss comprising a first compound anda second compound, where the first compound is an opioid antagonist and the secondcompound causes increased agonism of a melanocortin 3 receptor (MC3-R) or amelanocortin 4 receptor (MC4-R) compared to normal physiological conditions. Alsodisclosed are methods of affecting weight loss, increasing energy expenditure,increasing satiety in an individual, or suppressing the appetite of an individual,comprising identifying an individual in need thereof and treating that individual toantagonize opioid receptor activity and to enhance alpha-MSH activity.

]57[



__________________

171563]21][11[

חלקיקי� מושחלי�)1(תכשיר פרמצבטי המכיל)extruded(המכילי� אופיואיד אנטגוניסט) :2(

)3(–ו; חלקיקי� המכילי� אופיואיד אגוניסטהמטריצות בה החלקיקי� כל אחת משתי

מפוזרי� והשכבה ביניה� מורכבת מחומרי� הידרופוביי� שוני�

PHARMACEUTICAL PRODUCTCOMPRISING (I) EXTRUDEDPARTICLES CONTAINING ANOPIOID ANTAGONIST; (2)PARTICLES CONTAINING ANOPIOID AGONIST; AND (3) EACHOF THE TWO MATRICES INWHICH THE PARTICLES AREDISPERSED AND THE LAYERBETWEEN THEM CONSIST OFDIFFERENT HYDROPHOBICMATERIALS

]54[

19.04.2004]22[US]33[21.04.2003]32[60/464323]31[


Int. Cl.(2010.01) A61K 09//14, 09//20, 09//26, 09//50, 09//52, 09//54, 31//485, 45//06]51[EURO-CELTIQUE S.A.,LUXEMBOURG

]71[




]74[

Disclosed in certain embodiments is a dosage form comprising a plurality of extrudedparticles comprising an adverse agent or antagonist and a layer disposed about theparticles.

]57[

__________________

171825]21][11[

ניהול משאבי� ברשת תקשורת מסוג נקודהלמספר רב של נקודות או מספר של נקודות

ע י שימוש בשתי רמות"למספר רב של נקודות יעד

MANAGEMENT OF RESOURCESIN A POINT-TO-MULTIPOINT-ORMULTIPOINT-TO-MULTIPOINT-TYPE COMMUNICATIONNETWORK, USING TWOALLOCATION LEVELS

]54[

06.05.2004]22[FR]33[13.05.2003]32[03/05722]31[

Int. Cl.(2010.01) H04L 12//28]51[ALCATEL, FRANCE]71[WO/2004/102998]87[



]74[

The invention relates to a point-to-multipoint- or multipoint-to-multipoint-typecommunications network comprising remote traffic stations which are connected to atraffic management centre (CG) by means of resource-sharing radio links. Themanagement centre (CG) comprises management means (13) for determining aprimary resource distribution, including allocation margins, between the different radiolinks which they manage and which have been pre-set between the traffic stations,according to first information data representative of the occupancy rates, by type oftraffic, for the resources previously allocated to said radio links. Each traffic stationcan then determine a secondary distribution, between the different traffic types thereof,of the resources which have been allocated to the radio link thereof by the primary

]57[


distribution, taking account of at least the occupancy rates by type of traffic.

__________________

171868]21][11[

קפיצת תדירות מהירה ע� נווט לחלוקת צופ�OFDMAמולטיפלקס מערכת

FAST FREQUENCY HOPPINGWITH A CODE DIVISIONMULTIPLEXED PILOT IN ANOFDMA SYSTEM

]54[

07.05.2004]22[US]33[12.05.2003]32[60/470107]31[US03.12.2003 10/726944

Int. Cl.(2010.01) H04B 01//707]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

Techniques are provided to support fast frequency hopping with a code divisionmultiplexed (CDM) pilot in a multi-carrier communication system (e.g., an OFDMAsystem) [520]. Each transmitter (e.g., each terminal [420x]) in the system transmits awideband pilot on all subbands to allow a receiver (e.g., a base station) to estimate theentire channel response at the same time. The wideband pilot for each transmitter[420x] may be generated using direct sequence spread spectrum processing and basedon a pseudo-random number (PN) code assigned to that transmitter [420x]. This allowsthe receiver to individually identify and recover multiple wideband pilots transmittedconcurrently by multiple transmitters. For a time division multiplexed (TDM)/CDMpilot transmission scheme, each transmitter transmits the wideband pilot in bursts. For

]57[


a continuous CDM pilot transmission scheme, each transmitter [420x] continuouslytransmits the wideband pilot, albeit at a low transmit power level. Any frequencyhopping rate may be supported without impacting pilot overhead.

__________________

171882]21][11[

FLOODING הצפת מנות מידע בהתק� מיתוג לתקשורת OF DATA PACKETSIN A SWITCHINGTELECOMMUNICATIONDEVICE

]54[

10.11.2005]22[Int. Cl.(2010.01) H04L 12//18, 12//56]51[

בע. איי.סי. אי ECI פתח תקוה,מ"טלקום TELECOM LTD.]71[בע. איי.סי. אי ,מ"טלקום



]74[

A technique is described for flooding data packets in a telecommunication switchingdevice comprising a plurality of interface blades. The technique comprises arranging alogical ring by interconnecting a group of interface blades of the telecommunicationswitching device, wherein the interface blades of the group comprise all leaf ports ofthe telecommunication device. Upon receiving a packet with unknown destination at aparticular interface blade of the logical ring, the packet is forwarded along the logicalring using unicast transmission. At each of the interface blades holding at least oneleaf port, the packet is fed to at least one leaf port of the interface blade. The techniqueboth ensures that the packet will be received at its destination via any of the leaf portsand prevents burst flooding in the telecommunication switching device.

]57[

__________________

172122]21][11[


AIRCRAFT מגודר לעמול מטוסי�קרקע GROUND RUN-UPENCLOSURE

]54[

28.05.2003]22[Int. Cl.(2010.01) B64F 01//26]51[BURNS & MCDONNELLENGINEERING COMPANY, INC.,U.S.A.

]71[

MICHAEL E. ROARK, MARK S.BOE, WERNER HOELMER, JOOPH. M. GOODEN, GEROLD DEVALK, RENE PARCHEN, BARIEBRETTMANN

]72[




]74[

A ground run up enclosure (10) which comprises an air inlet structure (12), a testchamber (14), an acoustic enclosure (16) and a main enclosure door (118). The airinlet structure (12) is adapted to receive ambient air and redirect it into the testchamber (14). The test chamber (14) is designed to receive a portion of an aircraft (20)therein. The acoustic enclosure (16) receives the airflow from the test chamber (14).The airflow continues through the acoustic enclosure (14) until it contacts a frontsurface of the main enclosure door (118) and is redirected upward and out of theenclosure.

]57[

__________________

172180]21][11[

שימוש בלפחות תמצית אחת מצמח מסוגיוצר פיל� אחד אקוואיסטו� ולפחות חומר

להכנת תכשיר מקומי לטיפול באוניכוסכיזיה

USE OF AT LEAST ONE HERBEXTRACT FROM THE GENUSEQUISETUM AND AT LEAST ONEFILM FORMING AGENT FORTHE PREPARATION OF TOPICALCOMPOSITIONS FOR TREATINGONYCHOSCHIZIA

]54[


15.06.2004]22[EP]33[23.06.2003]32[03076934.3]31[

Int. Cl.(2010.01) A61K 08//73, 08//97, 09//70, 36//11, 47//10, 47//36]51[POLICHEM S.A., LUXEMBOURG]71[WO/2004/112814]87[




]74[

The present invention is directed to compositions containing a combination of a herbfrom the genus Equisetum together with one film forming agent and its use as a nailtopical formulation, like nail varnish, cream, gel, lotion or foam. The present inventionis further directed to the use of a water soluble film forming agent as an additive in anail topical formulation. These compositions can be used to treat specific alterations ofthe ungual structure, like reduced strength, onychoschizia and ungual brittleness.

]57[

__________________

172259]21][11[

שיטה, מתיל נוקלאוזיד–C–'2–דהאוקסי–'2 לייצורו ושימושיו

(2'R)-2'-DEOXY-2'-FLUORO-2'-C-METHYL NUCLEOSIDE, AMETHOD OF SYNTHESIZINGTHE NUCLEOSIDE AND USESTHEREOF

]54[

21.04.2004]22[US]33[30.05.2003]32[60/474368]31[

Int. Cl.(2010.01) A61K 09//127, 31//7064, 31//7076, A61P 31//12, C07H 19//06,19//14, 19//16

]51[

PHARMASSET, INC., U.S.A.]71[WO/2005/003147]87[

',בורוכוב קורח ושות מגדל כלל עתידים

אביב-תל58100.ד.ת,

BOROCHOV, KORAKH & CO.,15TH FLOOR, ATIDIM TOWER,KIRYAT ATIDIM,P.O.B. 58100,TEL AVIV 61580

]74[

The disclosed invention provides compositions and methods of treating aFlaviviridaeinfection, including hepatitis C virus, West Nile Virus, yellow fever virus, and arhinovirus infection in a host, including animals, and especially humans, using a (2’R)-2'-deoxy-2'-fluoro-2'-C-methyl nucleosides, or a pharmaceutically acceptable salt or

]57[


prodrug thereof.

__________________

172571]21][11[

מערכת ושיטה לסינכרו� שינויי� של מספר משי� לאובייקט משות משת

METHOD AND SYSTEM FORSYNCHRONIZING MULTIPLEUSER REVISIONS TO A SHAREDOBJECT

]54[

14.12.2005]22[US]33[14.01.2005]32[11/035698]31[

Int. Cl.(2010.01) G06F 12//00, 15//16, 17//00, 17//30, G06Q 10//00]51[MICROSOFT CORPORATION,U.S.A.

]71[



]74[

Many different users may access, revise and update the same shared objectsimultaneously through several different transports. Revisions to the shared object areautomatically synchronized such that all users can view the revisions to the sharedobject. Conficting revisions are reconciled and merged into a current version of theshared object. A client may request the current version of the shared object from astore when the current version of the shared object is not available from the store. Thecurrent version of the shared obect is synchronized with the client when the storereceives the current version of the shared object.

]57[

__________________

172574]21][11[

,ARMOR במיוחד שריו� גו , שריו� ESPECIALLY BODYARMOR

]54[

30.06.2004]22[US]33[01.07.2003]32[10/611512]31[

Int. Cl.(2010.01) F41H 05//04]51[ROBERT L. MULLER JR., U.S.A.]71[WO/2005/047807]87[




]74[

An armor, especially a body armor has at least one layer and preferably a multiplicityof layers (32, 33) of a woven ballistic fabric with titanium beads or disks (34, 35)threaded onto the yarns at the cross overs to serve as projectile shredders. The titaniumbeaded fabric layers (32, 33) may be used in conjunction with other ballistic fabricsand armor designed to catch and trap resultant projectile fragments in a body armor orother type of shield or armor.

]57[

__________________

172619]21][11[

נתר�)A(תכשירי רוקחות המכילי�ו)B(, לבותירוקסי� )C(–צלולוז מיקרוקרסטליי�לטי� שימוש בה� להכנת תרופות'ג–עמיל� פרה

, לטיפול בהפרעות של הורמו� הטירואיד ביונק.ותהלי� להכנת�

PHARMACEUTICALFORMULATIONS COMPRISING(A) LEVOTHYROXINE SODIUM,(B) MICRO CRYSTALLINECELLULOSE, AND (C)PREGELATINISED STARCH, USETHEREOF IN THEMANUFACTURE OFMEDICAMENTS FOR THETREATMENT OF THYROIDHORMONE DISORDERS IN AMAMMAL AND A PROCESS FORPREPARING SAIDPHARMACEUTICALFORMULATIONS

]54[

08.07.2004]22[GB]33[10.07.2003]32[0316206.2]31[

Int. Cl.(2010.01) A61K 09//20, 31//198]51[ASPEN GLOBAL INCORPORATION,MAURITIUS

]71[





]74[

There is provided a stable pharmaceutical formulation comprising (a) an effectiveamount of levothyroxine sodium, (b) microcrystalline cellulose which has a meanparticle size of less than 125µm and is present in an amount of 60 to 85% w/w basedupon the total weight of the formulation, and (c) pregelatinised starch present in anamount of 5 to 30% w/w based upon total weight of the formulation. There is alsoprovided a process for the preparation of such a formulation.

]57[

__________________

172624]21][11[

שיטה לביצוע כתיבת עדכוני� והקצאת זיכרו�תיבת קבצי� על אמצעי זיכרו� המשמשת לכ

צ יפ'בתצורה של כרטיס

METHOD FOR CARRYING OUTUPDATE WRITING ANDALLOCATING A MEMORY USEDFOR FILE WRITING ON AMEMORY CARRIER IN THEFORM OF A CHIP CARD

]54[

15.06.2004]22[FR]33[17.06.2003]32[0307290]31[

Int. Cl.(2010.01) G06F 12//02, G07F 07//10]51[THALES, FRANCE]71[WO/2004/111953]87[




]74[

The carrying out of the invention requires the preallocation of a memory spaces (AOA6) group (DHS) to a card. The number of allocated memory spaces is greater than thenumber of records (E1 E6) of a related file (FHS). The number of extra-allocatedmemory spaces makes it possible to carry out the inventive updating operations.During the updating, only new data (d7) are written on the card without losing old data(d1). For this purpose, new data (d7) are written in the memory spaces (A2) which arefree of old data (d1) of the file. Said memory spaces are selected from the preallocatedmemory spaces. When new data is written, a new descriptor (IHS2) of the file iswritten, thereby making it possible to retrieve the new file records from among theallocated memory spaces. Said invention is advantageously used for cyclic file writing.

]57[


__________________

172730]21][11[

חלקיקי� מובלטי� בהתכה לשחרור מבוקר–רבי המכיל אוקסיקודו�

MELT EXTRUDED CONTROLLEDRELEASE MULTIPARTICULATESCONTAINING OXYCODONE

]54[

23.06.2004]22[GB]33[27.06.2003]32[0315137.0]31[GB12.02.2004 0403102.7 GB16.06.20040413454.0

Int. Cl.(2010.01) A61K 09//00, C07D 48/9/00]51[EURO-CELTIQUE S.A.,LUXEMBOURG

]71[




]74[

Multiparticulates of oxycodone can be made by extrusion of a blend which suitablycontains (a) oxycodone, (b) water-insoluble ammonium methacrylate copolymer, (c)plasticiser, (d) lubricant and (e) water permeability modifier.

]57[

__________________

172739]21][11[

ו טבליות או חומרי/המכילות חומרי טע� ארומה

TABLETS COMPRISINGFLAVOURINGS AND/ORAROMATIZING SUBSTANCES

]54[


14.06.2004]22[DE]33[26.06.2003]32[10328666.7]31[

Int. Cl.(2010.01) A61K 09//20, 31//496]51[BAYER ANIMAL HEALTH GMBH,GERMANY

]71[




]74[

The invention relates to tablets for animals, said tablets containing enrofloxacin andflavouring agents and/or flavours.

]57[

__________________

172749]21][11[

BAG קופסא המכילה שקית IN BOX (BIB)]54[

17.06.2004]22[GB]33[25.06.2003]32[0314815.2]31[

Int. Cl.(2009.01) B65D 77/06]51[JOHN STEPHENSON, UNITEDKINGDOM

]71[




]74[

A bag in box container package (10) has a recessed neck piece (14) - such as a discreteinsert or part-integrated with box or bag - between inner bag liner (12) and outer boxcarton (11), to emulate a (rigid neck) jerrycan; with optional collapse fold, pull-outspout (33) and handle (34).

]57[


__________________

172820]21][11[

SMOKING פילטרי� של פריטי עישו� ARTICLE FILTERS]54[

09.07.2004]22[GB]33[10.07.2003]32[0316171.8]31[

Int. Cl.(2010.01) A24D 03//04, 03//08, 03//12, 03//16]51[BRITISH AMERICAN TOBACCO(INVESTMENTS) LIMITED, UNITEDKINGDOM

]71[




]74[

The invention describes a filter (1) with a first filter portion (6) comprising anadsorbent, for example carbon, and/or a catalyst, capable of reducing various vapourphase constituents of cigarette smoke. The adsorbent/catalyst is separated from asecond filter portion by means of a barrier (2) having pores therein of pore size lessthan 0.1 µm. The invention also describes a smoking article in which a rod of smokingmaterial, with or without encapsulated flavour, is attached to the above described filter.

]57[

__________________

172904]21][11[

IMAGING מערכת לתצפית מעבר למכשול SYSTEM FORVIEWING AROUND ANOBSTRUCTION

]54[

29.12.2005]22[Int. Cl.(2010.01) H04N 07//18]51[

ISRAEL לוד,מ"התעשיה האוירית לישראל בע AEROSPACEINDUSTRIES LTD.

]71[

SHIMON שמעון שמחוני SIMHONY]72[,ריינהולד כהן ושותפיו

'א26רחוב הברזלREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

]74[


RAMAT רמת החייל HACHAYAL 69710

An imaging system for obtaining images of a scene, comprising:(a) an imaging unit comprising a housing containing two or more cameras, eachcamera having a different orientation inside the housing, and further including atransmitter transmitting signals indicative of images obtained by the cameras,(b) a viewing unit comprising(i) a receiver receiving signals transmitted by the transmitter; and(ii) one or more viewing screens displaying images obtained by one or more of thecameras; and(c) a processor configured to:

(a) receive an input indicating a camera having a reference orientation;(b) determine from the input one or more cameras viewing the scene.

]57[

__________________

172930]21][11[

ANTIBALLISTIC בליסטיי� ותהלי�–חומרי� אנטי MATERIALSAND PROCESS

]54[

01.07.2004]22[US]33[01.07.2003]32[60/483630]31[US02.04.2004 60/521336 US05.05.200460/567795

Int. Cl.(2010.01) F41H 05//04]51[ANTIBALLISTIC SECURITY ANDPROTECTION INC., U.S.A.

]71[

WO/2005/043071]87[,פרל כהן צדק לצר



]74[

An antiballistic armored panel (200) comprising at least an interior surface (201), afirst panel (205) adjacent to the interior surface and mounted in a plurality of tracks(203), a first set of AramidFiber sheets (207A) adjacent and attached to the first panel,a second set of Aramid sheets (207B) attached to the first set of Aramid-Fiber sheets, afirst backer board (209) adjacent and attached to the second set of Aramid-Fibersheets, a layer of tiles (211) adjacent and attached to the first backer board, and asecond backer board (213) adjacent and attached to the layer of tiles. A second panel(615) may be attached adjacent to the second backer board along with a layer of forcedentry steel mesh (919) to provide anti-forced entry capability to the antiballistic

]57[


armored panel.



__________________

172997]21][11[

ד�–מתק� ושיטה לביצוע בו , זמני של גילוי סוג בדיקת הרכב סרו� ובדיקה לגילוי נוגד�

DEVICE AND METHOD FORSIMULTANEOUS CARRYINGOUT OF BLOOD GROUPDETERMINATION, SERUMCROSS-CHECK AND ANTIBODYDETECTION TEST

]54[

08.07.2004]22[DE]33[09.07.2003]32[103 30 981.0]31[

Int. Cl.(2010.01) G01N 33//558]51[MEDION DIAGNOSTICS AG,SWITZERLAND

]71[




]74[

The invention relates to a device for the simultaneous qualitative or quantitativedetermination of several analytes in a liquid sample, comprising a membrane (2) with acharging zone (5), for the application of the liquid sample, at least two indicator zoneswhich can interact with the analyte(s) and at least one absorption region (3), whichaccepts the fluid after passing through the indicator zones, whereby the indicator zoneslie between the charging zone (5) and an absorption region (3), characterised in thatthe flow directions (flow tracks) are essentially parallel from the application zone (5)through each indicator zone to an absorption region (3) and at least two different flowtracks are present. The invention further relates to a method for the determination ofseveral analytes or derivatives thereof in a liquid sample, comprising: application ofthe sample to the charging zone (5) of a membrane of the device as given in claims 1to 8, whereby said sample is present in sufficient amounts to permit the sample fluid toflow in the direction of the absorption region (3) through the indicator zones and topermit the analytes or derivatives thereof in the liquid sample to form a complex in theindicator zone.

]57[


__________________

173083]21][11[

שיטה לאבחו� שלמות הנתוני� של מידע על שימוש של תוכנת מחשב

METHOD FOR INDICATING THEINTEGRITY OF USE-INFORMATION OF A COMPUTERPROGRAM

]54[

13.07.2004]22[US]33[14.07.2003]32[10/617756]31[

Int. Cl.(2009.01) G06F 15/00, 19/00]51[ALADDIN תקווה-פתח,מ"אלדין מערכות מידע בע KNOWLEDGE SYSTEMS

LTD.]71[

אסף, רון דר זיו, ינקי מרגלית, דני מרגלית לוי

DANY MARGALIT, YANKIMARGALIT, RON DAR ZIV, ASAFLEVI

]72[




]74[

A method for indicating the integrity of the use-information of a program, comprising:providing a mechanism based on the state of a marker file (being one or more filesdedicated especially for this purpose) for generating upon request an asymmetric (i.e.can be read by a user but cannot be altered by him) and unique or pseudo-uniquevalue; instructing the mechanism to generate a value; sealing the use-information withthe generated value; and indicating the integrity of the sealed data by thecorrespondence of the stored value with the current value returned by the mechanism.In a preferred embodiment of the invention, the information is stored in a securemanner (e.g. encrypted, digitally signed, and so forth). The invention may beimplemented in any licensing model in which the use-information is important, like aTry before you Buy model, renting a program, and so forth.

]57[


__________________

173131]21][11[

ומעכבMGLUR2שילוב של אנטגוניסטACHEחריפות לטיפול בהפרעות עצבי� וכרוניות

USE OF A COMBINATION OFMGLUR 2 ANTAGONIST ANDACHE INHIBITOR IN THEMANUFACTURE OF AMEDICAMENT FORPREVENTING OR TREATINGACUTE AND/OR CHRONICNEUROLOGICAL DISORDERS

]54[

17.07.2004]22[EP]33[25.07.2003]32[03016968.4]31[

Int. Cl.(2010.01) A61K 31//55, 31//551, 31//7068, 45//00, 45//06]51[F. HOFFMANN-LA ROCHE AG,SWITZERLAND

]71[




]74[

The present invention relates to a method of treatment or prevention of acute and/orchronic neurological disorders, to a pharmaceutical composition comprising aninhibitor of acetylcholinesterase (AChE inhibitor) and a metabotropic Glutamatereceptor 2 antagonist (mGluR2 antagonist), to the use of an AChE inhibitor and amGluR2 antagonist in the preparation of a medicament, and. to kits comprising anAChE inhibitor and a mGluR2 antagonist.

]57[

__________________


173145]21][11[

להכנת תרופה לטיפולPAKשימוש של המעכב במחלת פרקי�

USE OF A PAK INHIBITOR FORTHE PRODUCTION OF AMEDICAMENT FOR THETREATMENT OF A JOINTDISEASE

]54[

15.07.2004]22[EP]33[18.07.2003]32[03016303.4]31[

Int. Cl.(2010.01) A61K 38//08, 38//43, A61P 19//02, C07K 16//40, G01N 33//68]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[




]74[

The invention refers to the use of a p21 -activated kinase (PAK) inhibitor for thetreatment of a joint disease such as osteoarthritis or rheumatoid arthritis or for thetreatment of a joint pain and the use of PAK as a target protein for the discovery of aPAK inhibitor as a medicament for the treatment of a joint disease.

]57[



__________________

173191]21][11[

פוליפפטידי� קטורדקטאז ופולינוקלאוטידי� המתייחסי� אליה�

KETOREDUCTASEPOLYPEPTIDES AND RELATEDPOLYNUCLEOTIDES

]54[

11.08.2004]22[US]33[11.08.2003]32[60/494195]31[US18.02.2004 60/545682

Int. Cl.(2010.01) C12N 09//04, 15//52, 15//53, 15//63, C12R 01//72]51[CODEXIS, INC, U.S.A.]71[WO/2005/017135]87[

REINHOLD,הולד כהן ושותפיוריינ COHN AND PARTNERS,]74[




The present invention is directed to variant polypeptides having enhancedketoreductase activity and/or thermostability for use in the stereospecific reduction ofketones. In addition, the present invention is directed to polynucleotides that encodethe ketoreductase polypeptides, including codon optimized versions of thepolynucleotides which provide for enhanced expression in host cells. In another aspect,the present invention is directed to nucleotide constructs, vectors and host cells that aretransformed with polynucleotides of the present invention.

]57[

__________________

173218]21][11[

PROGRAMMABLE ממיר כח הנית� לתכנות POWERCONVERTER

]54[

14.06.2004]22[US]33[18.07.2003]32[10/623060]31[

Int. Cl.(2010.01) H02M 01//10]51[IGO, INC., U.S.A.]71[WO/2005/015721]87[



]74[

A power converter (10) adapted for receiving an AC input signal and a DC input signaland responsive thereto for providing a converted DC signal in which the converted DCsignal has electrical characteristics which are selectable. The converter includes aprogramming circuitry (726) having a programmable memory (715) for storing aselection code, the programming circuitry (726) is cooperable for establishing theelectrical characteristics of the converted DC signal based on the selection code.

]57[


__________________

173258]21][11[

רצ נוקליאוטידי�, חלבוני� בעלי פעילות סיכה המקודד אות� ותכשירי� המכילי� אות�

PROTEINS POSSESSINGLUBRICATING ACTIVITY,NUCLEIC ACID SEQUENCESENCODING THEM ANDCOMPOSITIONS COMPRISINGTHEM

]54[

13.08.2004]22[US]33[14.08.2003]32[60/495741]31[

Int. Cl.(2010.01) A61K 38//00, 38//17, C07K 14//435, 14//475]51[WYETH LLC, U.S.A.]71[WO/2005/016130]87[



]74[

Recombinant lubricin molecules and uses thereof. Novel recombinant lubricinmolecules and their uses as lubricants, anti-adhesive agents and/or intra-articularsupplements for, e.g., synovial joints, meniscus, tendon, peritoneum, pericardium andpleura, are provided.

]57[



__________________

173311]21][11[


ו או בי� פנימית המפחיתה/מערכת מניעה פני� מערכות ושיטות עבור מערכות תקשורת לוויי�

INTRA-AND/OR INTER-SYSTEMINTERFERENCE REDUCINGSYSTEMS AND METHODS FORSATELLITE COMMUNICATIONSSYSTEMS

]54[

16.07.2004]22[US]33[30.07.2003]32[60/490993]31[US14.07.2004 10/890758

Int. Cl.(2010.01) H04B 07//185]51[ATC TECHNOLOGIES, LLC, U.S.A.]71[WO/2005/034361]87[

,ר יצחק הס ושותפיו"ד 279רחוב הירקון



]74[

A first radio signal is receivedvia a first satellite reception path, for example, anantenna or spot beam, which serves a satellite cell. The received first radio signalincludes a desired satellite uplink signal transmitted from a first source using afrequency assigned to the satellite cell and an interfering signal transmitted from asecond source using the frequency assigned to the satellite cell. A second radio signalis receivedvia a second satellite reception path, for example,via another antenna orspot beam of the system and/orvia a satellite antenna beam of another system. Thesecond radio signal includes the interfering signal. The first and second radio signalsare processed to recover the desired satellite uplink signal.

]57[

__________________

173659]21][11[

שיטות ומערכת לבקרת לשידור מידע משתמש תו� שימוש ערוצי תקשורת

METHODS AND APPARATUS OFTRANSMITTING USER DATAUSING TRAFFIC CHANNELS

]54[


13.08.2003]22[Int. Cl.(2010.01) H04W 72//06]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

The invention describes methods and apparatus to structure the air link resources, e.g.traffic channels, into segments of different transmission segment types (516) andeffectively use that novel structure. Different segment types (516) are structured toachieve different performance characteristics. The segments (516) may be alignedwith different offsetting start times chosen to minimize the variation in the maximumnumber of segments (516) starting at any given time slot (530-542). This staggering ofsegment start times minimizes waste in unused assignment messages due to structuralinefficiencies, and has an overall effect of balancing the traffic. Information collectedon the channel quality that various user's are experiencing may be used to classify theusers. Stored information on different segment types (516), each with differentbenefits, is used in the allocation process to effectively match classified users to well-suited segment types to increase performance, balance the system, conserve power,and satisfy the users.

]57[

__________________

173951]21][11[

מרווח עבור חיי. התרסקות לכביש או נתיב רכב–כלי

SPACER FOR ROAD ORMOTORWAY CRASH BARRIER

]54[

25.08.2004]22[IT]33[02.09.2003]32[MI2003A001691]31[

Int. Cl.(2010.01) E01F 15//04]51[PROVINCIA AUTONOMA DI TRENTO,ITALY

]71[




]74[

A new type of spacer (1) for road or motorway crash barrier is described, consisting ofan elastic body (2), fixed by means of bolts (4) or of other known fixing means to thesupporting posts (5) of the crash barrier, which is integral with means (3) forsupporting the longitudinal beam (6) belonging to the crash barrier. Preferably, theelastic body (2) is a rubber body with trapezoidal section and the means (3) forsupporting the longitudinal beam (6) are connected to the rubber body (2) byvulcanisation.

]57[

__________________

173979]21][11[

�תיאו� לביצוע בו זמני במערכת שידור תו שימוש בטייס מגוו� בעל חלוקת זמ�

SYNCHRONIZATION IN ABROADCAST OFDM SYSTEMUSING TIME DIVISIONMULTIPLEXED PILOTS

]54[

01.09.2004]22[US]33[02.09.2003]32[60/499951]31[

Int. Cl.(2010.01) H04J 11//00, H04L 05//06, 27//26]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2005/022797]87[ט ',קולב ושות.סנפורד מרמורק,4שער הגיא



]74[

n an OFDM system, a transmitter (120) broadcasts a first TDM pilot on a first set ofsubbands followed by a second TDM pilot on a second set of subbands in each frame.The subbands in each set are selected from among N total subbands such that (1) an

]57[


OFDM symbol for the first TDM pilot contains at least Sl identical pilot-1 sequencesof length Ll and (2) an OFDM symbol for the second TDM pilot contains at least S2identical pilot-2 sequences of length L2, where L2 > Ll, Sl x Ll = N, and S2 x L2 = N.The transmitter (120) may also broadcast an FDM pilot. A receiver ( 170) processesthe first TDM pilot to obtain frame timing (e.g., by performing correlation betweendifferent pilot-1 sequences) and further processes the second TDM pilot to obtainsymbol timing (e.g., by detecting for the start of a channel impulse response estimatederived from teh second TDM pilot).

__________________

174034]21][11[

SECURITY נרתיק בטיחותי לאקדח ע� ידית נעילה HOLSTER WITHLOCKING LEVER FOR A PISTOL

]54[

09.09.2004]22[US]33[09.09.2003]32[60/501387]31[

Int. Cl.(2010.01) F41C 33//02]51[JOHN N. RASSIAS, U.S.A.]71[WO/2005/033610]87[



]74[

Holster (10) is provided having shroud (20) with top (28), sides (34, 34′), slide bearingstop (22) with hole (24) facing slide guard. Cam slot (44) is provided through shroud(20). Protuberance slots (36, 36)′ are provided in shroud (20) for receiving pistolprotuberance (99). Screw (84) pivotally secures lever (70) to shroud (20). Lever (70)includes lever arm (72) having actuator (74) with bearing (76) and cam arm (78)having guide cam (80) positioned in cam slot (44) into side of shroud (20). A methodfor using holster is provided.

]57[


__________________

174240]21][11[

DIMETHOXY מסס אצטו� דימתוקסי דוקטקסל ושיטה להכנתו DOCETAXELACETONE SOLVATE ANDMETHOD FOR THEPREPARATION THEREOF

]54[

16.09.2004]22[FR]33[19.09.2003]32[0311016]31[

Int. Cl.(2010.01) A61K 31//335, C07D 30/5/14]51[AVENTIS PHARMA S.A., FRANCE]71[WO/2005/028462]87[




]74[

The invention relates to dimethoxy docetaxel acetone solvate or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2α-benzoyloxy-5?,20-epoxy-1-hydroxy-7β,10β-dimethoxy-9-oxo-tax-11-ene-13α-yle and to thepreparation thereof by crystallisation from a hydro-acetone solution.

]57[

__________________

174267]21][11[

METHOD דת פרמטרי� הקשורי� ללבשיטה ומכשיר למדי AND APPARATUS FORMEASURING HEART RELATEDPARAMETERS

]54[


13.09.2004]22[US]33[12.09.2003]32[60/502764]31[US09.10.2003 60/510013 US22.03.200460/555280

Int. Cl.(2010.01) A61B 05//04]51[BODYMEDIA, INC., U.S.A.]71[WO/2005/027720]87[



]74[

A monitor device (300) and associated methodology are disclosed which provide a selfcontained, relatively small and continuously wearable package for the monitoring ofheart related parameters, including ECG. The detection of heart related parameters ispredicated on the location of inequipotential signals located within regions of thehuman body conventionally defined as equivalent for the purpose of detection of heartrelated electrical activity, such as on single limbs. Amplification, filtering andprocessing methods and apparatus are described in conjunction with analytical toolsfor beat detection and display.

]57[

__________________

174501]21][11[

מערכת טלפו� אלחוטי הכוללת שרותי העברתקול בצורה דיגיטלית באינטרנט ושרותי טלפו�

רגילי�

WIRELESS TELEPHONE SYSTEMINCLUDING VOICE OVER IP ANDPOTS

]54[

14.09.2004]22[US]33[23.09.2003]32[10/669578]31[US23.09.2003 10/669314

Int. Cl.(2010.01) H04M 01//725]51[IBM CORPORATION, U.S.A.]71[


WO/2005/029889]87[,קת קנין רוחנימעבדות יבמ מחל

אוניברסיטת חיפה הר הכרמל חיפה

IBM LABORATORIES,HAIFA UNIVERSITY,HAIFA 31905

]74[

A telephone capable of placing or receiving calls over the PSTN or a packet network.The telephone can store multiple telephone numbers for each potential called partyalong with preferences that govern the order of selecting telephone numbers to serviceany given outgoing call. Some or all of the telephone numbers can be associated with apresence service. Presence indicators stored in the telephone are dynamically updatedvia the packet network connection and are used as part of the telephone numberselection algorithm. The preferred embodiment is a wireless system having a basestation and a remote device.

]57[

__________________

174503]21][11[

שיטה לייצור שיכבה אוקסיניטרידית על חומרGeמבוסס

METHOD FOR PRODUCING ANOXYNITRIDE LAYER ON A GE-BASED MATERIAL

]54[

23.09.2004]22[US]33[27.09.2003]32[10/672631]31[

Int. Cl.(2010.01) H01L 21//318]51[IBM CORPORATION, U.S.A.]71[WO/2005/031809]87[

,מעבדות יבמ מחלקת קנין רוחני אוניברסיטת חיפה הר הכרמל

חיפה


]74[

A method for producing thin, below 6nm of equivalent oxide thickness, germaniumoxynitride layer on Ge-based materials for use as gate dielectric is disclosed. Themethod involves a two step process. First, nitrogen is incorporated in a surface layer ofthe Ge-based material. Second, the nitrogen incorporation is followed by an oxidation

]57[


step. The method yields excellent thickness control of high quality gate dielectrics forGe-based field effect devices, such as MOS transistors. Structures of devices havingthe thin germanium oxynitride gate dielectric and processors made with such devicesare disclosed, as well.

__________________

174514]21][11[

איבר מערכת ושיטה לשיחזור תלת מימדי של צינורי

SYSTEM AND METHOD FORTHREE-DIMENSIONALRECONSTRUCTION OF ATUBULAR ORGAN

]54[

24.09.2004]22[US]33[25.09.2003]32[60/505430]31[US29.09.2003 60/506178 US07.06.200460/577981

Int. Cl.(2010.01) G06K 09//00]51[PAIEON INC., U.S.A.]71[

MOSHE משה קליימן KLAIMAN, MICHAELZARKH

]72[

WO/2005/031635]87[,אגמון-סורוקר

14רחוב שנקר, בית נולטון הרצליה פיתוח

SOROKER-AGMON,14 SHENKAR ST.,HERZLIYA PITUAH 46725

]74[

Embodiments of the present invention include methods and systems for three-dimensional reconstruction of a tubular organ (for example, coronary artery) using aplurality of two-dimensional images. Some of the embodiments may includedisplaying a first image of a vascular network, receiving input for identifying on thefirst image a vessel of interest, tracing the edges of the vessel of interest includingeliminating false edges of objects visually adjacent to the vessel of interest,determining substantially precise radius and densitometry values along the vessel,displaying at least a second image of the vascular network, receiving input foridentifying on the second image the vessel of interest, tracing the edges of the vessel of

]57[


interest in the second image, including eliminating false edges of objects visuallyadjacent to the vessel of interest, determining substantially precise radius anddensitometry values along the vessel in the second image, determining a threedimensional reconstruction of the vessel of interest and determining fused area (cross-section) measurements along the vessel and computing and presenting quantitativemeasurements, including, but not limited to, true length, percent narrowing (diameterand area), and the like.

__________________

174528]21][11[

DEFLECTION מערכת הטיית זר� גז בנחיר SYSTEM FOR AGAS STREAM IN A NOZZLE

]54[

23.03.2006]22[FR]33[23.03.2005]32[0502879]31[

Int. Cl.(2010.01) B64C 29//00, F02K 01//28]51[SNECMA, FRANCE]71[




]74[

Deflection system for a gas stream in an exhaust nozzle of a flying craft,comprising injection means for injecting pressurized gas in a given direction intothe gas stream flowing in the nozzle and control means for controlling the gasflow leaving the injection means, wherein the gas injection means comprise fixedstructural housings which extend inside the nozzle perpendicularly to the gasstream flowing in the nozzle and which are fed with deflection gas through one oftheir ends external to the nozzle, said housings containing in their side walls gasinjection slits oriented in given directions relative to the flow direction of the gasstream in the nozzle, and controlled means for the adjustable closure of saidinjection slits.

]57[


__________________

174536]21][11[

, שילוב הכולל קנדסארטא� ורוזוואסטאטי�תכשירי רוקחות המכילי� שילוב כזה ושימוש

בשילוב כזה כתרופה למניעה או לטיפול בטרשת ד�–עורקי� או באירועי לב וכלי

COMBINATION COMPRISINGCANDESARTAN ANDROSUVASTATIN,PHARMACEUTICALCOMPOSITIONS COMPRISINGSUCH COMBINATION AND USEOF SUCH COMBINATION AS AMEDICAMENT FOR THEPREVENTION OR TREATMENTOF ATHEROSCLEROSIS ORCARDIOVASCULAR EVENTS

]54[

22.09.2004]22[GB]33[26.09.2003]32[0322552.1]31[

Int. Cl.(2010.01) A61K 31//4184, 31//505, 45//06]51[ASTRAZENECA UK LIMITED,UNITED KINGDOM

]71[

JAY LAL MEHTA]72[WO/2005/030215]87[

',הורוביץ ושות.ש31רחוב אחד העם


S. HOROWITZ & CO.,31 AHAD HAAM STREETP.O. BOX 2499TEL AVIV 65202

]74[

A combination comprising candesartan and rosuvastatin for the prevention ortreatment of arteriosclerosis and for the prevention of cardiovascular events isdescribed.

]57[

__________________

174594]21][11[

,Th1/Th2המאפייני� את מאז�NKTתאישימושי� ותכשירי� רפואיי� שלה� המשמשי� לטיפול בהפרעות חיסניות

MANIPULATED NKT CELLSMODULATING THE TH1/TH2BALANCE, USES ANDTHERAPEUTIC COMPOSITIONSTHEREOF IN THE TREATMENTOF IMMUNE-RELATED

]54[


DISORDERS

20.09.2004]22[US]33[30.09.2003]32[10/676045]31[

Int. Cl.(2010.01) A61K 09//00, C12N 05//00]51[ENZO THERAPEUTICS, INC., U.S.A.]71[WO/2005/032463]87[




]74[

The present invention relates to a method for the treatment of immune-related orimmune-mediated disorders in a mammalian subject in need of such treatment. Thismethod comprises the step of manipulating the NKT cell population in said subject bysuitable means, said manipulation of the NKT cell population resulting in modulationof the Th1/Th2 balance toward anti-inflammatory cytokine producing cells.Manipulation of the NKT cell population may be performed either by depletion of saidcells by a suitable means or alternatively byex vivo education of the NKT cells, suchthat the educated NKT cells have the capability to modulate the Th1/Th2 balancetoward anti-inflammatory cytokine producing cells. The invention further relates topharmaceutical compositions for the treatment of immune-related or immune-mediateddisorders in a mammalian subject. These compositions comprising as an effectiveingredient anex vivo educated NKT cell. The invention further provides for anex vivoeducated NKT cell and uses thereof in the treatment of immune-related or immune-mediated disorders.

]57[



__________________

174687]21][11[

INKJET תכשיר דיו להזרקה המציג ברק בדרגה נמוכה INK COMPOSITIONEXHIBITING LOW GLOSS

]54[

04.11.2004]22[EP]33[12.11.2003]32[03025903.0]31[

Int. Cl.(2010.01) C09D 11//00]51[SICPA HOLDING S.A.,SWITZERLAND

]71[

WO/2005/049740]87[REINHOLD,ריינהולד כהן ושותפיו COHN AND PARTNERS,]74[




Non-visible ink-jet printing ink composition for marking a substrate, comprising atleast one marking compound absorbing light outside the visible wavelength range ofabout 400 - 700 nm, and which comprises a hydrocarbon compound, having two to sixcarbon atoms carrying two or three hydroxyl groups, as a non-particulate mattingagent, so as to adapt the gloss of the ink-jet printed marking to the gloss of thesubstrate.

]57[

__________________

174937]21][11[

סינתיסייזר דיגיטלי ישיר בעל עוצמה נמוכה ע� שיבו. אנאלוגי

LOW-POWER DIRECT DIGITALSYNTHESIZER WITH ANALOGINTERPOLATION

]54[

14.10.2004]22[US]33[14.10.2003]32[10/684797]31[

Int. Cl.(2010.01) G06F 01//02, 01//08]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

An MN counter with analog interpolation (an 'MNA counter') includes an MN counter,a multiplier, a delay generator, and a current generator. The MN counter receives aninput clock signal and M and N values, accumulates M for each input clock cycleusing a modulo-N accumulator, and provides an accumulator value and a countersignal with the desired frequency. The multiplier multiplies the accumulator value with

]57[


an inverse of M and provides an L-bit control signal. The current generator implementsa current locked loop that provides a reference current for the delay generator. Thedelay generator is implemented with a differential design, receives the counter signaland the L-bit control signal, compares a differential signal generated based on thecounter and control signals, and provides the output clock signal. The leading edges ofthe output clock signal have variable delay determined by the L-bit control signal andthe reference current.

__________________

174939]21][11[

גזרתיי�, שיטות והתק� לשיפור מעברי� פני�רב/ו או פני� תאיי� במערכת תקשורת אלחוטית

נשאית

METHODS AND APPARATUS FORIMPROVING INTER-SECTORAND/OR INTER-CELL HANDOFFSIN A MULTI-CARRIER WIRELESSCOMMUNICATIONS SYSTEM

]54[

15.10.2004]22[US]33[16.10.2003]32[60/511964]31[US14.10.2004 10/964908

Int. Cl.(2010.01) H04B 01//38]51[QUALCOMM INCORPORATED,U.S.A.

]71[




]74[

A wireless communications system, e.g., an OFDM system, uses a plurality of carrierfrequencies each with an associated frequency band. A base station sector transmitterin the system transmits ordinary signaling, e.g., user data, in its own assigned band. Inaddition the sector base station transmitter periodically transmits beacon signals intoits own frequency band and the frequency bands used by adjacent sector transmittersfor their ordinary signaling. Beacon signals, being short duration high power signals

]57[


with sector transmission power concentrated on one or a few tones, are easilydetectable. Each beacon signal may be identified as to the source base station sectortransmitter, e.g., based on tone. A mobile node, tuned to a single carrier band, receivesa plurality of beacon signals, identifies the sources of the received beacons, comparesthe received strength of the beacons, and makes handoff decisions, without having toswitch carrier band.

__________________

175060]21][11[

ראש מתביית, אדומה–גלאי בעל קרינה תתוטיל המונחה מעצמו, המצוייד ע� גלאי כזה

המצויד עמ ראש מתביית כזה

INFRARED RADIATIONDETECTOR, HOMING HEADEQUIPPED WITH SUCH ADETECTOR AND SELF-GUIDEDPROJECTILE EQUIPPED WITHSUCH A HOMING HEAD

]54[

20.04.2006]22[FR]33[22.04.2005]32[0504097]31[

Int. Cl.(2010.01) F42B 15//01]51[SAGEM DEFENSE SECURITE,FRANCE

]71[



]74[

A electromagnetic wave detector which comprises:a housing that defines a vacuum chamber; anda cold finger fastened in a vacuum-tight manner to said housing and comprising aDewar flask extending into said chamber and terminated by a wall on which anelectromagnetic wave sensor is mounted,said housing being made up essentially of three structural parts, which are a mainbody provided with vacuum-tight penetrations for connectors that connecet said sensor

]57[


to an electronic card, external to said housing,a collar for fastening the detector to a support, external to said housing and a coverprovided with an opening located in line with said sensor and closed in a vacuum-tightmanner by a window transparent to the electromagnetic radiation to which said sensoris sensitive,the detector being characterized in that said cold finger and its wall are made only oftitanium or a titanium alloy and said housing is formed only by the assembly of saidthree structural parts made of titanium or a titanium alloy.

__________________

175108]21][11[

AUTOMATED שיטה ומערכת אוטומטית לטיפול באפרוחי� HATCHLINGPROCESSING METHOD ANDSYSTEM

]54[

04.11.2004]22[US]33[06.11.2003]32[10/702370]31[

Int. Cl.(2010.01) A01K 41//00]51[NOVA-TECH ENGINEERING, INC.,U.S.A.

]71[




]74[

Hatchling processing methods and systems are disclosed that provide for theprocessing of hatchlings at a plurality of processing stations (104), with the hatchlingsbeing transferred between stations using an automated conveying system (108). Eachof the hatchlings is retained in a hatchling carrier (106) designed to be conveyed by theautomated conveying system. Each of the hatchling carriers is preferably designed toretain only one hatchling at a time. The systems and methods may also includeidentification tags (107) that may be used to direct the hatchling through theprocessing system with the automated conveying system. The identification tags maybe associated with the hatchlings themselves or they may be associated with thehatchling carriers.

]57[


__________________

175237]21][11[

שיטה, בנזוילגואנידי� פנטאפלואורוסולפניל לייצור� ותרופות המכילות אות�

PENTAFLUOROSULFANYLBENZOYLGUANIDINES,METHOD FOR THEIRPRODUCTION, THEIR USE ASMEDICAMENTS ANDMEDICAMENTS CONTAININGTHE SAME

]54[

03.11.2004]22[DE]33[13.11.2003]32[10353202.1]31[

Int. Cl.(2010.01) A01N 01//02, A61K 31//155, A61P 03//10, 09//00, 25//00, 29//00,33//02, 35//00, 37//06, 43//00, C07C 38/1/00

]51[


]71[

WO/2005/047239]87[,כהן צדק לצרפרל



]74[

The invention relates to pentafluorosulfanyl benzoylguanidines of formula (I), inwhich R1 to R4 are defined as cited in the claims. Said substances are suitable for useas anti-arrhythmic medicaments comprising cardio-protective components for theprophylaxis and treatment of infarcts, in addition to the treatment of angina pectoris.They also preventatively inhibit the pathophysiological events that occur duringischaemically induced traumas, in particular during the triggering of ischaemicallyinduced cardiac arrhythmia.

]57[


__________________

175445]21][11[

מערכת ושיטה לתיארו� שמירת רשומהבמערכת אחסו� מסוג כתוב פע� קרא פעמי�

רבות

SYSTEM AND METHOD FORRECORD RETENTION DATE IN AWRITE ONCE READ MANYSTORAGE SYSTEM

]54[

22.04.2004]22[US]33[03.11.2003]32[10/701373]31[

Int. Cl.(2010.01) G06F 12//00]51[NETWORK APPLIANCE, INC.,U.S.A.

]71[

WILLIAM, P. MCGOVERN,JEFFREY, L. HELLER

]72[

WO/2005/045556]87[,מ"בע) 1995(ארליך.אי.י'ג



]74[

This invention provides a specified retention date within a data set that is lockedagainst deletion or modification within a WORM storage implementation. Thisretention date scheme does not utilize any proprietary application program interfaces(APIs) or protocols, but rather, employs native functionality within conventional file(or other data containers, data sets or block-based logical unit numbers) propertiesavailable in commonly used operating systems. In an illustrative embodiment, theretention date/time is calculated by querying the file's last-modified time prior tocommit, adding the retention period to this value and thereby deriving a retention dateafter which the file can be released from WORM. Prior to commit, the computedretention date is stored in the file's 'last access time' property/attribute field, or anothermetadata field that remains permanently associated with the file and that, in being usedfor retention date, does not interfere with file management in a WORM state. Sincethis field is not utilized in a WORM context, it can be adapted to store this date. Oncestored, the retention date in this field is locked against modification. Where extension(never reduction) of a retention period is desired, the last access time field be updated,wherein the new retention period is added to the existing last access time value toderive a new, later retention date for the file. Upon expiry of the retention date, the

]57[


system allows deletion of the expired WORM file/data set.

__________________

175543]21][11[

הרכבי רוקחות נוזליי� לשחרור מושהה שללהכנת� ומוצר המכיל תהלי�, אינטרלוקיני�

הרכבי� אלו בצורת חלקיקי� תת מיקרוניי�

LIQUID PHARMACEUTICALFORMULATIONS FORPROLONGED RELEASE OFINTERLEUKIN(S), PROCESS FORTHEIR PREPARATION ANDDERIVED PRODUCTCOMPRISING SUBMICRONPARTICLES CONTAINING SUCHFORMULATIONS

]54[

19.11.2004]22[FR]33[21.11.2003]32[0350888]31[

Int. Cl.(2010.01) A61K 09//00, 38//20, 38//21, 47//34, 47//48]51[FLAMEL TECHNOLOGIES,FRANCE

]71[




]74[

The invention relates to novel pharmaceutical formulations based on fluids and stableaqueous colloidal suspensions for the sustained release of an interleukin IL- (and oneor more other optional active principles), and to the applications, particularly thetherapeutic applications, of said formulations. According to the invention, theformulation is a low-viscosity aqueous colloidal suspension of submicronic particles ofwater-soluble, biodegradable polymer PO bearing hydrophobic groups (GH). Theaforementioned particles are noncovalently associated with at least one interleukin(and one or more other optional active principles) and form a gelled deposit on theinjection site, said gelling being caused by a protein present in the physiological

]57[


medium.

__________________

175588]21][11[

התק� ושיטה להעברת מידע בי� המרשמי� לבי� הזיכרו�

DATA PROCESSING APPARATUSAND METHOD FOR MOVINGDATA BETWEEN REGISTERSAND MEMORY

]54[

01.07.2004]22[GB]33[09.12.2003]32[0328538.4]31[

Int. Cl.(2010.01) G06F 09//00, 09//30, 09//312, 09//315, 09//34, 09//345, 09//38,15//76, 15//80

]51[

ARM LIMITED, UNITED KINGDOM]71[WO/2005/057405]87[




]74[

A data processing apparatus and method are provided for moving data betweenregisters and memory. The data processing apparatus comprises a register data storehaving a plurality of registers operable to store data elements. A processor is operableto perform in parallel a data processing operation on multiple data elements occupyingdifferent lanes of parallel processing in at least one of the registers. Access logic isprovided which is responsive to a single access instruction to move a plurality of dataelements between a chosen one of the lanes in specified registers and a structure withinmemory having a structure format, the structure format having a plurality ofcomponents. The single access instruction identifies the number of components in thestructure format, and the access logic is operation to arrange the plurality of dataelements as they are moved such that data elements of different components are storedin different specified registers within the chosen lane whilst in memory the dataelements are stored as the structure.

]57[

__________________


175800]21][11[

שיטה עבור ייצור תרכובת ביסאמידו אלכוהולית אופטית פעילה

METHOD FOR PRODUCINGOPTICALLY ACTIVE BISAMIDOALCOHOL COMPOUND

]54[

21.12.2004]22[JP]33[22.12.2003]32[2003-424579]31[

Int. Cl.(2010.01) C07B 53//00, 61//00, C07C 21/3/00, 21/5/08, 23/1/02, 23/3/56]51[SUMITOMO CHEMICALCOMPANY, LIMITED., JAPAN

]71[


279רחוב הירקון תל אביב6451.ד.ת,


]74[

A method for producing an optically active bisamido alcohol compound representedby the following formula (3): (3) (wherein R1, R2, R3, R4, m and * are as definedbelow) is characterized in that an optically active amino alcohol compound representedby the following formula (1): (1) (wherein R1 represents a C1-6 alkyl group, anoptionally substituted phenyl group, an optionally substituted aralkyl group or ahydrogen atom, or two R1s bonded to a same carbon atom form a ring together withthe carbon atom; R2 represents a C1-6 alkyl group, an optionally substituted phenylgroup, a 1-naphtyl group, a 2-naphtyl group or an optionally substituted aralkyl group;and * represents an asymmetric center) is reacted with a diester compound representedby the following formula (2): (2) (wherein R3 and R4 may be the same or different andrespectively represent a hydrogen atom or a C1-3 alkyl group; R5 represents a C1-3 alkylgroup; and m represents an integer of 0-2) in the presence of a lithium compound.

]57[

__________________

175829]21][11[

SEMI-STATIC טכניקת הפצה סטאטית למחצה DISTRIBUTIONTECHNIQUE

]54[


24.11.2004]22[US]33[24.11.2003]32[10/720364]31[

Int. Cl.(2010.01) G06F 03//06]51[NETWORK APPLIANCE, INC.,U.S.A.

]71[

PETER F. CORBETT, ROBERT M.ENGLISH, STEVEN R. KLEIMAN

]72[

WO/2005/052784]87[,מ"בע) 1995(ארליך.אי.י'ג

מ,15קומה, מגדל איילון 11נחם בגין רחוב רמת גן


]74[

A semi-static distribution technique distributes parity across disks of an array.According to the technique, parity is distributed (assigned) across the disks of the arrayin a manner that maintains a fixed pattern of parity blocks among the stripes of thedisks. When one or more disks are added to the array, the semi-static techniqueredistributes parity in a way that does not require recalculation of parity or moving ofany data blocks. Notably, the parity information is not actually moved; the techniquemerely involves a change in the assignment (or reservation) for some of the parityblocks of each pre-existing disk to the newly added disk.

]57[

__________________

175939]21][11[

פרוטוקול אתחול ישיבה המבוסס על אתחול הנדאופ של משתמש

SESSION INITIATIONPROTOCOL (SIP) BASED USERINITIATED HANDOFF

]54[

30.11.2004]22[US]33[01.12.2003]32[60/526135]31[

Int. Cl.(2010.01) H04L 29//06, H04W 28//02, 28//16, 36//00, 76//00, 80//00]51[


INTERDIGITAL TECHNOLOGYCORPORATION, U.S.A.

]71[


'א26ב הברזל רחו רמת החייל


]74[

Method and apparatus for providing a solution to the handoff problem includes ahandoff is triggered by the WLAN network 14 assuming that there is a real timesession between PC 12 and a called party, shown at S1. WLAND network 14communicates with IP network 18, shown at S2, the IP network 18 provides the two-way communication between the PC 12 and service server 22, shown at S3. Both theuser PC 12 and UE 32 establish a connection with the network 23 at S4-S6. The userthen decides to trigger a handoff from PC 12 to the UE 32 at S7 and communicates thishandoff request to the WLAN network 14, which transmits an SIP message through IPnetwork 18 to service server 22. Service server 22 transmits an SIP 200 (OK) messageto acknowledge the handoff (HO) message.

]57[

__________________

176144]21][11[

COMMUNICATION ותוכנית מסו תקשורת TERMINALAND PROGRAM

]54[

22.12.2004]22[JP]33[26.12.2003]32[2003-435420]31[

Int. Cl.(2010.01) G06F 09//46, 09//54, H04M 01//00, 11//00, H04W 88//00, 88//02]51[NTT DOCOMO, INC., JAPANAPLIX CORPORATION, JAPAN

]71[




]74[


A communication terminal, in which an OS (operating system) does not manage anyapplication being activated, receives a message without establishing anycommunication connection, and notifies, when receiving a message addressed to anapplication being activated, the receipt thereof. In a mobile station (MS), a CPU (6)uses an OS software (82) and a JAM program (86) both stored in a nonvolatilememory (8) to write, into a key information area (73) of a RAM (7), key informationused for determining a Java application being activated by use of a KVM program(84). Upon receipt of an SMS message, the CPU (6) writes, into an area of the RAM(7) allocated to the Java application being activated, information indicative of receiptof that message when the content of that message is coincident with the keyinformation in the key information area (73).

]57[

__________________

176231]21][11[

MODULATOR מאפנ� ושיטה ליצירת אות מאופנ� AND METHODFOR PRODUCING AMODULATED SIGNAL

]54[

11.06.2006]22[US]33[14.06.2005]32[60/690138]31[

Int. Cl.(2010.01) H03C 03//00, 03//09, H04L 27//10]51[בע'גיוון אימג GIVEN יקנעם,מ"ינג IMAGING LTD.]71[IDO עידו בטש BETTESH]72[




]74[

An in-vivo sensing device comprising a modulator for producing a modulated signal,the modulator comprising:a direct modulation synthesizer circuit;a reference frequency oscillator for providing an input reference signal to the directmodulation synthesizer circuit for locking a carrier frequency to a stable frequency;anda pre-emphasis unit for receiving data bits and for producing a modulating signal fordirect modulation of the direct modulation synthesizer circuit, the modulating signalhaving data bit dependent voltage levels;characterized in that the pre-emphasis unit is a digital-to-analog converter and whereineach voltage level of the modulating signal is a function of the bit values of a givendata bit and of at least one data bit preceding the given data bit.

]57[


__________________

176321]21][11[

PROCESS תהלי� ידידותי לסביבה לסינתיזה של ברומובנז� FOR ECO-FRIENDLYSYNTHESIS OFBROMOBENZENE

]54[

15.12.2003]22[Int. Cl.(2010.01) C07C 17//12]51[COUNCIL OF SCIENTIFIC ANDINDUSTRIAL RESEARCH, INDIA

]71[




]74[

A new eco-friendly process is described in the present invention for the preparation ofbromobenzene through substitution of one of the C-H proton of benzene ring with ahighly reactive hypobromous acid generatedin situ, said process comprises the stepsof activating a water soluble, easy to handle, brominating reagent with a mineral acidat elevated temperature and atmospheric pressure to generate active bromine specieswhich in turn reacts with benzene.

]57[

__________________

176393]21][11[

PATTERNED טיפול תבניתי בלייזר של הרישתית LASERTREATMENT OF THE RETINA

]54[

02.12.2004]22[US]33[24.12.2003]32[10/745954]31[

Int. Cl.(2010.01) A61B 03//14]51[THE BOARD OF TRUSTEES OF THELELAND STANFORD JUNIORUNIVERSITY, U.S.A.

]71[

WO/2005/065116]87[,WOLFF,ברגמן וגולר, וולף BREGMAN AND GOLLER,]74[


.P.O.B ירושלים1352.ד.ת, 1352,JERUSALEM 91013

Patterned laser treatment of the retina is provided. A visible alignment pattern havingat least two separated spots is projected onto the retina. By triggering a. lasersubsystem, doses of laser energy are automatically provided to at least two treatmentlocations coincident. with the alignment spots. All of the doses of laser energy may bedelivered in less than about (1) second, which is a typical eye fixation time. A scannercan be used to sequentially move an alignment beam from spot to spot on the retinaand to move a treatment laser beam from location to location on the retina.

]57[

__________________

176394]21][11[

שדה הנית� לשינוי מערכת מקלט תדר רדיו בעל תצורה

FIELD CONFIGURABLE RADIOFREQUENCY RECEIVER SYSTEM

]54[

03.11.1998]22[US]33[03.11.1997]32[60/064097]31[US03.11.1997 60/064098 US03.11.199760/064132

Int. Cl.(2010.01) H03M 13//25, 13//41, H04B 01//24, 01//40, H04L 01//00, 25//497,27//18, 27//34

]51[

DIVISION FROM 135874]62[HARRIS CORPORATION, U.S.A.]71[WO/1999/023760]87[



]74[

A field system for providing a field configurable radio frequency receiver systemincluding a digital signal processing therefor. The digital processor receives thedemodulated signals in order to efficiently decode the treillis encoded modulatedsignals, which are received as part of the radio frequency carrier signals.

]57[


__________________

176435]21][11[

חומרי� הפולטי� הבזקי אור כשפוגעת בה� וני�קרינה רדיואקטיבית לגילוי נויטר

NEUTRON SCINTILLATINGMATERIALS

]54[

10.01.2005]22[EP]33[09.01.2004]32[04290068.8]31[

Int. Cl.(2010.01) C09K 11//85, G01T 01//20]51[STICHTING VOOR DETECHNISCHE WETENSCHAPPEN,THE NETHERLANDSUNIVERSITE DE BERNE,SWITZERLAND

]71[




]74[

The invention pertains to a neutron detector comprising a scintillating material of thegeneric formula Cs(2-z)RbZLiLn(1-X)X6 : xCe3+, where X is either Br or I, Ln is Y orGd or Lu or Sc or La, where z is greater or equal to 0 and less or equal to 2, and x isabove 0.0005, generally under the form of monocristal. The scintillating material has aremarkably low decay time.

]57[

__________________

176463]21][11[


פלט של מידע המשתמשת/שיטה לקלט במארג נקודות

INFORMATION INPUT ANDOUTPUT METHOD USING DOTPATTERN

]54[

24.12.2004]22[JP]33[25.12.2003]32[PCT/JP03/16763]31[

Int. Cl.(2010.01) G06K 07//10]51[KENJI YOSHIDA, JAPAN]71[WO/2005/064523]87[



]74[

There is provided a dot pattern in which an x-direction shift and a y-direction shift arealternately generated for each adjacent information dot on a virtual grating line, so thatthe x-direction shift and the y-direction shift are alternately generated for each dot.Accordingly, every other information dots are arranged on the same grating line. Forthis, when reading by an optical read device, the search algorithm for the virtualgrating line on the image memory is simplified, which in turn simplifies the search ofthe grating point on the image memory. As a result, it is possible to increase the dotpattern read speed without using a complicated program.

]57[

__________________

176651]21][11[

GASTROINTESTINAL התק� בדרכי העיכול DEVICE]54[

02.01.2005]22[US]33[02.01.2004]32[60/534196]31[

Int. Cl.(2010.01) A61F 02//00]51[ אביב-תל, יחיאל זיו

אביב-תל, אבינעם נבלרYEHIEL ZIVAVINOAM NEVLER

]71[

WO/2005/065575]87[DEKEL,מ"דקל פטנט בע PATENT LTD.,]74[


27חדר,18מנוחה ונחלה רחובות

18 MENUHA VENAHALA ST.,REHOVOT 76209

A gastrointestinal device including a casing including fixation elements adapted forintraluminal fixation of the device in a gastrointestinal tract (e.g., the anorectal wall), avalve disposed in the casing and controllable to move from a closed position, whichsignificantly restricts passage of gastrointestinal (e.g., fecal) matter therepast, and anopen position, which permits passage of gastrointestinal matter therepast, and acontroller operatively connected to the valve for externally controlling the position ofthe valve between the closed and open positions.

]57[

__________________

176696]21][11[

INTERVERTEBRAL פרוטזת דיסק בי� חוליתית DISCPROSTHESIS

]54[

04.02.2005]22[FR]33[04.02.2004]32[04/01024]31[

Int. Cl.(2010.01) A61F 02//44, 02//46]51[LDR MEDICAL, FRANCE]71[ISTVAN HOVORKA, PIERREBERNARD

]72[

WO/2005/074839]87[בע"ד ,מ"ר מרק פרידמן

ז,54.ק, מגדל משה אביב 7בוטינסקי'רחגן-רמת

DR. MARK FRIEDMAN LTD.,MOSHE AVIV TOWER, 54THFLOOR,7 JABOTINSKY ST.,RAMAT GAN 52520

]74[

The present invention relates to an intervertebral disc prosthesis comprising at leastthree pieces including an upper plate (1), a lower plate (2) and a mobile core (3) atleast relative to the lower plate, the upper surface of the core being in contact with atleast a part of the lower surface of the upper plate, cooperation means (22, 31) limiting

]57[


or preventing the movements of the core relative to the lower plate, in translation andin rotation, respectively, along an axis substantially parallel to the lower plate andabout an axis substantially perpendicular to the lower plate , characterised in that atleast the lower surface of the core has at least one hole (41) facilitating sliding of thecore relative to the upper surface of the lower plate with which it is in contact.

__________________

176782]21][11[

תכשירי� תרמופלסטיי� לעיצוב והשימוש בה�

THERMOPLASTIC MOULDINGCOMPOSITIONS AND USESTHEREOF

]54[

02.02.2005]22[DE]33[04.02.2004]32[102004005657.9]31[

Int. Cl.(2010.01) C08L 67//00]51[BASF SE, GERMANY]71[WO/2005/075563]87[



]74[

The invention relates to thermoplastic moulding masses, containing A) 10 to 99.99 wt.% of at least one thermoplastic polyester, B) 0.01 to 50 wt. % of a highly- orhyperbranched polyester of the type AxBy, whereby x represents at least 1.1 and y atleast 2.1 and C) 0 to 60 wt. % of other additives, the sum of the weight percentages ofthe constituents A) to C) being equal to 100 %.

]57[

__________________


176785]21][11[

תכשירי� תרמופלסטיי� לעיצוב והשימוש בה�

THERMOPLASTIC MOLDINGCOMPOSITIONS AND USESTHEREOF

]54[

02.02.2005]22[DE]33[04.02.2004]32[102004005652.8]31[

Int. Cl.(2010.01) C08L 67//02]51[BASF SE, GERMANY]71[WO/2005/075565]87[



]74[

The invention relates to thermoplastic moulding masses, containing A) 10 to 99.99 wt.% of at least one thermoplastic polyester, B) 0.01 to 50 wt. % of a hyperbranchedpolycarbonate, having a hydroxyl number of 1 to 600 mg KOH/g polycarbonate(according to DIN 53240, part 2) and C) 0 to 60 wt. % of other additives, the sum ofthe weight percentages of the constituents A) to C) being equal to 100 %.

]57[

__________________

176970]21][11[

שיטה ומערכת לבחינת שט אוויר בצינור נשימתי

METHOD AND SYSTEM FORANALYSING RESPIRATORYTRACT AIR FLOW

]54[

06.02.2005]22[US]33[04.02.2004]32[10/771139]31[

Int. Cl.(2010.01) A61B 05//087, 07//00]51[DEEPBREEZE אור עיקבא,מ"דיפבריז בע LTD]71[


'א26רחוב הברזלילרמת החי


]74[

A method for determining airflow in a portion of a respiratory tract comprisingdetermining a total acoustic energy in a region of a body surface overlying the portionof the respiratory tract. The airflow may be integrated over a time interval in order todetermine an air volume that has flowed in the portion of the respiratory tract during

]57[


the time interval. A graph of the flow rate as a function of the volume may bedisplayed and analyzed as in spirometry. The invention also provides a system (100)for carrying out the method.

__________________

177074]21][11[

SOLID מוצק לליקוט תמונההתק� במצב STATE IMAGE PICKUPDEVICE

]54[

21.01.2005]22[JP]33[26.01.2004]32[2004-017423]31[

Int. Cl.(2010.01) H04N 05//335]51[HAMAMATSU PHOTONICS K.K.,JAPAN

]71[

SEIICHIRO MIZUNO, YASUHIROSUZUKI, MASAKI MIZOGUCHI

]72[




]74[

A solid state image pickup device, when applied as one element of a solid state imagepickup device array, allows a non-sensitive area between itself and each of adjacentdevices to be reduced in size, thereby providing a more precise image pickup result.The solid state image pickup device comprises a light detection part, an output part, arow selection part and a column selection part, and further comprises M waveformshaping circuits as waveform shaping means for shaping the waveform of a rowselection signal. A row selection signal outputted from the row selection part is shapedin waveform by the waveform shaping circuit and thereafter inputted to N pixelsconstituting the m-th row of the light detection part.

]57[


__________________

177104]21][11[

לטיפול בסרט�CCX–CKR2גורמי� הקושרי�.ולריפוי של פצעי�, ודלקת פרקי�

CCX-CKR2 BINDING AGENTSFOR TREATMENT OF CANCERAND ARTHRITIS AND FORWOUND HEALING

]54[

02.02.2005]22[US]33[03.02.2004]32[60/541849]31[US04.08.2004 60/598958 US08.11.200460/626195

Int. Cl.(2010.01) A61K 38//17, 38//19, 39//395, C07K 16//28]51[CHEMOCENTRYX, INC., U.S.A.]71[WO/2005/074645]87[




]74[

The present invention provides method and compositions for modulating angiogenesis]57[

__________________


177333]21][11[

מסילה קבועה עבור כלי רכב מסילתי ושיטה ליצורה

FIXED CARRIAGEWAY FOR RAILVEHICLES AND METHOD OFMANUFACTURING THE SAME

]54[

15.02.2006]22[DE]33[19.04.2005]32[102005018195.3]31[

Int. Cl.(2010.01) E01B 01//00, 21//02]51[RAIL. ONE GMBH, GERMANY]71[WO/2006/111113]87[




]74[

Disclosed is a solid railway for track vehicles, comprising ties embedded in a railwayplate and a reinforcement that encompasses several longitudinal and transversal ironmembers which are disposed parallel and perpendicular to the ties in the railway plate.The longitudinal iron members (11, 12, 13) and the transversal iron members (10) areelectrically insulated from each other.

]57[

__________________

177505]21][11[

תהלי� להכנת חומרי ביניי� עבור תרכובות רצפטור אנדותילבעלות פעילות כנגד

PROCESS FOR PREPARINGINTERMEDIATES FORCOMPOUNDS WHICH POSSESSENDOTHELIN RECEPTORANTAGONIST ACTIVITY

]54[

17.02.2005]22[


GB]33[20.02.2004]32[0403744.6]31[Int. Cl.(2010.01) C07D 40/1/14, 41/3/14, C07F 05//02]51[ASTRAZENECA AB, SWEDEN]71[PHILIP JOHN HOGAN, MARGARETANNE BUTLIN, ANDREAS MEUDT,ROGER JOHN BUTLIN

]72[

WO/2005/080403]87[',הורוביץ ושות.ש

31רחוב אחד העם תל אביב2499.ד.ת,

S. HOROWITZ & CO.,31 AHAD HAAM STREETP.O. BOX 2499TEL AVIV 65202

]74[

Process for preparing compounds of Formula (I); and (IV); are described.]57[



__________________

177511]21][11[

4CXCRPROCESSתהלי� להכנת אנטגוניסט FOR THE SYNTHESISOF A CXCR4 ANTAGONIST

]54[

11.03.2005]22[US]33[15.03.2004]32[60/553589]31[

Int. Cl.(2010.01) A61K 31//4709, C07D 21/5/38]51[ANORMED CORPORATION,CANADA

]71[




]74[

This invention relates to a process for synthesizing heterocyclic pharmaceuticalcompound which binds to the CXCR4 chemokine receptor. In one embodiment, theprocess comprises: a) reacting a 5,6,7,8-tetrahydroquinolinylamine and an alkyl

]57[


aldehyde bearing a phthalimide or a di-tertiary-butoxycarbonyl (di-BOC) protectinggroup to form an imine; b) reducing the imine to form a secondary amine; c) reactingthe secondary amine with a haloalkyl substituted heterocyclic compound, to form aphthalimido-protected or di-tert-butoxycarbonyl protected tertiary amine; and d)hydrolyzing the protected amine to obtain a compound having Formula (I’).

__________________

177519]21][11[

ר IDENTIFICATION פואימערכת להכרת מידע מזוהה עבור התק� INFORMATIONRECOGNITION SYSTEM FOR AMEDICAL DEVICE

]54[

19.04.2005]22[US]33[27.05.2004]32[10/855872]31[

Int. Cl.(2010.01) A61M 05//14, 39//00, 39//28]51[BAXTER INTERNATIONAL INC.,U.S.A.

]71[

WO/2005/118027]87[,יינהולד כהן ושותפיור



]74[

A medical delivery system (10) is provided for delivering a medicament (17) or fluid(17) to a patient. The system comprises a disposable element such as a line set (14)associated with a container (16) containing the fluid (17), an identifier (18) associatedwith the line set (14) and having identification information associated therewith, and adelivery device (12) configured to engage the line set (14) and deliver the fluid (17) tothe patient. The delivery device (12) includes a recognition system (20) that is capableof obtaining the identification information associated with the identifier (18). Theidentification information may include information regarding the identification of thefluid (17), a type of line set (14), or a type of administration associated with the line set(14). The device (12) can be capable of configuration based on the identificationinformation.

]57[


__________________

177562]21][11[

HIDDEN מתק� ניקוי רקטלי מוחבא ובידה RECTAL CLEANINGAPPARATUS AND BIDET

]54[

31.03.2004]22[Int. Cl.(2010.01) A61H 35//00, E03D 09//08]51[ECZACIBASI YAPI GERECLERISANAYI VE TICARET A.S.,TURKEY

]71[




]74[

In a hidden rectal cleaning apparatus (A) or a bidet (B) that operates by the pressure ofthe washing water and spring force, there are one empty cylindrical lower body (15)and linked to this, one empty cylindrical upper body (2); within the lower body (15)there is a rectal cleaning pipe (16) and/or bidet pipe (39),which moves forward by thewater pressure and is activated for washing. There is also spring (6) or bidet pressurespring (40) which helps the rectal cleaning pipe (16) or bidet pipe (39) to returnpassive mode by reversing backward following the washing operation. In addition tothose, rectal cleaning apparatus (A) or bidet (B); includes one seal ring (5), onemovable stopper (3), one o-ring (10), one gasket (18) and one or more exit nozzles(20) linked to the cleaning pipe (16) or one or more bidet exit nozzles (19) linked tothe bidet pipe (39).

]57[


__________________

177676]21][11[

VERSATILE יתיתכל–אטנואטור רב ATTENUATOR]54[

29.07.2005]22[US]33[02.08.2004]32[10/909569]31[

Int. Cl.(2010.01) H03M 01//18]51[RAYTHEON COMPANY, U.S.A.]71[WO/2006/017378]87[




]74[

A versatile attenuator (10, 20). The versatile attenuator (10, 20) includes a firstmechanism (16, 18, 22) for receiving an input signal. A second mechanism (24, 26,30) measures the input signal and provides a signal-level indication in responsethereto. A third mechanism (36) selectively attenuates the input signal when the signal-level indication surpasses a predetermined threshold and provides an attenuated signalin response thereto. In a more specific embodiment, the third mechanism (36) furtherprovides attenuation information. An additional mechanism (14, 38) then employs theattenuation information and a computer (14) to selectively adjust an output signal of acircuit (48, 52) connected between the third mechanism (36) and the computer (14) toaccommodate effects that attenuation of the input signal by the third mechanism (36)has on the output signal.

]57[


__________________

177690]21][11[

דו, שיטה והתק� להדמייה –בעיקר של חפ. מימדי

METHOD AND ARRANGEMENTFOR IMAGING A PRIMARILYTWO-DIMENSIONAL TARGET

]54[

03.03.2005]22[HU]33[05.03.2004]32[P0400533]31[

Int. Cl.(2010.01) H04N 01//195]51[ZOLTAN HORVATH, HUNGARYTIBOR VIRAG, HUNGARY

]71[




]74[

To imaging a two-dimensional target (T) and ensuring primarily scanning,photography and digitalization of the whole surface of book-pages in a way that theexpensive or museum piece book needs to be opened at a relatively little angle ofslightly exceeding 45°, a method is proposed comprising the steps of matching at leastone optical unit adapted for influencing the direction of rays of light falling onto itwith the target (T), illuminating the target (T) while directing an optical recordingmeans to the optical unit and turning away the optical recording means and displacingin a receding manner from the plane of the target (T) at a predetermined angle alpha ina curved course compared to the optical axis (OA) originating from the centre of thetarget (T) while tilting a mirror (M) half to the extent of said displacement - i.e. withan angle alpha/2 - of the optical recording means, and mapping the pixels of the target(T) reaching the optical recording means through the optical unit by projecting the raysoriginating from the pixels of the target (T) at right angles to the target (T) through theoptical unit to sensor means of the optical recording means in the whole range of theoptical angle of the optical recording means.

]57[


__________________

177748]21][11[

שיטה ומתק� עבור מאפיי� ממוש� של בקרת איכות של עיצוב זיכרו� של נת� חוט מתכת

METHOD AND APPARATUS FORTHE CONTINUOUS QUALITYCONTROL OF A SHAPEMEMORY ALLOY WIRE

]54[

28.04.2005]22[IT]33[29.04.2004]32[MI2004A

000864]31[

Int. Cl.(2010.01) G01N 25//16]51[SAES GETTERS S.P.A., ITALY]71[WO/2005/106441]87[

,ר יצחק הס ושותפיו"ד 279רחוב הירקון



]74[

A method for the continuous quality control of a wire of shape memory alloycomprises: a) supplying the wire through a plurality of controlled temperature areassuitable for reproducing a temperature profile encompassing the characteristictransition temperatures of the material the wire is made of; b) measuring the elongationof the wire at each area at controlled temperature; c) using the data of temperature andelongation to obtain by points the hysteresis curve of the material in the temperature-elongation diagram. Preferably the wire is supplied at a known velocity and with aconstant tension, and the measurement of the elongation is obtained by measuring thevelocity of the wire. An apparatus carrying out the method comprises supplying units(B, B', V, V') suitable for adjusting the tension and the supplying velocity of the wire(F) through a series of thermostatic chambers (T) containing idle pulleys (M) whereonthe wire (F} is wound without sliding, whose rotational velocity can be measuredfor example by high-definition encoders.

]57[


__________________

177796]21][11[

KEY-BASED הצפנה מבוססת מפתח ENCRYPTION]54[

01.03.2005]22[GB]33[09.03.2004]32[0405245.2]31[

Int. Cl.(2010.01) H04L 29//06]51[IBM CORPORATION, U.S.A.]71[WO/2005/086452]87[

,מעבדות יבמ מחלקת קנין רוחני אוניברסיטת חיפה הר הכרמל

חיפה


]74[

There is disclosed a method, apparatus, computer program and computer programproduct for facilitating secure data communications. The secure data communicationsis carried out using a secret key for encrypting data flowing between first and secondentities over a communications link. First it is determined that the communicationslink has been idle. Once it is determined that there is now data to flow over thepreviously idle communications link, the generation of a new secret key is initiated.This new secret key is then used for encrypting data sent between the first and thesecond entities over the communications link.

]57[

__________________

177820]21][11[


SYSTEM כת ושיטה לסיוע בשידורי רשת לרשתמער AND METHOD FORFACILITATING NETWORK-TO-NETWORK TRANSITIONS

]54[

10.03.2005]22[US]33[26.04.2004]32[10/831847]31[

Int. Cl.(2010.01) H04Q 09//00]51[MOTOROLA, INC., U.S.A.]71[WO/2005/109912]87[

,ינהולד כהן ושותפיורי'א26רחוב הברזל רמת החייל


]74[

A system and method for facilitating network-to-network transitions of mobile stationscomprising includes at least one access point (204). At least one receiver (202, 224 or230) is coupled to the at least one access point. The at least one receiver (202, 224 or230) determines information concerning a wide area network and provides theinformation to the access point (204). The access point (204) conveys the informationto at least one mobile station (206).

]57[

__________________

177919]21][11[

SYSTEM מערכת ושיטה לבחירת מצב שדה הראיה והתק� AND METHOD FORSELECTING A VIEW MODE ANDSETTING

]54[

30.07.2004]22[US]33[30.04.2004]32[10/837069]31[

Int. Cl.(2010.01) G09G 05//00]51[MICROSOFT CORPORATION,U.S.A.

]71[

WO/2005/111985]87[




]74[

A method and apparatus for selecting a view mode from a plurality of view modes andfor selecting a setting within the selected view mode for displaying one or more itemsin a screen display. A single user input indicates both a selected view mode and aselected setting within that view mode. The input mechanism can be a hardwaredevice, such as a keyboard or mouse, or a software control presented in a graphicaluser interface. The software view control may include a setting range displayindicating a plurality of available settings, a view mode range display indicating aplurality of available view modes corresponding to the plurality of available settings,and a user selection component.

]57[

__________________

178268]21][11[

CEMENTED קרבידי� מודבקי� CARBIDES]54[

05.10.2005]22[JP]33[19.10.2004]32[2004-304944]31[

Int. Cl.(2010.01) B23B 27//14]51[SUMITOMO ELECTRICINDUSTRIES, LTD., JAPANSUMITOMO ELECTRICHARDMETAL CORP., JAPAN

]71[

KAZUHIRO HIROSE, EIJIYAMAMOTO

]72[




]74[

Cemented carbides which include WC having an average particle diameter of 0.3µmor less as a hard phase and 5.5 to 15 mass % of at least one iron group metal elementas a binding phase, and comprise, in addition to the above hard phase and bindingphase, 0.005 to 0.06 mass % of Ti, Cr in a wt ratio relative to the binding phase of 0.04to 0.2, and the balanced amount of inevitable impurities. Especially, the abovecemented carbides contain no Ta. The above cemented carbides are composed of WCin the alloy which forms uniformly fine particles and is effectively inhibited in thegrowth to a rough WC, which results in the provision of cemented carbides being

]57[


excellent in both strength and toughness.

__________________

178365]21][11[

SELECTIVE אדנוזי�A2Aאנטגוניסטי� ברירניי� לקולטי ANTAGONISTS OFA2A ADENOSINE RECEPTORS

]54[

04.04.2005]22[US]33[02.04.2004]32[60/559159]31[

Int. Cl.(2010.01) A61K 31//52, C07D 21/1/16, 47/3/02, 47/3/34]51[ADENOSINE THERAPEUTICS, LLC,U.S.A.

]71[


ליםירוש1352.ד.ת,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,JERUSALEM 91013

]74[

Selective antagonists of A2A adenosine receptors are provided. The novel A2A blockersare useful for the treatment of Parkinson's disease and other diseases.

]57[

__________________

178391]21][11[

NET רשת ואלמנט לשיכו� הרשת AND MAT]54[

31.03.2005]22[US]33[31.03.2004]32[60/557868]31[

Int. Cl.(2010.01) E01B 05//18, E01F 15//00]51[UNIVERSAL SAFETY RESPONSE,INC., U.S.A.

]71[




]74[

An energy absorbing, vehicle capturing system spanning the width of a roadway,includes a net (500) for capturing the vehicle (30), and a mat (2000) uniquely shaped

]57[


to accommodate the net (500), when the net is not deployed and is laying against theroadway surface, thus protecting the net from abrasion by vehicle tires running overthe net, when the net is not in a deployed position.

__________________

178530]21][11[

הנחייה ואימו�, חוקשיטה והתק� להפעלה מר, לגילוי ריח של חיה המשוטטת חופשית

באמצעות גירוי מוח

METHOD AND APPARATUS FORTELEOPERATION, GUIDANCEAND ODOR DETECTIONTRAINING OF A FREELYROAMING ANIMAL THROUGHBRAIN STIMULATION

]54[

06.04.2005]22[US]33[06.04.2004]32[60/559793]31[US24.06.2004 60/582652

Int. Cl.(2010.01) A01K 01//03, 15//00, 15//02, A61N 01//08, 01//32, 01//36, 01//372,G06N 03//00, H02H 01//00

]51[

JOHN K. CHAPIN, U.S.A.TIMOTHY L. HANSON, U.S.A.LINDA HERMER-VAZQUEZ, U.S.A.RAYMOND HERMER-VAZQUEZ,U.S.A.

]71[



]74[

Electronic components, including a transceiver (220) for two-way wirelesscommunications, are carried by a freely roaming animal (190) such as a rat. Electrodesare implanted in the brain of the animal to provide cues and rewards to the animal toachieved desired behaviors, including controlling the direction and speed of movementof the animal, and training the animal to recognize odors. Network interface

]57[


components (265) allow a network of the animals to work together. Sensors (225, 230,235, 245, 255, 260) carried by the animal provide information to a remote base stationregarding, e.g., heading and location. Chemical or gas sensors, along with a videocamera and a microphone provide information regarding an environment of the animal.The animal can search for people buried in rubble piles, and detect explosives,chemicals or other dangerous materials. A vehicle (500) for deploying the animal isalso provided.

__________________

178737]21][11[

POWER אריזת מעגל כח ושיטה לייצורה CIRCUIT PACKAGE ANDFABRICATION METHOD

]54[

19.10.2006]22[US]33[26.10.2005]32[11/259992]31[

Int. Cl.(2010.01) H01L 23//051, 23//057, 25//07]51[GENERAL ELECTRIC COMPANY,U.S.A.

]71[

',זליגסון גבריאלי ושות31יבנה' רח



]74[

A power circuit pachage comprising:a base comprising a substrate, a plurality of interconnect circuit layers over thesubstrate with each comprising a substrate insulating layer patterned with substrateelectrical interconnects and via connections extending from a top surface of thesubstrate to at least one of the substrate electrical interconnects;a power semiconductor module comprising power semiconductor devices eachcomprising device pads on a top surface of the respective power semiconductor deviceand backside contacts on a bottom surface of the respective power semiconductordevice, the power semiconductor devices being coupled to a membrane structure, themembrane structure comprising a membrane insulating layer and membrane electricalinterconnects over the membrane insulating layer and selectively extending to the

]57[


device pads, wherein the backside contacts, are coupled to selected substrate electricalinterconnects or via connections and surface mount components coupled to selectedsubstrate electrical interconnects or via connections.

__________________

178751]21][11[

כח מכני בי� ציר לח. גבוהה לבי� התק� יציאת ציר לח. נמו� של מנועי טורבינה דו צירית

DEVICE FOR THE OFFTAKE OFMECHANICAL POWERBETWEEN THE HP AND LPSHAFTS OF A DOUBLE-SHAFTTURBINE ENGINE

]54[

19.10.2006]22[FR]33[21.10.2005]32[0553212]31[

Int. Cl.(2010.01) F02C 07//36]51[HISPANO-SUIZA, FRANCE]71[




]74[

Device for driving auxiliary machines of a double-shaft turbine engine with an LPshaft and an HP shaft, the said machines being installed in an accessory gearboxcomprising a common drive shaft,characterized in that it comprises a differentialgear with a first input shaft and a second input shaft and an output shaft , the firstinput shaft being connected via a selective coupling either to the LP shaft or to the HPshaft, the second input shaft being connected to the HP shaft, and the output shaftbeing connected to the drive shaft of the gearbox.

]57[

__________________

178770]21][11[

METHOD מימדי–שיטה להכנת סיב רשת לולייני דו FOR MAKING A TWO-DIMENSIONAL HELICAL FIBREWEB

]54[

20.04.2005]22[FR]33[23.04.2004]32[0404310]31[


Int. Cl.(2010.01) D04H 03//05, 13//00]51[MESSIER-BUGATTI, FRANCE]71[WO/2005/111292]87[




]74[

A transverse fibre web (102) is lapped by being guided reciprocatingly in asubstantially radial direction along a travel path between the outer and inner peripheraledges of said web, wherein the transverse web (202) is turned over at each end of thetravel thereof and the width thereof is reduced between the outer peripheral edge andthe inner peripheral edge. The transverse web is held while being lapped. Substantiallymutually parallel yarns or cables (204) are taken up to form a helical longitudinal web(202) with a surface density that decreases from the outer to the inner edge thereof.The transverse and longitudinal helical webs are stacked, continuously fed via a rotarymotion in a planar state and assembled to form a two-dimensional helical web (402)that is thereafter discharged.

]57[

__________________

178983]21][11[

DEVICE התק� וציוד לאבחו� לחות AND APPARATUS FORDETECTING MOISTURE

]54[

12.05.2005]22[NZ]33[12.05.2004]32[532900]31[

Int. Cl.(2010.01) A61B 05//00]51[ROBIN WHALLEY, NEW ZEALANDPAUL DONALD LE GROS, NEWZEALAND

]71[


SANFORD T.COLB & CO.,P.O.B. 2273,

]74[


REHOVOT רחובות2273.ד.ת, 76122

A device for detecting the presence of bodily fluid, the device including a detector (1)means having two spaced apart electrodes (2, 3), each electrode is connected to asignal generating means via a lead (6, 7). The electrodes are encased in a flexible non-conductive material with each including at least one protruding conductive element(4). The protruding elements are separated by the same distance as the spacingbetween the two electrodes. The device also includes a signal processing means thatdetects a change of state across the electrodes produced by the introduction of a fluidand an alarm actuated by the change of state.

]57[

__________________

179008]21][11[

שימוש בתכשיר סטרילי הכולל חומצהדאוקסיקולית להכנת תכשיר רוקחי להפחתה

מקומית של מאגרי שומ�

USE OF A STERILECOMPOSITION COMPRISINGDEOXYCHOLIC ACID IN THEPREPARATION OF APHARMACEUTICALCOMPOSITION FOR THEREMOVAL OF LOCALIZED FATDEPOSITS

]54[

19.05.2005]22[US]33[19.05.2004]32[60/572879]31[

Int. Cl.(2010.01) A61K 31//205, 36//575, 45//00, A61P 03//00, A61Q 19//06]51[THE REGENTS OF THEUNIVERSITY OF CALIFORNIA,U.S.A.LOS ANGELES BIOMEDICALRESEARCH INSTITUTE ATHARBOR UCLA MEDICALCENTER, U.S.A.

]71[

WO/2005/112942]87[




]74[

Compositions and methods useful in the reduction of localized fat deposits in patientsin need thereof using pharmacologically active detergents are disclosed. Thepharmacologically active detergent compositions can additionally include anti-inflammatory agents, analgesics, dispersion or anti-dispersion agents andpharmaceutically acceptable excipients. The pharmacologically active detergentcompositions are useful for treating localized accumulations of fat including, forexample, lower eyelid fat herniation, lipodystrophy grid fat deposits associated withcellulite and do not require surgical procedures such as liposuction.

]57[



__________________

179320]21][11[

מערכות תלת מימדיות של רקמה רב תאית ותרביות רקמה ושיטות לייצור�

THREE DIMENTIONALMULTICELLULAR TISSUE ANDORGAN CULTURE SYSTEMS ANDMETHOD FOR PRODUCING SAME

]54[

09.05.2005]22[DE]33[21.05.2004]32[102004025081.2]31[

Int. Cl.(2010.01) C12N 05//00, G01N 33//50]51[FRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V., GERMANY

]71[


גבמר 5שנקר'רח,1ים-כז הרצליה12704.ד.ת,


]74[

The invention relates to methods for producing three-dimensional multicellular tissueand organ culture systems while using multicellular mammal cell aggregates, to thesesystems themselves, and to their use for different medical purposes, particularly

]57[


implantations.

__________________

179597]21][11[

שיטות ומערכת טרנזקציית כרטיס נתוני� חכ� לאספקת אחסו� והעברה מאובטחת

SMART CARD DATATRANSACTION SYSTEM ANDMETHODS FOR PROVIDINGSTORAGE AND TRANSMISSIONSECURITY

]54[

28.05.2004]22[US]33[22.05.2003]32[10/443670]31[

Int. Cl.(2010.01) G07F 07//10]51[IBM CORPORATION, U.S.A.]71[WO/2005/119606]87[

,R&Dמעבדות יבמ, סוזן ארז הר הכרמל, אוניברסיטת חיפה

חיפה

SUZANNE EREZ, IBM R&DLABORATORIES,HAIFA UNIVERSITY,HAIFA 31905

]74[

A smart card system is disclosed for secure transmission of post issuance data to aembedded chip using a chip relay module, a plurality of hardware security modules, afirst communication system having two security layers and a second communicationsystem having four security layers. The first communication system may be considereda server side system and comprises a chip management system, a security serverhaving a first hardware security module, a distribution server having a secondhardware security module and a computer system connected by a network. The firstcommunication system has a first security layer and a second security layer. The firstsecurity layer comprises mutual authentication that makes each component of the firstcommunication system a trusted node to the others through client mutualauthentication. The second security layer comprises system keys for securecommunication between the hardware security modules. The second communicationsystem may be considered a client side system and comprises the computer system

]57[


connected to the distribution server by a network, a PC/SC card reader driver, a Webbrowser application, and a chip relay module and is for secure communication betweenthe distribution server and the chip of a smart card inserted in the card reader/writer.The second communication system has a third, fourth, fifth and sixth security layer.

__________________

179664]21][11[

CHARGED כלי ירי לחלקיקי� טעוני� PARTICLE GUN]54[

13.05.2005]22[GB]33[03.06.2004]32[0412426.9]31[

Int. Cl.(2010.01) H01J 03//02]51[NANOBEAM LIMITED, UNITEDKINGDOM

]71[




]74[

An electron gun (1) includes an emitter (2), a tubular support (3) and an adaptor (4) forreceiving the emitter. The adaptor includes a tapered plugging surface (7) and thetubular support includes a correspondingly tapered seating surface (9) for receiving theplugging surface. The plugging surface and seating surface have conical profiles whichhelp to position the adaptor concentrically with the support.

]57[


__________________

179676]21][11[

METHOD שיטה לייצור סטנט מפולג OF MAKING ABIFURCATED STENT

]54[

30.04.1997]22[US]33[03.05.1996]32[642297]31[

Int. Cl.(2008.04) A61F 2/06, A61M 29/00]51[DIVISION FROM 144230]62[

MEDINOL תל אביב,מ"מדינול בע LTD.]71[עורכי דין ועורכי, קבוצת איתן מהולל

,פטנטים10שדרות אבא אבן



]74[

A method of making a bifurcated stent comprising the steps of:(a) preparing a first expandable tubular member having a proximal end and a distal endand a longitudinal bore therethrough, said first tubular member provided with a branchaperture disposed between said proximal end and said distal end, said branch aperturecommunicating with said longitudinal bore and said aperture sized and adapted toreceive and secure a second expandable tubular member;(b) delivering said first expandable tubular member to a bifurcated vessel having a firstlumen and a second lumen so that said first expandable member is disposed withinsaid first lumen and said branch aperture communicates with said second lumen;(c) expanding said first expandable member in an amount sufficient to secure said firstexpandable member in said first lumen;(d) preparing a second expandable tubular member having a proximal end and a distalend having a longitudinal bore therethrough;(e) widening said branch aperture;(f) delivering said second expandable tubular member into said branch aperture so thatsaid distal end of said second expandable tubular member is disposed within saidsecond lumen and said proximal end of said second expandable tubular member isdisposed within said longitudinal bore of said first longitudinal member; and(g) expanding said second expandable tubular member in an amount sufficient tosecure said second expandable tubular member within said second lumen and withinsaid branch aperture.

]57[




__________________

179776]21][11[

לוגיי� מסיכה לזיהומי� סביבתיי� ביו המתאימה לאזרחי�

BIOHAZARD MASK SUITABLEFOR CIVILIANS

]54[

03.06.2005]22[US]33[03.06.2004]32[10/861231]31[

Int. Cl.(2010.01) A62B 07//10]51[DAVID R. FRERIKS, U.S.A.]71[WO/2006/083287]87[



]74[

An Exhalate filter medium for a biohazard mask made of polytetrafluoroethylene(PTFE) and surrounding layers of a wicking material and an antimicrobial material.The exhalate filter may be contained in a removable and replaceable cartridge snap-fitinto the surface of a biohazard mask.

]57[

__________________

179829]21][11[

מתק� לשחרור קרינת לייזר לתפעול דוגמהוהמאפשר לייש�, נוזלית בצורת טיפות בודדות

טיפול כימי וביולוגי

LASER RADIATIONDESORPTION DEVICE FORMANIPULATING A LIQUIDSAMPLE IN THE FORM OFINDIVIDUAL DROPS, THEREBYMAKING IT POSSIBLE TOCARRY OUT THE CHEMICALAND BIOLOGICAL TREATMENTTHEREOF

]54[

06.06.2005]22[FR]33[04.06.2004]32[0406081]31[

Int. Cl.(2010.01) B01F 13//00, B01L 03//00, F04B 19//00]51[SANOFI-AVENTIS, FRANCE]71[WO/2006/003292]87[

LUZZATTO,לוצאטו את לוצאטו & LUZZATTO,INDUSTRIAL PARK, OMER,

]74[



P.O.B. 5352,BEER-SHEVA 84152

The invention relates to an integrated system for microfluidic analysis of a liquidsample comprising a liquid sample preparing means (100) which is provided with adisplacement means (101) for introducing the sample and reagents and for transmittingsaid sample and reagents to a second means (200) for chemically or biochemicallytreating the liquid sample drops, wherein said treating means comprises also means(201) for displacing sample drops to means (300) for drop analysis. Said invention isparticularly suitable for a laser radiation desorption device comprising a system formanipulating the sample and reagents in the form of drops, which is provided with oneor several loading posts, one or several transport paths consisting of interdigitatedelectrodes, one or several chemical or biochemical treatment areas and at least onesystem for switching to a conductive post on which a laser radiation desorption can becarried out.

]57[

__________________

179964]21][11[

COLD מערכת ליצירת גלילה בקור ROLL FORMINGAPPARATUS

]54[

22.06.2005]22[AU]33[23.06.2004]32[2004903390]31[

Int. Cl.(2010.01) B21B 31//02, 31//16, B21D 19//02]51[SMORGON STEEL LITESTEELPRODUCT PTY LTD., AUSTRALIA

]71[




]74[

A cold roll forming mill for the manufacture of hollow flange seam welded beamsfrom a single strip of metal comprises a forming station (1), a seam guide and weldingstation (2) and a shaping station (3). Either or both of the forming and shaping stations

]57[


(1, 3) comprise independently supported side engaging roll combinations (7, 12)adapted, in use, to roll either or both of opposite sides of the strip. Adjacent transversepairs of side engaging roll (7, 12) combinations are selectively movable relative toeach other in a transverse direction perpendicular to a direction of travel of said stripthrough said mill. At least some of the side engaging roll combinations (7, 12) aredriven. Drive rolls (6) spaced within the forming and shaping stations (1, 3) engage thestrip between opposite edges thereof.

__________________

180118]21][11[

מיימניי� וממיסי–חד, נתרניי�–מלחי� דו אתנול להעברת נשאי� פעילי�

DISODIUM SALTS,MONOHYDRATES ANDETHANOL SOLVATES FORDELIVERING ACTIVE AGENTS

]54[

05.04.2000]22[US]33[05.04.1999]32[60/127754]31[US01.03.2000 60/186143 US01.03.200060/186142US21.03.200060/191286

Int. Cl.(2010.01) A61K 47//16, C07C 23/5/00, 23/5/60]51[DIVISION FROM 145546]62[EMISPHERE TECHNOLOGIES, INC.,U.S.A.

]71[




]74[

The inventors have discovered that the disodium salt of certain delivery agents hassurprisingly greater efficacy for delivering active agents than the correspondingmonosodium salt. Furthermore, the inventors have discovered that the disodium saltsof these delivery agents form solvates with ethanol and hydrates with water. The

]57[


delivery agents have formula (I) wherein R1, R2, R3, and R4 are indepedentlyhydrogen, halogen, C1-C4 alkyl, or C1-C4 alkoxy; and R5 is a substituted orunsubstituted C2-C16 alkylene, substituted or unsubstituted C2-C16 alkenylene,substituted or unsubstituted C1-C12 alkyl(arylene), or substituted or unsubstitutedaryl(C1-C12 alkylene). The hydrates and solvates of present invention also havesurprisingly greater efficacy for delivering active agents, such as heparin andcalcitonin, than their corresponding monosodium salts and free acids. The presentinvention provides an alcohol solvate, such as ethanol solvate, of a disodium salt of adelivery agent of formula (I) above. Preferred delivery agents include, but are notlimited to,N-(5-chlorosalicyloyl)-8-aminocaprylic acid (5-CNAC),N-(10-[2-hydroxybenzoyl]amino)decanoic acid (SNAD), and sodiumN-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC). The invention also provides methods ofpreparing the disodium salt, ethanol solvate, and hydrate and compositions containingthe disodium salt, ethanol solvate, and/or hydrate.

__________________

180385]21][11[

ICE-CONTAINING מוצרי� המכילי� קרח PRODUCTS]54[

20.06.2005]22[EP]33[19.07.2004]32[04254313.2]31[

Int. Cl.(2010.01) A23G 09//44, A23L 01//212]51[UNILEVER PLC, UNITEDKINGDOM

]71[




]74[

A method is provided for producing an ice-containing product which methodcomprises in the following order: (i) cooling a product concentrate to a temperature ofbelow -4 °C; (ii) combining the cooled concentrate with frozen particles, a substantialproportion of which have a particle size of greater than 5 mm; and (iii) mechanicallyreducing the size of the frozen particles such that substantially all of the resultingfrozen particles have a size of greater than 0.5 mm and less than 5 mm.

]57[


__________________

180493]21][11[

–דיפניל–5,5–מתוקסימתיל–1הלי� להכנתת חומצה ברביטורית

PROCESS FOR PREPARING 1-METHOXYMETHYL-5,5-DIPHENYLBARBITURIC ACID

]54[

30.06.2005]22[US]33[02.07.2004]32[60/584955]31[

Int. Cl.(2010.01) C07D 23/9/62]51[TARO מפרץ חיפה,מ"תרו תעשיה רוקחית בע PHARMACEUTICAL

INDUSTRIES LTD.]71[

WO/2006/003651]87[בע, אסנת בר פלד ,מ"תרו תעשיה רוקחית

יקום, בית איטליה, יורו פארקASNAT BAR PELED, TAROPHARMACEUTICAL INDUSTRIESLTD.,YAKUM 60972

]74[

The present invention provides a novel process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid. In particular, the present invention provides a process forpreparing 1-methoxymethyl-5,5-diphenylbarbituric acid by reacting 1,3-bis(methoxymethyl)-5,5-diphenylbarbituric acid with a Lewis acid to remove onemethoxymethyl group from 1,3-bis(methoxymethyl)-5,5-diphenylbarbituric acid.

]57[

__________________

180505]21][11[

ELECTRIC מגולל צינורות חשמלי HOSE WINDER]54[

04.07.2005]22[CN]33[13.04.2005]32[200520101572.5]31[

Int. Cl.(2010.01) B65H 75//34]51[XU XIAOHUA, CHINA]71[XU XIAOHUA]72[WO/2006/108327]87[

,משרד עורכי דין, ליס-עדין48בית אמות בטוח דרך מנחם בגין

אביב-תל

ADIN-LISS,48 MENAHEM BEGIN RD., TEL AVIV

]74[

The present invention relates to a farm implement part, in particularly to an electrichose winder for winding water hose. It comprises a frame and a reel rotatably

]57[


supported thereon. Said reel consists of two end-wheels and a connector disposedtherebetween. A driven motor is located within the connector of the reel, which issecured to the frame by a hollow shaft through which an electric line of the motor isdirected. The output end of the motor engaged with one of the end-wheel of the reelthrough a clutch. The device according to the present invention has the advantages ofcompact, light, convenience to be used, stable operation and so on. So it can solve thetechnical problems in the prior art, for example, the reel is driven by a hand in the priorart so that it is used inconveniently.

__________________

180556]21][11[

ושיטת זיגוג שכבת מג� עבור רכיב לייזר אנקפסולציה

ARTICULATED GLAZECLADDING FOR LASERCOMPONENTS AND METHOD OFENCAPSULATION

]54[

20.12.2005]22[US]33[23.12.2004]32[11/021413]31[

Int. Cl.(2010.01) H01S 03//06]51[RAYTHEON COMPANY, U.S.A.]71[WO/2006/130180]87[

טסנפו ',קולב ושות. רד מרמורק,4שער הגיא



]74[

A glaze encapsulated solid-state laser component (30). The novel laser component (30)includes a core (10) and a cladding (32) of ceramic glaze disposed on a surface of thecore (10). In an illustrative embodiment, the core (10) is fabricated from a laser gainmedium and the cladding material is a multi-oxide eutectic ceramic glaze having arefractivity slighter lower than the refractivity of the gain medium, such that the glazelayer forms a step-index refractivity interface cladding that can effectively suppressparasitic oscillations in the core gain medium. The glaze cladding (32) can be appliedby coating the core (10) with the glaze and then firing the glaze coated core, or by

]57[


fabricating pre-formed cladding strips from the ceramic glaze in a first firing cycle,mounting the pre-formed strips to the core (10), and then fusing the pre-formed stripsto the core (10) in a secondary firing cycle.

__________________

180643]21][11[

METHODS שיטות לקבלת פאקליטאקסל מצמחי טאקסוס FOR OBTAININGPACLITAXEL FROM TAXUSPLANTS

]54[

24.06.2005]22[EP]33[13.07.2004]32[04016493.1]31[

Int. Cl.(2010.01) C07D 30/5/00, 30/5/14]51[INDENA S.P.A., ITALY]71[WO/2006/005429]87[



]74[

Methods for obtaining paclitaxel from plants containing paclitaxel are disclosed. Plantmaterial is first obtained from plants containing paclitaxel. Paclitaxel is then extractedfrom the plant material. Subsequently, paclitaxel is separated from the paclitaxelextract using a series of column chromatography separation steps to obtain at least onefraction containing paclitaxel. The paclitaxel in a fraction that is obtained from thefinal chromatography step is crystallized. Using these methods, high purity paclitaxelmay be efficiently obtained from plants containing paclitaxel.

]57[

__________________


180943]21][11[

עבור חומרי� צורת מינו� רוקחית רב חלקיקיתפעילי� בעלי מסיסות נמוכה ושיטה ליצור את

צורת המינו� הרוקחית

MULTIPARTICLEPHARMACEUTICAL DOSAGEFORM FOR A LOW-SOLUBLEACTIVE SUBSTANCES ANDMETHOD FOR PRODUCING SAIDPHARMACEUTICAL DOSAGEFORM

]54[

08.07.2005]22[DE]33[27.07.2004]32[102004036437.0]31[

Int. Cl.(2010.01) A61K 09//16, 09//20, 09//48, 31//427, 31//506, 31//55]51[EVONIK ROHM GMBH, GERMANY]71[WO/2006/010453]87[



]74[

The invention relates to an oral multiparticle pharmaceutical dosage form in the formof a receptacle reducing the pH values of stomach, containing a plurality of pellets,particles, granules or agglomerates whose mean diameter ranges from 50 to 2500µnsubstentially consisting of a) an internal matrix layer containing an active agent whichis neither peptide or protein, nor the derivatives or conjugates thereof, a lipophilicmatrix whose melting point is greater than 37 °C and a polymer with mucoadhesiveeffect, b) an external film coating substentially consisting of a polymer or an anioniccopolymer which is optionally formulated with conventional pharmaceutical additives,wherein the active agent has a water solubility according to DAB 10, of at least 30volume parts of water for one part by weight of the active agent and is coated with thelipophilic matrix and said active agent-containing lipophilic matrix is coated with amatrix made of a polymer with mucoadhesive effect. A method for producing theinventive multiparticle pharmaceutical dosage is also disclosed.

]57[

__________________

181067]21][11[

WATER בתו� מתיז המי� מתיז מי� ופילטר נייד ושימוש DISPENSER AND FILTERCARTRIDGE FOR USE THEREIN

]54[

30.01.2007]22[US]33[02.04.2004]32[60/559351]31[

Int. Cl.(2010.01) B67D 01//16]51[


DIVISION FROM 167788]62[אור,מ"בע) 1991(חברת תנה תעשיות

יהודהTANA INDUSTRIES (1991) LTD.]71[



]74[

A water dispenser comprising:a water inlet (434) adapted to receive water from a water supply;a water filter operative to filter water received from said water supply via said waterinlet; andan ultraviolet radiation assembly (212) operative to disinfect said water received fromsaid water supply, said ultraviolet radiation assembly including a UV lamp assembly(450) and a UV lamp socket, said UV lamp assembly comprising a UV lamp includingat least one filament (460) and a plurality of male contacts including first (462) andsecond (464) contacts, said UV lamp socket defining female contacts (472, 474) forreceiving said first and second contacts, said first contacts providing electrical contactwith said at least one filament in said UV lamp and said second contacts providingelectrical contact with an electrical power supply.

]57[

__________________

181405]21][11[

REMOVABLE כיסוי למשטח הנית� להורדה SURFACECOVERING

]54[

12.08.2005]22[ES]33[20.08.2004]32[P200402065]31[ES08.02.2005 P200500247


ES10.06.2005P200501392Int. Cl.(2010.01) E04F 15//02]51[VICENTE-FRANCISO SANSANOMARTI, SPAIN

]71[




]74[

The invention relates to a removable surface covering comprising a combination oflower supports with plastic support legs and upper ceramic parts which are joined tothe supports by means of contact faces and with the aid of an adhesive material, suchas to form covering modules which are interconnected using tongue-and-grooveanchoring elements. According to the invention, the plastic supports and the ceramicparts are joined using a thick layer of adhesive which covers almost all of the contactsurfaces thereof. In addition, the ceramic parts are equipped with channels and aperipheral notch which house respectively ribs and a frame belonging to the plasticsupport. The thickness of the adhesive extends over at least part of the thickness of theribs and the frame of the plastic support. In another embodiment of the invention, theparts are joined at strategic points with a chemical-mechanical connection.

]57[

__________________

181441]21][11[

RADIO מערכת מקלט תדר רדיו FREQUENCY RECEIVERSYSTEM

]54[

03.11.1998]22[US]33[03.11.1997]32[60/064097]31[US03.11.1997 60/064098 US03.11.199760/064132

Int. Cl.(2010.01) H03M 13//25, 13//41, H04B 01//24, 01//40, H04L 01//00, 25//497,27//18, 27//34

]51[

DIVISION FROM 135874]62[


HARRIS CORPORATION, U.S.A.]71[WO/1999/023760]87[



]74[

A radio frequency receiver for receiving trellisencoded modulated radio frequency signals and outputting trellis encoded intermediatefrequency modulated digital signals;an intermediate frequency digital demodulator circuit for demodulating the trellisencoded intermediate frequency modulated digital signals to baseband trellis encodeddigital signals;digital signal processor means to convert the baseband trellis encoded signals to polarform for processing the signals with a decoder so as to reduce the complexity ofcomputations by allowing masking to be used instead of complex modulo arithmeticwherein:the digital processor includes a decoder including circuit means for generating a firsttable containing a current symbol and a previous symbol to bring a trellis to a givenstate, and for generating a second table containing a current symbol, a previoussymbol, and a symbol previous to the previous symbol necessary to bring a trellis to agiven state, and for calculating a path metric for a received signal by indexing thevalues of the first and second tables into a branch metric decoding calculation.

]57[

__________________

181442]21][11[

RADIO רדיו מערכת מקלט תדר FREQUENCY RECEIVERSYSTEM

]54[

03.11.1998]22[US]33[03.11.1997]32[60/064097]31[US03.11.1997 60/064098 US03.11.199760/064132

Int. Cl.(2010.01) H03M 13//25, 13//41, H04B 01//24, 01//40, H04L 01//00, 25//497,27//18, 27//34

]51[


DIVISION FROM 135874]62[HARRIS CORPORATION, U.S.A.]71[WO/1999/023760]87[



]74[

A radio frequency receiver for receiving trellis encoded modulated radio frequencysignals and outputting trellis encoded intermediate frequency modulated digitalsignals;an intermediate frequency digital demodulator circuit for demodulating the trellisencoded intermediate frequency modulated digital signals to baseband trellis encodeddigital signals;digital signal processor means to convert the baseband trellis encoded signals to polarform for processing the signals with a decoder so as to reduce the complexity ofcomputations by allowing masking to be used instead of complex modulo arithmeticwherein:the digital processor includes a decoder including circuit means for generating a firsttable containing a current symbol and a previous symbol to bring a trellis to a givenstate, and for generating a second table containing a current symbol, a previoussymbol, and a symbol previous to the previous symbol necessary to bring a trellis to agiven state, and for calculating a path metric for a received signal by indexing thevalues of the first and second tables into a branch metric decoding calculation.

]57[

__________________

181620]21][11[

התק� להתעמלות מתקנת ע� תומ� מגביל לכ הרגל

REFORMER EXERCISEAPPARATUS FOOT BARSUPPORT

]54[

30.08.2005]22[US]33[01.09.2004]32[10/933015]31[


Int. Cl.(2010.01) A63B 21//055]51[BALANCED BODY INC]71[WO/2006/028935]87[



]74[

A reformer exercise apparatus has a generally rectangular frame having a head end anda foot end and including a pair of spaced apart parallel track members, a movablecarriage mounted on the frame for movement along the track members between saidhead and foot ends against one or more springs connected between the carriage and thefoot end of the frame and an adjustable foot bar assembly mounted at the foot end ofthe frame. The foot bar assembly includes a foot bar and a foot bar support bar that fitsinto a pair of support brackets. Each bracket is a generally block shaped body fastenedto the foot end of the frame. The bracket has a plurality of vertically spaced,downwardly opening slanted slots therein for receiving the support bar, each slantedslot having an entrance portion extending upward to an enlarged support portion at abase of the slot for retaining the support bar therein. The enlarged support portionforms a pocket to positively retain the support bar. A lock block that removably fastensto the foot bar support bar may be slidably inserted into the support portion of thebracket to lock the support bar in the support portion of the bracket.

]57[

__________________

181892]21][11[

ULTRASOUND קולית לטיפול–מערכת על SYSTEM FORPROVIDING TREATMENT

]54[

22.09.2005]22[US]33[24.09.2004]32[10/950112]31[

Int. Cl.(2010.01) A61B 18//18, A61H 01//00, A61N 01//18, 07//00]51[GUIDED THERAPY SYSTEMS,L.L.C, U.S.A.

]71[





]74[

A non-invasive method and system for combined ultrasound treatment are provided.An exemplary combined ultrasound treatment system comprises a transducerconfigured to deliver ultrasound energy to provide two or more energy effects to aregion of interest. The energy effects facilitate the initiation of one or more responsesin the region of interest. In accordance with an exemplary embodiment of the presentinvention, a transducer is configured to deliver energy over varying temporal and/orspatial distributions in order to provide energy effects and initiate responses in a regionof interest.

]57[

__________________

181947]21][11[

SLOW מתק� לסגירה איטית של מכסה אסלה CLOSURE MECHANISMFOR TOILET COVERS

]54[

16.09.2005]22[TR]33[28.09.2004]32[2004/02481]31[

Int. Cl.(2010.01) A47K 13//12]51[ECZACIBASI YAPI GERECLERISANAYI VE TICARET A.S.,TURKEY

]71[


עומר, גן תעשייהשב5352.ד.ת, עבאר


]74[

The subject of the invention is a slow closure mechanism (A) for toilet covers whereinit comprises two-hinge bodies (1), two pins (2), two dampers (3) and a body cover (4).

]57[


Slow closing and easy opening process of toilet covers are achieved by tightlyrecessing the pins (2) and dampers (3) in the hinge body (1), connecting toilet coversand body cover (4) to pin shaft (23) and damper shaft (31) in slow closure mechanism(A).

__________________

182133]21][11[

SYSTEM מערכת להתאמת מיקו� של מעטפת סנסור FOR ADJUSTING APOSITION OFA SENSORPACKAGE

]54[

20.09.2005]22[US]33[24.09.2004]32[10/951044]31[

Int. Cl.(2010.01) F16M 11//12]51[RAYTHEON COMPANY, U.S.A.]71[WO/2006/135422]87[




]74[

According to one embodiment of the present invention, a method for adjusting aposition of an object to compensate for tilt includes providing a rotatable basesupporting an object and directing the object relative to the base such that the positionof the object is controlled relative to a first axis. The object is stabilized along a secondaxis. The object is positioned relative to the base using first and second bearing arms.The first and second bearing arms movably couple the object to the base at a firstposition relative to a third axis and a fourth axis. The first bearing arm couples to theobject at a first pivot point. The second bearing arm coupled to the object at a secondpivot point. Each bearing arm includes a first portion and a second portion, which arecoincident with the third axis and fourth axis, respectively. The object is adjusted to asecond position using the first and second bearing arms to maintain the first axis whena tilt angle of the base is detected.

]57[


__________________

182623]21][11[

שיטה לייצור פיל� מסוגסג ומכשיר עבור השיטה

METHOD OF MANUFACTURINGAN ALLOYED FILM ANDAPPARATUS FOR THE METHOD

]54[

03.11.2005]22[GB]33[03.11.2004]32[0424355.6]31[

Int. Cl.(2010.01) B29C 47//14, 47//16]51[OLE-BENDT RASMUSSEN,SWITZERLAND

]71[




]74[

A method and apparatus for carrying out the method are for forming a sheet or film ofthermoplastic polymer alloy by extruding an intimate blend of incompatible polymermaterials, such as polypropylene dispersed in LLDPE, through an extrusion die andstretching after extrusion. In the die upstream from the exit is a grid chambercomprising one or more grids, the grid or grids having at least 4 (in the longitudinalsections perpendicular to the main surfaces of the flow) closely spaced lamellae (303)having walls extending several millimetres in the direction of the flow, which areinterconnected (306) at intervals such that viewed in sections perpendicular to thedirection of flow they form a network, the intervals being essentially longer than thedistance between each pair of lamellae and between the lamellae apertures of a sizeselected to reduce the average size of the dispersed phase of P1 or P2 in the blend, thegrid or grids being located at a position in the chamber where the gap is wider than thesaid exit gap, the grip chamber further comprising a gap reduction portion between thescreen and the die exit wherein the gap through which the blend flows is reduced atleast part way to the gap of the die exit. There may be two grids with parallel lamellaearranged so that the lamellae of the downstream grid are located mid-way between the

]57[


lamellae of the upstream grid.

__________________

182761]21][11[

ב VERA–בJAK2–זיהוי מוטציהPOLYCYTHEMIA

IDENTIFICATION OF JAK2MUTATION IN POLYCYTHEMIAVERA

]54[

26.10.2005]22[FR]33[27.10.2004]32[0411480]31[

Int. Cl.(2010.01) A61K 31//713, C07K 14//47, 16//18, C12N 09//12, 15//54, C12Q01//68, G01N 33//53

]51[

L'ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, FRANCEINSTITUT GUSTAVE ROUSSY,FRANCEINSTITUT NATIONAL DE LASANTE ET DE LA RECHERCHEMEDICALE (I.N.S.E.R.M.), FRANCEUNIVERSITE PARIS SUD, FRANCEUNIVERSITE DE VERSAILLES-STQUENTIN EN YVELINES, FRANCE

]71[




]74[

The invention relates to variant V617F of protein tyrosine kinase JAK2, said variantbeing responsible for Polycythemia vera. The invention also relates to a method for thepreliminary diagnosis of erythrocytosis and thrombocytosis, thereby enabling same tobe related to myeloproliferative syndromes or the detection of variant JAK2 V617F in

]57[


said myeloproliferative syndromes, such that they can be reclassified in a newnosological group, and to the identification of specific inhibitors and siRNA.

__________________

182763]21][11[

–תולדות חומצה קרבוקסילית של ביפנילאילד� ותכשירי–3–אינדול–הידראזינו

רוקחות המכילי� אות� לויסות פעילות תרומבופויטי�

INDOL-3-YLIDENE-HYDRAZINO-BIPHENYL- CARBOXYLIC ACIDDERIVATIVES ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM FOR MODULATINGTHROMBOPOIETIN ACTIVITY

]54[

21.10.2005]22[US]33[25.10.2004]32[60/621879]31[US25.04.2005 60/675001

Int. Cl.(2010.01) A61K 31//404, A61P 07//00, C07D 20/9/40, 40/1/04, 40/3/12,40/5/04, 40/5/10, 40/9/04

]51[

LIGAND PHARMACEUTICALSINCORPORATED, U.S.A.

]71[




]74[

Disclosed herein are substituted arylhydrazino compounds, pharmaceuticalcompositions comprising the same, methods of modulating the activity athrombopoietin receptor using the same, methods of identifying compounds asthrombopoietin receptor modulators, and methods of treating disease by administeringa compound of the invention to a patient in need thereof.

]57[

לתקנות35פירוט זה נבח) בהתא� לתקנה 1968–ח"תשכ, הפטנטי�

This specification was examined in accordancewith regulation 35 of the Patent Regulations,5728 - 1968

ת חלוקה מבקשה זו בקשו.שטר� פורסמו


__________________


182897]21][11[

ליב עיני מסוג שמ� במי� ע� פוטנציאל זטא תח חיובי יציב

OPHTHALMIC OIL-IN-WATERTYPE EMULSION WITH STABLEPOSITIIVE ZETA POTENTIAL

]54[

10.10.2005]22[EP]33[09.11.2004]32[04292645.1]31[US18.11.2004 10/991346

Int. Cl.(2010.01) A61K 09//00, 09//107]51[NOVAGALI PHARMA SA, FRANCE]71[WO/2006/050838]87[



]74[

An ophthalmic oil-in-water type emulsion, which comprises colloid particles having anoily core surrounded by an interfacial film, said emulsion comprising at least onecationic agent, at least one non ionic surfactant said emulsion having a positive zetapotential and meeting zeta potential stability Test A requirements. Process for makingsaid emulsions. Delivery device selected from the group comprising lenses, ocularpatch, implant, insert, said device containing an emulsion according to the invention.

]57[

__________________

183247]21][11[

,DEVICES ושיטות למת� תרופות, מערכות, מתקני� SYSTEMS ANDMETHODS FOR MEDICAMENTDELIVERY

]54[

22.11.2004]22[Int. Cl.(2010.01) A61M 05//00]51[INTELLIJECT,INC., U.S.A.]71[WO/2006/057636]87[




]74[

Certain exemplary embodiments comprise an apparatus, comprising: a compressed gas]57[


container; a plurality of vials adapted to store a liquid medicament, each vial defininga longitudinal axis, the longitudinal axes of the plurality of vials parallel and non-co-axial, the plurality of vials fluidly coupleable to an actuating portion of a contents ofthe gas container; and a plurality of pistons, each piston adapted to move within acorresponding vial from the plurality of vials, the plurality of pistons adapted to, inresponse to discharge of the actuating portion of the contents of the compressed gascontainer, transfer at least a portion of the liquid medicament from the plurality ofvials and through a needle that is extendable into a patient.

__________________

183269]21][11[

OPTICAL מתג אופטי מצומת CROSSBAR SWITCH]54[

17.11.2005]22[IL]33[17.11.2004]32[PCT/IL2004/001058]31[

Int. Cl.(2010.01) G02B 06//35]51[FIBERZONE NETWORKS LTD.]71[WO/2006/054300]87[

,אנטיס קניין רוחני'סר אלון"ד6ראול וולנברג רמת החייל

אביב-תל

DR. ALON C. ENTIS,6 RAOUL WALLENBERG ST., RAMATHAHAYAL

]74[

An optical crossbar switch for optically coupling optic fibers comprising: at least onefirst fiber (21) and a plurality of second fibers (22) ; a moveable fiber-end carriage (41)coupled to an end of the at least one first fiber and constrained to move along apredetermined trajectory; at least one moveable slack-control carriage (42) coupled tothe body of the at least one first fiber and constrained to move along a predeterminedtrajectory; and at least one moving device (70, 80)controllable to move the carriages;wherein to optically couple a first fiber of the at least one first fiber to a second fiber ofthe plurality of second fibers, the at least one moving device moves the fiber-endcarriage of the first fiber along its trajectory to a position at which the end of the firstfiber is optically coupled to an end of the second fiber and moves the at least one slack-control carriage to take up slack in the first fiber generated by movement of its fiber-

]57[


end carriage.

__________________

183294]21][11[

אומטיות מערכת כירורגית בעלת סעפות פנ אינטגרליות

SURGICAL SYSTEM HAVINGINTEGRAL PNEUMATICMANIFOLDS

]54[

17.05.2007]22[US]33[19.05.2006]32[11/437301]31[

Int. Cl.(2010.01) A61F 09//00, A61M 01//00]51[ALCON, INC., SWITZERLAND]71[




]74[

An ophthalmic surgical system (200), comprising a surgical console (100) having acassette-receiving portion (110) adapted to receive a cassette (10) for managingirrigation and aspiration fluid flows by means of pneumatic sub-systems, comprising:

(a) a common primary fluidics and pneumatics manifold (210)(b) an infusion manifold (230)(c) an aspiration manifold (220)characterized in that(a) the common primary fluidics and pneumatics manifold (210) is adapted to bemounted in the cassette-receiving portion (110) of the surgical console (100) sothat the cassette may be fluidly coupled to the console;(b) the infusion manifold (230) is mounted on the primary manifold;(c) the aspiration manifold (220) is mounted on the primary manifold, wherein theaspiration manifold (220) and the infusion manifold (230) are adapted topneumatically communicate with each other and with the cassette (10) through theprimary manifold.

]57[


__________________

183436]21][11[

DEPTH-BASED הדמייה מעקב המבוססת על עומק SURVEILLANCEIMAGING

]54[

12.01.2006]22[US]33[21.01.2005]32[11/040597]31[

Int. Cl.(2010.01) G01S 13//89]51[SAFEVIEW, INC., U.S.A.]71[WO/2006/078569]87[




]74[

A subject (38) may be interrogated with electromagnetic radiation (40, 42) forproducing image data (97) representative of an image of the subject (38). First andsecond image data (97), produced based on reflectivity in first and second frequencyranges, may be related. In some examples, image data (97) for one picture element(162) may be produced based at least in part on reflectivity of the radiation (40, 42) ata depth selected based at least in part on a depth of another picture element (162). Insome examples, plural images (200, 206) may be produced based on reflectivity atdifferent depths. In some examples, a value of reflectivity may be determined for anintermediate depth between two adjacent depths of image data (97) based at least in

]57[


part on reflectivity of the radiation (40, 42) for a plurality of spaced-apart depths.

__________________

183550]21][11[

CYCLOPROPANATION תהלי� ציקלופרופנציה PROCESS]54[

20.12.2005]22[GB]33[24.12.2004]32[0428294.3]31[GB30.08.2005 0517584.9

Int. Cl.(2010.01) C07C 02//42, 02//86, 29//32, 29//36, 41//30, 43//115, 67//343]51[GIVAUDAN SA, SWITZERLAND]71[WO/2006/066436]87[

,ריינהולד כהן ושותפיו'א26רזל רחוב הב

רמת החייל


]74[

A process for the cyclopropanation of a substituted alkene, comprising the reaction ofthe alkene with a carbenoide, generated from dibromomethane and a tri-(C2 - C8)-alkyl aluminium compound, in the presence of a catalytic amount of a metal compoundselected from the group consisting of Lewis acids, metallocenes and metal carbonylcomplexes. The process advantageously uses transition metal compounds as catalystsand the dibromomethane can be recovered. The process is especially useful for thepreparation of ingredients for the flavour and fragrance industry.

]57[

__________________

183714]21][11[

METHOD שיטה והתק� למיו� חלקיקי� AND APPARATUS FOR]54[


SORTING PARTICLES

17.04.2003]22[US]33[17.04.2002]32[60/373256]31[US24.06.2002 10/179488 US24.06.200210/179586US16.09.200260/411058US23.12.200210/329008

Int. Cl.(2010.01) B03B 05//22, B07C 05//34]51[DIVISION FROM 164601]62[CYTONOME/ST, LLC, U.S.A.]71[WO/2003/089158]87[



]74[

A method and apparatus for sorting particles (Fig. 1) caried in a fluid suspension thatare moving through a closed channel of a microstructure system (10), wherein a bubblevalve (25) is used to selectively generate a pressure pulse to separate a particle (18b)having a predetermined characteristic.

]57[

__________________

183722]21][11[

מערכת מכאנית לשינוי הספק בי� כניסתו ליציאתו

MECHANICAL SYSTEM FORPOWER CHANGE BETWEEN THEINPUT AND OUTPUT THEREOF

]54[

05.12.2005]22[US]33[06.12.2004]32[11/005399]31[

Int. Cl.(2010.01) F16H 33//00, 35//00, 57//00]51[QUINN INDUSTRIES, LLC, U.S.A.]71[TODD C. QUINN]72[


WO/2006/063040]87[,מ"בע) 1995(ארליך.אי.י'ג



]74[

The system includes at least two power disc elements (26, 42) each mounted forrotation on a central shaft which is typically fixed. The first power disc elementincludes a first peripheral gear portion (33) at the rim (32) thereof by which the firstpower disc element may be turned by a first system gear mounted on a first systemshaft which is offset from the central shaft. The first power disc element also has asecond peripheral gear portion (35) in the vicinity of the rim, extending forwardly. Asecond power disc element has a plurality of outer drive gears (50, 52, 54) mounted forrotation to a rearwardly facing surface thereof, positioned to mate with the secondperipheral gear portion on the first power disc element. A central gear (64) is fixed tothe central shaft to mate with the outer drive gears on the second power disc element.A second system gear mates with a peripheral gear portion of the second power discelement, the second system gear mounted on a second system shaft which is offsetfrom the central shaft. The central gear may be substantially larger in diameter than theouter drive gears. The forward peripheral gear portion on the first power disc elementalso may have a substantially smaller diameter than the outside diameter thereof.Further, the system can include two sets of power disc elements, with two members orless, wherein the power disc elements mate with an input/output power disc element sothat a single input can produce two output rotations, and vice versa.

]57[

__________________

183748]21][11[

METHOD שיטה ומערכת להרחבת אלומה בהתק� תצוגה AND SYSTEM FORBEAM EXPANSION IN A DISPLAYDEVICE

]54[

07.12.2005]22[US]33[13.12.2004]32[11/011480]31[

Int. Cl.(2010.01) G02B 27//01, 27//44]51[NOKIA CORPORATION, FINLAND]71[WO/2006/064325]87[

REINHOLD,ריינהולד כהן ושותפיו COHN AND PARTNERS,26A HABARZEL ST.,

]74[



RAMAT HACHAYAL 69710

An exit pupil extender wherein the relative amount of different color components inthe exit beam is more consistent with that of the input beam. In order to compensatefor the uneven amount in the diffracted color components in the exit beam, the exitpupil extender, comprises a plurality of layers having additional diffraction gratings soas to increase the amount of diffracted light for those color components with a loweramount. Additionally, color filters disposed between layers to reduce the diffractedlight components with a higher amount.

]57[

__________________

184136]21][11[

MOP דלי לסחבה BUCKET]54[

21.06.2007]22[ES]33[23.06.2006]32[U200601491]31[

Int. Cl.(2010.01) A47J 47//18, A47L 13//50, 13//58]51[SP BERNER PLASTIC GROUP, S.L.,SPAIN

]71[




]74[

A mop bucket comprising a hollow body or bucket (1) having a bottom part and anopen upper part, a mop wringer basket (3) provided on said open upper part and a pairof wheels (5) provided on said bottom part, wherein said wheels face the samedirection and are located forwardly of a transverse plane that contains the center ofgravity, wherein said bottom part comprises a rear portion (8) extending behind saidpair of wheels and a narrow front portion that faces outwards and upwards forwardlyof said pair of wheels in such a manner that, in a rest position, said bucket is onlysupported on a floor by said rear portion, and when a mop (9) is pressed against a frontpart of said bucket, said bucket will oscillate to a traveling position in which said rearportion will be lifted and cease to be supported by the floor, and said bucket will be

]57[


able to move while being supported by at least said pair of wheels.

__________________

184156]21][11[

PLASTIC בסיס לבקבוק פלסטיק BOTTLE BASE]54[

21.12.2005]22[IT]33[24.12.2004]32[PD2004A000323]31[

Int. Cl.(2010.01) B65D 01//02]51[ACQUA MINERALE S. BENEDETTO-S.P.A., ITALY

]71[




]74[

A bottle base made of plastic material, particularly for beverages, of the type whichhas, on its bottom (11) , reinforcement recesses. The reinforcement recesses comprise arecess (13, 113) which runs along a transverse reference dimension of the base (10,110); the recess (13, 113) forms a main rib (14, 114) inside the base (10,110).

]57[


__________________

184264]21][11[

, שיטה לאבטחת מיכלי� ולהשגחה עליה� ומיכל בעל אמצעי אבטחה והשגחה

METHOD FOR THE SECURINGAND MONITORING OFCONTAINERS AND CONTAINERWITH SECURING ANDMONITORING MEANS

]54[

21.06.2005]22[DE]33[06.01.2005]32[102005001118.7]31[

Int. Cl.(2010.01) B65D 79//02, G08B 13//12]51[DEUTSCHE POST AG, GERMANY]71[WO/2006/072268]87[

עורכי דין ועורכי, קבוצת איתן מהולל,פטנטים

10שדרות אבא אבן הרצליה2081.ד.ת,


]74[

The invention relates to a method for monitoring a container (10) for housing products(20), whereby one or more surfaces of the container are provided with an electrically-conducting material. Said material is used as sensor means (30) for the determinationof state changes in the physical properties of the container material and a dataprocessing unit (40) on the container obtains said state information from the sensormeans. Said method is characterised in that the position of the container (10) isdetermined by a positioning means (50) in connection with the container (10) and theposition of the container (10) is provided with the state information obtained from thesensor means (30). The invention relates to a container for housing products and forcarrying out said method.

]57[


__________________

184472]21][11[

PRESSURE התק� בקרת לח. למיכלי� CONTROL DEVICEFOR A CONTAINER

]54[

11.01.2006]22[NL]33[11.01.2005]32[1027998]31[

Int. Cl.(2010.01) B65D 81//26, 83//14]51[HEINEKEN SUPPLY CHAIN B.V.,THE NETHERLANDS

]71[




]74[

pressure control device (8) for medium-containing containers (2) such as liquid or gascontainers, which pressure control device comprises a pressure control chamber (25)with at least one movable wall part (22) for operating a mechanism for opening and/orclosing a gas supply opening (27) of a gas holder, while a scavenger (31) isaccommodated in the pressure control chamber. Preferably, the pressure control deviceis stored at atmospheric conditions before the beverage and the pressure control deviceare brought into contact .

]57[


__________________

184546]21][11[

MOTORIZED כלי שיט ממונע ע� מכשיר שליטה WATERCRAFT WITHCONTROL DEVICE

]54[

10.01.2006]22[DE]33[13.01.2005]32[102005001817.3]31[

Int. Cl.(2010.01) B63C 11//46]51[ROTINOR GMBH, GERMANY]71[WO/2006/074896]87[




]74[

The invention relates to a motorized watercraft with a control device (1) and with adrive unit (30) having a water propeller that is driven by an electric motor (31). Theelectric motor (31), an operating unit (10), a motor controller (20), a battery controller(50) and a battery (60) are placed in a vehicle hull, and the water propeller is mountedin a flow channel in the vehicle hull. In order to connect the controlling componentsand the components to be controlled by means of a system architecture, a system busand of a man-machine interface, the invention provides that the operating unit (10), themotor controller (20), and the battery controller (50) are data-connected by means of acommunications device controlled by the control device (1). This enables an, inparticular, fail-safe transmission of data, a constant monitoring of the systemcomponents, and when required, an emergency shut-down.

]57[

__________________


184625]21][11[

PERFUSION תמיסת שימור ופרפוסיה עבור איברי� ANDPRESERVATION SOLUTION FORORGANS

]54[

13.01.2006]22[US]33[14.01.2005]32[11/035197]31[

Int. Cl.(2010.01) A01N 01//02]51[PHILADELPHIA COLLEGE OFOSTEOPATHIC MEDICINE, U.S.A.

]71[




]74[

The present invention relates to a solution for preservation, perfusion, and/orreperfusion of an organ, especially the heart, for transplantation. The solution containspeptide inhibitor(s) of protein kinase C betaII (PKC betaII) and/or of protein kinase Czeta (PKCzeta) and/or peptide activator(s) of protein kinase C delta (PKCdelta).Methods for using the inventive solution are also disclosed, including methods forpreserving an organ for transplantation, for protecting an ischemic organ fromdamage, for attenuating organ dysfunction after ischemia, for maintaining nitric oxiderelease and/or inhibiting superoxide release in an ischemic organ, and for protecting anorgan from damage when isolated from the circulatory system.

]57[

__________________

185115]21][11[

INDEPENDENTLY מנעול התחברות אינטראקטיבי באופ� בלתי תלוי INTERACTIVEINTERCONNECTED LOCK

]54[

15.02.2006]22[


US]33[28.02.2005]32[11/069402]31[Int. Cl.(2010.01) E05B 59//00, 63//16]51[ASSA ABLOY INC., U.S.A.]71[WO/2006/093684]87[



]74[

An independently interactive interconnected lock includes an interconnectingmechanism that retracts a latchbolt and a deadbolt when an inner handle is movedbetween an up position, an intermediate position and a down position. The deadbolt isretracted by a deadbolt lock mechanism as the inner handle moves from the up positionto the intermediate position. The latchbolt is retracted by a latchbolt lock mechanismas the inner handle continues to move from the intermediate position to the downposition. When the inner handle is moved to the up position, both the latchbolt anddeadbolt are extended and the deadbolt lock mechanism is disconnected from thelatchbolt lock mechanism such that manipulation of the latchbolt lock mechanism toretract the latchbolt does not retract the deadbolt. The inner handle operates with lowhandle torque because the deadbolt and the latchbolt are not retracted simultaneously.

]57[

__________________

185217]21][11[

טריפלואורו–2,4,6–הלו–5שיטה ליצור חומצה איזופתאלית

METHOD FOR PRODUCING 5-HALO-2,4,6-TRIFLUOROISOPHTHALIC ACID

]54[

16.03.2006]22[DE]33[18.03.2005]32[102005013038.0]31[

Int. Cl.(2010.01) C07C 25//13, 51//08]51[BASF SE, GERMANY]71[WO/2006/097510]87[

REINHOLD,ריינהולד כהן ושותפיו COHN AND PARTNERS,]74[




The invention relates to a method for producing 5-halo-2,4,6-trifluoroisophthalic acidof formula (I), wherein X represents F, Cl, Br, or I, by hydrolysis of 5-halo-2,4,6-trifluoroisophthalodinitrile of formula (II). Said invention is characterised in that in afirst step, isophthalodinitrile (II) or a solution containing isophthalodinitrile (II) isreacted with a concentrated sulphuric acid at room temperature in order to form a 5-haIo-2,4,6-trifluoroisophthalodiamide of general formula (III), and is, subsequently,heated and in a second step, isophthalic acid (I) is produced after additional heatingand addition of water.

]57[

__________________

185255]21][11[

CRADLE נרתיק למכשיר תקשורת נישא ביד FOR A HANDHELDCOMMUNICATION DEVICE

]54[

14.08.2007]22[US]33[14.08.2006]32[11/503643]31[

Int. Cl.(2010.01) B60R 11//02, E05B 57//00, 65//12]51[HARRIS CORPORATION, U.S.A.]71[



]74[

A cradle for a handheld communication device (106), comprising:a rigid structure (160) defining a compartment for receiving at least a portion of ahandheld communication device, said compartment comprising an aperture and at leastone sidewall structure (314) extending from said aperture;a latch actuator (302) comprising a first end portion and a second end portion opposedfrom said first end portion, and movable in a sliding motion aligned with said at leastone sidewall structure between a first position and a second position;a latch (300) pivotally mounted to said rigid structure and coupled to said first endportion of said latch actuator;an engagement face (514) at least partially extending into said compartment when saidlatch actuator is in said first position, said engagement face directly or indirectlycoupled to said latch actuator; anda resilient member (304) resiliently biasing said latch actuator in said first position;

]57[


wherein a force applied to said engagement face when said handheld communicationdevice is inserted into said compartment causes said latch actuator to move said latchfrom a first latch position, where said latch is disengaged from said handheldcommunication device, to a second latch position in which said latch engages saidhandheld communication device.

__________________

185331]21][11[

BABY מושב לתינוק ברכב CAR SEAT]54[

16.02.2006]22[IL]33[17.02.2005]32[166957]31[IL01.08.2005 170021

Int. Cl.(2010.01) B60N 02//28]51[ כפר ויתקין, גדעון פסח

מיתר, צדוק פירסטGIDON PESACHZADOK FUERST

]71[


ר עומ, גן תעשייה באר שבע5352.ד.ת,


]74[

The present invention relates to a car baby seat system, which comprises: (a) a babyseat; (b) a supporting device for the baby seat; (c) positioning mechanism associatedwith said supporting device and baby seat, for transversally moving the supporting

]57[


device and baby seat along the rear passengers' seat between at least three states, a safecenter-car state, a side-car state, and a loading/unloading state, wherein in theloading/unloading state the baby seat is positioned by said mechanism at least partiallyoutside the car in a rotated orientation relative to the normal use orientation, therebyenabling convenience of loading and unloading of the baby, and additional space forrotation.

__________________

185700]21][11[

שיטה ומערכת לניווט של כלי טייס לא מאוייש באיזור עירוני

METHOD AND SYSTEM FORNAVIGATION OF AN UNMANNEDAERIAL VEHICLE IN AN URBANENVIRONMENT

]54[

04.09.2007]22[US]33[05.09.2006]32[11/470134]31[

Int. Cl.(2010.01) B64C 19//00, G01C 21//00]51[HONEYWELL INTERNATIONALINC., U.S.A.

]71[

,ריינהולד כהן ושותפיו'א26רזל רחוב הב

רמת החייל


]74[

A method for navigation of an unmanned aerial vehicle in an urban environment, themethod comprising:capturing a first set of Global Positioning System (GPS)-tagged images (210) in aninitial fly-over of the urban environment at a first altitude, with each of the GPS-tagged images being related to respective GPS-aided positions;stitching the captured GPS-tagged images (220) together into an image mosaic usingthe GPS-aided positions;capturing a second set of images in a subsequent fly-over (230) of the urbanenvironment at a second altitude that is lower than the first altitude;matching image features (240) from the second set of images with image features from

]57[


the image mosaic during the subsequent fly-over; andcalculating a current position of the unmanned aerial vehicle (250) relative to the GPS-aided positions based on the matched images features from the second set of imagesand the image mosaic.

__________________

185919]21][11[

METHOD שיטה ומערכת להרמת נוזל AND A SYSTEM FORRAISING A LIQUID

]54[

16.03.2006]22[EP]33[17.03.2005]32[05102128.5]31[

Int. Cl.(2010.01) F04F 01//02]51[FRANCOIS BRAUN, BELGIUM]71[WO/2006/097519]87[




]74[

A method and a device for extracting a liquid from a liquid pond, wherein in a firstphase air is removed from an airtight reservoir, a venting and a rising pipe in order tocreate depression therein and a suck-up of the liquid in the liquid pond. In a secondphase, a distribution device is brought from a first to a second operating position inorder to supply pressurised gas to said venting pipe which has an outlet connected tothe rising pipe. In a third phase the liquid is pushed from the venting pipe to the risingpipe and thereafter to the reservoir by means of pressurised air and an interfacemember. In a fourth phase the distribution device is brought back to its first operation

]57[


position.

__________________

186014]21][11[

]0. 3.3[אזאביציקלו–2תהלי� להכנת תולדות חומצה קרבוקסילית–3–אוקטא�

PROCESS FOR THE PREPARATIONOF 2-AZABICYCLO[3.3.0] OCTANE-3-CARBOXYLIC ACIDDERIVATIVES

]54[

02.03.2006]22[DE]33[19.03.2005]32[102005012771.1]31[

Int. Cl.(0) C07C 26/9/04, 27/1/06]51[EVONIK DEGUSSA GMBH,GERMANY

]71[




]74[

The present invention is aimed at a process for the preparation of compounds of thegeneral formula (I) through the hydrogeneration of cyclization of the intermediates ofthe formula (II)

]57[


__________________

186062]21][11[

שיטה להכנת�, פיפראזי�–תולדות אינדאניל ותכשירי רוקחות המכילי� אות�

INDANYL-PIPERAZINEDERIVATIVES, METHOD FORPREPARING SAME ANDPHARMACEUTICALCOMPOSITIONS CONTAININGSAME

]54[

29.03.2006]22[FR]33[30.03.2005]32[0503071]31[

Int. Cl.(2010.01) A61K 31//495, 31//496, A61P 01//08, 03//04, 25//08, 25//18, 25//22,25//24, 25//30, C07D 22/3/04, 29/5/08, 29/5/096, 29/5/12, 29/5/155, 40/1/12, 40/9/12

]51[

LES LABORATOIRES SERVIER,FRANCE

]71[




]74[

The invention concerns a compound of formula (I), wherein: R3 represents a hydrogenatom; and R1 and R2 form together, with the carbon atoms bearing them, a benzene,naphthalene or quinoline ring, each of said rings being optionally substituted, or R1

represents a hydrogen atom, and R2 and R3 form together, with the atoms bearingthem, a benzene, naphthalene or quinoline ring, each of said rings being optionallysubstituted; n represents 1 or 2;-X- represents a group selected among -(CH2)m-O-Ak-, -(CH2)m-NR4-Ak-, - (CO)-NR4-Ak- and -(CH2)m-NR4-(CO)-; m represents an integerbetween 1 and 6 inclusive; Ak represents an optionally substituted alkylene chain; andR4 represents a hydrogen atom or an alkyl group; Ar represents an aryl or heteroarylgroup; its optical isomers, as well as a pharmaceutically acceptable acid-addition saltthereof. The invention is applicable to medicines.

]57[


__________________

186196]21][11[

DEVICE התק� למינו� ולעירפול יבש FOR DOSING AND DRYNEBULIZATION

]54[

07.04.2006]22[DE]33[08.04.2005]32[102005016100.6]31[

Int. Cl.(2010.01) A61M 11//06, 15//00, 16//20, B05B 07//14, 11//06]51[NYCOMED GMBH, GERMANY]71[WO/2006/108558]87[



]74[

The invention relates to a device (1) for dosing and dry nebulization of nebulizablematerial (12) , comprising a nebulization channel (3) , which has a first attachmentpiece and a second attachment piece, and a source of compressed carrier gas connectedto the first attachment piece via a valve (16) for the purpose of sending a carrier gaspressure pulse into the nebulization channel. The device is characterized in thatbetween the first attachment piece and second attachment piece, and above thenebulization channel, a reservoir (10) open only towards the nebulization channel, andused for receiving the nebulizable material, is connected to the nebulizaton channelsuch that it is gas-tight with respect to the environment, and that, when the valve isclosed, a pressure compensation (22) takes place in the nebulization channel and in thereservoir. The invention also relates to the use of this device for inhaled administrationof a powdered pharmaceutical preparation, and to a method for dosing and drynebulization of nebulizable material by means of such a device.

]57[

__________________


186304]21][11[

DETACHABLE פרוב נתיק לניתוח בהקפאה ע� ידית מתנתקת CRYOSURGICALPROBE WITH BREAKAWAYHANDLE

]54[

26.04.2006]22[US]33[28.04.2005]32[11/116873]31[

Int. Cl.(2010.01) A61B 18//02]51[ENDOCARE, INC., U.S.A.]71[WO/2006/116457]87[

',שלמה כהן ושותר"ד 124אבן גבירול



]74[

The detachable cryosurgical probe includes a disposable probe assembly and areusable probe assembly. The disposable probe assembly includes a breakaway collar(44) which, when twisted away, activates a finger lock element (24) which providesrelease of the disposable probe assembly from the reusable probe assembly. Additionalfeatures include a safety valve assembly for impeding cryogenic working fluid flowwhen the disposable probe assembly is detached from the reusable probe assembly andan electrical confirmation assembly for providing electrical confirmation that thedisposable probe assembly is connected. Other embodiments include a slidingmechanism that allows for selectively positioning of the vacuum tube relative to theshaft to create an ice ball of the desired size and configuration.

]57[

__________________

186655]21][11[

הרכבי� המכילי� קסילוגלוקא� נדבקלריריות היעילי� בהתקני� רפואיי�

ובהרכבי רוקחות ותהלי� לטיהור פולימר טבעי בעל מבנה קסילוגלוקאני

MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONSUSEFUL IN MEDICAL DEVICESAND IN PHARMACEUTICALFORMULATIONS AND A PROCESSFOR PURIFICATION OF NATURALPOLYMER HAVING XYLOGLUCANSTRUCTURE

]54[


01.06.2006]22[IT]33[06.06.2005]32[BO2005A000388]31[

Int. Cl.(2010.01) A61K 09//00]51[ALFA WASSERMANN S.P.A., ITALY]71[WO/2006/131262]87[



]74[

Object of the invention are mucoadhesive and controlled release formulationsconsisting of aqueous solutions containing 0.05% to 5% by weight of a natural purifiedpolymer having xyloglucan structure and 10% to 70% by weight of glycerol. Theseformulations are suitable for the application on human mucous membranes, such asnasal, oral and vaginal mucous membranes, as moisturizing and softening agents or aspharmaceutical release system. Further objects of the invention are pharmaceuticalformulations and medical devices suitable for the application to human mucousmembranes, containing the mucoadhesive and controlled release formulations togetherwith active ingredients and excipients.

]57[

__________________

187622]21][11[

LOCATING מתק� מיקו� למדפסת הזרקת דיו DEVICE FOR AN INK-JET PRINTER

]54[

24.05.2006]22[AT]33[25.05.2005]32[A 895/2005]31[

Int. Cl.(2010.01) B41J 02//01, 11//00, 11//06, 13//00]51[DURST PHOTOTECHNIK DIGITALTECHNOLOGY GMBH, AUSTRIA

]71[

WO/2006/125239]87[,כהן ושותפיוריינהולד



]74[

The invention relates to an locating device for an ink-jet printing device (1) for variousprinting media (2), comprising a printing head arrangement (3) with at least oneprinting head (4) for printing the medium (2), a printing table (11), forming a supportplane (12) for support of the medium (2) for printing, and, in said support plane (12),openings (13) of a vacuum device (14) are provided at least in some areas for holding

]57[


the medium (2) during the printing process and a feed device (6) for the medium (2)for printing. Within the printing table (11), the medium (2) for printing is providedwith at least one pressure device (16) at least in the region of a side edge facing thefeed direction (7) with a pressure force acting perpendicularly relative to the supportplane (12).

__________________

187866]21][11[

RNAשיטות וערכות לייצור SENSEMETHODS AND KITS FOR SENSERNA SYNTHESIS

]54[

08.06.2006]22[US]33[10.06.2005]32[11/150794]31[

Int. Cl.(2010.01) C07H 21//04, C12P 19//34, C12Q 01//68]51[GENISPHERE, LLC]71[WO/2006/135684]87[




]74[

Methods and kits are provided for performing multiple rounds of sense RNA synthesis.The sense RNA molecules can be used in various research and diagnostic applications,such as gene expression studies involving nucleic acid microarrays.

]57[


__________________

188604]21][11[

שיטות, טבעת מלחצת וחיבורי� לצינורות וסידורי� המכילי� אותה

CLAMPING RING AND PIPECONNECTIONS AND METHODSAND ARRANGEMENTSCOMPRISING SAME

]54[

07.07.2006]22[EP]33[08.07.2005]32[05106243.8]31[

Int. Cl.(2010.01) B29C 45//00, 65//68, F16L 47//22]51[UPONOR INNOVATION AB,SWEDEN

]71[

JARMO SMAHL, PETER HAUKI,THOMAS LARSSON, YNGVELUNDEQUIST, MATS HALLEN

]72[




]74[

A pipe connection comprises a connecting piece (2), a pipe (1 ) and a clamping ring(6). The pipe (1) and the clamping ring (6) are made of a material having memoryproperties. An end of the pipe (1) and the clamping ring (6) have been reversiblyexpanded co-jointly and firmly and sealingly shrunk to the connecting piece (2) byback shrinkage. Preferably the clamping ring (6) is made from a cross-linkedpolyolefin by injection molding.

]57[

__________________


189180]21][11[

METHOD תהלי� להכנת ביקלוטאמיד וגביש הימנו FOR PRODUCINGBICALUTAMIDE AND ACRYSTAL THEREOF

]54[

13.12.2002]22[JP]33[13.12.2001]32[2001-380686]31[JP06.06.2002 2002-166213

Int. Cl.(2010.01) C07C 31/5/02, 31/7/44]51[DIVISION FROM 162398]62[SUMITOMO CHEMICALCOMPANY, LIMITED, JAPAN

]71[



]74[

The invention relates to crystals of bicalutamide having a specific crystal form, andindustrially practicable processes for the production of bicalutamide and crystalsthereof which are excellent in environmental friendliness, economical efficiency, andsafeness. The invention provides a process for the production of bicalutamiderepresented by formula (1)&colon; (1) characterized by comprising at least the step ofreacting a compound represented by formula (3) with an oxidizing agent&colon; (3) aprocess for the production of crystals of bicalutamide&semi; and a crystal form ofbicalutamide as determined by X−ray diffraction (XRD) or solid−state13C NMRspectroscopy.

]57[

__________________

189608]21][11[

מכלול מחט עבור מערכת הזרקה המלאה טר� ההזרקה

NEEDLE ASSEMBLY FOR APREFILLED SYRINGE SYSTEM

]54[


03.08.2006]22[EP]33[30.08.2005]32[05255298.1]31[

Int. Cl.(2010.01) A61M 05//32]51[CILAG GMBH INTERNATIONAL,SWITZERLAND

]71[




]74[

A needle assembly (10; 210) for a prefilled injection syringe is described. A needleholder (12; 212) has a needle (14; 214) secured to it and is adapted to be secured to asyringe barrel of the injection syringe. A needle sheath (16; 216) has a distal endforming a releasable sterile seal with the needle holder (12; 212), and surrounds andshields the needle (14; 214) . A needle seal (18; 218) surmounts the needle tip and isarranged at least in part in the proximal end of the needle sheath (16; 216) and closedoff by a closure element (20; 220) . A closure connection between the closure element(20; 220) and the needle sheath (16; 216) is configured as a non-releasable and sterilebarrier (54; 254) produced by means of bonding or welding.

]57[

__________________

189750]21][11[

התקני� לאספקה של חיסוני� דר� העורולאספקה של תרופות דר� העור והשימושי�

בה�

DEVICES FORTRANSCUTANEOUS DELIVERYOF VACCINES ANDTRANSDERMAL DELIVERY OFDRUGS AND USES THEREOF

]54[

05.09.2006]22[US]33[02.09.2005]32[60/714073]31[

Int. Cl.(2010.01) A61M 35//00, 37//00]51[INTERCELL USA,INC., U.S.A.]71[


WO/2007/028167]87[',זליגסון גבריאלי ושות

31יבנה' רח תל אביב1426.ד.ת,


]74[

The invention provides devices for the disruption of one or more layers of skin andmethods of their use to administer therapeutic agents,e.g., antigens or drugs. Thedevices are designed to disrupt a defined area of skin. The defined area canapproximate the area that a patch or other suitable vehicle for therapeutic agent, e.g.,drug or vaccine, delivery is designed to contact. Exemplary devices employ a mask todefine the area to be disrupted. Other devices disrupt a defined area by rotating inplace. For devices that employ a mask that is secured to the skin, the inventionprovides methods of disrupting the stratum corneum by first securing the mask to theskin and then disrupting the skin. For rotating devices, the disrupting member issimply placed against the skin and actuated to effect disruption.

]57[



__________________

191131]21][11[

DROSPIRENONE דרוספירנו� לטיפול הורמונלי חילופי FOR HORMONEREPLACEMENT THERAPY

]54[

18.01.2001]22[EP]33[18.01.2000]32[00200183.2]31[US18.01.2000 09/484026

Int. Cl.(2010.01) A61K 31//585]51[DIVISION FROM 150775]62[BAYER SCHERING PHARMAAKTIENGESELLSCHAFT,GERMANY

]71[

WOLFGANG HEIL, JURGENHILMANN, RALPH LIPP, ROLFSCHURMANN

]72[




]74[

A pharmaceutical composition comprising drospirenone together with a]57[


pharmaceutically acceptable carrier of excipient, wherein said composition does notcontain an estrogen and wherein said drospirenone is in micronised form.

__________________

191223]21][11[

MANDRELש להדפסה דיגיטלית על גבי פחיותסר� המשמ FOR USE FORDIGITAL PRINTING ON CANMEMBERS

]54[

03.11.2006]22[EP]33[03.11.2005]32[05110323.2]31[

Int. Cl.(2010.01) B41F 17//00]51[BALL PACKAGING EUROPEHOLDING GMBH & CO. KG,GERMANY

]71[




]74[

Disclosed is a mandrel for a rotationally symmetric hollow member embodied as abeverage can that is monolithically composed of a body and a bottom. The aim of theinvention is to transmit accurate coupling and precise controlling of the movement ofthe mandrel to the hollow member. Said aim is achieved by providing severalclamping segments (2; 2a, 2b, 2c) that form an outward-facing cylindrical clampingarea (16) so as to grip an internal surface of the hollow member. The clampingsegments are guided in a radially movable manner. A force transmitting mechanism(10, 13) that is arranged inside the mandrel (1) is used for synchronously controllingthe radial movement of the clamping segments (2) such that a hollow member which isclamped by the clamping device can be accurately moved in a controlled fashion.

]57[

__________________


192255]21][11[

ARTIFICIAL דשא מלאכותי לנו GRASS FORLANDSCAPING

]54[

05.09.2001]22[US]33[05.09.2000]32[60/229601]31[US21.03.2001 60/277274

Int. Cl.(2010.01) E01C 09//00]51[DIVISION FROM 154637]62[FIELDTURF TARKETT INC.,CANADA

]71[




]74[

A synthetic turf system (10) to be illuminated, the synthetic turf system comprising:an artifical turf (14) having a surface and a plurality of synthetic turf fibers (20)extending away from a backing material (18) being supported by a base and an infill(22) interspersed between the synthetic turf fibers; and,between the individual synthetic turf fibers so that the lighting material whenilluminated by the light source is visible on the surface of the artificial turf.

]57[

__________________

193149]21][11[

ותרכובות רוקחיות הכוללותC17–ILנוגד� כנגד אותו

ANTI IL-17C ANTIBODY ANDTHERAPEUTIC COMPOSITIONSCOMPRISING SAME

]54[

14.05.1999]22[US]33[15.05.1998]32[60/085579]31[US23.12.1998 60/113621


Int. Cl.(2010.01) A61K 39//395, C07K 16//24]51[DIVISION FROM 138930]62[GENENTECH, INC., U.S.A.]71[WO/1999/060127]87[



]74[

An antibody which specifically binds to a polypeptide selected from the groupconsisting of:(a) an LL-17C (Interleukin 17C) polypeptide consisting of the sequence of amino acidresidues 1 to 197 shown in Figure 3 (SEQ ID IN: 3), and(b) an LL-17C polypeptide consisting of the sequence of amino acid residues 19 to 197shown in Figure 3 (SEW ID IN: 3).

]57[

__________________

921931]21][11[

שיטות לתפעול הרכבת פילטר לפתח כניסת האוויר של מנוע

METHOD OF OPERATING ANENGINE AIR INTAKE FILTERASSEMBLY

]54[

02.06.2000]22[US]33[03.06.1999]32[09/325697]31[US01.12.1999 09/452311

Int. Cl.(2010.01) B01D 46//00, F02M 35//08]51[DIVISION FROM 167798]62[DONALDSON COMPANY, INC.,U.S.A.

]71[


עומר, גן תעשייהLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

]74[


.P.O.B באר שבע5352.ד.ת, 5352,BEER-SHEVA 84152A method of operating an engine air intake filter assembly having a pulse jet cleaningarrangement constructed and arranged to selectively direct pulses of air through an airfilter arrangement, the method comprising:(a) measuring time of operation since a previous pulse valve arrangement operation;and, if a preselected period of time has occurred, actuating a pulse jet cleaning system;measuring an accumulator tank pressure; and, activating a pulse valve arrangement, ifthe accumulator tank pressure is determined to be at least a predetermined accumulatorpressure, to direct one or more pulses of air, in a reverse direction, through the air filterarrangement; and, also,(b) measuring a pressure drop across the air filter arrangement; and, if a measuredpressure drop across the air filter arrangement exceeds a predetermined pressure drop,actuating the pulse jet cleaning system; and, activating the pulse valve arrangement, ifaccumulator tank pressure is determined to be at least a predetermined accumulatorpressure, to direct one or more pulses of air, in a reverse direction, through the air filterarrangement.

]57[

__________________

193373]21][11[

ד יכ.א.נ.רצפי ולת לויסות שעתוק ושיטות בעלי לגילוי ולשימוש ברצפי� אלו

DNA SEQUENCES COMPRISINGGENE TRANSCRIPTIONREGULATORY QUALITIES ANDMETHODS FOR DETECTING ANDUSING SUCH DNA SEQUENCES

]54[

14.06.2002]22[EP]33[04.07.2001]32[01202581.3]31[US05.07.2001 60/303199

Int. Cl.(2010.01) C12N 15//11, 15//67, 15//85]51[DIVISION FROM 159674]62[CHROMAGENICS B.V., THENETHERLANDS

]71[

ARIE PIETER OTTE, ARTHUR LEOKRUCKEBERG

]72[


,פטנטיםEITAN MEHULAL LAW GROUP,10 ABBA EBEN BLVD.,

]74[


10אבן שדרות אבא הרצליה2081.ד.ת,

P.O. B. 2081,HERZLIYA 46120

The invention is concerned with the systematic elucidation and identification ofregulatory sequences. The invention provides among others screenings and detectionmethods with which regulatory sequences can be identified. The invention furtherprovides regulatory sequences and use thereof in various fields such as, but not limitedto protein production, diagnostics, transgenic plants and animals, and the therapeuticfield.

]57[

__________________

193374]21][11[

ד א בעלי יכולת לויסות שעתוק ושיטות.נ.רצפי לגילוי ולשימוש ברצפי� אלו

DNA SEQUENCES COMPRISINGGENE TRANSCRIPTIONREGULATORY QUALITIES ANDMETHODS FOR DETECTING ANDUSING SUCH DNA SEQUENCES

]54[

14.06.2002]22[EP]33[04.07.2001]32[01202581.3]31[US05.07.2001 60/303199

Int. Cl.(2010.01) C12N 15//11, 15//67, 15//85]51[DIVISION FROM 159674]62[CHROMAGENICS B.V., THENETHERLANDS

]71[

ARIE PIETER OTTE, ARTHUR LEOKRUCKEBERG

]72[


,פטנטים10שדרות אבא אבן



]74[

The invention is concerned with the systematic elucidation and identification ofregulatory sequences. The invention provides among others screenings and detectionmethods with which regulatory sequences can be identified. The invention furtherprovides regulatory sequences and use thereof in various fields such as, but not limitedto protein production, diagnostics, transgenic plants and animals, and the therapeuticfield.

]57[


__________________

193803]21][11[

MANAGING ניהול טלפוניה מבוססת חבילות PACKET-BASEDTELEPHONY

]54[

18.09.2002]22[US]33[22.10.2001]32[60/350685]31[US23.05.2002 10/154056

Int. Cl.(2010.01) H04L 12//66, H04M 03//00, 03//42]51[DIVISION FROM 151798]62[MICROSOFT CORPORATION,U.S.A.

]71[




]74[

A computerized method for assisting a user in selecting and registering with one of aplurality of packet-based telephony service providers, the method comprising:determining, by one or more computing devices, whether a user has registered forservice with one or more of the plurality of packet-based telephony service providers;in response to determining that the user is not registered with the one or more of theplurality of packet-based telephony service providers, providing, from the one or morecomputing devices, to the user a list of packet-based telephony service providers,wherein said packet-based telephony service providers on the list have not providedtelephony service to the user;providing, from the one or more computing devices, one or more parametersassociated with each of the packet-based telephony service providers on the list to theuser, said one or more parameters including at least one of the following: a reputationof the packet-based telephony service provider, a geographic region served by thepacket-based telephony service provider, a language supported by the packet-basedtelephony service provider, and pricing of the service of the packet-based telephonyservice provider;receiving, at the one or more computing devices, from the user a selection of one of thepacket-based telephony service providers on the list, said selection being indicative ofthe one or more parameters of the packet-based telephony service provider desired bythe user;storing, at a memory area accessible by the one or more computing devices,information indicating that registration of the user with said selected one of the packet-based telephony service providers is pending;sending, from the one or more computing devices, registration information of the userto said selected one of the packet-based telephony service providers, said registrationinformation including confirmation that registration is pending for the selected packet-based telephony service provider; and

]57[


receiving at the one or more computing devices, information from said one of thepacket-based telephony service providers indicating that the user is registeredtherewith, and modifying the stored information to indicate that registration of theuser with said one of the packet-based telephony service providers has occurred.

__________________

194381]21][11[

TIMING שיטה תזמו� סגירה CLOSUREMETHODOLOGY

]54[

22.12.1998]22[US]33[24.12.1997]32[60/068827]31[US02.04.1998 09/054379

Int. Cl.(2010.01) G06F 17//50, H01L 21//70, 21//82]51[DIVISION FROM 136709]62[INTERNATIONAL BUSINESSMACHINES CORPORATION, U.S.A.SYNOPSYS, INC., U.S.A.

]71[




]74[

An automated method for designing an integrated circuit layout with a computer,comprising:(a) selecting a plurality of cells that are intended to be used in the integrated circuitlayout;(b) determining delay values for corresponding cells in the selected plurality of cells asa function of delay to be provided by the corresponding cells and delay to be providedby loads on the corresponding cells in order to satisfy delay constraints; and(c) performing a placement of the selected plurality of cells after determining saiddelay values, the placement including assigning loads for the selected plurality of cellsand determining size or area of the selected plurality of cells in response to saidassigned loads and said delay values.

]57[


The 136709בקשת הורה לבקשה זו שטר� פורסמה parent application from whichthis application has been divided hasnot yet been published

__________________

194534]21][11[

ANTHRANILAMIDE תכשירי אנתרנילאמיד להדברת פרוקי רגליי�COMPOSITIONS FORCONTROLLING ARTHROPODS

]54[

20.03.2001]22[US]33[22.03.2000]32[60/191242]31[US24.07.2000 60/220232 US11.12.200060/254635US17.01.200160/262015

Int. Cl.(2010.01) A01N 43//00, 47//02, 55//10, C07C 23/7/30, 32/7/48, C07D 20/7/34,21/3/78, 23/1/14, 23/9/28, 26/1/08, 26/3/34, 27/7/56, 33/3/38, 40/1/12, 51/3/04, C07F07//18

]51[

DIVISION FROM 151267]62[E.I. DU PONT DE NEMOURS ANDCOMPANY, U.S.A.

]71[




]74[

This invention provides compounds of Formula (1), theirN-oxides and agriculturallysuitable salts wherein A, B, J, R1, R2, R3 and R4 and n are as defined in thedisclosure. Also disclosed are methods for controlling arthropods comprisingcontacting the arthropods or their environment with an arthropodicidally effectiveamount of a compound of Formula (1) and compositions containing the compounds ofFormula (1).

]57[


__________________

195723]21][11[

USE להכנת תכשיר רפואי53Pשימוש במעכבי� של OF P53 INHIBITORS FORTHE PREPARATION OFMEDICAMENT

]54[

28.01.2000]22[US]33[29.01.1999]32[60/117881]31[

Int. Cl.(2010.01) A61K 31//427, 31//428, 31//429, 45//00, 45//06]51[DIVISION FROM 144294]62[BOARD OF TRUSTEES OF THEUNIVERSITY OF ILLINOIS

]71[

WO/2000/044364]87[בע.אי.קיו בי ,מ"מפעלים

יהודית אברהמס' לידי דר ציונה-נס4071.ד.ת,

QBI ENTERPRISES LTD.,P.O.B. 4071NESS-ZIONA 70400

]74[

The therapeutic use of temporary p53 inhibitors in the treatment of p53-mediateddiseases, conditions, and injuries is disclosed.

]57[

__________________

197620]21][11[

פל(שיטה לחיזוק תקרות וופלה –)קל–לדוגמה ותקרות מחוזקות על פי שיטה

METHOD OF REINFORCING AWAFFLE-STRUCTURE CEILINGAND CEILING REINFORCED

THEREBY

]54[

16.03.2009]22[


Int. Cl.(2010.01) E04G 23//02, 23//04]51[AHARON כפר ורדים, אהרון רביץ RAVITZ]71[

בי'ג בע, יי אמ ,מ"פקטור אנד קו הר חוצבים, רחוב המרפא

ירושלים45087.ד.ת,


]74[

A method of reinforcing a waffle-structure ceiling (110) comprising vertical members(112) around forms (114) and a continuous upper layer (118) covering the verticalmembers and forms, the method comprising:drilling at least one hole (60) at least half way through at least one vertical member,and inserting a reinforcement pin (40) into the hole such that shear stresses on thevertical member are transferred to the pin, and comprising at least one of the followinglimitations:

(a) the drilling is from above and the hole passes through the upper layer and atleast half way through the vertical member;(b) the drilling is from above and the hole passes into a lower layer (122) and is ablind hole;(c) the drilling is from above and the hole passes through the lower layer and is athrough hole;(d) the drilling is from above and the hole passes at least half way through thevertical member;(e) the hole is a through hole and the adhesive (50) is provided in excess such thata blob of adhesive is formed beyond the farther surface from a point of injection,and(f) the hole is a through hole, the pin is threaded at both ends and lockingcomprises applying nuts onto the threaded ends thereby tensioning the pin andcompressing the structure therearound.

]57[

לתקנות35פירוט זה נבח) בהתא� לתקנה 1968–ח"תשכ,�הפטנטי

This specification was examined inaccordance with regulation 35 of the PatentRegulations, 5728 - 1968

__________________

197624]21][11[


METHOD שיטה ליצור ומילוי של מיכל אטו� OF MAKING ANDFILLING A SEALED CONTAINER

]54[

03.09.2003]22[US]33[03.09.2002]32[60/408068]31[

Int. Cl.(2010.01) A61J 01//14, B65B 03//04, B65D 53//00, B67B 03//24]51[DIVISION FROM 167224]62[MEDICAL INSTILLTECHNOLOGIES, INC., U.S.A.

]71[



]74[

A method comprising the following steps:forming a container body defining a chamber in a first mold in a clean roomenvironment;forming, in a second mold in the same clean room environment as the first mold, athermoplastic stopper defining a needle penetration region that is pierceable with aneedle to form a needle aperture therethrough and heat resealable to hermeticallyseal the needle aperture by applying laser radiation at a predetermined wavelengthand power thereto; andassembling the stopper and container body in the clean room environment to forma sealed empty chamber.

]57[



__________________

198164]21][11[

מערכת לקיו� ועידת שמע ומראה מרובת נקודות חיבור

MULTIPOINT AUDIOVISUALCONFERENCING SYSTEM

]54[


30.01.2003]22[US]33[30.01.2002]32[60/353053]31[

Int. Cl.(2010.01) G06F 13//00, H04J 03//16, H04L 12//18, 12//28, 12//66, H04M03//56, 07//00, 11//00, H04N 07//15, H04Q 11//04

]51[

DIVISION FROM 163299]62[INTERACTIVE IDEAS LLC, U.S.A.]71[WO/2003/065706]87[



]74[

A program storage device, tangibly embodying a program of instructions executableby a machine to perform a method for establishing a connection for an endpoint to ascheduled audiovisual conference between a plurality of participants, the plurality ofparticipants connecting to the audiovisual conference from a plurality of endpoints,connections for the plurality of endpoints to the audiovisual conference beingmaintained by a multipoint control unit, said instructions embodied in said programstorage device comprising:(a) receiving a request at a conference control server from a participant to connect anendpoint associated with the participant to the scheduled audiovisual conference;(b) obtaining an IP address or a telephone number for the endpoint;(c) writing the IP address or the telephone number for the endpoint to the multipointcontrol unit;(d) communicating audiovisual conference data from the multipoint control unit to theendpoint via the IP address or the telephone number, thereby facilitating a dynamicallyallocated IP address or a dynamically provided ISDN/PSTN telephone number for atleast one endpoint in an audiovisual conference and enabling the endpoint to beconnected to the audiovisual conference.

]57[

__________________

200056]21][11[

תכשיר הכולל נוגד� אגוניסטי מבודד אשר מגיבלשימוש בהשראת, שוני�Apo–2Lע� קולטני

מוות בתאי סרט� מיונקי�

COMPOSITION COMPRISING ANISOLATED AGONISTICANTIBODY WHICHSPECIFICALLY CROSS REACTSWITH DIFFERENT APO - 2LRECEPTORS FOR USE IN

]54[


INDUCING APOPTOSIS INMAMMALIAN CANCER CELLS

10.06.1999]22[US]33[12.06.1998]32[09/096637]31[

Int. Cl.(2010.01) A61K 39//395, C07K 16//28]51[DIVISION FROM 139419]62[GENENTECH, INC., U.S.A.]71[WO/1999/064461]87[



]74[

A method of making monoclonal antibodies according to a mixed antigenimmunization protocol is described. In addition, antibodies obtainable by the methodare disclosed which specifically cross-react with two or more different receptors towhich Apo-2 ligand (Apo-2L) can bind.

]57[


__________________

200686]21][11[

APPARATUS עצמותמכשיר לגילו פני השטח של מפרק בי� FOR SCULPTINGTHE SURFACE OF A BONE JOINT

]54[

14.06.2002]22[US]33[14.06.2001]32[09/882591]31[US12.02.2002 10/075829

Int. Cl.(2010.01) A61B 17//16, 17//32, 17//56, A61F 02//32, 02//46]51[DIVISION FROM 159325]62[ALEXANDRIA RESEARCHTECHNOLOGIES LLC

]71[




]74[

An apparatus for sculpting the articular surface of a first bone (10) that normallyarticulates in a predetermined manner with a second bone (16), the apparatuscomprising, a bone sculpting tool (60) for sculpting the articular surface of the first

]57[


bone, and a bone mount (62), in which, the bone sculpting tool is attached to the bonemount,characterized in that the bone mount is attachable to the second bone betweenthe first and second bone such that the bone-sculpting tool is in bone-sculptingengagement with the articular surface of the first bone so that the articular surface ofthe first bone can be sculpted as one of the bones is articulated relative to the other.


__________________

202789]21][11[

יצור ציוד משתמש לזיהוי קוד מערבל יחודי עבור ערו. מהיר בעל שיתו מבוקר

GENERATION OF USEREQUIPMENT IDENTIFICATIONSPECIFIC SCRAMBLING CODEFOR THE HIGH SPEED SHAREDCONTROL CHANNEL

]54[

05.05.2003]22[US]33[07.05.2002]32[60/378509]31[US13.05.2002 60/378170 US01.07.200210/187640

Int. Cl.(2010.01) H04N 07//167]51[DIVISION FROM 183067]62[INTERDIGITAL TECHNOLOGYCORPORATION, U.S.A.

]71[





]74[

An apparatus comprising:an input configured to accept a user identification comprising L bits; anda 1/2 rate convolutional encoder for processing at least the bits of the useridentification by a1/2 rate convolutional code to produce a code used for scrambing ahigh speed shared control channel (HS-SCCH).

]57[

__________________


PATENTS פטנטים

פטנטים שניתנוPATENTS GRANTED

151353 151211 137520 137489 136454 135607 134578 115382 152317 152284 152215 151857 151746 151729 151570 151479 153295 153291 153289 153067 153058 152754 152654 152414 153818 153720 153682 153656 153394 153333 153320 153317 154426 154346 154327 154318 154294 154155 154006 153894 154790 154723 154712 154658 154657 154544 154529 154520 155546 155471 155466 155297 155228 155123 155018 154853 172835 155850 155823 155787 155778 155702 155612 155611 173224 173137 173078 173056 173034 172874 172838 172837 173609 173530 173517 173363 173345 173309 173291 173230 174198 174118 174089 174024 173989 173981 173745 173713 174734 174727 174496 174487 174408 174309 174272 174219 175261 175234 175231 175162 175079 174956 174914 174751 175906 175771 175591 175548 175507 175501 175462 175287 176455 176410 176405 176379 176358 176212 176076 175975 176845 176787 176736 176724 176611 176593 176478 176466 177390 177334 177306 177182 177086 177027 177026 176859 177775 177720 177600 177521 177517 177485 177469 177393 178567 178316 178204 178131 178077 177846 177804 177777 178949 178867 178858 178836 178752 178656 178624 178570 179652 179551 179549 179542 179219 179119 179027 178994 138716 138473 123646 121243 179860 179704 179657 179655 141531 141221 140937 140893 140604 140136 140090 138759 156106 156089 156012 142231 141846 141797 141759 141613 156617 156562 156434 156282 156214 156190 156117 156111 157123 157041 156984 156982 156973 156962 156903 156853 157550 157541 157533 157469 157427 157405 157239 157163 158109 158097 157974 157891 157828 157793 157752 157558 158653 158601 158534 158427 158364 158246 158209 158208 159301 159247 159221 159220 158983 158859 158858 158730 159665 159664 159565 159535 159518 159387 159371 159337 160000 159973 159862 159851 159819 159807 159717 159716 160527 160439 160408 160403 160389 160329 160322 160249 180100 180086 180033 179971 160803 160732 160681 160556 182072 181446 180922 180720 180593 180473 180388 180214 187061 186144 185764 185387 184227 182324 182282 182272 142440 132670 132049 131561 131149 108328 187592 187482 144467 143847 143534 142959 142852 142815 142631 142516 146295 146193 146042 145938 145919 145895 145536 145395


166996 166921 166708 166688 166680 166657 166655 166572 167437 167299 167291 167287 167160 167085 167074 167016 168074 167924 167868 167725 167655 167625 167597 167464 168680 168562 168475 168453 168343 168258 168158 168133 169071 168946 168928 168882 168832 168800 168742 168728 169368 169270 169236 169235 169151 169119 169093 169076 169878 169766 169762 169577 169556 169498 169422 169407 170355 170310 170295 170246 170232 170200 170140 169970 170570 170569 170548 170485 170480 170473 170407 170365 170983 170888 170864 170851 170759 170755 170626 170573 171680 171670 171522 171509 171354 171309 171249 171168 171888 171887 171886 171855 171785 171754 171745 171734 172397 172312 172288 172219 171905 171891 171890 171889 172687 172642 172625 172594 172558 172523 172446 172431 146918 146659 146486 146395 128331 126126 114278 172740 148251 148113 147715 147472 147447 147446 147321 147167 149600 149282 149142 148945 148908 148806 148582 148261 150772 150763 150674 150367 150350 150334 150243 150021 161158 161147 161136 161135 161127 161112 161019 161015 161415 161410 161338 161301 161244 161201 161193 161189 161728 161687 161677 161651 161625 161608 161538 161533 162334 162305 162237 162187 162130 162057 161889 161837 162557 162538 162509 162498 162423 162375 162371 162335 163106 163090 163025 163016 162983 162740 162652 162627 163495 163489 163465 163314 163313 163186 163157 163117 164054 164013 163792 163735 163714 163582 163565 163557 164468 164458 164435 164417 164385 164114 164108 164097 164862 164736 164721 164685 164588 164568 164534 164482 165181 165143 165131 165120 165044 164970 164926 164901 165529 165519 165502 165419 165390 165341 165326 165265 166274 166073 165987 165982 165658 165630 165588 165585 189430 189161 188703 188464 166476 166397 166352 166321

196978 193064 192597 190905

פטנטים שחודשוPATENTS RENEWED

103286 103214 103192 103191 103183 103182 103176 103017 119239 119238 119226 119217 113671 103303 103301 103288 119329 119328 119324 119322 119316 119314 119310 119298 123563 123521 123418 120977 120771 120750 119590 119333 123755 123720 123709 123640 123635 123632 123604 123565 124467 124019 123964 123954 123953 123821 123815 123776 137546 137084 136450 133868 131261 129476 129073 124987 138454 138418 138394 138355 138290 138229 138037 137986 138865 138710 138695 138661 138651 138634 138581 138567


142982 140033 139784 139327 138897 138879 138867 138866 147334 146983 144400 144361 144270 144202 144118 143375 148337 148330 148320 148309 148140 147927 147652 147335 148456 148454 148440 148370 148369 148367 148365 148363 148620 148595 148574 148570 148530 148529 148494 148488 148670 148659 148645 148638 148635 148633 148629 148621 148858 148840 148803 148765 148764 148747 148728 148709 149644 149026 148970 148917 148910 148880 148872 148868 151094 150676 150613 150350 150293 150167 150120 150111 153904 153183 152620 152256 152112 151940 151918 151441 154405 154341 154340 154339 154338 154337 154266 153922 156994 156799 156611 156423 156041 155392 155234 154618 158107 157875 157854 157753 157616 157392 157304 157047 159255 159239 159023 158867 158854 158785 158331 158242 159829 159825 159803 159788 159525 159507 159485 159362 160327 160191 160062 160038 160029 160024 159984 159930 161179 161076 160929 160914 160894 160846 160595 160335 162132 162126 162109 161866 161794 161702 161419 161233 162915 162835 162782 162737 162558 162449 162403 162163 164277 164237 164081 163781 163299 163237 163042 162997 164575 164551 164439 164348 164335 164320 164317 164312 165292 165126 164958 164940 164894 164859 164856 164836 165766 165747 165727 165701 165697 165521 165500 165422 166563 166321 166255 166154 166111 165956 165809 165795 167242 167056 167045 166949 166929 166815 166779 166672 167824 167807 167776 167685 167591 167325 167314 167290 168659 168246 168185 168125 167965 167893 167885 167872 170153 170117 170067 169958 169862 169673 169584 169141 171712 171663 170872 170796 170320 170210 170204 170179 173520 173475 173469 173028 172805 172218 172152 172125 174662 174492 174290 174057 174032 174027 173668 173540 176221 175854 175208 175162 174971 174966 174905 174725 179720 178712 178206 178018 177908 177135 176434 176421 189779 189508 189507 188860 184686 182744 180016 179989

197396 192394

פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידושPATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL

FEES

138984 138925 138707 127480 114570 112325 109052 108708 157836 157506 157103 156007 140502 140501 139188 138987 159970 159655 159225 158842 158476 158420 158312 158266 180562 160499 160479 160334 160246 160163 160125 160096 116846 116832 116794 116784 116779 116775 188006 184739 116952 116940 116938 116930 116923 116921 116882 116855


117008 117001 116989 116988 116986 116984 116959 116954 117091 117085 117061 117055 117046 117038 117020 117019 117170 117169 117158 117141 117134 117121 117119 117114 117259 117246 117244 117241 117229 117225 117203 117198 117310 117295 117280 117279 117278 117269 117264 117260 117366 117349 117340 117332 117322 117320 117317 117315 134217 134133 134127 118912 117390 117382 117380 117368 134450 134405 134389 134388 134380 134360 134285 134245 134629 134626 134599 134530 134481 134468 134462 134457 147872 137185 136779 134877 134743 134681 134674 134630 175040 150665 150604 149759 149269 148883 148547 148060 144221 144216 144067 143982 143928 143364 142446 175207 144501 144459 144401 144398 144379 144375 144284 144263 144636 144621 144616 144597 144570 144557 144545 144528 144756 144704 144702 144697 144686 144679 144675 144641 144889 144884 144851 144823 144822 144821 144813 144762 144955 144943 144941 144929 144915 144912 144899 144897 145131 145086 145080 145079 145042 145011 145008 144986 145817 145413 145356 145275 145237 145230 145192 145166 161846 161737 161726 161491 161422 161320 161042 145894 165098 164389 164075 163148 163086 162067 162043 161910 100692 100679 166529 166356 165876 165448 165300 165123 100787 100786 100757 100752 100743 100730 100728 100719 100928 100901 100890 100874 100866 100865 100811 100810 101063 101022 101021 101013 100994 100993 100984 100943 101134 101129 101122 101102 101101 101097 101094 101082 151853 151545 151335 132061 129507 121926 121492 101139 153748 153591 153589 153577 153392 153184 152699 152396 155717 155716 155156 154867 153908 153907 153901 153888 169611 169453 169383 169273 167305 167042 166594 155800

172238 170638 169961

פטנטים שפג תוקפםPATENTS EXPIRED

93122 93120 93119 93117 93109 93099 93090 93081 93208 93207 93199 93186 93165 93159 93152 93132 93294 93284 93282 93281 93280 93263 93236 93232 93371 93366 93357 93356 93342 93331 93318 93314 93454 93445 93444 93434 93432 93427 93397 93394 93513 93509 93490 93489 93485 93468 93465 93455 93606 93594 93587 93572 93556 93545 93537 93515

108914 107937 93660 93646 93607


פטנטים שלגביהם הוגשובקשות להארכת תקופת

ד סימן' ההגנה על פי פרק לחוק הפטנטים1'ב

Patents for whichapplications have been filedfor extension of the patentterm under chapter 4, partB1 of the patents Law

.No 152988:פטנט בסיסי' מס of basic patent:

:Proprietors:שם המבקש24/8/2010Date תארי� הגשת הבקשה of application

SMITHKLINE BEECHAM CORPORATION


NOTICEהודעה)4.(טז64לפי סעיף

-לחוק הפטנטיםNOTICE UNDER SECTION64P.(4) OF THE PATENTS LAW-

הארכת מועד להגשת בקשה למתן צו הארכה

Period for filing application forextension order has been extended

.No 193619:הפטנט' מס of Patent:














NOTICE הודעה, לחוק הפטנטים66לפי סעיף

1967-ז"תשכUnder section 66 of the PatentsLaw, 5727-1967

מודע בזאת כי ניתנה רשות'לבעלת בקשת הפטנט מס

131283 This is to notify that permissionhas been granted to the owner ofPatent Application No.

Acceptance 4/2008 דבר הקיבול פורסם ביומן published in journalלתקן את הפירוט של בקשת

הפטנט האמורהTo amend the specification of thesaid Patent Application.

כל אדם רשאי להתנגד למתן הרשות תוך שלושה חודשים

כפי, מתאריך יומן פטנטים זהלחוק ובתקנה67שנקבע בסעיף

-ח"התשכ, לתקנות הפטנטים 991968.

Any person may oppose suchgrant of permission within threemonths from the date of thisPatents Journal, as prescribed bysection 67 of the Law and byregulation 99 of the PatentRegulations, 5728-1968.








כל אדם רשאי להתנגד למתןהרשות תוך שלושה חודשים

כפי, מתאריך יומן פטנטים זהלחוק ובתקנה67שנקבע בסעיף










כל אדם רשאי להתנגד למתןהרשות תוך שלושה חודשים

כפי, מתאריך יומן פטנטים זהחוק ובתקנהל67שנקבע בסעיף




DESIGNSמדגמים

מדגמים שנרשמוDESIGNS REGISTERED

48327 24Class)03( סוג פרסום

14.09.2009 בע.בי.איי .A.Bמ"דנטל דיוייסס DENTAL DEVICES LTD.

Implant שתל

48809 ,48810 25Class)02( סוג פרסום

27.12.2009 ROY רועי יולוס JOULUS

Window אדנית box


08.03.2009 LABORATOIRES LA PRAIRIE SA

Container מארז


09.03.2009 UNILEVER PLC

Soap סבוןהממלכה(תאריך האמנה

)המאוחדת19.09.2008 Convention date (Great Britain)



10.03.2009 BEAUTE PRESTIGE INTERNATIONAL

Flask בקבוקוןConvention 12.09.2008)איחוד אירופי(תאריך האמנה date (OHIM)


15.03.2009 EQUMEN PTY LTD.

A גופיה singletConvention 15.09.2008)אוסטרליה(תאריך האמנה date (Australia)

47419 ,47420 2Class)02( סוג פרסום

15.03.2009 EQUMEN PTY LTD.

Shirt חולצהConvention 15.09.2008)אוסטרליה(תאריך האמנה date (Australia)


16.04.2009 SHUGONמ"שוגון תיקים ומוצרי עור בע BAGS &

LEATHERGOODS LTD.Backpack תיק גב


23.04.2009


DANIEL דניאל בקי BACHICahir כסא



03.05.2009 COLGATE-PALMOLIVE COMPANY

Container מיכלConvention 31.10.2008)ארצות הברית(תאריך האמנה date (U.S.A.)

47758 ,47785 2Class)02( סוג פרסום

31.05.2009 DIESEL S.P.A

Pants מכנסיים


23.06.2009 BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Pill מושיט גלולות dispenserConvention 23.12.2008)איחוד אירופי(תאריך האמנה date (OHIM)


08.07.2009 ORמ"בע.)מ.ג(אור מכניקה MECHANICS LTD.

-Break מתקן לפריצת דלת in door device


20.07.2009 GOLANמ"גולן מוצרי פלסטיק בע PLASTICS PRODUCTS

LTD.


Pipe אביזר לחיבור צנרת connector acessory



22.07.2009 BLISANIAמ"בע 1982ליסניהב 1982 LTD.

Shutter תומך הזזה לתריס moving support


30.07.2009 ELIYAHU אליהו אסרף ASARAF

A סככה shed


24.09.2009 SANO-BRUNO'Sמ"סנו מפעלי ברונוס בע ENTERPRISES

LTD.Bottle בקבוק


18.10.2009 IRIVER LIMITED

Network נגן מולטימידה multimedia playerשל(תאריך האמנה רפובליקה

)קוראה08.07.2009 Convention date (Republic of

Korea)


18.10.2009 IRIVER LIMITED


Network נגן מולטימדיה multimedia playerשל(תאריך האמנה רפובליקה

)קוראה08.07.2009 Convention date (Republic of

Korea)

Modular ארון חיבורים בהרכבים connection cabinet


48878 ,48879 ,48880 48881 ,48882

2Class)04( סוג פרסום18.01.2010

BANANAמ"בננה תעשיות נעליים בע SHOES INDUSTRY LTD.Shoe נעל


21.01.2010 THEBEN AG

Timer קוצב זמןConvention 23.09.2009)איחוד אירופי(תאריך האמנה date (OHIM)


01.02.2010 YARDEN ירדן קרקו KARAKO

Pendant תליון


25.02.2010 KARSHIמ"קארשי אינטרנשיונל בע INTERNATIONAL LTD.

Horn שופר

49156 ,49157 ,49158 49159 ,49160


AMY-ARTמ"עמי מוצרי נוי בע WORK LTD.Candlestick פמוט



21.03.2010 AMY-ARTמ"עמי מוצרי נוי בע WORK LTD.

Decorative חפץ קישוטי object


30.09.2009 SCALPAL LLC

Writing כלי כתיבה instrument

49398 ,49399 ,49400 49402 ,49404 ,49405


AMY-ARTמ"עמי מוצרי נוי בע WORK LTD.Hanukkia חנוכייה


28.03.2010 SHOKETמ"שוקת אלומיניום בע ALUMINIUM LTD.

Profile פרופיל

49227 ,49228 ,49229 49230 ,49231


KARSHIמ"קארשי אינטרנשיונל בע INTERNATIONAL LTD.


Candlestick פמוט


49336 ,49337 ,49338 49339 ,49342


H. STERN COMERCIO E INDUSTRIA S.A.Jewel תכשיט


מדגמים שחודשוDESIGNS RENEWED

34130 34129 34128 34119 34118 34106 34105 34104 41427 41426 41425 41424 41369 34589 34407 34131

41808 41729 41511 41429 41428


מדגמים שבוטלוDESIGNS VOID

25126 25081 25080 25079 25078 25071 25048 25047 33182 33171 33117 25169 25140 25130 25128 25127

33257 33233 33232 33231 33231 33184


מדגמים שהוזנחוWITHDRAWN DESIGNS

47435 47432 47411 47410 47370 47335 47334 47256 48890 48533 47474 47473 47465 47464 47463 47462 49364 49358 49341 49003 49002 48988 48987 48891

ר מאיר נועם"ד המדגמים, רשם הפטנטים וסימני מסחר

Dr. Meir NoamCommissioner of Patents,Designs and Trade Marks


DESIGNS מדגמים


מפתחות לבקשות שקובלוINDICES OF APPLICATIONS ACCEPTED

NAMEמפתח שמי INDEX

163541-אביב צידון176651-אבינעם נבלר197620-אהרון רביץ

-מ"אופטידטק טכנולוגיות זיהוי אופטי בע160318

171056-מ"אורטומדיטק בעבע. איי.סי. אי ,165958-מ"טלקום

171882בע. איי.סי.אי 161216-מ"טלקום

167063- אילן גולדמן173083-מ"אלדין מערכות מידע בע

167923-גדעון גראדר185331-גדעון פסחבע'גיוון אימג 176231-מ"ינג

176970-מ"דיפבריז בע

164857-המכון למחקר ביולוגי בישראל-מ"התעשיה האוירית לישראל בע

172904

-מ"בע) 1991(חברת תנה תעשיות181067

157926-מ"ידע חברה למחקר ופיתוח בע

176651-יחיאל זיו

179676-מ"מדינול בע165193-מ"מור יישום מחקרים בע

בע- מור 162750-מ"יישום מחקריםמכון רפפורט המכון למחקר במדעי

ע 170793-ש משפחת רפפורט"הרפואהפ בע.ס.מ.מפעלי 167566-מ"מיגון

150325-מ"סימה נאנוטק ישראל בע167923-מ"סלריס בע154234-מ"סרקונט בע

185331-צדוק פירסט

165193-מ"קיורטק בע162750-מ"בעקלינטיקה

171224-מ"קרוש טכנולוגיות בע

בערפאל מערכות לחימה מתק -מ"דמות168000

180493-מ"תרו תעשיה רוקחית בע

ABBOTT LABORATORIES -167434ACQUA MINERALE S. BENEDETTO-S.P.A. -184156ADENOSINE THERAPEUTICS, LLC -178365AHARON RAVITZ - 197620AIRSENSE ANALYTICS GMBH -170730AKZO NOBEL N.V. - 161248ALADDIN KNOWLEDGE SYSTEMS

LTD. - 173083ALCATEL - 171825ALCON, INC. - 183294ALEXANDRIA RESEARCHTECHNOLOGIES LLC -200686ALFA WASSERMANN S.P.A. -186655AMYLIN PHARMACEUTICALS, INC. -140223, 145830ANORMED CORPORATION -160115,


177511ANTIBALLISTIC SECURITY ANDPROTECTION INC. -172930APLIX CORPORATION -176144APPLIED RESEARCH SYSTEMS ARSHOLDING N.V. - 150837, 152567ARM LIMITED - 155058, 175588ASPEN GLOBAL INCORPORATION -172619ASSA ABLOY AB - 164087ASSA ABLOY INC. - 185115ASTRAZENECA AB -177505ASTRAZENECA UK LIMITED - 174536ATC TECHNOLOGIES, LLC -173311AVENTIS PHARMA S.A. -135751,174240AVINOAM NEVLER - 176651AVIV TZIDON - 163541AXALTO S.A. - 161807AZULINDUS Y MARTI, S.A - 181405

BALANCED BODY INC - 181620BALL PACKAGING EUROPE HOLDINGGMBH & CO. KG - 191223BASF AGRO B.V. ARNHEM (NL),WADENSWIL-BRANCH - 144306BASF AKTIENGESELLSCHAFT -163708BASF CORPORATION -154259BASF SE -176782, 176785, 185217BAXTER INTERNATIONAL INC. -177519BAYER AKTIENGESELLSCHAFT -147680BAYER ANIMAL HEALTH GMBH -172739BAYER CROPSCIENCE AG -165218BAYER S.A.S. -144306BAYER SCHERING PHARMA AG -172739BAYER SCHERING PHARMAAKTIENGESELLSCHAFT -191131BIO-CANCER TREATMENTINTERNATIONAL LIMITED - 165858BIOSENSE WEBSTER INC. -158545BIOVEX LIMITED - 152055BIOVITRUM AB - 158593BOARD OF TRUSTEES OF THE

UNIVERSITY OF ILLINOIS - 195723BODYMEDIA, INC. - 174267BOEHRINGER INGELHEIM PHARMAGMBH & CO. KG - 163736BRITISH AMERICAN TOBACCO(INVESTMENTS) LIMITED - 172820BURNS & MCDONNELLENGINEERING COMPANY, INC. -172122

CAPROTEC BIOANALYTICS GMBH -169437CELLARIS LTD. - 167923CHEMOCENTRYX, INC. -167714CHEMOCENTRYX, INC. -177104CHROMAGENICS B.V. -193373, 193374CHROMATIC MICRO OPTICS, INC. -166174CILAG GMBH INTERNATIONAL -189608CIMA NANOTECH ISRAEL LTD -150325CLEANETICA LTD. - 162750CODEXIS, INC -173191COLGATE-PALMOLIVE COMPANY -169182COMMONWEALTH SCIENTIFIC ANDINDUSTRIAL RESEARCHORGANISATION -145142COUNCIL OF SCIENTIFIC ANDINDUSTRIAL RESEARCH -176321CURETECH LTD. -165193CYTONOME, INC. -183714CYTONOME/ST, LLC -183714

DAIICHI SANKYO COMPANY LIMITED- 166696DAINIPPON SUMITOMO PHARMA CO.LTD. - 169451DATASCOPE INVESTMENT CORP. -187866DAVID R. FRERIKS -179776DEEPBREEZE LTD -176970DEUTSCHE POST AG -184264DONALDSON COMPANY, INC. -193192DOV PHARMACEUTICAL, INC. -156889


DSM IP ASSETS B.V. -167566, 168386DUKE UNIVERSITY - 159053DURST PHOTOTECHNIK DIGITALTECHNOLOGY GMBH -187622

E.I. DU PONT DE NEMOURS ANDCOMPANY - 194534ECI TELECOM LTD. -161216ECI TELECOM LTD. -165958, 171882ECZACIBASI YAPI GERECLERISANAYI VE TICARET A.S. - 177562,181947EISAI CO. LTD. -168784EISAI CO., LTD. -170175EISAI R&D MANAGEMENT CO., LTD. -168784, 170175ELECTRONIC NAVIGATIONRESEARCH INSTITUTE -170304ELEMENT SIX LIMITED - 162356EMERSON S. HAWLEY -163406EMISPHERE TECHNOLOGIES, INC. -166158, 180118ENCYSIVE PHARMACEUTICALS INC. -146312ENDOCARE, INC. -186304ENZO THERAPEUTICS, INC. -174594EURO-CELTIQUE S.A. -171563, 172730EVONIK DEGUSSA GMBH -186014EVONIK ROHM GMBH - 180943

F. HOFFMANN-LA ROCHE AG -166833, 173131FERRING BV -163710FIBERZONE NETWORKS LTD. -183269FIELDTURF (IP) INC. -192255FIELDTURF TARKETT INC. -192255FLAMEL TECHNOLOGIES -175543FMC CORPORATION -171291FMS ENTERPRISES MIGUN LTD. -167566FOURNIER LABORATORIES IRELANDLIMITED - 170519FOX CHASE CANCER CENTER -131229FRANCOIS BRAUN -185919FRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V. -179320

GENE STREAM PTY LTD. -157756GENENCOR INTERNATIONAL, INC. -163139GENENTECH, INC. -155482, 193149,200056GENERAL ELECTRIC COMPANY -178737GENISPHERE INC. -187866GENISPHERE, LLC -187866GIDEON GRADER -167923GIDON PESACH -185331GIVAUDAN SA - 183550GIVEN IMAGING LTD. - 176231GLAXO GROUP LIMITED - 156640,166424, 172619GUIDED THERAPY SYSTEMS, L.L.C -181892

HAMAMATSU PHOTONICS K.K. -177074HARRIS CORPORATION -135874,135875, 176394, 181441, 181442,185255HEINEKEN SUPPLY CHAIN B.V. -184472HISPANO-SUIZA -178751HK PHARMACEUTICALS, INC. -169437HONEYWELL INTERNATIONAL INC. -161731, 185700HUBERT KOSTER -169437HUNTAIR, INC. - 170635

IBM CORPORATION -174501, 174503,177796, 179597ID BIOMEDICAL CORPORATION OFQUEBEC -150602IGO, INC. -173218ILAN GOLDMAN - 167063IMMUNEX CORPORATION -140938IMMUNOMEDICS, INC. - 166632INDENA S.P.A. -180643INSTITUT GUSTAVE ROUSSY -182761INSTITUT NATIONAL DE LA SANTEET DE LA RECHERCHE MEDICALE(I.N.S.E.R.M.) -182761INTELLIJECT,INC. -183247


INTERACTIVE IDEAS LLC - 198164INTERCELL USA,INC. -189750INTERDIGITAL TECHNOLOGYCORPORATION -164656, 175939,202789INTERNATIONAL BUSINESSMACHINES CORPORATION -194381ISRAEL AEROSPACE INDUSTRIESLTD. - 172904ISRAEL INSTITUTE FOR BIOLOGICALRESEARCH -164857

JAPAN TOBACCO INC. -142691JOHN K. CHAPIN -163406, 178530JOHN N. RASSIAS -174034JOHN STEPHENSON -172749JON P. GENNA -198164

KAKUICHI SHIOMI - 170304KENJI YOSHIDA - 176463KEVIN R. ORTON -142581KOMET GROUP HOLDING GMBH -167175KROOSH TECHNOLOGIES LTD -171224

LARRY E. ROHER -198164L'ASSISTANCE PUBLIQUE-HOPITAUXDE PARIS -182761LDR MEDICAL - 176696LEK PHARMACEUTICALS D.D. -162448LEO PHARMA A/S -155483LES LABORATOIRES SERVIER -186062LIFESCAN, INC. -164860LIGAND PHARMACEUTICALSINCORPORATED -182763LINDA HERMER-VAZQUEZ - 178530LOS ANGELES BIOMEDICALRESEARCH INSTITUTE AT HARBORUCLA MEDICAL CENTER - 179008LOS ANGELES BIOMEDICALRESEARCH INSTITUTE AT HARBORUCLA MEDICAL CENTER - 179008LTS LOHMANN THERAPIE-SYSTEMEAG - 168483

MAGMA DESIGN AUTOMATION, INC.- 194381MANNKIND CORPORATION -133912MARINE POLYMER TECHNOLOGIES,INC. - 157327MATTEO BONAN - 170338MEDICAL INSTILL TECHNOLOGIES,INC. - 197624MEDINOL LTD. - 179676MEDION DIAGNOSTICS AG -172997MEDION DIAGNOSTICS GMBH -172997MERCK SERONO S.A. -150837, 152567MESSIER-BUGATTI -178770MICROSOFT CORPORATION -172571,177919, 193803MOR RESEARCH APPLICATIONS, LTD.- 165193MOR-RESEARCH APPLICATIONS LTD.- 162750MOSAID TECHNOLOGIESINCORPORATED -154234MOTOROLA, INC. -169106MOTOROLA, INC. -169234MOTOROLA, INC. -177820

N.V. ORGANON -161248NANOBEAM LIMITED - 179664NDS LIMITED - 155260NET - EXPRESS -123129NETWORK APPLIANCE, INC. -175445NETWORK APPLIANCE, INC. -175829NEXMED HOLDINGS, INC. -170963NICOX S.A. -171417NOKIA CORPORATION -183748NORTHROP GRUMMANCORPORATION -170574NOVAGALI PHARMA SA - 182897NOVARTIS AG - 150484, 161257,171053NOVARTIS AG - 166158NOVARTIS VACCINES ANDDIAGNOSTICS, INC. -164324NOVA-TECH ENGINEERING, INC. -175108NTT DOCOMO, INC. -176144


NYCOMED GMBH - 186196

OLE-BENDT RASMUSSEN -182623ONCOLYTICS BIOTECH INC. -153846OPTIDTECH OPTICALIDENTIFICATION TECHNOLOGIESLTD. - 160318OREXIGEN THERAPEUTICS, INC. -171519ORTHO-MCNEIL PHARMACEUTICAL,INC. - 153710ORTHOMEDITEC LTD. -171056

PAIEON INC. -174514PATHOGENES, INC -165106PAUL DONALD LE GROS -178983PHARMACIA CORPORATION -166599PHARMASSET, INC. -172259PHILADELPHIA COLLEGE OFOSTEOPATHIC MEDICINE -184625PHILIP MORRIS PRODUCTS S.A. -169963POLICHEM S.A. -172180PROSIDION LIMITED -169954PROTEOLOGICS INC. -161764PROVINCIA AUTONOMA DI TRENTO -173951

QUALCOMM FLARIONTECHNOLOGIES, INC. -173659, 174939QUALCOMM INCORPORATED -161719, 166580, 170226, 171868, 173979,174937QUALCOMM INCORPORATED -170335, 173659, 174939QUINN INDUSTRIES, LLC -183722

RAFAEL ADVANCED DEFENSESYSTEMS LTD. -168000RAIL. ONE GMBH - 177333RAPPAPORT FAMILY INSTITUTE FORRESEARCH IN THE MEDICALSCIENCES -170793RAVEN BIOTECHNOLOGIES -165128RAYMOND HERMER-VAZQUEZ -178530RAYTHEON COMPANY -162514

RAYTHEON COMPANY -177676,182133RAYTHEON COMPANY -180556REGENERON PHARMACEUTICALS,INC. - 168050ROBERT L. MULLER JR. -172574ROBIN WHALLEY - 178983ROTINOR GMBH -184546

SAES GETTERS S.P.A. -177748SAFEVIEW, INC. -183436SAGEM DEFENSE SECURITE -175060SAINT-GOBAIN CRISTALERIA, S.A. -164945SALVATORE ROMANO -170338SANJIV K. TALWAR - 163406SANOFI-AVENTIS -179829SANOFI-AVENTIS DEUTSCHLANDGMBH - 155657SANOFI-AVENTIS DEUTSCHLANDGMBH - 160605, 169900, 175237SANOFI-AVENTIS DEUTSCHLANDGMBH - 173145SCHERING CORPORATION -164584SCHERING-PLOUGH LTD. -165106SERCONET LTD. -154234SHAOHUA XU - 163406SHOWA DENKO K.K. -166443SICPA HOLDING S.A. -174687SILVERBROOK RESEARCH PTY. LTD.- 162280SILVERBROOK RESEARCH PTY. LTD.- 155493SMORGON STEEL LITESTEELPRODUCT PTY LTD. -179964SNECMA -174528SP BERNER PLASTIC GROUP, S.L. -184136STICHTING VOOR DE TECHNISCHEWETENSCHAPPEN -176435SUMITOMO CHEMICAL COMPANY,LIMITED - 189180SUMITOMO CHEMICAL COMPANY,LIMITED. - 175800SUMITOMO ELECTRIC HARDMETALCORP. -178268SUMITOMO ELECTRIC INDUSTRIES,


LTD. - 178268SUSUMU KOBAYASHI - 170304SYNGENTA LIMITED - 168487SYNGENTA PARTICIPATIONS AG -169092SYNOPSYS, INC. -194381

TANA INDUSTRIES (1991) LTD. -181067TARO PHARMACEUTICALINDUSTRIES LTD. -180493TEXAS BIOTECHNOLOGYCORPORATION -146312THALES - 172624THE BOARD OF TRUSTEES OF THELELAND STANFORD JUNIORUNIVERSITY - 176393THE CUPRON CORPORATION -167564THE DIRECTV GROUP, INC. -166883THE REGENTS OF THE UNIVERSITYOF CALIFORNIA - 179008THE RESEARCH FOUNDATION OFTHE STATE UNIVERSITY OF NEWYORK - 163406THINKSHARP, INC. -164210TIBOR VIRAG - 177690TIBOTEC PHARMACEUTICALS LTD. -163959TIMOTHY L. HANSON - 178530TOYAMA CHEMICAL CO., LTD. -171388TRUSTEES OF TUFTS COLLEGE -148482

UNILEVER PLC -180385UNIVERSAL SAFETY RESPONSE, INC.- 178391UNIVERSITA' DEGLI STUDI DIFIRENZE -159479UNIVERSITE DE BERNE -176435UNIVERSITE DE VERSAILLES-STQUENTIN EN YVELINES - 182761UNIVERSITE PARIS SUD -182761UNIVERSITY OF SOUTHERNCALIFORNIA - 149144, 151527UPONOR INNOVATION AB -188604

VANTIA LIMITED - 163710VICENTE-FRANCISO SANSANOMARTI - 181405

WYETH LLC - 173258

XU XIAOHUA - 180505

YEDA RESEARCH ANDDEVELOPMENT CO., LTD. -157926YEHIEL ZIV - 176651

ZADOK FUERST -185331ZOLTAN HORVATH - 177690

SUBJECTמפתח ענייני MATTER INDEX

A01K - 165128, 175108A01N - 154259, 163708, 184625,

194534A23G -180385A24D - 169963, 172820A47K - 181947A47L - 184136

A61B - 158545, 163406, 164210,164860, 171056, 174267,176393, 176970, 178983,181892, 186304

A61F -176651, 176696, 183294,200686

A61K - 131229, 140223, 142691,


145830, 150484, 150602,150837, 152055, 152567,153846, 157327, 160605,163736, 164324, 165106,166424, 167564, 168386,168483, 170519, 170963,171291, 171519, 171563,172180, 172619, 172730,172739, 173131, 173145,174536, 174594, 175543,177104, 177511, 179008,180943, 182897, 186655,191131, 195723, 200056

A61L - 161731A61M - 162750, 177519, 183247,

186196, 189608, 189750A61M - 179676A61N - 142581A62B - 179776A63B - 181620

B01D -193192B01F -179829B03B -183714B07B -171224B21B -179964B23B -167175, 178268B29C -164945, 182623, 188604B41F -191223B41J -187622B60N -185331B63C -184546B64C -174528, 185700B64D -163541B64F -172122B65B -197624B65D -172749B65D -184156, 184472B65H -180505B67D -181067

C04B -167923C06B -168000C07C -144306, 148482, 155657,

156640, 163959, 166158,166443, 166599, 175237,175800, 176321, 180118,

183550, 185217, 189180C07D -146312, 153710, 158593,

160115, 161257, 164584,164857, 165218, 166696,166833, 167434, 167714,168487, 168784, 169451,169900, 169954, 170175,171053, 171388, 171417,174240, 178365, 180493,180643, 182763, 186062

C07D -155483, 156889C07F -177505C07H -169092, 172259C07J -161248C07K -133912, 135751, 140938,

149144, 157926, 159479,162448, 163710, 165193,165858, 166632, 168050,173258, 193149

C08F -167566C08K -147680C08L -176782, 176785C09D -174687C09K -176435C11D -169182C12N -145142, 151527, 155482,

161764, 173191, 182761,193373, 193374

C12P -187866C12Q -157756C12Q -159053C22C -150325C30B -162356

D04H -178770

E01B -177333E01C -192255E01F -173951, 178391E03D -177562E04F -181405E04G -197620E05B -167063, 185115, 185255

F02C -178751F04D -170635F04F -185919


F16H -183722F16M -182133F41C -174034F41H -172574, 172930F42B -175060

G01C -170574G01N -163139, 169437, 170730,

170793, 172997, 177748,179320

G01S -183436G02B -166174, 183269, 183748G05B -164087G06F -123129, 155058, 170304,

170338, 172571, 174937,175445, 175588, 175829,194381

G06F -173083G06K -160318, 162514, 174514,

176463G06N -178530G06Q -155260G07F -172624, 179597G08B -184264G09G -177919

H01J -179664H01L - 161807, 174503, 178737H01S -180556H02M - 173218H03M - 155493, 177676H04B -135875, 164656, 165958,

170335, 171868, 173311,174939

H04B -166580, 166883H04L - 135874, 169234, 170226,

171825, 171882, 173979,176231, 176394, 177796,181441, 181442, 193803,198164

H04L - 161719H04M - 154234, 174501, 176144H04N -162280, 172904, 177074,

177690, 202789H04Q -161216, 177820H04W -169106, 173659, 175939


קודים למדינת המופיעים ביומןCOUNTRY CODES APPEARING IN THIS JOURNAL

Code Country or Organization Code Country or OrganizationAR Argentina MX MexicoAT Austria MY MalaysiaAU Australia NL The NetherlandsBA Herzegovina NO NorwayBE Belgium NZ New ZealandBR Brazil PL PolandCA Canada PT PortugalCH Switzerland RU Russian FederationCN China SE SwedenCU Cuba SG SingaporeCZ Czech Republic SI SloveniaDE Germany SK SlovakiaDK Denmark TH ThailandEC Ecuador TR TurkeyEP European Patent Office TW TaiwanES Spain UA UkraineFI Finland US United States of AmericaFR France UY UruguayGB United Kingdom UZ UzbekistanGE Georgia WO World Intellectual PropertyGR Greece Organization (W.I.P.O.)GT Guatemala ZA South AfricaHR CroatiaHU HungaryIE IrelandIL IsraelIN IndiaIT ItalyJP JapanKR Republic of KoreaLK Sri LankaLU LuxembourgLV Latvia


ע � ירושלי�, משרד המשפטי�,י רשות הפטנטי�"נער

EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM

Documents

ISRAEL STATE RECORDS - Nevo.co.il · israel aerospace industries ltd. 22/10/2009 201681 b64d ( 010.012 ) uav system and method " ˘ ˘ " ˘ ˘ israel aerospace industries ltd. 15/11/2009